0001213900-13-002263.txt : 20130508 0001213900-13-002263.hdr.sgml : 20130508 20130508081713 ACCESSION NUMBER: 0001213900-13-002263 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 10 CONFORMED PERIOD OF REPORT: 20130331 FILED AS OF DATE: 20130508 DATE AS OF CHANGE: 20130508 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Neonode, Inc CENTRAL INDEX KEY: 0000087050 STANDARD INDUSTRIAL CLASSIFICATION: ELECTRONIC COMPONENTS, NEC [3679] IRS NUMBER: 941517641 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-35526 FILM NUMBER: 13822361 BUSINESS ADDRESS: STREET 1: 2350 MISSION COLLEGE BLVD STREET 2: SUITE 190 CITY: SANTA CLARA STATE: CA ZIP: 95054 BUSINESS PHONE: 408 496-6722 MAIL ADDRESS: STREET 1: 2350 MISSION COLLEGE BLVD STREET 2: SUITE 190 CITY: SANTA CLARA STATE: CA ZIP: 95054 FORMER COMPANY: FORMER CONFORMED NAME: SBE INC DATE OF NAME CHANGE: 19920703 10-Q 1 f10q0313_neonode.htm QUARTERLY REPORT f10q0313_neonode.htm


UNITED STATES SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

FORM 10-Q

(Mark one)

x Quarterly report pursuant to section 13 or 15(d) of the Securities Exchange Act of 1934

For the quarterly period ended March 31, 2013
 
o Transition report pursuant to section 13 or 15(d) of the Securities and Exchange Act of 1934

For the transition period from _______ to ________

Commission file number 1-35526
 
 
NEONODE INC.
 
 
(Exact name of registrant as specified in its charter)
 
 
Delaware   94-1517641
(State or other jurisdiction of  
 incorporation or organization)
 
(I.R.S. Employer
Identification No.)
 
 
2350 Mission College Blvd, Suite 190, Santa Clara, CA 95054 USA
 
 
(Address of principal executive offices and zip code)
 
 
 
(408) 496-6722
 
 
(Registrant's telephone number, including area code)
 
 
Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
Yes  x No ¨

        Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).
Yes x No o

Indicate by check mark whether the registrant is an large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company. See the definitions of  “large accelerated filer”, “non-accelerated filer” and “smaller reporting company”  in Rule 12b-2 of the Exchange Act.
 
Large accelerated filer o Accelerated filer   x
       
Non-accelerated filer o Smaller reporting company o
       
(do not check if a smaller reporting company)
   
 
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act.  Yes ¨ No x

The number of shares of the registrant’s common stock outstanding as of May 3, 2013, was 34,080,153.
 
 
 

 

NEONODE INC.
 
INDEX TO MARCH 31, 2013 FORM 10-Q
 
PART I Financial Information  
       
 
Item 1
Financial Statements
 
       
   
Condensed Consolidated Balance Sheets as of
 
   
March 31, 2013 (Unaudited) and December 31, 2012 (Audited)
3
       
   
Unaudited Condensed Consolidated Statements of Operations
 
   
for the three months ended March 31, 2013 and 2012
4
       
   
Unaudited Condensed Consolidated Statements of Comprehensive Loss for the
   
three months ended March 31, 2013 and 2012
5
       
   
Unaudited Condensed Consolidated Statements of Cash Flows for the
 
   
three months ended March 31, 2013 and 2012
6
       
   
Notes to Unaudited Condensed Consolidated Financial Statements
7
       
 
Item 2
Management's Discussion and Analysis of Financial
 
   
Condition and Results of Operations
19
       
 
Item 3
Quantitative and Qualitative Disclosures about Market Risk
23
       
 
Item 4
Controls and Procedures
23
       
PART II
Other Information
 
       
 
Item 1
Legal Proceedings
23
       
 
Item 1A
Risk Factors
23
       
 
Item 6
Exhibits
24
       
 
SIGNATURES
25
       
 
EXHIBITS
 

 
 

 

PART I. Financial Information
 
Item 1.    Financial Statements

NEONODE INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
(In thousands, except share and per share amounts)
 
   
March
31, 2013
   
December
31, 2012
 
ASSETS
 
(Unaudited)
   
(Audited)
 
Current assets:
           
Cash
  $ 7,582     $ 9,097  
Accounts receivable
    812       2,123  
Prepaid expenses and other current assets
   
731
      550  
Total current assets
   
9,125
      11,770  
                 
Deposit
    68       68  
Property and equipment, net
    328       330  
Total assets
  $ 9,521     $ 12,168  
                 
LIABILITIES AND STOCKHOLDERS' EQUITY
               
Current liabilities:
               
Accounts payable
  $ 321     $ 539  
Accrued expenses
    984       804  
Deferred revenue
    2,920       2,725  
                 
Total current liabilities
    4,225       4,068  
                 
Total liabilities
    4,225       4,068  
                 
Commitments and contingencies (Note 6)
               
                 
Stockholders' equity:
               
Series A Preferred stock, 444,541 shares authorized with par value $0.001 per share;
0 and 83 issued and outstanding at March 31, 2013 and
December 31, 2012, respectively. (In the event of dissolution,
each share of Series A Preferred stock has a liquidation preference equal to
par value of $0.001 over the shares of common stock)
    --       --  
Series B Preferred stock, 54,425 shares authorized with par
value $0.001 per share; 83 and 95 shares issued and outstanding
at March 31, 2013 and December 31, 2012, respectively. (In the event of
dissolution, each share of Series B Preferred stock has a liquidation
preference equal to par value of $0.001 over the shares of common stock)
    --       --  
Common stock, 70,000,000 shares authorized with par value $0.001per share;
33,875,625 and 33,331,182 shares issued and outstanding at
March 31, 2013 and December 31, 2012, respectively
    34       33  
Additional paid-in capital
    147,429       146,677  
Accumulated other comprehensive income
    18       5  
Accumulated deficit
    (142,185 )     (138,615 )
Total stockholders' equity
    5,296       8,100  
Total liabilities and stockholders' equity
  $ 9,521     $ 12,168  
 
See accompanying notes to condensed consolidated financial statements.
 
 
3

 
 
NEONODE INC.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(In thousands, except per share amounts)
(Unaudited)
 
   
Three months ended
March 31,
 
   
2013
   
2012
 
                 
Net revenues
  $ 548     $ 1,164  
Cost of revenues
    16       249  
Gross margin
    532       915  
                 
Operating expenses:
               
Product research and development
    1,634       687  
Sales and marketing
    805       799  
General and administrative
    1,652       995  
                 
Total operating expenses
    4,091       2,481  
                 
Loss before provision for income taxes
    (3,559 )     (1,566 )
                 
Provision for income taxes
    11       22  
                 
Net loss
  $ (3,570 )   $ (1,588 )
                 
Loss per common share:
               
Basic and diluted loss per share
  $ (0.11 )   $ (0.05 )
                 
Basic and diluted – weighted average
number of common shares outstanding
    33,511       32,809  

See accompanying notes to condensed consolidated financial statements.
 
 
4

 

NEONODE INC.
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS
(In thousands, except per share amounts)
(Unaudited)
 
 
  
Three Months  Ended March 31,
 
 
  
2013
   
2012
 
Net loss  
  
$
(3,570
 
$
(1,588
)  
Other comprehensive gain (loss):
  
             
Foreign currency translation adjustments
  
 
13
  
   
44
  
Total comprehensive loss
  
$
(3,557
)  
 
$
(1,544
)  
 
See accompanying notes to condensed consolidated financial statements.
 
 
5

 
 
NEONODE INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(In thousands)
 (Unaudited)
 
   
Three months ended March 31,
 
   
2013
   
2012
 
Cash flows from operating activities:
             
Net loss
  $ (3,570 )   $ (1,588 )
Adjustments to reconcile net loss to net cash (used in) provided by operating activities:
               
Stock-based compensation expense
    586       34  
Depreciation and amortization
    32       18  
Changes in operating assets and liabilities:
               
Accounts receivable
    1,316       2,273  
Prepaid expenses and other current assets
    (186 )     (26 )
Accounts payable and accrued expenses
    (36 )     (199 )
Deferred revenue
    195       11  
Net cash (used in) provided by operating activities
    (1,663 )     523  
                 
Cash flows from investing activities:
               
Purchase of property and equipment
    (28 )     (201 )
Net cash used in investing activities
    (28 )     (201 )
                 
Cash flows from financing activities:
               
Proceeds from stock option exercises
    167       --  
Net cash provided by financing activities
    167       --  
                 
Effect of exchange rate changes on cash
    9       45  
                 
Net decrease (increase) in cash
    (1,515 )     367  
                 
Cash at beginning of period
    9,097       12,940  
Cash at end of period
  $ 7,582     $ 13,307  
                 
Supplemental disclosure of cash flow information:
               
Income taxes paid
  $ 11     $ 22  
 
See accompanying notes to condensed consolidated financial statements.

 
6

 
 
NEONODE INC.
Notes to the Condensed Consolidated Financial Statements
(Unaudited)

1.   Interim Period Reporting
 
The accompanying unaudited interim condensed consolidated financial statements, include all adjustments, consisting of normal recurring adjustments that are, in the opinion of management, necessary for a fair presentation of the financial position and results of operations and cash flows for the interim periods presented. The results of operations for the three months ended March 31, 2013 are not necessarily indicative of expected results for the full 2013 fiscal year.
 
The accompanying condensed consolidated financial statements as of March 31, 2013 and for the three months ended March 31, 2013 and 2012 have been prepared by us, pursuant to the rules and regulations of the Securities and Exchange Commission (SEC). Certain information and footnote disclosures normally contained in financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted.  These condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto contained in our Annual Report on Form 10-K for the fiscal year ended December 31, 2012.

Operations

Neonode Inc. (“we”, “us”, “our”, the “Company”), develops and licenses MultiSensing™ touch user interfaces and optical multi-touch solutions. The cornerstone of our interface solutions is zForce®, our patented touch technology. Neonode licenses its MultiSensing touch technology to Original Equipment Manufacturers (“OEMs”) and Original Design Manufacturers (“ODMs”) who embed Neonode technology into devices that they produce and sell.
 
2.   Summary of Significant Accounting Policies

Principles of Consolidation

The condensed consolidated balance sheet at December 31, 2012 and the condensed consolidated statements of operations, other comprehensive loss, and cash flows for the three months ended March 31, 2012 includes our accounts and the accounts of our wholly owned Swedish subsidiary Neonode Technologies AB (“NTAB”).  All significant intercompany accounts and transactions have been eliminated.

The condensed consolidated balance sheet at March 31, 2013 and the condensed consolidated statements of operations, other comprehensive loss, and cash flows for the three months ended March 31, 2013  include our accounts and the accounts of our wholly owned subsidiaries, NTAB, Neonode Americas Inc. (“NAI”), Neonode Japan Inc. (“NJKK”), NEON Technologies Inc. (“NTI”) and Neonode UI AB (“NUIAB”).  All significant intercompany accounts and transactions have been eliminated.
 
Neonode management has made several strategic decisions to establish their presence in international markets that provide access to tier one customers and demonstrate Neonode’s long term commitment to these markets. NJKK was created in January 2013 to reach out to customers with global reach in electronics, automotive and home appliance markets.  NUIAB was created to address particular opportunities that exist in this significant user interface arena as some aspects of our technology lends itself to ease of interacting with electronic devices. NTI and NAI were established to create a more focused organization with specific marketing, research and development goals. Furthermore, by creating separate entities, their performances can be directed and observed more clearly.
 
Estimates

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires making estimates and assumptions that affect, at the date of the financial statements, the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities and the reported amounts of revenue and expenses. Actual results could differ from these estimates. Significant estimates include, but are not limited to, collectibility of accounts receivable, recoverability of long-lived assets, the valuation allowance related to our deferred tax assets and the fair value of options and warrants issued for stock-based compensation.
 
Concentration of Cash Balance Risks

Cash balances are maintained at various banks in the U.S., Japan and Sweden. At times, deposits held with financial institutions in the United States of America may exceed the amount of insurance provided by the Federal Deposit Insurance Corporation (“FDIC”), which provides basic deposit coverage with limits up to $250,000 per owner. The Swedish government provides insurance coverage up to 100,000 euro per customer and covers deposits in all types of accounts. As of March 31, 2013, the Company has approximately $7.2 million in excess of insurance limits.
 
7

 
 
Accounts Receivable and Allowance for Doubtful Accounts  
 
Our accounts receivable are stated at net realizable value. Our policy is to maintain allowances for estimated losses resulting from the inability of our customers to make required payments. Credit limits are established through a process of reviewing the financial history and stability of each customer. Where appropriate, we obtain credit rating reports and financial statements of the customer when determining or modifying its credit limits. We regularly evaluate the collectibility of our trade receivable balances based on a combination of factors. When a customer’s account balance becomes past due, we initiate dialogue with the customer to determine the cause. If it is determined that the customer will be unable to meet its financial obligation, such as in the case of a bankruptcy filing, deterioration in the customer’s operating results or financial position or other material events impacting its business, we record a specific allowance to reduce the related receivable to the amount we expect to recover. Should all efforts fail to recover the related receivable, we will write-off the account. We also record an allowance based on certain other factors including the length of time the receivables are past due and historical collection experience with customers.  We determined that an allowance for doubtful accounts was not necessary at March 31, 2013 and December 31, 2012.

Property and Equipment

Property and equipment are stated at cost, net of accumulated depreciation and amortization. Depreciation and amortization are computed using the straight-line method based upon estimated useful lives of the assets as follows:

 
Estimated useful lives
Computer equipment
3 years
Furniture and fixtures
5 years

Equipment purchased under capital leases is amortized on a straight-line basis over the estimated useful life of the asset or the term of the lease, whichever is shorter.
 
Upon retirement or sale of property and equipment, cost and accumulated depreciation and amortization are removed from the accounts and any gains or losses are reflected in the consolidated statement of operations. Maintenance and repairs are charged to expense as incurred.
 
Long-lived Assets

We assess any impairment by estimating the future cash flow from the associated asset in accordance with relevant accounting guidance. If the estimated undiscounted future cash flow related to these assets decreases or the useful life is shorter than originally estimated, we may incur charges for impairment of these assets.  At March 31, 2013, we believe there is no impairment of our long-lived assets.

Foreign Currency Translation and Transaction Gains and Losses

The functional currency of our foreign subsidiaries is the applicable local currency, the Swedish Krona and Japanese Yen. The translation from Swedish Krona and Japanese Yen to U.S. Dollars is performed for balance sheet accounts using current exchange rates in effect at the balance sheet date and for income statement accounts using a weighted-average exchange rate during the period. Foreign currency translation gains were $13,000 and $44,000 during the three months ended March 31, 2013 and 2012, respectively. Gains or losses resulting from translation are included as a separate component of accumulated other comprehensive loss. Gains or losses resulting from foreign currency transactions are included in general and administrative expense in the accompanying condensed consolidated statements of operations and were $37,000 and $62,000 during the three months ended March 31, 2013 and 2012, respectively.
 
 
8

 
 
Concentration of Credit and Business Risks
 
Our accounts receivable as of March 31, 2013 was due from twelve customers, five of which accounted for 72% of our accounts receivable as of March 31, 2013. Our net revenues for the three months ended March 31, 2013 was earned from nine customers. Our customers are located in the U.S., Europe and Asia. Customers which accounted for 10% or more of our net revenues during the three months ended March 31, 2013 are as follows:

        
Kobo - 44%
●        
Sony Corporation -20%
●        
Netronix – 21%
●        
Barnes & Noble – 10%

Our accounts receivable as of December 31, 2012 was due from fifteen customers, none of which accounted for more than10% of our accounts receivable as of December 31, 2012. Our net revenues for the three months ended March 31, 2012 was earned from ten customers. Our customers are located in the U.S., Europe and Asia. Customers which accounted for 10% or more of our net revenues during the three months ended March 31, 2012 are as follows:

●        
Amazon - 55%
●        
Sony Corporation -16%
 
Revenue Recognition

Licensing Revenues:

We derive revenue from the licensing of internally developed intellectual property (“IP”). We enter into IP licensing agreements that generally provide licensees the right to incorporate our IP components in their products with terms and conditions that vary by licensee. The IP licensing agreements generally include a nonexclusive license for the underlying IP. Fees under these agreements may include license fees relating to our IP and royalties payable following the distribution by our licensees of products incorporating the licensed technology. The license for our IP has standalone value and can be used by the licensee without maintenance and support. Neonode meets all the accounting requirements for revenue recognition as per unit royalty products are distributed or licensed by the Company’s customers.  For technology license arrangements that do not require significant modification or customization of the underlying technology, we recognize technology license revenue when: (1) we enter into a legally binding arrangement with a customer for the license of technology; (2) the customer distributes or licenses the products; (3) the customer payment is deemed fixed or determinable and free of contingencies or significant uncertainties; and (4) collection is reasonably assured. Our customers report to us the quantities of products distributed or licensed by them after the end of the reporting period stipulated in the contract, generally 30 to 45 days after the end of the month or quarter.

Explicit return rights are not offered to customers. There have been no returns through March 31, 2013.

Engineering Services:
 
We may sell engineering consulting services to our customers on a flat rate or hourly rate basis. We recognize revenue from these services when all of the following conditions are met: (1) evidence existed of an arrangement with the customer, typically consisting of a purchase order or contract; (2) our services were performed and risk of loss passed to the customer; (3) we completed all of the necessary terms of the contract; (4) the amount of revenue to which we were entitled was fixed or determinable; and (5) we believed it was probable that we would be able to collect the amount due from the customer. To the extent that one or more of these conditions has not been satisfied, we defer recognition of revenue.  Generally, we recognize revenue as the engineering services stipulated under the contract are completed and accepted by our customers.  

 
9

 
 
Deferred Revenue

From time-to-time the Company receives pre-payments from its customers related to future services or future license fee revenues. We defer the license fees until we have met all accounting requirements for revenue recognition as per unit royalty products are distributed or licensed by the Company’s customers and the engineering development fee revenue until such time as the engineering work has been completed and accepted by our customers.

Advertising

Advertising costs are expensed as incurred. Advertising costs for the quarters ended March 31, 2013 and 2012 amounted to approximately $124,000 and $197,000, respectively.

Product Research and Development

Research and development (“R&D”) costs are expensed as incurred. R&D costs consist mainly of personnel related costs in addition to some external consultancy costs such as testing, certifying and measurements.

Stock-Based Compensation Expense

We measure the cost of employee services received in exchange for an award of equity instruments, including stock options, based on the fair value of the award on the grant date, and recognize the value as compensation expense over the period the employee is required to provide services in exchange for the award, usually the vesting period, net of estimated forfeitures.
 
 We account for equity instruments issued to non-employees at their fair value. The measurement date for the fair value for the equity instruments issued is determined at the earlier of (i) the date at which a commitment for performance by the consultant or vendor is reached, or (ii) the date at which the consultant or vendor’s performance is complete. In the case of equity instruments issued to consultants, the fair value of the equity instruments is primarily recognized over the term of the consulting agreement. The fair value of the stock-based compensation is periodically re-measured and expense is recognized during the vesting term.

When determining stock-based compensation expense involving options and warrants, we determine the estimated fair value of options and warrants using the Black-Scholes option pricing model.

Income Taxes

We recognize deferred tax liabilities and assets for the expected future tax consequences of items that have been included in the consolidated financial statements or tax returns. We estimate income taxes based on rates in effect in each of the jurisdictions in which we operate. Deferred income tax assets and liabilities are determined based upon differences between the financial statement and income tax bases of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse. The realization of deferred tax assets is based on historical tax positions and expectations about future taxable income. Valuation allowances are recorded against net deferred tax assets when, in our opinion, realization is uncertain based on the “more likely than not” criteria of the accounting guidance.

Based on the uncertainty of future pre-tax income, we fully reserved our net deferred tax assets as of March 31, 2013 and December 31, 2012. In the event we were to determine that we would be able to realize our deferred tax assets in the future, an adjustment to the deferred tax asset would increase income in the period such determination was made. The provision for income taxes represents the net change in deferred tax amounts, plus income taxes paid or payable for the current period.

We follow the relevant accounting guidance related to uncertain tax positions, which provisions include a two-step approach to recognizing, de-recognizing and measuring uncertain tax positions.  As a result, we did not recognize a liability for unrecognized tax benefits.  As of March 31, 2013 and December 31, 2012, we had no unrecognized tax benefits.
 
 
10

 
 
Net Loss Per Share

Net loss per share amounts have been computed based on the weighted-average number of shares of common stock outstanding during the period. Net loss per share, assuming dilution amounts from common stock equivalents, is computed based on the weighted-average number of shares of common stock and potential common stock equivalents outstanding during the period. The weighted-average number of shares of common stock and potential common stock equivalents used in computing the net loss per share for periods ended March 31, 2013 and 2012 exclude the potential common stock equivalents, as the effect would be anti-dilutive (See Note 8).

Comprehensive Income (Loss)

Our comprehensive loss includes foreign currency translation gains and losses.  The cumulative amount of translation gains and losses are reflected as a separate component of stockholder’ equity in the condensed consolidated balance sheets as accumulated other comprehensive income.

Cash Flow Information

Cash flows in foreign currencies have been converted to U.S. dollars at an approximate weighted-average exchange rate for the respective reporting periods. The weighted-average exchange rate for the consolidated statements of operations and comprehensive loss was 6.43 and 6.75 Swedish Krona to one U.S. Dollar for the three months ended March 31, 2013 and 2012, respectively. The exchange rate for the consolidated balance sheets was 6.52 and 6.52  Swedish Krona to one U.S. Dollar as of March 31, 2013 and December 31, 2012, respectively.  The weighted-average exchange rate for the consolidated statement of operations and comprehensive loss was 92.19 Japanese Yen to one U.S. Dollar for the three months ended March 31, 2013. The exchange rate for the consolidated balance sheet was 94.16 Japanese Yen to one U.S. Dollar as of March 31, 2013.  

 3.  Stockholders’ Equity

On February 29, 2012, the Company filed a Certificate of Correction with the Secretary of State of Delaware effectively reducing the amount of its authorized shares from 848,000,000 shares of Common Stock and 2,000,000 shares of Preferred Stock to 70,000,000 shares of Common Stock and 1,000,000 shares of Preferred Stock. This correction reflects the new capital structure of the Company following its 1-for-25 reverse split that became effective at the close of business on March 25, 2011.

On May 1, 2012, the Company began trading its common stock on the NASDAQ Stock Market under trading symbol NEON.

Common Stock

During the three months ended March 31, 2013, warrant holders (excluding our CFO) exercised warrants to purchase 270,094 shares of common stock using the net exercise provision allowed in the warrant and received 198,512 shares of our common stock.

On February 26, 2013, David Brunton, our CFO, exercised warrants to purchase 320,000 shares of common stock using the net exercise provision allowed in the warrant and received 266,228 shares of our common stock.

On March 16, 2012, John Reardon, a member of our board of directors, exercised a warrant to purchase 200,000 shares of common stock using the net exercise provision allowed in the warrant and received 174,798 shares of our common stock.

 
11

 
 
Preferred Stock

On March 21, 2013, Series A Preferred stockholders exchanged 83 shares of Series A Preferred stock for 39,790 shares of our common stock, eliminating all Series A Preferred shares outstanding.

 On February 27, 2013, Series B Preferred stockholders exchanged 4 shares of Series B Preferred stock for 528 shares of our common stock.

On March 21, 2013, Series B Preferred stockholders exchanged 8 shares of Series B Preferred stock for 929 shares of our common stock.

The terms of the Series A and Series B Preferred stock are as follows:
 
Dividends and Distributions.
     
 
Series A Preferred:
The holders of shares of Series A Preferred stock are entitled to participate with the holders of our common stock with respect to any dividends declared on the common stock in proportion to the number of shares of common stock issuable upon conversion of the shares of Series A Preferred stock held by them.
     
 
Series B Preferred:
The holders of shares of Series B Preferred stock are entitled to participate with the holders of our common stock with respect to any dividends declared on the common stock in proportion to the number of shares of common stock issuable upon conversion of the shares of Series B Preferred stock held by them.
     
Liquidation Preference.
     
 
Series A Preferred:
In the event of any liquidation, dissolution, or winding up of our operations, either voluntary or involuntary, subject to the rights of any other series of Preferred stock to be established by the Board of Directors (the “Senior Preferred Stock”), the holders of Series A Preferred stock shall be entitled to receive, after any distribution to the holders of Senior Preferred Stock and prior to and in preference to any distribution to the holders of common stock, $0.001 for each share of Series A Preferred stock then outstanding.
     
 
Series B Preferred:
In the event of any liquidation, dissolution, or winding up of our operations, either voluntary or involuntary, subject to the rights of the Series A Preferred stock and Senior Preferred Stock, the holders of Series B Preferred stock shall be entitled to receive, after any distribution to the holders of Senior Preferred Stock and prior to and in preference to any distribution to the holders of common stock, $0.001 for each share of Series B Preferred stock then outstanding.
     
Voting.
 
     
The holders of shares of Series A Preferred stock and Series B Preferred stock shall have one vote for each share of Series A Preferred stock and Series B Preferred stock held by them.
     
Conversion.
 
 
Initially, each share of Series A Preferred stock and each share of Series B Preferred stock was convertible into one share of our common stock.  Any modification to the conversion rate requires shareholder approval. On March 31, 2009, our shareholders approved a resolution to increase the authorized share capital, and to increase the conversion ratio to 480.63 shares of common stock for each share of Series A Preferred stock and to 132.07 shares of our common stock for each shares of Series B Preferred stock, thus completing the restructuring begun in December 2008.  
 
 
12

 
 
On April 24, 2009, we initiated the process of allowing the shareholders of our preferred stock to convert the Series A and B Preferred stock to shares of our common stock. In order to convert the preferred stock to common stock each preferred stock shareholder is required to submit the preferred stock certificate to our transfer agent and request conversion to common stock. The conversion to common stock is not mandatory and shareholders who own preferred stock may choose not to convert their preferred stock to shares of our common stock.  The following table summarizes the Preferred stock not yet converted as of March 31, 2013.

   
Shares of Preferred Stock Not Exchanged as of March 31, 2013
   
Conversion Ratio
   
Shares of Common Stock after Conversion of all Outstanding Shares of Preferred Stock Not yet Exchanged at March 31, 2013
 
                   
Series B preferred stock
   
83
     
132.07 
     
10,962
 
        
4.  Deferred Revenue

As of March 31, 2013 and December 31, 2012, we have $2.0 million and $2.1 million, respectively, of deferred license fee revenue related to prepayments for future license fees from three customers and a total of $0.9 million and $0.6 million, respectively, of deferred engineering development fees from thirteen customers. We defer the license fees until we have met all accounting requirements for revenue recognition as per unit royalty products are distributed or licensed by the Company’s customers and the engineering development fee revenue until such time as the engineering work has been completed and accepted by our customers.

5.  Stock-Based Compensation

We have several approved stock option plans for which stock options and restricted stock awards are available to grant to employees, consultants and directors. All employee and director stock options granted under our stock option plans have an exercise price equal to the market value of the underlying common stock on the grant date. There are no vesting provisions tied to performance conditions for any options, as vesting for all outstanding option grants is based only on continued service as an employee, consultant or director. All of our outstanding stock options and restricted stock awards are classified as equity instruments.

Stock Options

As of March 31, 2013, we had two equity incentive plans:
 
  The 1998 Non-Officer Stock Option Plan (the 1998 Plan), which expired in June 2008 ;
  The 2006 Equity Incentive Plan (the 2006 Plan).
     
We also had one non-employee director stock option plan as of March 31, 2013:
     
 
The 2001 Non-Employee Director Stock Option Plan (the Director Plan) which expired in March 2011.
 
 
13

 
 
A summary of the combined activity under all of the stock option plans is set forth below:

  
 
Number of Options Outstanding
   
Weighted Average Exercise Price
 
Outstanding at January 1, 2013
   
1,715,200
   
$
5.04
 
Granted
   
15,000
     
5.97
 
Cancelled or expired
   
(200
   
125.00
 
Exercised
   
(38,456
   
4.33
 
Outstanding at March 31, 2013
   
1,691,544
   
$
5.05
 
  
On March 11, 2013, the Board approved the increase of the number of common stock authorized for issuance as incentive stock options under the 2006 Plan by 2 million shares.
 
The aggregate intrinsic value of the 1,691,544 stock options that are outstanding, vested and expected to vest at March 31, 2013 is $2.4 million.
 
               On March 19, 2013, the Company received an aggregate of $167,000 from two employees in connection with the exercise of stock options into 38,456 shares of common stock.  The intrinsic value related to the options exercised was $58,000 on the date of exercise.

For the three months ended March 31, 2013 and 2012, the Company recorded $576,000 and $0, respectively, of compensation expense related to the vesting of stock options. The fair value of the stock-based compensation was calculated  using the Black-Scholes option pricing model as of the date of grant of the stock option.
 
We granted an option to purchase 15,000 shares of our common stock to an employee during the three months ended March 31, 2013 with a grant date fair value of $80,000 computed using the Black-Scholes option pricing model. We did not grant any options to purchase shares of our common stock to employees or members of our Board of Directors during the three months ended March 31, 2012.

See below for assumptions used in the valuation of stock options:
 
 
 
For the three months
 
 
 
ended March 31, 2013
 
 
 
 
 
 Annual dividend yield
    -  
 Expected life (years)
    4.3  
 Risk-free interest rate
    0.65%  
 Expected volatility
    154%  

The 1998 Plan terminated effective June 15, 2008 and the Director Plan terminated effective March 2011. Although we can no longer issue stock options out of the plans, the outstanding options at the date of termination will remain outstanding and vest in accordance with their terms. Options granted under the Director Plan vested over a one to four-year period, expire five to seven years after the date of grant and have exercise prices reflecting market value of the shares of our common stock on the date of grant. Stock options granted under the 1998 and 2006 Plans are exercisable over a maximum term of ten years from the date of grant, vest in various installments over a one to four-year period and have exercise prices reflecting the market value of the shares of common stock on the date of grant.

Warrants

During the three months ended March 31, 2013, certain warrant holders exercised their warrants under the cash and net cash provisions, as defined in the agreements. See Note 3 for details of such exercises and number of common stock shares issued.

On December 3, 2010, we issued 120,000 warrants at an exercise price of $1.63 per share to an employee. The fair value of the warrants was $198,000 on the date of grant, using the Black-Scholes option pricing model, which has been amortized to expense over 24 months. During the three months ended March 31, 2012, we recorded $25,000 of stock based compensation expense related to vesting of such warrants.

On September 12, 2011, we issued 20,000 three-year stock purchase warrants to an employee at an exercise price of $3.90 per share with a vesting period over 24 months. The warrant granted to an employee had a fair value on the date of grant of $75,000. This amount is expensed over the vesting period and $10,000 and $9,000 of expense related to this warrant is included in product research and development expense for the three months ended March 31, 2013 and 2012, respectively. The fair value of stock-based compensation related to the issuance of warrants is calculated using the Black-Scholes option pricing model as of the grant date of the underlying warrant.
 
 
14

 
 
The stock-based compensation expense for the three months ended March 31, 2013 and 2012 reflects the fair value of the vested portion of options and warrants granted to directors, employees and non-employees. Stock-based compensation expense in the accompanying consolidated statements of operations is as follows (in thousands):
                            
   
2013
   
2012
 
             
Product research and development
 
$
60
   
$
10
 
Sales and marketing
   
196
     
24
 
General and administrative
   
330
     
--
 
Stock compensation expense
 
$
586
   
$
34
 

   
Remaining unamortized
expense at
March 31,
2013
 
Stock-based compensation
 
$
3,060
 

The remaining unamortized expense related to stock options and warrants will be recognized on a straight line basis monthly as compensation expense over the remaining vesting period which approximates 3.0 years.
 
The fair value of stock-based awards to employees is calculated using the Black-Scholes option pricing model, even though this model was developed to estimate the fair value of freely tradable, fully transferable options without vesting restrictions, which differ significantly from our stock options. The Black-Scholes model also requires subjective assumptions, including future stock price volatility and expected time to exercise, which greatly affect the calculated values. The expected term and forfeiture rate of options granted is derived from historical data on employee exercises and post-vesting employment termination behavior, as well as expected behavior on outstanding options. The risk-free rate is based on the U.S. Treasury rates in effect during the corresponding period of grant. The expected volatility is based on the historical volatility of our stock price. These factors could change in the future, which would affect fair values of stock options granted in such future periods, and could cause volatility in the total amount of the stock-based compensation expense reported in future periods.

A summary of all warrant activity is set forth below:
 
   
March 31, 2013
 
Outstanding and exercisable
 
Warrants
   
Weighted
Average
Exercise Price
   
Weighted
Average
Remaining
Contractual Life
 
January 1, 2013
   
4,704,636
   
$
1.61
     
1.41
 
   Issued
   
--
     
--
     
--
 
   Expired/forfeited
   
(40,000
   
1.00
     
--
 
   Exercised
   
(590,094
)
   
1.17
     
--
 
Outstanding and exercisable, March 31, 2013
   
4,074,542
   
$
1.69
     
1.15
 
 
 
15

 
 
During the three months ended March 31, 2013, warrant holders (excluding our CFO) exercised warrants to purchase 270,094 shares of common stock using the net exercise provision allowed in the warrant and received 198,512 shares of our common stock.

On February 26, 2013, David Brunton, our CFO, exercised warrants to purchase 320,000 shares of common stock using the net exercise provision allowed in the warrant and received 266,228 shares of our common stock.

Below is a summary of Outstanding Warrants to Purchase
Common Stock as of March 31, 2013:
 
                   
Description
 
Issue  Date
 
Exercise Price
 
Shares
 
Expiration Date
 
                   
August 2009 Employee Warrants
 
8/25/2009
 
$
0.50
 
80,000
   
8/25/2016
 
2007 Debt Extension Warrants
 
9/22/2010
 
$
1.00
 
16,000
   
9/22/2015
 
September 2010 Repricing Warrant
 
9/28/2010
 
$
1.38
 
4,000
   
9/28/2013
 
October 2010 Repricing Warrants
 
10/18/2010
 
$
1.38
 
2,078,433
   
10/18/2013
 
October 2010 Employee Warrants
 
10/15/2010
 
$
1.38
 
920,000
   
10/15/2013
 
December 2010 Employee Warrants
 
12/3/2010
 
$
1.63
 
200,000
   
12/3/2015
 
January 2011 Employee Warrant
 
1/21/2011
 
$
2.00
 
20,000
   
1/21/2014
 
February 2011 Legal Advisor Warrant
 
2/22/2011
 
$
2.50
 
80,000
   
2/22/2016
 
March  2011 Investor Warrants
 
3/9/2011
 
$
3.13
 
602,009
   
3/9/2016
 
March  2011 Investor Warrants
 
4/7/2011
 
$
3.13
 
34,100
   
4/7/2016
 
May 2011 Consultant Warrant
 
5/17/2011
 
$
4.05
 
20,000
   
5/17/2014
 
September 2011 Employee Warrant
 
9/12/2011
 
$
3.90
 
20,000
   
9/12/2014
 
Total Warrants Outstanding
           
4,074,542
       

6.   Commitments and Contingencies

Non-Recurring Engineering Development Costs

                Neonode and Texas Instruments Inc. (“TI”) entered into an Analog Device Development Agreement (“Agreement”) on January 24, 2010 where TI integrated Neonode’s intellectual property into an Application Specific Integrated Circuit (“ASIC”) developed by TI. The TI ASIC is designated as NN1001 and can be sold by TI exclusively to licensees of Neonode. Under the terms of the Agreement, Neonode is obligated to contribute $500,000 of non-recurring engineering development costs (“NRE”) to TI based on shipments of the NN1001. Neonode will contribute to TI the NRE as follows:

For each of the first one million units:  $0.08 per unit
For the next eight million units: $0.05 per unit

              In the three months ended March 31, 2013, $217,600 of NRE expense related to this agreement is included in product research and development on the condensed consolidated statement of operations. No amounts were recorded in the three months ended March 31, 2012 as no shipments of NN1001 took place.
 
 
16

 
 
Operating Leases

Neonode Technologies AB has a lease with Vasakronan Fastigheter AB for 2,723 square feet of office space located at Linnegatan 89D, Stockholm, Sweden for approximately $8,000 per month including property tax (excluding VAT). The annual payment for this space equates to approximately $93,000 per year including property tax (excluding VAT). This lease is valid thru December 31, 2014, with a nine month notice period. The contract will be extended for an additional three years if it is not terminated according to the terms in the contract.

On April 15, 2012, Neonode Technologies AB entered into a lease with No Picnic for 2,853 square feet of office space located at Storgatan 23C, Stockholm, Sweden for approximately $14,000 per month including property tax (excluding VAT). The annual payment for this space equates to approximately $174,000 per year including property tax (excluding VAT). This lease is valid through April 15, 2013. On April 16, 2013 this lease was extended for one year until April 15, 2014 under the same terms and conditions. Rent remains at approximately $14,000 per month including property tax (excluding VAT).
 
On March 22, 2012, we entered into a three year lease with 2350 Mission Investors LLC for 3,185 square feet of office space located at 2350 Mission College Blvd, Suite 190, Santa Clara, CA 95054 USA. The initial lease payment is $7,007 per month, increasing to $7,657 per month over the term of the lease. This lease is valid through July 31, 2015. The annual payment for this space equates to approximately $86,000 per year.

On October 12, 2012, we entered into a two year lease with Space design Inc., Meiko Building 3F, 1-18-2 Shimbashi, Minato-ku, 105-0004 Tokyo for office space located at 608 Bureau Shinagawa, 4-1-6 Konan, Minato-ku, 108-0075 Tokyo, Japan. The lease payment is approximately $3,000 per month. This lease is valid through October 12, 2014. The annual payment for this space equates to approximately $36,000 per year.

For the three months ended March  31, 2013 and 2012, the Company recorded approximately $120,000 and $103,000, respectively, for rent expense.
 
A summary of future minimum payments under non-cancellable operating lease commitments as of March 31, 2013 is as follows (in thousands):
 
Year ending December 31,
 
Total
 
2013
 
$
293
 
2014
   
255
 
2015
   
23
 
   
$
571
 

7Segment Information

The Company has one reportable segment, which is comprised of the touchscreen technology licensing business. All of our sales for the three months ended March 31, 2013 and 2012 were to customers located in the U.S., Europe and Asia.

The following table presents net revenues by geographic region for the three months ended March 31, 2013 and 2012 (dollars in thousands):

   
2013
 
   
Amount
   
Percentage
 
Net revenues from customers in the U.S.
 
$
292
     
53
%
Net revenues from customers in Europe
   
18
     
43
Net revenues from customers in Asia
   
238
     
44
%
                 
 Total
 
$
548
     
100
%
       
   
2012
 
   
Amount
   
Percentage
 
Net revenues from customers in the U.S.
 
$
974
     
84
%
Net revenues from customers in Europe
   
--
       
 --
Net revenues from customers in Asia
   
190
     
16
%
                 
 Total
 
$
1,164
     
100
%
 
 
17

 
 
8.  Net Loss Per Share

Basic net loss per common share for the three months ended March 31, 2013 and 2012 was computed by dividing the net loss for the relevant period by the weighted average number of shares of common stock outstanding. Diluted loss per common share is computed by dividing net loss by the weighted average number of shares of common stock and common stock equivalents outstanding.
 
Potential common stock equivalents of approximately 309,000 and 11,500 outstanding stock options, 2.8 million and 3.2 million outstanding stock warrants under the treasury stock method and 11,000 and 52,000 shares issuable upon conversion of preferred stock are excluded from the diluted earnings per share calculation for the periods ended March 31, 2013 and 2012, respectively, due to their anti-dilutive effect.

(in thousands, except per share amounts)
 
Three Months ended
March 31,
 
   
2013
   
2012
 
BASIC AND DILUTED
           
Weighted average number of common shares outstanding
    33,511       32,809  
Number of shares for computation of net loss per share
    33,511       32,809  
                 
Net loss
  $ (3,570 )   $ (1,588 )
                 
Net loss per share - basic and diluted
  $ (0.11 )   $ (0.05 )
 
9.  Subsequent Events
 
On April 1, 2013, warrant holders exercised warrants to purchase 55,000 shares of common stock using the net exercise provision allowed in the warrant and received 25,720 shares of our common stock.

On April 3, 2013, the Company issued a warrant to an investor to purchase 40,000 shares of common stock at an exercise price of $1.00 per share. On April 4, 2013 the warrant holder paid $40,000 and exercised the warrant.

On April 5, 2013, a warrant holder paid $120,244 in connection with a cash exercise of a warrant to purchase 80,000 shares of common stock with an exercise price of $1.38 per share and a warrant to purchase 3,145 shares of common stock with an exercise price of $3.13 per share.
 
On April 16, 2013, Neonode Technologies AB renewed a lease with No Picnic for 2,853 square feet of office space located at Storgatan 23C, Stockholm, Sweden for approximately $14,000 per month including property tax (excluding VAT). The annual payment for this space equates to approximately $174,000 per year including property tax (excluding VAT). This lease is valid through April 15, 2014.
 
On April 18, 2013, a warrant holder exercised a warrant to purchase 40,000 shares of common stock using the net exercise provision allowed in the warrant and received 30,663 shares of our common stock.

On May 3, 2013, a warrant holder paid $34,500 in connection with a cash exercise of a warrant to purchase 25,000 shares of common stock with an exercise price of $1.38 per share.

 
18

 
 
Item 2.       Management's Discussion and Analysis of Financial Condition and Results of Operations

Forward Looking Statements

This Quarterly Report contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, adopted pursuant to the Private Securities Litigation Reform Act of 1995.  Statements that are not purely historical may be forward-looking.  You can identify some forward-looking statements by the use of words such as "believes," "anticipates," "expects," "intends" and similar expressions.  Forward looking statements involve inherent risks and uncertainties regarding events, conditions and financial trends that may affect our future plans of operation, business strategy, results of operations and financial position.  A number of important factors could cause actual results to differ materially from those included within or contemplated by such forward-looking statements, including, but not limited to risks relating to the uncertainty of growth in market acceptance for our technology, a history of losses since inception, our ability to remain competitive in response to new technologies, the costs to defend, as well as risks of losing, patents and intellectual property rights, a reliance on our future customers’ ability to develop and sell products that incorporate our technology, our customer concentration and dependence on a limited number of customers, the uncertainty of demand for our technology in certain markets, our ability to manage growth effectively, our dependence on key members of our management and development team, our limited experience in conducting operations internationally, and our ability to obtain adequate capital to fund future operations, For a discussion of these and other factors that could cause actual results to differ from those contemplated in the forward-looking statements, please see the discussion under ‘‘Risk Factors’’ contained in our Annual Report on Form 10-K for the fiscal year ended December 31, 2012 and in our publicly available filings with the Securities and Exchange Commission. Forward-looking statements reflect our analysis only as of the date hereof.  Actual events or results may differ materially from the results discussed in or implied by the forward-looking statements. We do not undertake any responsibility to update or revise any of these factors or to announce publicly any revisions to forward-looking statements, whether as a result of new information, future events or otherwise.

The following Management’s Discussion and Analysis should be read in conjunction with the condensed consolidated financial statements and the notes thereto included in Item 1 of this Quarterly Report on Form 10-Q and consolidated financial statements for the year ended December 31, 2012 included in our Annual Report on Form 10-K.

Overview

Neonode develops and licenses MultiSensing™ touch user interfaces and optical multi-touch solutions. Based on zForce®, our patented touch technology, Neonode has developed a variety of features that sense an object’s size, its pressure on a surface, its depth, its velocity and even its proximity to any type of surface.  Neonode licenses MultiSensing touch technology to Original Equipment Manufacturers (“OEMs”) and Original Design Manufacturers (“ODMs”) who embed our technology into devices that they produce and sell. Our technology licensing model allows us to focus on the development of solutions for multi-touch enabled screens, and thus we do not manufacture products or components. We license the right to use zForce and Neonode MultiSensing software which, together with standard components from partners, create an optical touch solution.

During the three months ended March 31, 2013, we had six customers using our touchscreen technology in products that were shipping to customers. We had an additional seventeen customers with signed license agreements currently in the product development stage. In most circumstances, our target customers will have to successfully integrate our technology into their products and then sell those products to their customers before we will receive any cash from our technology license agreements.

As of March 31, 2013, we have signed twenty-eight technology license agreements with global OEMs. Subsequent to March 31, 2013, we signed one new license agreement with a global OEM to develop a multi-sensing touch solution for their banking Automatic Teller Machines (“ATM”). Seven of our customers are currently shipping products and we anticipate others will initiate product shipments as they complete their final product development and manufacturing cycle throughout 2013.  In addition, we are currently developing prototype products and are engaged in product engineering design discussions with numerous global OEMs who are in the process of qualifying our touchscreen technology for incorporation in various products such as laptop computers, printer products, GPS devices, e-Readers, tablets, touch panels for automobiles, household appliances, mobile phones, and games and toys. The development and product release cycle for these products typically takes six to eighteen months.
 
 
19

 
 
Results of Operations

Net Revenues

Net revenues for the three months ended March 31, 2013 and 2012 was $548,000 and $1.2 million, respectively.  Our net revenues for the three months ended March 31, 2013 included $539,000 from technology license fees related to product shipments by six customers plus $9,000 in fees for engineering design services related to our touch screen solution for another customer. Our net revenues for the three months ended March 31, 2012 included $896,000 from technology license fees related to product shipments by four customers plus $268,000 in fees for engineering design services related to our touch screen solution for other customers.
 
Gross Margin

Gross margin was $532,000 and $915,000 for the three months ended March 31, 2013 and 2012, respectively. Our cost of revenues includes the direct cost of production of certain customer prototypes, costs of Company employed engineering personnel and engineering consultants to complete the engineering design contract. Our gross margin has decreased due to the decrease in our total revenue particularly our license fee revenue. The gross margin related to our license fees is 100% and when license fees as a percentage of our total revenue decrease our gross margin will decrease.

Product Research and Development

 Product research and development (“R&D”) expenses for the three month period ended March 31, 2013 were $1.6 million compared to $687,000 for the same period in 2012.  R&D costs mainly consist of personnel related costs in addition to some external consultancy costs such as testing, certifying and measurements along with costs related to developing and building new product prototypes. We continue to pursue and expand R&D expenditures on the development of our touchscreen and other technologies. As of March 31, 2013, our R&D department has twenty-nine full time employees compared to seventeen at March 31, 2012. Included in R&D expenses are approximately $60,000 of non-cash stock option and warrant expense for the three months ended March 31, 2013 compared to approximately $10,000 for the same period in 2012.

Sales and Marketing

  Sales and marketing (“S&M”) expenses for the three month period ended March 31, 2013 were $805,000 compared to $799,000 for the same period in 2012. This increase in 2013 as compared to 2012 is primarily related to non-cash stock option expense in 2013 related to stock options issued to employees in the second quarter of 2012 that was offset by a reduction in overall marketing expense and travel.  Included in S&M expenses are approximately $196,000 of non-cash stock option and warrant expense for the three months ended March 31, 2013 compared to approximately $24,000 for the same period in 2012.

Our sales activities focus primarily on OEM customers who will integrate our touchscreen technology into their products. Our OEM customers will then sell and market their products incorporating our technology to their customers.

General and Administrative

General and administrative (“G&A”) expenses for the three months ended March 31, 2013 were $1.7 million compared to $995,000 for the same period in 2012. This increase in 2013 as compared to 2012 is related to an increase in finance department staff that took place in the second and third quarters of 2012 and an increase in legal fees related to patent filings and customer contract reviews. In addition, there was an increase in non-cash stock option expense in 2013 related to stock options issued to employees and members of our Board of Directors in the second quarter of 2012.  Included in G&A expenses are approximately $330,000 of non-cash stock option and warrant expense for the three months ended March 31, 2013 compared to none for the same period in 2012.

 
20

 
 
Income Taxes

Our effective tax rate was 0% in the three months ended March 31, 2013 and 2012, respectively.  We recorded valuation allowances for the three month periods ended March 31, 2013 and 2012 for deferred tax assets related to net operating losses due to the uncertainty of realization. In the event of future taxable income, our effective income tax rate in future periods could be lower than the statutory rate as such tax assets are realized.

Net Loss

As a result of the factors discussed above, we recorded a net loss of $3.6 million for the three month period ended March 31, 2013, compared to a net loss of $1.6 million in the comparable period in 2012.
 
Off-Balance Sheet Arrangements
 
We do not have any transactions, arrangements, or other relationships with unconsolidated entities that are reasonably likely to affect our liquidity or capital resources other than operating leases. We have no special purpose or limited purpose entities that provide off-balance sheet financing, liquidity, or market or credit risk support; or engage in leasing, hedging, research and development services, or other relationships that expose us to liability that is not reflected on the face of the financial statements.
 
Contractual Obligations and Commercial Commitments
 
Non-Recurring Engineering Development Costs
 
Neonode and Texas Instruments Inc. (“TI”) entered into an Analog Device Development Agreement (“Agreement”) on January 24, 2010 where TI integrated Neonode’s intellectual property into an Application Specific Integrated Circuit (“ ASIC”) developed by TI. The TI ASIC is designated as NN1001 and can be sold by TI exclusively to licensees of Neonode. Under the terms of the Agreement, Neonode is obligated to  contribute $500,000 of non-recurring engineering development costs (“NRE”) to TI based on shipments of the NN1001. In the three months ended March 31, 2013, $217,600 of NRE expense related to this agreement is included in product research and development on the condensed consolidated statement of operations.  As of March 31, 2013, no cash payment had been made to TI.
 
Operating Leases
 
We lease office space in one U.S. location. Outside the U.S., we lease office space in Stockholm, Sweden and Tokyo, Japan. The future minimum lease payments under all of our non-cancelable operating leases with an initial term in excess of one year as of March 31, 2013 were $571,000.  There have been no material changes in those obligations during the first three months of fiscal 2013.  

On April 16, 2013, Neonode Technologies AB renewed a lease with No Picnic for 2,853 square feet of office space located at Storgatan 23C, Stockholm, Sweden for approximately $14,000 per month including property tax (excluding VAT). The annual payment for this space equates to approximately $174,000 per year including property tax (excluding VAT). This lease is valid through April 15, 2014.

Liquidity and Capital Resources

Our liquidity is dependent on many factors, including sales volume, operating profit and the efficiency of asset use and turnover. Our future liquidity will be affected by, among other things:

actual versus anticipated licensing of our technology;
our actual versus anticipated operating expenses;
 
 
21

 
 
the timing of our OEM customer product shipments;
the timing of payment for our technology licensing agreements;
our actual versus anticipated gross profit margin;
our ability to raise additional capital, if necessary; and
our ability to secure credit facilities, if necessary.

At March 31, 2013, we had cash of $7.6 million, as compared to $9.1 million at December 31, 2012.

Working capital (current assets less current liabilities) was $4.9 million at March 31, 2013, compared to working capital of $7.7 million at December 31, 2012.
 
Net cash used in operating activities for the three months  ended March 31, 2013 was primarily the result of (i) a net loss of approximately $3.6 million and (ii) approximately $1.3 million in net cash provided by changes in operating assets and liabilities, primarily accounts receivable. Cash used to fund net losses is reduced by approximately $0.6 million in non-cash operating expenses, comprised of depreciation and amortization and stock-based compensation.
 
Accounts receivable decreased approximately $1.3 million at March 31, 2013 compared with December 31, 2012, primarily as a result of a decrease in net revenues from approximately $2.3 million in the fourth quarter of 2012 compared to approximately $0.6 million in the first quarter of 2013. During the three months ended March 31, 2013, we were successful in collecting cash from net revenues to our customers in accordance with our standard payment terms. 

 Deferred revenue increased approximately $0.2 million during the three months ended March 31, 2013 compared with December 31, 2012, primarily as a result of additional license technology agreements and engineering projects entered into during the three months ended March 31, 2013.
 
In the three months ended March 31, 2013, we purchased $28,000 of property and equipment, primarily computers and test equipment.

Net cash provided by financing activities was the result of net proceeds of $167,000 received in connection with the exercise of stock options for shares of our common stock during the three months ended March 31, 2013.

We believe we have sufficient cash to operate for the next twelve months.

In the future, we may require sources of capital in addition to cash on hand to continue operations and to implement our strategy. If our operations do not become cash flow positive, we may be forced to seek credit line facilities from financial institutions, additional private equity investment or debt arrangements. No assurances can be given that we will be successful in obtaining such additional financing on reasonable terms, or at all. If adequate funds are not available on acceptable terms, or at all, we may be unable to adequately fund our business plans and it could have a negative effect on our business, results of operations and financial condition. In addition, if funds are available, the issuance of equity securities or securities convertible into equity could dilute the value of shares of our common stock and cause the market price to fall, and the issuance of debt securities could impose restrictive covenants that could impair our ability to engage in certain business transactions.

We may from time to time raise capital under our current shelf registration in amounts, at prices, and on terms to be announced when and if the securities are offered. The specifics of any future offerings, along with the use of proceeds of any securities offered, will be described in detail in a prospectus supplement, or other offering materials, at the time of the offering.  At March 31, 2013, there were 1,000,000 shares that remained registered and available for issuance under our shelf registration.

The functional currency of our foreign subsidiaries in Sweden is the Swedish Krona and in Japan is the Japanese Yen. They are subject to foreign currency exchange rate risk. Any increase or decrease in the exchange rate of the U.S. Dollar compared to the Swedish Krona or Japanese Yen will impact Neonode’s future operating results.
 
 
22

 
 
Item 3.       Quantitative and Qualitative Disclosures about Market Risk
 
We are exposed to risks associated with changes in currency exchange rates.  All of our revenue and approximately 58% of our consolidated costs are denominated in U.S. dollars We do not believe changes in foreign currency exchange rates will be material to our financial position or results of operation. We do not currently enter into forward-exchange contracts to hedge exposure denominated in foreign currencies or any other derivative financial instruments for trading or speculative purposes. In the future, if our operations change and we determine that our foreign exchange exposure has increased, we may consider entering into hedging transactions to mitigate such risk.
 
Item 4.       Controls and Procedures
 
Evaluation of disclosure controls and procedures
 
Under the supervision of and with the participation of our management, including the Company’s Chief Executive Officer and Chief Financial Officer, we evaluated the effectiveness of our disclosure controls and procedures (as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) as of December 31, 2012. Based upon that evaluation, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures were effective.
 
Changes in internal control over financial reporting
 
There were no changes in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) during the period covered by this report that have materially affected or are reasonably likely to materially affect, our internal controls over financial reporting.

PART II.   Other Information
 
ITEM  1.    Legal Proceedings
 
We are not currently involved in any material legal proceedings. However, from time to time, we may become subject to legal proceedings, claims, and litigation arising in the ordinary course of business, including, but not limited to, employee, customer and vendor disputes.

ITEM  1A.  Risk Factors
 
There have been no material changes from the risk factors as previously disclosed in our Annual Report on Form 10-K for the year ended December 31, 2012.
 
23

 
 
ITEM 6.     Exhibits

Exhibits
 
Exhibit #
 
Description
     
3.1
 
Amended and Restated Certificate of Incorporation of Neonode Inc., dated April 17, 2009 (incorporated by reference to Exhibit 10.22 of our Quarterly Report on Form 10-Q filed on August 4, 2009).
     
3.1.1
 
Certificate of Amendment, dated December 13, 2010 (incorporated by reference to Exhibit 3.1.1 of our Annual Report on Form 10-K filed on March 31, 2011)
     
3.1.2
 
Certificate of Amendment, dated March 18, 2011 (incorporated by reference to Exhibit 3.1 of our Current Report on Form 8-K filed on March 28, 2011)
     
3.1.3
 
Certificate of Correction, dated February 29, 2011 (incorporated by reference to Exhibit 3.1.3 of our Annual Report on Form 10-K filed on March 30, 2012)
     
3.2
 
Bylaws (incorporated by reference to Exhibit 3.2 of our Annual Report on Form 10-K filed on April 15, 2008)
     
31.1
 
Certification of Principal Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act Of 2002*
     
31.2
 
Certification of Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act Of 2002*
     
32
 
Certifications pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002*
     
101.INS
 
XBRL Instance Document *
101.SCH
 
XBRL Taxonomy Extension Schema Document *
101.CAL
 
XBRL Taxonomy Extension Calculation Linkbase Document *
101.DEF
 
XBRL Taxonomy Extension Definition Linkbase Document *
101.LAB
 
XBRL Taxonomy Extension Label Linkbase Document *
101.PRE
 
XBRL Taxonomy Extension Presentation Linkbase Document *
 
* Furnished herewith
 
 
24

 
 
SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized, on May 8, 2013.
 
   
Neonode Inc.
 
   
Registrant
 
       
Date:  May 8, 2013 By: /s/ David W. Brunton  
   
David W. Brunton
 
   
Chief Financial Officer,
 
   
Vice President, Finance
 
   
and Secretary
 
   
(Principal Financial and
 
   
Accounting Officer)
 
 
 
25
EX-31.1 2 f10q0313ex31i_neonode.htm CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 Unassociated Document
EXHIBIT 31.1

Certification Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

I, Thomas Eriksson, certify that:

1.           I have reviewed this quarterly report on Form 10-Q of Neonode Inc.;

2.           Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.           Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.           The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13(a)-15(e) and 15(d)-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a)    Designed such disclosure controls and procedures or caused such disclosure controls and procedures to be designed under the supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this quarterly report is being prepared;
 
b)    Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
 
c)    Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report  based on such evaluation; and
 
d)    Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during registrant’s most recent fiscal quarter (the registrant’s fourth quarter in the case of an annual report) that has materially affected or is reasonably likely to materially affect, the registrant’s internal control over financial reporting and

5.           The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal controls over financial reporting, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent function):

a)    All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
 
b)    Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
 
/s/ Thomas Eriksson   
Thomas Eriksson
Chief Executive Officer
May 8, 2013
 
 
EX-31.2 3 f10q0313ex31ii_neonode.htm CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 Unassociated Document
EXHIBIT 31.2

Certification Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

I, David W. Brunton, certify that:

1.           I have reviewed this quarterly report on Form 10-Q of Neonode Inc.;

2.           Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.           Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.           The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13(a)-15(e) and 15(d)-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a)    Designed such disclosure controls and procedures or caused such disclosure controls and procedures to be designed under the supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this quarterly report is being prepared;
 
b)    Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
 
c)    Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report  based on such evaluation; and
 
d)    Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during registrant’s most recent fiscal quarter (the registrant’s fourth quarter in the case of an annual report) that has materially affected or is reasonably likely to materially affect, the registrant’s internal control over financial reporting and

5.           The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal controls over financial reporting, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent function):

a)    All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b)    Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
 
/s/ David W. Brunton   
David W. Brunton
Chief Financial Officer,
Vice President, Finance
and Secretary
May 8, 2013
 
 
EX-32.1 4 f10q0313ex32i_neonode.htm CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 Unassociated Document
EXHIBIT 32.1

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
 
In connection with the quarterly report of Neonode Inc. (the “Company”) on Form 10-Q for the fiscal period ended March 31, 2013 as filed with the Securities and Exchange Commission (the “Report”), the undersigned principal executive officer and principal financial officer of the Company, each hereby certify, solely for purposes of 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to his knowledge:

1.  
The Report fully complies with the requirements of Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934, as amended; and
2.  
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company.
 
/s/ Thomas Eriksson   /s/ David W. Brunton  
Thomas Eriksson   David W. Brunton  
Chief Executive Officer   Chief Financial Officer  
May 8, 2013  
Vice President, Finance
and Secretary
May 8, 2013
 
 
The foregoing certification is being furnished (but not filed) solely pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
EX-101.INS 5 neond-20130331.xml 0000087050 2010-01-23 2010-01-24 0000087050 us-gaap:WarrantMember 2010-12-03 0000087050 us-gaap:WarrantMember 2010-12-01 2010-12-03 0000087050 2010-12-31 0000087050 neond:ThreeYearStockPurchaseWarrantsMember 2011-09-12 0000087050 neond:ThreeYearStockPurchaseWarrantsMember 2011-09-01 2011-09-12 0000087050 neond:VasakronanFastigheterAbMember 2011-01-01 2011-12-31 0000087050 neond:VasakronanFastigheterAbMember neond:MonthMember 2011-01-01 2011-12-31 0000087050 2011-12-31 0000087050 neond:MemberOfBoardOfDirectorsMember 2012-03-16 0000087050 2012-03-01 2012-03-16 0000087050 neond:MissionInvestorsLlcMember 2012-03-22 0000087050 2012-01-01 2012-03-31 0000087050 us-gaap:WarrantMember 2012-01-01 2012-03-31 0000087050 us-gaap:ConvertiblePreferredStockMember 2012-01-01 2012-03-31 0000087050 neond:CustomerOneMember 2012-01-01 2012-03-31 0000087050 neond:CustomerTwoMember 2012-01-01 2012-03-31 0000087050 country:US 2012-01-01 2012-03-31 0000087050 us-gaap:SegmentGeographicalGroupsOfCountriesGroupOneMember 2012-01-01 2012-03-31 0000087050 us-gaap:SegmentGeographicalGroupsOfCountriesGroupTwoMember 2012-01-01 2012-03-31 0000087050 us-gaap:StockOptionMember 2012-01-01 2012-03-31 0000087050 us-gaap:ResearchAndDevelopmentExpenseMember us-gaap:WarrantMember 2012-01-01 2012-03-31 0000087050 us-gaap:SellingAndMarketingExpenseMember us-gaap:WarrantMember 2012-01-01 2012-03-31 0000087050 us-gaap:GeneralAndAdministrativeExpenseMember us-gaap:WarrantMember 2012-01-01 2012-03-31 0000087050 us-gaap:WarrantMember 2012-01-01 2012-03-31 0000087050 neond:ThreeYearStockPurchaseWarrantsMember 2012-01-01 2012-03-31 0000087050 2012-03-31 0000087050 neond:MissionInvestorsLlcMember 2012-03-01 2012-03-31 0000087050 neond:MissionInvestorsLlcMember neond:MonthMember 2012-03-01 2012-03-31 0000087050 neond:MissionInvestorsLlcMember neond:AnnualMember 2012-03-01 2012-03-31 0000087050 neond:NoPicnicMember 2012-04-15 0000087050 neond:NoPicnicMember 2012-04-01 2012-04-30 0000087050 neond:NoPicnicMember neond:MonthMember 2012-04-01 2012-04-30 0000087050 neond:NoPicnicMember neond:AnnualMember 2012-04-01 2012-04-30 0000087050 neond:SpaceDesignIncMember 2012-10-11 2012-10-12 0000087050 neond:SpaceDesignIncMember neond:MonthMember 2012-10-11 2012-10-12 0000087050 neond:SpaceDesignIncMember neond:AnnualMember 2012-10-11 2012-10-12 0000087050 2012-01-01 2012-12-31 0000087050 us-gaap:MinimumMember 2012-01-01 2012-12-31 0000087050 us-gaap:WarrantMember 2012-01-01 2012-12-31 0000087050 2012-12-31 0000087050 us-gaap:SeriesAPreferredStockMember 2012-12-31 0000087050 us-gaap:SeriesBPreferredStockMember 2012-12-31 0000087050 neond:PrepaymentsFromFutureLicenseFeesMember 2012-12-31 0000087050 neond:DeferredEngineeringDevelopmentFeesMember 2012-12-31 0000087050 us-gaap:ChiefFinancialOfficerMember 2013-02-26 0000087050 us-gaap:SeriesBPreferredStockMember 2013-02-25 2013-02-27 0000087050 us-gaap:CommonStockMember us-gaap:SeriesBPreferredStockMember 2013-02-25 2013-02-27 0000087050 us-gaap:StockOptionsMember 2013-03-10 2013-03-11 0000087050 us-gaap:StockOptionsMember 2013-03-19 0000087050 us-gaap:SeriesAPreferredStockMember 2013-03-20 2013-03-21 0000087050 us-gaap:SeriesBPreferredStockMember 2013-03-20 2013-03-21 0000087050 us-gaap:CommonStockMember us-gaap:SeriesAPreferredStockMember 2013-03-20 2013-03-21 0000087050 us-gaap:CommonStockMember us-gaap:SeriesBPreferredStockMember 2013-03-20 2013-03-21 0000087050 2013-01-01 2013-03-31 0000087050 us-gaap:WarrantMember 2013-01-01 2013-03-31 0000087050 us-gaap:ConvertiblePreferredStockMember 2013-01-01 2013-03-31 0000087050 us-gaap:SeriesAPreferredStockMember 2013-01-01 2013-03-31 0000087050 us-gaap:SeriesBPreferredStockMember 2013-01-01 2013-03-31 0000087050 neond:PrepaymentsFromFutureLicenseFeesMember 2013-01-01 2013-03-31 0000087050 us-gaap:MinimumMember 2013-01-01 2013-03-31 0000087050 neond:CustomerTwoMember 2013-01-01 2013-03-31 0000087050 neond:KoboMember 2013-01-01 2013-03-31 0000087050 us-gaap:ComputerEquipmentMember 2013-01-01 2013-03-31 0000087050 us-gaap:FurnitureAndFixturesMember 2013-01-01 2013-03-31 0000087050 us-gaap:MaximumMember 2013-01-01 2013-03-31 0000087050 neond:AugustTwoThousandNineEmployeeWarrantsMember 2013-01-01 2013-03-31 0000087050 neond:DebtExtensionWarrantsMember 2013-01-01 2013-03-31 0000087050 neond:SeptemberTwoThousandTenRepricingWarrantMember 2013-01-01 2013-03-31 0000087050 neond:OctoberTwoThousandTenRepricingWarrantsMember 2013-01-01 2013-03-31 0000087050 neond:OctoberTwoThousandTenEmployeeWarrantsMember 2013-01-01 2013-03-31 0000087050 neond:DecemberTwoThousandTenEmployeeWarrantsMember 2013-01-01 2013-03-31 0000087050 neond:JanuaryTwoThousandElevenEmployeeWarrantMember 2013-01-01 2013-03-31 0000087050 neond:FebruaryTwoThousandElevenLegalAdvisorWarrantMember 2013-01-01 2013-03-31 0000087050 neond:MarchTwoThousandElevenInvestorWarrantsMember 2013-01-01 2013-03-31 0000087050 neond:MarchTwoThousandElevenInvestorWarrantsOneMember 2013-01-01 2013-03-31 0000087050 neond:MayTwoThousandElevenConsultantWarrantMember 2013-01-01 2013-03-31 0000087050 neond:SeptemberTwoThousandElevenEmployeeWarrantMember 2013-01-01 2013-03-31 0000087050 us-gaap:WarrantMember 2013-01-01 2013-03-31 0000087050 neond:VasakronanFastigheterAbOneMember 2013-01-01 2013-03-31 0000087050 neond:VasakronanFastigheterAbOneMember neond:MonthMember 2013-01-01 2013-03-31 0000087050 neond:VasakronanFastigheterAbOneMember neond:AnnualMember 2013-01-01 2013-03-31 0000087050 neond:BarnesAndNobleMember 2013-01-01 2013-03-31 0000087050 neond:DeferredEngineeringDevelopmentFeesMember 2013-01-01 2013-03-31 0000087050 us-gaap:StockOptionsMember 2013-01-01 2013-03-31 0000087050 country:US 2013-01-01 2013-03-31 0000087050 us-gaap:SegmentGeographicalGroupsOfCountriesGroupOneMember 2013-01-01 2013-03-31 0000087050 us-gaap:SegmentGeographicalGroupsOfCountriesGroupTwoMember 2013-01-01 2013-03-31 0000087050 us-gaap:StockOptionMember 2013-01-01 2013-03-31 0000087050 us-gaap:ResearchAndDevelopmentExpenseMember us-gaap:WarrantMember 2013-01-01 2013-03-31 0000087050 us-gaap:SellingAndMarketingExpenseMember us-gaap:WarrantMember 2013-01-01 2013-03-31 0000087050 us-gaap:GeneralAndAdministrativeExpenseMember us-gaap:WarrantMember 2013-01-01 2013-03-31 0000087050 neond:NetronixMember 2013-01-01 2013-03-31 0000087050 neond:NonOfficerStockOptionPlanMember 2013-01-01 2013-03-31 0000087050 neond:NonEmployeeDirectorStockOptionPlanMember 2013-01-01 2013-03-31 0000087050 neond:NonEmployeeDirectorStockOptionPlanMember us-gaap:MinimumMember 2013-01-01 2013-03-31 0000087050 neond:NonEmployeeDirectorStockOptionPlanMember us-gaap:MaximumMember 2013-01-01 2013-03-31 0000087050 neond:NonOfficerStockOptionPlanMember us-gaap:MinimumMember 2013-01-01 2013-03-31 0000087050 neond:NonOfficerStockOptionPlanMember us-gaap:MaximumMember 2013-01-01 2013-03-31 0000087050 neond:EquityIncentivePlanMember us-gaap:MinimumMember 2013-01-01 2013-03-31 0000087050 neond:EquityIncentivePlanMember us-gaap:MaximumMember 2013-01-01 2013-03-31 0000087050 neond:EquityIncentivePlanMember 2013-01-01 2013-03-31 0000087050 neond:ThreeYearStockPurchaseWarrantsMember 2013-01-01 2013-03-31 0000087050 2013-03-31 0000087050 country:US 2013-03-31 0000087050 us-gaap:SeriesAPreferredStockMember 2013-03-31 0000087050 us-gaap:SeriesBPreferredStockMember 2013-03-31 0000087050 neond:PrepaymentsFromFutureLicenseFeesMember 2013-03-31 0000087050 neond:AugustTwoThousandNineEmployeeWarrantsMember 2013-03-31 0000087050 neond:DebtExtensionWarrantsMember 2013-03-31 0000087050 neond:SeptemberTwoThousandTenRepricingWarrantMember 2013-03-31 0000087050 neond:OctoberTwoThousandTenRepricingWarrantsMember 2013-03-31 0000087050 neond:OctoberTwoThousandTenEmployeeWarrantsMember 2013-03-31 0000087050 neond:DecemberTwoThousandTenEmployeeWarrantsMember 2013-03-31 0000087050 neond:JanuaryTwoThousandElevenEmployeeWarrantMember 2013-03-31 0000087050 neond:FebruaryTwoThousandElevenLegalAdvisorWarrantMember 2013-03-31 0000087050 neond:MarchTwoThousandElevenInvestorWarrantsMember 2013-03-31 0000087050 neond:MarchTwoThousandElevenInvestorWarrantsOneMember 2013-03-31 0000087050 neond:MayTwoThousandElevenConsultantWarrantMember 2013-03-31 0000087050 neond:SeptemberTwoThousandElevenEmployeeWarrantMember 2013-03-31 0000087050 neond:VasakronanFastigheterAbOneMember 2013-03-31 0000087050 country:SE 2013-03-31 0000087050 neond:DeferredEngineeringDevelopmentFeesMember 2013-03-31 0000087050 us-gaap:WarrantMember 2013-03-31 0000087050 us-gaap:StockOptionsMember 2013-03-31 0000087050 us-gaap:SubsequentEventMember 2013-03-29 2013-04-01 0000087050 us-gaap:SubsequentEventMember 2013-04-03 0000087050 us-gaap:SubsequentEventMember 2013-04-02 2013-04-03 0000087050 us-gaap:SubsequentEventMember 2013-04-02 2013-04-04 0000087050 us-gaap:SubsequentEventMember 2013-04-05 0000087050 us-gaap:SubsequentEventMember 2013-04-02 2013-04-05 0000087050 us-gaap:SubsequentEventMember 2013-04-16 0000087050 neond:NoPicnicMember 2013-04-02 2013-04-16 0000087050 us-gaap:SubsequentEventMember 2013-04-02 2013-04-16 0000087050 us-gaap:SubsequentEventMember neond:MonthMember 2013-04-02 2013-04-16 0000087050 us-gaap:SubsequentEventMember neond:AnnualMember 2013-04-02 2013-04-16 0000087050 us-gaap:SubsequentEventMember 2013-04-18 0000087050 us-gaap:SubsequentEventMember 2013-04-02 2013-04-18 0000087050 2013-05-03 0000087050 us-gaap:SubsequentEventMember 2013-05-03 0000087050 us-gaap:SubsequentEventMember 2013-05-01 2013-05-03 0000087050 us-gaap:WarrantMember 2012-12-31 0000087050 us-gaap:StockOptionsMember 2012-12-31 xbrli:shares iso4217:USD iso4217:USDxbrli:shares iso4217:EUR xbrli:pure neond:Customer neond:Plan utr:sqft neond:Segment Neonode, Inc 0000087050 false --12-31 10-Q 2013-03-31 2013 Q1 Yes Accelerated Filer 34080153 9097000 7582000 2123000 812000 550000 731000 11770000 9125000 330000 328000 12168000 9521000 539000 321000 804000 984000 2725000 2100000 600000 2920000 2000000 900000 4068000 4225000 4068000 4225000 33000 34000 146677000 147429000 5000 18000 -138615000 -142185000 12168000 9521000 2000000 1000000 444541 54425 444541 54425 0.001 0.001 0.001 0.001 83 95 0 83 83 95 0 83 0.001 0.001 0.001 0.001 848000000 70000000 70000000 70000000 0.001 0.001 33331182 33875625 33331182 33875625 1164000 974000 190000 548000 292000 18000 238000 249000 16000 915000 532000 687000 1634000 799000 805000 995000 1652000 2481000 4091000 -1566000 -3559000 22000 11000 -0.05 -0.11 32809 33511 44000 13000 34000 586000 18000 32000 -2273000 -1316000 26000 186000 -199000 -36000 11000 195000 523000 -1663000 201000 28000 -201000 -28000 40000 120244 34500 167000 45000 9000 367000 -1515000 12940000 13307000 9097000 7582000 22000 11000 <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: -36pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">1.&#160;&#160; Interim Period Reporting</font></div> <div style="text-indent: 0pt; display: block;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></div> <div style="text-align: justify; text-indent: 36pt; display: block;"><font style="display: inline; font-family: times new roman; font-size: 10pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">The accompanying unaudited interim condensed consolidated financial statements, include all adjustments, consisting of normal recurring adjustments that are, in the opinion of management, necessary for a fair presentation of the financial position and results of operations and cash flows for the interim periods presented. The results of operations for the three months ended March 31, 2013 are not necessarily indicative of expected results for the full 2013 fiscal year.</font> </font></div> <div style="text-align: left; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">The accompanying condensed consolidated financial statements as of March 31, 2013 and for the three months ended March 31, 2013 and 2012 have been prepared by us, pursuant to the rules and regulations of the Securities and Exchange Commission (SEC). Certain information and footnote disclosures normally contained in financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted.&#160;&#160;These condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto contained in our Annual Report on Form 10-K for the fiscal year ended December&#160;31, 2012.</font></div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;">&#160;</div> <div style="text-align: justify; text-indent: 18pt; display: block; margin-left: 18pt; margin-right: 0pt;"><font style="font-style: italic; display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Operations</font></div> <div style="text-indent: 0pt; display: block;">&#160;</div> <div align="justify" style="text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="justify" style="text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Neonode Inc. (&#8220;we&#8221;, &#8220;us&#8221;, &#8220;our&#8221;, the &#8220;Company&#8221;), develops and licenses MultiSensing&#8482; touch user interfaces and optical multi-touch solutions. The cornerstone of our interface solutions is zForce&#174;, our patented touch technology. Neonode licenses its MultiSensing touch technology to Original Equipment Manufacturers (&#8220;OEMs&#8221;) and Original Design Manufacturers (&#8220;ODMs&#8221;) who embed Neonode technology into devices that they produce and sell.</font></font></div> </div> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;"><font style="display: inline; font-weight: bold;">2.&#160;&#160; </font><font style="display: inline; font-weight: bold;">Summary of Significant Accounting Policies</font></font></div> <div style="text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 18pt; display: block; margin-left: 18pt; margin-right: 0pt;"><font style="font-style: italic; display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Principles of Consolidation</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">The condensed consolidated balance sheet at December 31, 2012 and the condensed consolidated statements of operations, other comprehensive loss, and cash flows for the three months ended March 31, 2012 includes our accounts and the accounts of our wholly owned Swedish subsidiary Neonode Technologies AB (&#8220;NTAB&#8221;).&#160;&#160;All significant intercompany accounts and transactions have been eliminated.</font></font></div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;"></font></font>&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">The condensed consolidated balance sheet at March 31, 2013 and the condensed consolidated statements of operations, other comprehensive loss, and cash flows for the three months ended March 31, 2013&#160;&#160;include our accounts and the accounts of our wholly owned subsidiaries, NTAB, Neonode Americas Inc. (&#8220;NAI&#8221;), Neonode Japan Inc. (&#8220;NJKK&#8221;), NEON Technologies Inc. (&#8220;NTI&#8221;) and Neonode UI AB (&#8220;NUIAB&#8221;).&#160;&#160;All significant intercompany accounts and transactions have been eliminated.</font></font></div> </div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Neonode management has made several strategic decisions to establish their presence in international markets that provide access to tier one customers and demonstrate Neonode&#8217;s long term commitment to these markets. NJKK was created in January 2013 to reach out to customers with global reach in electronics, automotive and home appliance markets.&#160;&#160;NUIAB was created to address particular opportunities that exist in this significant user interface arena as some aspects of our technology lends itself to ease of interacting with electronic devices. NTI and NAI were established to create a more focused organization with specific marketing, research and development goals. Furthermore, by creating separate entities, their performances can be directed and observed more clearly.</font></div> </div> </div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;">&#160;</div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 36pt; margin-right: 0pt;"><font style="font-style: italic; display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Estimates</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;"><font style="margin-left: 36pt;" ></font>The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires making estimates and assumptions that affect, at the date of the financial statements, the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities and the reported amounts of revenue and expenses. Actual results could differ from these estimates. Significant estimates include, but are not limited to, collectibility of accounts receivable, recoverability of long-lived assets, the valuation allowance related to our deferred tax assets and the fair value of options and warrants issued for stock-based compensation.</font></div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;">&#160;</div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 36pt; margin-right: 0pt;"><font style="font-style: italic; display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Concentration of Cash Balance Risks</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Cash balances are maintained at various banks in the U.S., Japan and Sweden. At times, deposits held with financial institutions in the United States of America may exceed the amount of insurance provided by the Federal Deposit Insurance Corporation (&#8220;FDIC&#8221;), which provides basic deposit coverage with limits up to $250,000 per owner. The Swedish government provides insurance coverage up to 100,000 euro per customer and covers deposits in all types of accounts. As of March 31, 2013, the Company has approximately $7.2 million in excess of insurance limits. </font></font></div> </div> <div style="text-indent: 0pt; margin-left: 0pt; margin-right: 0pt;" >&#160;</div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 36pt; margin-right: 0pt;"><font style="font-style: italic; display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Accounts Receivable and Allowance for Doubtful Accounts&#160;&#160;</font></div> <div style="text-align: left; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Our accounts receivable are stated at net realizable value. Our policy is to maintain allowances for estimated losses resulting from the inability of our customers to make required payments. Credit limits are established through a process of reviewing the financial history and stability of each customer. Where appropriate, we obtain credit rating reports and financial statements of the customer when determining or modifying its credit limits. We regularly evaluate the collectibility of our trade receivable balances based on a combination of factors. When a customer&#8217;s account balance becomes past due, we initiate dialogue with the customer to determine the cause. If it is determined that the customer will be unable to meet its financial obligation, such as in the case of a bankruptcy filing, deterioration in the customer&#8217;s operating results or financial position or other material events impacting its business, we record a specific allowance to reduce the related receivable to the amount we expect to recover. Should all efforts fail to recover the related receivable, we will write-off the account. We also record an allowance based on certain other factors including the length of time the receivables are past due and historical collection experience with customers.&#160;&#160;We determined that an allowance for doubtful accounts was not necessary at March 31, 2013 and December 31, 2012.</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 36pt; margin-right: 0pt;"><font style="font-style: italic; display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Property and Equipment</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Property and equipment are stated at cost, net of accumulated depreciation and amortization. Depreciation and amortization are computed using the straight-line method based upon estimated useful lives of the assets as follows:</font></div> <div style="text-indent: 0pt; display: block;">&#160;</div> <div align="center"> <table style="width: 80%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0"> <tr> <td valign="top" width="26%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td valign="top" width="26%"> <div style="text-align: left; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; text-decoration: underline;">Estimated useful lives</font></font></div> </td> </tr> <tr bgcolor="#cceeff"> <td valign="top" width="26%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Computer equipment</font></div> </div> </td> <td valign="top" width="26%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">3 years</font></div> </div> </td> </tr> <tr bgcolor="white"> <td valign="top" width="26%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Furniture and fixtures</font></div> </div> </td> <td valign="top" width="26%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">5 years</font></div> </div> </td> </tr> </table> </div> <div style="text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Equipment purchased under capital leases is amortized on a straight-line basis over the estimated useful life of the asset or the term of the lease, whichever is shorter.</font></div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Upon retirement or sale of property and equipment, cost and accumulated depreciation and amortization are removed from the accounts and any gains or losses are reflected in the consolidated statement of operations. Maintenance and repairs are charged to expense as incurred.</font></div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></div> <div style="text-align: left; text-indent: 0pt; display: block; margin-left: 36pt; margin-right: 0pt;"><font style="font-style: italic; display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Long-lived Assets</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">We assess any impairment by estimating the future cash flow from the associated asset in accordance with relevant accounting guidance. If the estimated undiscounted future cash flow related to these assets decreases or the useful life is shorter than originally estimated, we may incur charges for impairment of these assets.&#160;&#160;At March 31, 2013, we believe there is no impairment of our long-lived assets.</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 36pt; margin-right: 0pt;"><font style="font-style: italic; display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Foreign Currency Translation and Transaction Gains and Losses</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">The functional currency of our foreign subsidiaries is the applicable local currency, the Swedish Krona and Japanese Yen. The translation from Swedish Krona and Japanese Yen to U.S. Dollars is performed for balance sheet accounts using current exchange rates in effect at the balance sheet date and for income statement accounts using a weighted-average exchange rate during the period. Foreign currency translation gains were $13,000 and $44,000 during the three months ended March 31, 2013 and 2012, respectively. Gains or losses resulting from translation are included as a separate component of accumulated other comprehensive loss. Gains or losses resulting from foreign currency transactions are included in general and administrative expense in the accompanying condensed consolidated statements of operations and were $37,000 and $62,000 during the three months ended March 31, 2013 and 2012, respectively.</font></div> <div style="text-indent: 0pt; display: block;">&#160;<font style="font-style: italic; display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">&#160;</font></div> <div style="text-indent: 0pt; display: block; margin-left: 36pt;"><font style="font-style: italic; display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Concentration of Credit and Business Risks</font></div> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Our accounts receivable as of March 31, 2013 was due from twelve customers, five of which accounted for 72% of our accounts receivable as of March 31, 2013. Our net revenues for the three months ended March 31, 2013 was earned from nine customers. Our customers are located in the U.S., Europe and Asia. Customers which accounted for 10% or more of our net revenues during the three months ended March 31, 2013 are as follows:</font></div> <div style="text-indent: 0pt; display: block;">&#160;</div> <div> <table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0"> <tr valign="top"> <td style="text-align: right; width: 63pt;"> <div style="text-align: right;"><font style="display: inline; font-family: times new roman;">&#9679;<font style="font-style: italic; display: inline;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></font></div> </td> <td> <div align="justify" style="text-indent: 0pt; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Kobo - 44%</font></div> </td> </tr> </table> </div> <div> <table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0"> <tr valign="top"> <td align="right" style="width: 63pt;"> <div><font style="font-style: italic; display: inline; font-family: times new roman; font-size: 10pt;">&#9679;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div> </td> <td> <div align="justify" style="text-indent: 0pt; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Sony Corporation -20%</font></div> </td> </tr> </table> </div> <div> <table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0"> <tr valign="top"> <td align="right" style="width: 63pt;"> <div><font style="font-style: italic; display: inline; font-family: times new roman; font-size: 10pt;">&#9679;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div> </td> <td> <div align="justify" style="text-indent: 0pt; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Netronix &#8211; 21%</font></div> </td> </tr> </table> </div> <div> <table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0"> <tr valign="top"> <td align="right" style="width: 63pt;"> <div><font style="font-style: italic; display: inline; font-family: times new roman; font-size: 10pt;">&#9679;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div> </td> <td> <div align="justify" style="text-indent: 0pt; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Barnes &amp; Noble &#8211; 10%</font></div> </td> </tr> </table> </div> <div style="text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Our accounts receivable as of December 31, 2012 was due from fifteen customers, none of which accounted for more than10% of our accounts receivable as of December 31, 2012. Our net revenues for the three months ended March 31, 2012 was earned from ten customers. Our customers are located in the U.S., Europe and Asia. Customers which accounted for 10% or more of our net revenues during the three months ended March 31, 2012 are as follows:</font></div> <div style="text-indent: 0pt; display: block;">&#160;</div> <div> <table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0"> <tr valign="top"> <td align="right" style="width: 63pt;"> <div><font style="font-style: italic; display: inline; font-family: times new roman; font-size: 10pt;">&#9679;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div> </td> <td> <div align="justify" style="text-indent: 0pt; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Amazon - 55%</font></div> </td> </tr> </table> </div> <div> <table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0"> <tr valign="top"> <td align="right" style="width: 63pt;"> <div><font style="font-style: italic; display: inline; font-family: times new roman; font-size: 10pt;">&#9679;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div> </td> <td> <div align="justify" style="text-indent: 0pt; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Sony Corporation -16%</font></div> </td> </tr> </table> </div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;">&#160;</div> <div style="text-align: justify; text-indent: 18pt; display: block; margin-left: 18pt; margin-right: 0pt;"><font style="font-style: italic; display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Revenue Recognition</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 18pt; display: block; margin-left: 18pt; margin-right: 0pt;"><font style="font-style: italic; display: inline; font-family: times new roman; font-size: 10pt;">Licensing Revenues:</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">We derive revenue from the licensing of internally developed intellectual property (&#8220;IP&#8221;). We enter into IP licensing agreements that generally provide licensees the right to incorporate our IP components in their products with terms and conditions that vary by licensee. The IP licensing agreements generally include a nonexclusive license for the underlying IP. Fees under these agreements may include license fees relating to our IP and&#160;royalties payable following the distribution by our licensees of products incorporating the licensed technology. The license for our IP has standalone value and can be used by the licensee without maintenance and support. Neonode meets all the accounting requirements for revenue recognition as per unit royalty products are distributed or licensed by the Company&#8217;s customers.&#160; For technology license arrangements that do not require significant modification or customization of the underlying technology, we recognize technology license revenue when: (1) we enter into a legally binding arrangement with a customer for the license of technology; (2) the customer distributes or licenses the products; (3) the customer payment is deemed fixed or determinable and free of contingencies or significant uncertainties; and (4) collection is reasonably assured. Our customers report to us the quantities of products distributed or licensed by them after the end of the reporting period stipulated in the contract, generally 30 to 45 days after the end of the month or quarter.</font></font></div> </div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Explicit return rights are not offered to customers. There have been no returns through March 31, 2013.</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 18pt; display: block; margin-left: 18pt; margin-right: 0pt;"><font style="font-style: italic; display: inline; font-family: times new roman; font-size: 10pt;">Engineering Services:</font></div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">We may sell engineering consulting services to our customers on a flat rate or hourly rate basis. We recognize revenue from these services when all of the following conditions are met: (1) evidence existed of an arrangement with the customer, typically consisting of a purchase order or contract; (2) our services were performed and risk of loss passed to the customer; (3) we completed all of the necessary terms of the contract; (4) the amount of revenue to which we were entitled was fixed or determinable; and (5) we believed it was probable that we would be able to collect the amount due from the customer. To the extent that one or more of these conditions has not been satisfied, we defer recognition of revenue.&#160;&#160;Generally, we recognize revenue as the engineering services stipulated under the contract are completed and accepted by our customers.&#160;&#160;</font></div> <div style="text-align: justify; text-indent: 18pt; display: block; margin-left: 0pt; margin-right: 0pt;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="font-style: italic; display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Deferred Revenue</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">From time-to-time the Company receives pre-payments from its customers related to future services or future license fee revenues.&#160;We defer the license fees until we have met all accounting requirements for revenue recognition as per unit royalty products are distributed or licensed by the Company&#8217;s customers and the engineering development fee revenue until such time as the engineering work has been completed and accepted by our customers.</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="font-style: italic; display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Advertising</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Advertising costs are expensed as incurred. Advertising costs for the quarters ended March 31, 2013 and 2012 amounted to approximately $124,000 and $197,000, respectively.</font></font></div> </div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="font-style: italic; display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Product Research and Development</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Research and development (&#8220;R&amp;D&#8221;) costs are expensed as incurred. R&amp;D costs consist mainly of personnel related costs in addition to some external consultancy costs such as testing, certifying and measurements.</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="font-style: italic; display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Stock-Based Compensation Expense</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">We measure the cost of employee services received in exchange for an award of equity instruments, including stock options, based on the fair value of the award on the grant date, and recognize the value as compensation expense over the period the employee is required to provide services in exchange for the award, usually the vesting period, net of estimated forfeitures.</font></div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;We account for equity instruments issued to non-employees at their fair value. The measurement date for the fair value for the equity instruments issued is determined at the earlier of (i) the date at which a commitment for performance by the consultant or vendor is reached, or (ii) the date at which the consultant or vendor&#8217;s performance is complete. In the case of equity instruments issued to consultants, the fair value of the equity instruments is primarily recognized over the term of the consulting agreement. The fair value of the stock-based compensation is periodically re-measured and expense is recognized during the vesting term.</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">When determining stock-based compensation expense involving options and warrants, we determine the estimated fair value of options and warrants using the Black-Scholes option pricing model.</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="font-style: italic; display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Income Taxes</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">We recognize deferred tax liabilities and assets for the expected future tax consequences of items that have been included in the consolidated financial statements or tax returns. We estimate income taxes based on rates in effect in each of the jurisdictions in which we operate. Deferred income tax assets and liabilities are determined based upon differences between the financial statement and income tax bases of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse. The realization of deferred tax assets is based on historical tax positions and expectations about future taxable income. Valuation allowances are recorded against net deferred tax assets when, in our opinion, realization is uncertain based on the &#8220;more likely than not&#8221; criteria of the accounting guidance.</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Based on the uncertainty of future pre-tax income, we fully reserved our net deferred tax assets as of March 31, 2013 and December 31, 2012. In the event we were to determine that we would be able to realize our deferred tax assets in the future, an adjustment to the deferred tax asset would increase income in the period such determination was made. The provision for income taxes represents the net change in deferred tax amounts, plus income taxes paid or payable for the current period.</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">We follow the relevant accounting guidance related to uncertain tax positions, which provisions include a two-step approach to recognizing, de-recognizing and measuring uncertain tax positions.&#160;&#160;As a result, we did not recognize a liability for unrecognized tax benefits.&#160;&#160;As of March 31, 2013 and December&#160;31, 2012, we had no unrecognized tax benefits.</font></div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font>&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="font-style: italic; display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Net Loss Per Share</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Net loss per share amounts have been computed based on the weighted-average number of shares of common stock outstanding during the period. Net loss per share, assuming dilution amounts from common stock equivalents, is computed based on the weighted-average number of shares of common stock and potential common stock equivalents outstanding during the period. The weighted-average number of shares of common stock and potential common stock equivalents used in computing the net loss per share for periods ended March 31, 2013 and 2012 exclude the potential common stock equivalents, as the effect would be anti-dilutive&#160;(See Note 8).</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="font-style: italic; display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Comprehensive Income (Loss)</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Our comprehensive loss includes foreign currency translation gains and losses.&#160;&#160;The cumulative amount of translation gains and losses are reflected as a separate component of stockholder&#8217; equity in the condensed consolidated balance sheets as accumulated other comprehensive income.</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="font-style: italic; display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Cash Flow Information</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Cash flows in foreign currencies have been converted to U.S. dollars at an approximate weighted-average exchange rate for the respective reporting periods. The weighted-average exchange rate for the consolidated statements of operations and comprehensive loss was 6.43 and 6.75 Swedish Krona to one U.S. Dollar for the three months ended March 31, 2013 and 2012, respectively. The exchange rate for the consolidated balance sheets was 6.52 and 6.52&#160;&#160;Swedish Krona to one U.S. Dollar as of March 31, 2013 and December 31, 2012, respectively.&#160;&#160;The weighted-average exchange rate for the consolidated statement of operations and comprehensive loss was 92.19 Japanese Yen to one U.S. Dollar for the three months ended March 31, 2013. The exchange rate for the consolidated balance sheet was 94.16 Japanese Yen to one U.S. Dollar as of March 31, 2013.</font></font></div> </div> <div style="text-align: justify; text-indent: 0pt; display: block;"><font style="display: inline; font-family: times new roman; font-size: 10pt;"><font style="display: inline; font-weight: bold;">3. &#160;</font><font style="display: inline; font-weight: bold;">Stockholders&#8217; Equity</font></font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">On February 29, 2012, the Company filed a Certificate of Correction with the Secretary of State of Delaware effectively reducing the amount of its authorized shares from 848,000,000 shares of Common Stock and 2,000,000 shares of Preferred Stock to 70,000,000 shares of Common Stock and 1,000,000 shares of Preferred Stock. This correction reflects the new capital structure of the Company following its 1-for-25 reverse split that became effective at the close of business on March 25, 2011.</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">On May 1, 2012, the Company began trading its common stock on the NASDAQ Stock Market under trading symbol NEON.</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 36pt; margin-right: 0pt;"><font style="font-style: italic; display: inline; font-family: times new roman; font-size: 10pt;">Common Stock</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">During the three months ended March 31, 2013, warrant holders (excluding our CFO) exercised warrants to purchase 270,094 shares of common stock using the net exercise provision allowed in the warrant and received 198,512 shares of our common stock.</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">On February 26, 2013, David Brunton, our CFO, exercised warrants to purchase 320,000 shares of common stock using the net exercise provision allowed in the warrant and received 266,228 shares of our common stock.</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">On March 16, 2012, John Reardon, a member of our board of directors, exercised a warrant to purchase 200,000 shares of common stock using the net exercise provision allowed in the warrant and received 174,798 shares of our common stock.</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="font-style: italic; display: inline; font-family: times new roman; font-size: 10pt;">Preferred Stock</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">On March 21, 2013, Series A Preferred stockholders exchanged 83 shares of Series A Preferred stock for 39,790 shares of our common stock, eliminating all Series A Preferred shares outstanding.</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;On February 27, 2013, Series B Preferred stockholders exchanged 4 shares of Series B Preferred stock for 528 shares of our common stock.</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">On March 21, 2013, Series B Preferred stockholders exchanged 8 shares of Series B Preferred stock for 929 shares of our common stock.</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">The terms of the Series A and Series B Preferred stock are as follows:</font></div> <div>&#160;</div> <div align="center"> <table style="font-size: 10pt; width: 100%; font-family: times new roman;" cellspacing="0" cellpadding="0" bgcolor="white"> <tr> <td style="text-align: center;" width="5%"><font style="font-family: times new roman; font-size: 10pt;"><font style="display: inline; font-family: times new roman;">&#9679;</font></font></td> <td width="95%" colspan="2"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="font-family: times new roman; font-size: 10pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Dividends and Distributions.</font></font></div> </td> </tr> <tr> <td width="5%"><font style="font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td width="12%"><font style="font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td width="83%"><font style="font-family: times new roman; font-size: 10pt;">&#160;</font></td> </tr> <tr> <td width="5%"><font style="font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td valign="top" width="12%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="font-family: times new roman; font-size: 10pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Series A Preferred:</font></font></div> </td> <td width="83%"> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="font-family: times new roman; font-size: 10pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">The holders of shares of Series A Preferred stock are entitled to participate with the holders of our common stock with respect to any dividends declared on the common stock in proportion to the number of shares of common stock issuable upon conversion of the shares of Series A Preferred stock held by them.</font></font></div> </td> </tr> <tr> <td width="5%"><font style="font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td width="12%"><font style="font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td width="83%"><font style="font-family: times new roman; font-size: 10pt;">&#160;</font></td> </tr> <tr> <td width="5%"><font style="font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td valign="top" width="12%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="font-family: times new roman; font-size: 10pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Series B Preferred:</font></font></div> </td> <td width="83%"> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="font-family: times new roman; font-size: 10pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">The holders of shares of Series B Preferred stock are entitled to participate with the holders of our common stock with respect to any dividends declared on the common stock in proportion to the number of shares of common stock issuable upon conversion of the shares of Series B Preferred stock held by them.</font></font></div> </td> </tr> <tr> <td width="5%"><font style="font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td width="12%"><font style="font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td width="83%"><font style="font-family: times new roman; font-size: 10pt;">&#160;</font></td> </tr> <tr> <td style="text-align: center;" width="5%"><font style="font-family: times new roman; font-size: 10pt;"><font style="display: inline; font-family: times new roman;">&#9679;</font></font></td> <td width="95%" colspan="2"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="font-family: times new roman; font-size: 10pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Liquidation Preference.</font></font></div> </td> </tr> <tr> <td width="5%"><font style="font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td width="12%"><font style="font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td width="83%"><font style="font-family: times new roman; font-size: 10pt;">&#160;</font></td> </tr> <tr> <td width="5%"><font style="font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td valign="top" width="12%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="font-family: times new roman; font-size: 10pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Series A Preferred:</font></font></div> </td> <td width="83%"> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="font-family: times new roman; font-size: 10pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">In the event of any liquidation, dissolution, or winding up of our operations, either voluntary or involuntary, subject to the rights of any other series of Preferred stock to be established by the Board of Directors (the &#8220;Senior Preferred Stock&#8221;), the holders of Series A Preferred stock shall be entitled to receive, after any distribution to the holders of Senior Preferred Stock and prior to and in preference to any distribution to the holders of common stock, $0.001 for each share of Series A Preferred stock then outstanding.</font></font></div> </td> </tr> <tr> <td width="5%"><font style="font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td width="12%"><font style="font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td width="83%"><font style="font-family: times new roman; font-size: 10pt;">&#160;</font></td> </tr> <tr> <td width="5%"><font style="font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td valign="top" width="12%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="font-family: times new roman; font-size: 10pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Series B Preferred:</font></font></div> </td> <td width="83%"> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="font-family: times new roman; font-size: 10pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">In the event of any liquidation, dissolution, or winding up of our operations, either voluntary or involuntary, subject to the rights of the Series A Preferred stock and Senior Preferred Stock, the holders of Series B Preferred stock shall be entitled to receive, after any distribution to the holders of Senior Preferred Stock and prior to and in preference to any distribution to the holders of common stock, $0.001 for each share of Series B Preferred stock then outstanding.</font></font></div> </td> </tr> <tr> <td width="5%"><font style="font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td width="12%"><font style="font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td width="83%"><font style="font-family: times new roman; font-size: 10pt;">&#160;</font></td> </tr> <tr> <td style="text-align: center;" width="5%"><font style="font-family: times new roman; font-size: 10pt;"><font style="display: inline; font-family: times new roman;">&#9679;</font></font></td> <td width="12%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="font-family: times new roman; font-size: 10pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Voting.</font></font></div> </td> <td width="83%"><font style="font-family: times new roman; font-size: 10pt;">&#160;</font></td> </tr> <tr> <td style="text-align: center;" width="5%"><font style="font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td width="12%"><font style="font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td width="83%"><font style="font-family: times new roman; font-size: 10pt;">&#160;</font></td> </tr> <tr> <td style="text-align: center;" width="100%" colspan="3"> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="font-family: times new roman; font-size: 10pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;"><font style="margin-left: 36pt;"></font>The holders of shares of Series A Preferred stock and Series B Preferred stock shall have one vote for each share of Series A Preferred stock and Series B Preferred stock held by them.</font></font></div> </td> </tr> <tr> <td style="text-align: center;" width="5%"><font style="font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td width="12%"><font style="font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td width="83%"><font style="font-family: times new roman; font-size: 10pt;">&#160;</font></td> </tr> <tr> <td style="text-align: center;" width="5%"><font style="font-family: times new roman; font-size: 10pt;"><font style="display: inline; font-family: times new roman;">&#9679;</font></font></td> <td width="12%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="font-family: times new roman; font-size: 10pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Conversion.</font></font></div> </td> <td width="83%"><font style="font-family: times new roman; font-size: 10pt;">&#160;</font></td> </tr> </table> </div> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;"><font style="margin-left: 36pt;"></font>Initially, each share of Series A Preferred stock and each share of Series B Preferred stock was convertible into one share of our common stock.&#160;&#160;Any modification to the conversion rate requires shareholder approval. On March 31, 2009, our shareholders approved a resolution to increase the authorized share capital, and to increase the conversion ratio to 480.63 shares of common stock for each share of Series A Preferred stock and to 132.07 shares of our common stock for each shares of Series B Preferred stock, thus completing the restructuring begun in December 2008.</font></div> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">On April 24, 2009, we initiated the process of allowing the shareholders of our preferred stock to convert the Series A and B Preferred stock to shares of our common stock. In order to convert the preferred stock to common stock each preferred stock shareholder is required to submit the preferred stock certificate to our transfer agent and request conversion to common stock. The conversion to common stock is not mandatory and shareholders who own preferred stock may choose not to convert their preferred stock to shares of our common stock.&#160;&#160;The following table summarizes the Preferred stock not yet converted as of March 31, 2013.</font></div> <div style="text-indent: 0pt; display: block;">&#160;</div> <div align="left"> <table style="font-size: 10pt; width: 100%; font-family: times new roman;" cellspacing="0" cellpadding="0"> <tr> <td align="left" style="padding-bottom: 2px;" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="padding-bottom: 2px;" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td style="border-bottom: black 2px solid;" valign="bottom" colspan="2"> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Shares of Preferred Stock Not Exchanged as of March 31, 2013</font></div> </td> <td align="left" style="padding-bottom: 2px;" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="padding-bottom: 2px;" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td style="border-bottom: black 2px solid;" valign="bottom" colspan="2"> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Conversion Ratio</font></div> </td> <td align="left" style="padding-bottom: 2px;" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="padding-bottom: 2px;" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td style="border-bottom: black 2px solid;" valign="bottom" colspan="2"> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Shares of Common Stock after Conversion of all Outstanding Shares of Preferred Stock Not yet Exchanged at March 31, 2013</font></div> </td> <td align="left" style="padding-bottom: 2px;" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> <tr> <td align="left" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" colspan="2"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td align="left" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" colspan="2"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td align="left" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" colspan="2"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td align="left" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> <tr bgcolor="#cceeff"> <td style="padding-bottom: 4px;" valign="bottom" width="64%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Series B preferred stock</font></div> </div> </td> <td style="padding-bottom: 4px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td style="border-bottom: black 4px double;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td style="border-bottom: black 4px double;" valign="bottom" width="9%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">83</font></div> </div> </td> <td style="padding-bottom: 4px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td style="padding-bottom: 4px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td style="padding-bottom: 4px;" valign="bottom" width="9%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">132.07&#160;</font></div> </div> </td> <td style="padding-bottom: 4px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td style="padding-bottom: 4px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td style="border-bottom: black 4px double;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td style="border-bottom: black 4px double;" valign="bottom" width="9%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">10,962</font></div> </div> </td> <td style="padding-bottom: 4px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> </table> <font style="display: inline; font-family: times new roman; font-size: 10pt;"></font></div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;"><font style="display: inline;">4</font>.&#160; Deferred Revenue</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">As of March 31, 2013 and December 31, 2012, we have $2.0 million and $2.1 million, respectively, of deferred license fee revenue related to prepayments for future license fees from three customers and a total of $0.9 million and $0.6 million, respectively, of deferred engineering development fees from thirteen customers. We defer the license fees until we have met all accounting requirements for revenue recognition as per unit royalty products are distributed or licensed by the Company&#8217;s customers and the engineering development fee revenue until such time as the engineering work has been completed and accepted by our customers.</font></div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;"><font style="display: inline; font-weight: bold;">5. &#160;</font><font style="display: inline; font-weight: bold;">Stock-Based Compensation</font></font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;"><font style="margin-left: 36pt;" ></font>We have several approved stock option plans for which stock options and restricted stock awards are available to grant to employees, consultants and directors. All employee and director stock options granted under our stock option plans have an exercise price equal to the market value of the underlying common stock on the grant date. There are no vesting provisions tied to performance conditions for any options, as vesting for all outstanding option grants is based only on continued service as an employee, consultant or director. All of our outstanding stock options and restricted stock awards are classified as equity instruments.</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="font-style: italic; display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Stock Options</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">As of March 31, 2013, we had two equity incentive plans:</font></div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;">&#160;</div> <div align="center"> <table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0" bgcolor="white"> <tr> <td style="text-align: center;" width="4%"><font style="font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left;" width="4%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#9679;</font></td> <td width="92%"><font style="font-family: times new roman; font-size: 10pt;">The 1998 Non-Officer Stock Option Plan (the 1998 Plan), which expired in June 2008 ;</font></td> </tr> <tr> <td style="text-align: center;" width="4%"><font style="font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left;" width="4%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#9679;</font></td> <td width="92%"><font style="font-family: times new roman; font-size: 10pt;">The 2006 Equity Incentive Plan (the 2006 Plan).</font></td> </tr> <tr> <td style="text-align: center;" width="4%"><font style="font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left;" width="4%"><font style="font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td width="92%"><font style="font-family: times new roman; font-size: 10pt;">&#160;</font></td> </tr> <tr> <td style="text-align: center;" width="4%" colspan="3"> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">We also had one non-employee director stock option plan as of March 31, 2013:</font></div> </td> </tr> <tr> <td style="text-align: center;" width="4%"><font style="font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left;" width="4%"><font style="font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td width="92%"><font style="font-family: times new roman; font-size: 10pt;">&#160;</font></td> </tr> <tr> <td style="text-align: center;" width="4%"><font style="font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left;" width="4%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#9679;</font></td> <td width="92%"> <div style="text-align: left; text-indent: 0pt; margin-left: 0pt; margin-right: 0pt;"><font style="font-family: times new roman; font-size: 10pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">The 2001 Non-Employee Director Stock Option Plan (the Director Plan)<font style="display: inline; font-family: times new roman;"> which expired in March 2011.</font></font></font></div> </td> </tr> </table> </div> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;">&#160;<font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></div> <div align="left" style="text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">A summary of the combined activity under all of the stock option plans is set forth below:</font></div> <div style="text-indent: 0pt; display: block;">&#160;</div> <div align="left"> <table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0"> <tr> <td align="left" style="padding-bottom: 2px;" valign="bottom"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 1.6pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;&#160;</font></div> </td> <td align="left" style="padding-bottom: 2px;" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td style="border-bottom: 2px solid black;" valign="bottom" colspan="2"> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 3.6pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Number of Options Outstanding</font></div> </td> <td align="left" style="padding-bottom: 2px;" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="padding-bottom: 2px;" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td style="border-bottom: 2px solid black;" valign="bottom" colspan="2"> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 3.6pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Weighted Average Exercise Price</font></div> </td> <td align="left" style="padding-bottom: 2px;" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> <tr bgcolor="#cceeff"> <td align="left" valign="bottom" width="76%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 1.6pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Outstanding at January 1, 2013</font></div> </td> <td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">1,715,200</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></div> </td> <td align="right" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">5.04</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> <tr bgcolor="white"> <td align="left" valign="bottom" width="76%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 1.6pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Granted</font></div> </td> <td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">15,000</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">5.97</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> <tr bgcolor="#cceeff"> <td align="left" valign="bottom" width="76%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 1.6pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Cancelled or expired</font></div> </td> <td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">(200</font></div> </td> <td align="left" valign="bottom" width="1%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">)&#160;</font></div> </td> <td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">125.00</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> <tr bgcolor="white"> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="76%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 1.6pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Exercised</font></div> </td> <td align="right" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="border-bottom: 2px solid black;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" style="border-bottom: 2px solid black;" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">(38,456</font></div> </td> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">)&#160;</font></div> </td> <td align="right" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="border-bottom: 2px solid black;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" style="border-bottom: 2px solid black;" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">4.33</font></div> </td> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> <tr bgcolor="#cceeff"> <td align="left" style="padding-bottom: 4px;" valign="bottom" width="76%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 1.6pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Outstanding at March 31, 2013</font></div> </td> <td align="right" style="padding-bottom: 4px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="border-bottom: 4px double black;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" style="border-bottom: 4px double black;" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">1,691,544</font></div> </td> <td align="left" style="padding-bottom: 4px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" style="padding-bottom: 4px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="border-bottom: 4px double black;" valign="bottom" width="1%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></div> </td> <td align="right" style="border-bottom: 4px double black;" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">5.05</font></div> </td> <td align="left" style="padding-bottom: 4px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> </table> </div> <div style="text-indent: 0pt; display: block;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;<a name="fis_unidentified_table_22"></a><!--EFPlaceholder-->&#160;</font></div> <div style="text-indent: 0pt; display: block;"> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">On March 11, 2013, the Board approved the increase of the number of common stock authorized for issuance as incentive stock options under the 2006 Plan by 2 million shares.</font></div> </div> <div style="text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">The aggregate intrinsic value of the 1,691,544 stock options that are outstanding, vested and expected to vest at March 31, 2013 is $2.4 million.</font></div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;On March 19, 2013, the Company received an aggregate of $167,000 from two employees in connection with the exercise of stock options into 38,456 shares of common stock.&#160;&#160;The intrinsic value related to the options exercised was $58,000 on the date of exercise.</font></div> </div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">For the three months ended March 31, 2013 and 2012, the Company recorded $576,000 and $0, respectively, of compensation expense related to the vesting of stock options. The fair value of the stock-based compensation was calculated&#160;&#160;using the Black-Scholes option pricing model as of the date of grant of the stock option.</font></div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">We granted an option to purchase 15,000 shares of our common stock to an employee during the three months ended March 31, 2013 with a grant date fair value of $80,000 computed using the Black-Scholes option pricing model. We did not grant any options to purchase shares of our common stock to employees or members of our Board of Directors during the three months ended March 31, 2012.</font></font></div> </div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 36pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">See below for assumptions used in the valuation of stock options:</font></font></div> </div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;">&#160;</div> <div align="center"> <table style="width: 75%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0"> <tr> <td align="left" valign="bottom" width="63%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></div> </td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td valign="bottom" width="10%" colspan="2"> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">For the three months</font></div> </td> <td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> </tr> <tr> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="63%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></div> </td> <td style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="border-bottom: 2px solid black;" valign="bottom" width="10%" colspan="2"> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">ended March 31, 2013</font></div> </td> <td style="text-align: left; padding-bottom: 2px;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> </tr> <tr> <td align="left" valign="bottom" width="63%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td align="left" valign="bottom" width="10%" colspan="2"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></div> </td> <td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> </tr> <tr bgcolor="#cceeff"> <td align="left" valign="bottom" width="63%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;Annual dividend yield</font></div> </td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: center;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">-</font></td> <td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> </tr> <tr bgcolor="white"> <td align="left" valign="bottom" width="63%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;Expected life (years)</font></div> </td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: center;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">4.3</font></td> <td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> </tr> <tr bgcolor="#cceeff"> <td align="left" valign="bottom" width="63%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;Risk-free interest rate</font></div> </td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: center;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">0.65%</font></td> <td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap">&#160;</td> </tr> <tr bgcolor="white"> <td align="left" valign="bottom" width="63%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;Expected volatility</font></div> </td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: center;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">154%</font></td> <td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap">&#160;</td> </tr> </table> </div> <div style="text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">The 1998 Plan terminated effective June 15, 2008 and the Director Plan terminated effective March 2011. Although we can no longer issue stock options out of the plans, the outstanding options at the date of termination will remain outstanding and vest in accordance with their terms. Options granted under the Director Plan vested over a one to four-year period, expire five to seven years after the date of grant and have exercise prices reflecting market value of the shares of our common stock on the date of grant. Stock options granted under the 1998 and 2006 Plans are exercisable over a maximum term of ten years from the date of grant, vest in various installments over a one to four-year period and have exercise prices reflecting the market value of the shares of common stock on the date of grant.</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 18pt; display: block; margin-left: 18pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Warrants</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">During the three months ended March 31, 2013, certain warrant holders exercised their warrants under the cash and net cash provisions, as defined in the agreements. See Note 3 for details of such exercises and number of common stock shares issued.</font></font></div> </div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">On December 3, 2010, we issued 120,000 warrants at an exercise price of $1.63 per share to an employee. The fair value of the warrants was $198,000 on the date of grant, using the Black-Scholes option pricing model, which has been amortized to expense over 24 months. During the three months ended March 31, 2012, we recorded $25,000 of stock based compensation expense related to vesting of such warrants.</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">On September 12, 2011, we issued 20,000 three-year stock purchase warrants to an employee at an exercise price of $3.90 per share with a vesting period over 24 months. The warrant granted to an employee had a fair value on the date of grant of $75,000. This amount is expensed over the vesting period and $10,000 and $9,000 of expense related to this warrant is included in product research and development expense for the three months ended March 31, 2013 and 2012, respectively. The fair value of stock-based compensation related to the issuance of warrants is calculated using the Black-Scholes option pricing model as of the grant date of the underlying warrant.</font></div> <div align="left" style="text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font>&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">The stock-based compensation expense for the three months ended March 31, 2013 and 2012 reflects the fair value of the vested portion of options and warrants granted to directors, employees and non-employees. Stock-based compensation expense in the accompanying consolidated statements of operations is as follows (in thousands):</font></div> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div> <div align="center"> <table style="width: 80%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0"> <tr> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="56%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td style="border-bottom: 2px double black;" valign="bottom" width="10%" colspan="2"> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">2013</font></div> </td> <td style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td style="border-bottom: 2px double black;" valign="bottom" width="10%" colspan="2"> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">2012</font></div> </td> <td style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> <tr> <td align="left" valign="bottom" width="56%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="10%" colspan="2"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="10%" colspan="2"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> <tr bgcolor="#cceeff"> <td align="left" valign="bottom" width="56%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Product research and development</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></div> </td> <td align="right" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">60</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></div> </td> <td align="right" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">10</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> <tr bgcolor="white"> <td align="left" valign="bottom" width="56%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Sales and marketing</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">196</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">24</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> <tr bgcolor="#cceeff"> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="56%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">General and administrative</font></div> </td> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="border-bottom: 2px solid black;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" style="border-bottom: 2px solid black;" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">330</font></div> </td> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="border-bottom: 2px solid black;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" style="border-bottom: 2px solid black;" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">--</font></div> </td> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> <tr bgcolor="white"> <td align="left" style="padding-bottom: 4px;" valign="bottom" width="56%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Stock compensation expense</font></div> </td> <td align="left" style="padding-bottom: 4px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="border-bottom: 4px double black;" valign="bottom" width="1%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></div> </td> <td align="right" style="border-bottom: 4px double black;" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">586</font></div> </td> <td align="left" style="padding-bottom: 4px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="padding-bottom: 4px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="border-bottom: 4px double black;" valign="bottom" width="1%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></div> </td> <td align="right" style="border-bottom: 4px double black;" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">34</font></div> </td> <td align="left" style="padding-bottom: 4px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> </table> </div> <div style="text-indent: 0pt; display: block;">&#160;</div> <div align="center"> <table style="width: 80%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0"> <tr> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="68%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td style="border-bottom: 2px solid black;" valign="bottom" width="10%" colspan="2"> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Remaining unamortized</font></div> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">expense at</font></div> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">March 31,</font></div> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">2013</font></div> </td> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> <tr bgcolor="#cceeff"> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="68%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Stock-based compensation</font></div> </td> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="border-bottom: 2px solid black;" valign="bottom" width="1%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></div> </td> <td style="border-bottom: 2px solid black; text-align: right;" valign="bottom" width="9%"> <div style="text-align: right; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">3,060</font></div> </td> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> </table> </div> <div style="text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">The remaining unamortized expense related to stock options and warrants will be recognized on a straight line basis monthly as compensation expense over the remaining vesting period which approximates 3.0 years.</font></div> <div style="text-align: justify; text-indent: 45pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">The fair value of stock-based awards to employees is calculated using the Black-Scholes option pricing model, even though this model was developed to estimate the fair value of freely tradable, fully transferable options without vesting restrictions, which differ significantly from our stock options. The Black-Scholes model also requires subjective assumptions, including future stock price volatility and expected time to exercise, which greatly affect the calculated values. The expected term and forfeiture rate of options granted is derived from historical data on employee exercises and post-vesting employment termination behavior, as well as expected behavior on outstanding options. The risk-free rate is based on the U.S. Treasury rates in effect during the corresponding period of grant. The expected volatility is based on the historical volatility of our stock price. These factors could change in the future, which would affect fair values of stock options granted in such future periods, and could cause volatility in the total amount of the stock-based compensation expense reported in future periods.</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">A summary of all warrant activity is set forth below:</font></div> <div style="text-indent: 0pt; display: block;">&#160;</div> <div style="text-indent: 0pt; display: block;"> <div style="text-align: left; text-indent: 0pt; margin-left: 36pt; margin-right: 0pt;"> <table style="text-align: center; width: 80%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0"> <tr style="text-align: center;"> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="44%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td style="border-bottom: 2px solid black;" valign="bottom" width="34%" colspan="10"> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">March 31, 2013</font></div> </td> <td style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">&#160;</font></td> </tr> <tr> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="44%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Outstanding and exercisable</font></div> </td> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td style="border-bottom: 2px solid black;" valign="bottom" width="10%" colspan="2"> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Warrants</font></div> </td> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td style="border-bottom: 2px solid black;" valign="bottom" width="10%" colspan="2"> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Weighted </font></div> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Average </font></div> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Exercise Price</font></div> </td> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td style="border-bottom: 2px solid black;" valign="bottom" width="10%" colspan="2"> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Weighted </font></div> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Average</font></div> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Remaining </font></div> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Contractual Life</font></div> </td> <td style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="44%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">January 1, 2013</font></div> </div> </td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td valign="bottom" width="9%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">4,704,636</font></div> </div> </td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td valign="bottom" width="1%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></div> </div> </td> <td valign="bottom" width="9%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">1.61</font></div> </div> </td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td valign="bottom" width="9%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">1.41</font></div> </div> </td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> </tr> <tr bgcolor="white"> <td valign="bottom" width="44%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;&#160;&#160;Issued</font></div> </div> </td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td valign="bottom" width="9%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">--</font></div> </div> </td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td valign="bottom" width="9%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">--</font></div> </div> </td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td valign="bottom" width="9%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">--</font></div> </div> </td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="44%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;&#160;&#160;Expired/forfeited</font></div> </div> </td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td valign="bottom" width="9%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">(40,000</font></div> </div> </td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">)&#160; </font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td valign="bottom" width="9%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">1.00</font></div> </div> </td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td valign="bottom" width="9%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">--</font></div> </div> </td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> </tr> <tr bgcolor="white"> <td style="padding-bottom: 2px;" valign="bottom" width="44%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;&#160;&#160;Exercised</font></div> </div> </td> <td style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td style="border-bottom: 2px solid black;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td style="border-bottom: 2px solid black;" valign="bottom" width="9%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">(590,094</font></div> </div> </td> <td style="padding-bottom: 2px;" valign="bottom" width="1%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">)</font></div> </div> </td> <td style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td style="border-bottom: 2px solid black;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td style="border-bottom: 2px solid black;" valign="bottom" width="9%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">1.17</font></div> </div> </td> <td style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td style="border-bottom: 2px solid black;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td style="border-bottom: 2px solid black;" valign="bottom" width="9%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">--</font></div> </div> </td> <td style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> </tr> <tr bgcolor="#cceeff"> <td style="padding-bottom: 4px;" valign="bottom" width="44%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Outstanding and exercisable, March 31, 2013</font></div> </div> </td> <td style="padding-bottom: 4px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td style="border-bottom: 4px double black;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td style="border-bottom: 4px double black;" valign="bottom" width="9%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">4,074,542</font></div> </div> </td> <td style="padding-bottom: 4px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td style="padding-bottom: 4px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td style="border-bottom: 4px double black;" valign="bottom" width="1%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></div> </div> </td> <td style="border-bottom: 4px double black;" valign="bottom" width="9%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">1.69</font></div> </div> </td> <td style="padding-bottom: 4px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td style="padding-bottom: 4px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td style="border-bottom: 4px double black;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td style="border-bottom: 4px double black;" valign="bottom" width="9%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">1.15</font></div> </div> </td> <td style="padding-bottom: 4px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> </tr> </table> </div> </div> <div style="text-indent: 0pt; display: block;">&#160;&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">During the three months ended March 31, 2013, warrant holders (excluding our CFO) exercised warrants to purchase 270,094 shares of common stock using the net exercise provision allowed in the warrant and received 198,512 shares of our common stock.</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">On February 26, 2013, David Brunton, our CFO, exercised warrants to purchase 320,000 shares of common stock using the net exercise provision allowed in the warrant and received 266,228 shares of our common stock.</font></div> <div style="text-indent: 0pt; display: block;">&#160;</div> <div align="center"> <table style="width: 90%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0"> <tr> <td valign="bottom" width="89%" colspan="11"> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 12.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Below is a summary of Outstanding Warrants to Purchase</font></div> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 12.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Common Stock as of March 31, 2013:</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> <tr> <td align="left" valign="bottom" width="47%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td align="left" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="10%" colspan="2"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="10%" colspan="2"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> <tr> <td align="left" style="border-bottom: 2px solid black;" valign="bottom" width="47%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Description</font></div> </td> <td style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">&#160;</font></td> <td style="border-bottom: 2px solid black;" valign="bottom" width="9%"> <div align="center" style="text-indent: 9pt; display: block; margin-left: 0pt; margin-right: 1.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Issue&#160;&#160;Date</font></div> </td> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td style="border-bottom: 2px solid black;" valign="bottom" width="10%" colspan="2"> <div align="center" style="text-indent: 9pt; display: block; margin-left: 0pt; margin-right: 1.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Exercise Price</font></div> </td> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td style="border-bottom: 2px solid black;" valign="bottom" width="9%"> <div align="center" style="text-indent: 18pt; display: block; margin-left: 0pt; margin-right: 1.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Shares</font></div> </td> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td style="border-bottom: 2px solid black;" valign="bottom" width="10%" colspan="2"> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 1.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Expiration Date</font></div> </td> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> <tr> <td align="left" valign="bottom" width="47%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td align="left" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="10%" colspan="2"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="10%" colspan="2"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="47%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">August 2009 Employee Warrants</font></div> </div> </td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td valign="bottom" width="9%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">8/25/2009</font></div> </div> </td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td valign="bottom" width="1%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></div> </div> </td> <td valign="bottom" width="9%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">0.50</font></div> </div> </td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td valign="bottom" width="9%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;"><font style="display: inline; font-family: times new roman;">8</font>0,000</font></div> </div> </td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td valign="bottom" width="9%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">8/25/2016</font></div> </div> </td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> <tr bgcolor="white"> <td valign="bottom" width="47%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">2007 Debt Extension Warrants</font></div> </div> </td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td valign="bottom" width="9%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">9/22/2010</font></div> </div> </td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td valign="bottom" width="1%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></div> </div> </td> <td valign="bottom" width="9%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">1.00</font></div> </div> </td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td valign="bottom" width="9%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">16,000</font></div> </div> </td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td valign="bottom" width="9%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">9/22/2015</font></div> </div> </td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="47%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">September 2010 Repricing Warrant</font></div> </div> </td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td valign="bottom" width="9%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">9/28/2010</font></div> </div> </td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td valign="bottom" width="1%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></div> </div> </td> <td valign="bottom" width="9%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">1.38</font></div> </div> </td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td valign="bottom" width="9%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;"><font style="display: inline; font-family: times new roman;">4</font>,000</font></div> </div> </td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td valign="bottom" width="9%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">9/28/2013</font></div> </div> </td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> <tr bgcolor="white"> <td valign="bottom" width="47%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">October 2010 Repricing Warrants</font></div> </div> </td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td valign="bottom" width="9%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">10/18/2010</font></div> </div> </td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td valign="bottom" width="1%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></div> </div> </td> <td valign="bottom" width="9%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">1.38</font></div> </div> </td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td valign="bottom" width="9%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">2,078,433</font></div> </div> </td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td valign="bottom" width="9%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">10/18/2013</font></div> </div> </td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="47%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">October 2010 Employee Warrants</font></div> </div> </td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td valign="bottom" width="9%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">10/15/2010</font></div> </div> </td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td valign="bottom" width="1%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></div> </div> </td> <td valign="bottom" width="9%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">1.38</font></div> </div> </td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td valign="bottom" width="9%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">920,000</font></div> </div> </td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td valign="bottom" width="9%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">10/15/2013</font></div> </div> </td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> <tr bgcolor="white"> <td valign="bottom" width="47%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">December 2010 Employee Warrants</font></div> </div> </td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td valign="bottom" width="9%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">12/3/2010</font></div> </div> </td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td valign="bottom" width="1%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></div> </div> </td> <td valign="bottom" width="9%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">1.63</font></div> </div> </td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td valign="bottom" width="9%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">200,000</font></div> </div> </td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td valign="bottom" width="9%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">12/3/2015</font></div> </div> </td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="47%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">January 2011 Employee Warrant</font></div> </div> </td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td valign="bottom" width="9%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">1/21/2011</font></div> </div> </td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td valign="bottom" width="1%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></div> </div> </td> <td valign="bottom" width="9%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">2.00</font></div> </div> </td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td valign="bottom" width="9%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">20,000</font></div> </div> </td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td valign="bottom" width="9%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">1/21/2014</font></div> </div> </td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> <tr bgcolor="white"> <td valign="bottom" width="47%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">February 2011 Legal Advisor Warrant</font></div> </div> </td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td valign="bottom" width="9%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">2/22/2011</font></div> </div> </td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td valign="bottom" width="1%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></div> </div> </td> <td valign="bottom" width="9%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">2.50</font></div> </div> </td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td valign="bottom" width="9%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">80,000</font></div> </div> </td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td valign="bottom" width="9%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">2/22/2016</font></div> </div> </td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="47%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">March&#160;&#160;2011 Investor Warrants</font></div> </div> </td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td valign="bottom" width="9%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">3/9/2011</font></div> </div> </td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td valign="bottom" width="1%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></div> </div> </td> <td valign="bottom" width="9%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">3.13</font></div> </div> </td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td valign="bottom" width="9%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">602,009</font></div> </div> </td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td valign="bottom" width="9%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">3/9/2016</font></div> </div> </td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> <tr bgcolor="white"> <td valign="bottom" width="47%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">March&#160;&#160;2011 Investor Warrants</font></div> </div> </td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td valign="bottom" width="9%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">4/7/2011</font></div> </div> </td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td valign="bottom" width="1%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></div> </div> </td> <td valign="bottom" width="9%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">3.13</font></div> </div> </td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td valign="bottom" width="9%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">34,100</font></div> </div> </td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td valign="bottom" width="9%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">4/7/2016</font></div> </div> </td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="47%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">May 2011 Consultant Warrant</font></div> </div> </td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td valign="bottom" width="9%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">5/17/2011</font></div> </div> </td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td valign="bottom" width="1%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></div> </div> </td> <td valign="bottom" width="9%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">4.05</font></div> </div> </td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td valign="bottom" width="9%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">20,000</font></div> </div> </td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td valign="bottom" width="9%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">5/17/2014</font></div> </div> </td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> <tr bgcolor="white"> <td style="padding-bottom: 2px;" valign="bottom" width="47%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">September 2011 Employee Warrant</font></div> </div> </td> <td style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="padding-bottom: 2px;" valign="bottom" width="9%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">9/12/2011</font></div> </div> </td> <td style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td style="padding-bottom: 2px;" valign="bottom" width="1%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></div> </div> </td> <td style="padding-bottom: 2px;" valign="bottom" width="9%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">3.90</font></div> </div> </td> <td style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td style="border-bottom: 2px solid black;" valign="bottom" width="9%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">20,000</font></div> </div> </td> <td style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td style="padding-bottom: 2px;" valign="bottom" width="9%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">9/12/2014</font></div> </div> </td> <td style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> <tr bgcolor="#cceeff"> <td style="padding-bottom: 4px;" valign="bottom" width="47%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Total Warrants Outstanding</font></div> </div> </td> <td style="padding-bottom: 4px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="padding-bottom: 4px;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td style="padding-bottom: 4px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td style="padding-bottom: 4px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td style="padding-bottom: 4px;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td style="padding-bottom: 4px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td style="border-bottom: 4px double black;" valign="bottom" width="9%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div style="text-align: right; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">4,074,542</font></div> </div> </td> <td style="padding-bottom: 4px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td style="padding-bottom: 4px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td style="padding-bottom: 4px;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td style="padding-bottom: 4px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> </table> </div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">6.&#160;&#160; Commitments and Contingencies</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 36pt; margin-right: 0pt;"><font style="font-style: italic; display: inline; font-family: times new roman; font-size: 10pt;">Non-Recurring Engineering Development Costs</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Neonode and Texas Instruments Inc. (&#8220;TI&#8221;) entered into an Analog Device Development Agreement (&#8220;Agreement&#8221;) on January 24, 2010 where TI integrated Neonode&#8217;s intellectual property into an Application Specific Integrated Circuit (&#8220;ASIC&#8221;) developed by TI. The TI ASIC is designated as NN1001 and can be sold by TI exclusively to licensees of Neonode. Under the terms of the Agreement, Neonode is obligated to contribute $500,000 of non-recurring engineering development costs (&#8220;NRE&#8221;) to TI based on shipments of the NN1001. Neonode will contribute to TI the NRE as follows:</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 99pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">For each of the first one million units:&#160;&#160;$0.08 per unit</font></div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 99pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">For the next eight million units: $0.05 per unit</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;In the three months ended March 31, 2013, $217,600 of NRE expense related to this agreement is included in product research and development on the condensed consolidated statement of operations. No amounts were recorded in the three months ended March 31, 2012 as no shipments of NN1001 took place.</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;&#160;</div> <div style="text-align: justify; text-indent: 18pt; display: block; margin-left: 18pt; margin-right: 0pt;"><font style="font-style: italic; display: inline; font-family: times new roman; font-size: 10pt;">Operating Leases</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Neonode Technologies AB has a lease with Vasakronan Fastigheter AB for 2,723 square feet of office space located at Linnegatan 89D, Stockholm, Sweden for approximately $8,000 per month including property tax (excluding VAT). The annual payment for this space equates to approximately $93,000 per year including property tax (excluding VAT). This lease is valid thru December 31, 2014, with a nine month notice period. The contract will be extended for an additional three years if it is not terminated according to the terms in the contract.</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">On April 15, 2012, Neonode Technologies AB entered into a lease with No Picnic for 2,853 square feet of office space located at Storgatan 23C, Stockholm, Sweden for approximately $14,000 per month including property tax (excluding VAT). The annual payment for this space equates to approximately $174,000 per year including property tax (excluding VAT). This lease is valid through April 15, 2013. On April 16, 2013 this lease was extended for one year until April 15, 2014 under the same terms and conditions. Rent remains at approximately $14,000 per month including property tax (excluding VAT).</font></div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">On March 22, 2012, we entered into a three year lease with 2350 Mission Investors LLC for 3,185 square feet of office space located at 2350 Mission College Blvd, Suite 190, Santa Clara, CA 95054 USA. The initial lease payment is $7,007 per month, increasing to $7,657 per month over the term of the lease. This lease is valid through July 31, 2015. The annual payment for this space equates to approximately $86,000 per year.</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">On October 12, 2012, we entered into a two year lease with Space design Inc., Meiko Building 3F, 1-18-2 Shimbashi, Minato-ku, 105-0004 Tokyo for office space located at 608 Bureau Shinagawa, 4-1-6 Konan, Minato-ku, 108-0075 Tokyo, Japan. The lease payment is approximately $3,000 per month. This lease is valid through October 12, 2014. The annual payment for this space equates to approximately $36,000 per year.</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="left" style="text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">For the three months ended March&#160;&#160;31, 2013 and 2012, the Company recorded approximately $120,000 and $103,000, respectively, for rent expense.</font></font></div> </div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">A summary of future minimum payments under non-cancellable operating lease commitments as of March 31, 2013 is as follows (in thousands):</font></font></div> </div> <div style="text-align: center;">&#160;</div> <div style="text-align: center;"> <table style="text-align: center; width: 80%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0"> <tr style="text-align: center;"> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="68%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; text-decoration: underline;">Year ending December 31,</font></div> </td> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td style="border-bottom: 2px solid black;" valign="bottom" width="10%" colspan="2"> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Total</font></div> </td> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> <tr bgcolor="#cceeff"> <td align="left" valign="bottom" width="68%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 18pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">2013</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></div> </td> <td align="right" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">293</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> <tr bgcolor="white"> <td align="left" valign="bottom" width="68%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 18pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">2014</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">255</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> <tr bgcolor="#cceeff"> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="68%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 18pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">2015</font></div> </td> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="border-bottom: 2px solid black;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" style="border-bottom: 2px solid black;" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">23</font></div> </td> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> <tr bgcolor="white"> <td align="left" style="padding-bottom: 4px;" valign="bottom" width="68%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="padding-bottom: 4px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="border-bottom: 4px double black;" valign="bottom" width="1%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></div> </td> <td align="right" style="border-bottom: 4px double black;" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">571</font></div> </td> <td align="left" style="padding-bottom: 4px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> </table> </div> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;"><font style="display: inline; font-weight: bold;">7</font><font style="display: inline; font-family: times new roman; font-weight: bold;">.&#160; </font><font style="display: inline; font-weight: bold;">Segment Information</font></font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;"><font style="margin-left: 36pt;"></font><font style="display: inline;">The Company has one reportable segment, which is comprised of the touchscreen technology licensing business.</font> All of our sales for the three months ended March 31, 2013 and 2012 were to customers located in the U.S., Europe and Asia.</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;"><font style="margin-left: 36pt;"></font>The following table presents net revenues by geographic region for the three months ended March 31, 2013 and 2012 (dollars in thousands):</font></div> <div style="text-indent: 0pt; display: block;">&#160;</div> <div align="left"> <table style="font-size: 10pt; width: 100%; font-family: times new roman;" cellspacing="0" cellpadding="0"> <tr> <td align="left" style="padding-bottom: 2px;" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="padding-bottom: 2px;" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td style="border-bottom: black 2px solid;" valign="bottom" colspan="6"> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">2013</font></div> </td> <td align="left" style="padding-bottom: 2px;" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> <tr> <td align="left" style="padding-bottom: 2px;" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="padding-bottom: 2px;" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td style="border-bottom: black 2px solid;" valign="bottom" colspan="2"> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;"><font style="display: inline;">Amount</font></font></div> </td> <td align="left" style="padding-bottom: 2px;" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="padding-bottom: 2px;" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td style="border-bottom: black 2px solid;" valign="bottom" colspan="2"> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;"><font style="display: inline;">Percentage</font></font></div> </td> <td align="left" style="padding-bottom: 2px;" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> <tr bgcolor="#cceeff"> <td align="left" valign="bottom" width="76%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Net revenues from customers in the U.S.</font></div> </td> <td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></div> </td> <td align="right" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">292</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">53</font></div> </td> <td align="left" valign="bottom" width="1%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">%</font></div> </td> </tr> <tr bgcolor="white"> <td align="left" valign="bottom" width="76%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Net revenues from customers in Europe</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">18</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">43</font></div> </td> <td align="left" valign="bottom" width="1%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">%&#160;</font></div> </td> </tr> <tr bgcolor="#cceeff"> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="76%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Net revenues from customers in Asia</font></div> </td> <td align="right" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="border-bottom: black 2px solid;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" style="border-bottom: black 2px solid;" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">238</font></div> </td> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="border-bottom: black 2px solid;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" style="border-bottom: black 2px solid;" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">44</font></div> </td> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">%</font></div> </td> </tr> <tr bgcolor="white"> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="76%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="border-bottom: black 2px solid;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="border-bottom: black 2px solid;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="border-bottom: black 2px solid;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="border-bottom: black 2px solid;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> <tr bgcolor="#cceeff"> <td align="left" style="padding-bottom: 4px;" valign="bottom" width="76%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;Total</font></div> </td> <td align="right" style="padding-bottom: 4px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="border-bottom: black 4px double;" valign="bottom" width="1%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></div> </td> <td align="right" style="border-bottom: black 4px double;" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">548</font></div> </td> <td align="left" style="padding-bottom: 4px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" style="padding-bottom: 4px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="border-bottom: black 4px double;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" style="border-bottom: black 4px double;" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">100</font></div> </td> <td align="left" style="padding-bottom: 4px;" valign="bottom" width="1%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">%</font></div> </td> </tr> <tr bgcolor="white"> <td align="left" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" colspan="6"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td align="left" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> <tr bgcolor="white"> <td align="left" style="padding-bottom: 2px;" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="padding-bottom: 2px;" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td style="border-bottom: black 2px solid;" valign="bottom" colspan="6"> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">2012</font></div> </td> <td align="left" style="padding-bottom: 2px;" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> <tr bgcolor="white"> <td align="left" style="padding-bottom: 2px;" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="padding-bottom: 2px;" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td style="border-bottom: black 2px double;" valign="bottom" colspan="2"> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;"><font style="display: inline;">Amount</font></font></div> </td> <td align="left" style="padding-bottom: 2px;" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="padding-bottom: 2px;" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td style="border-bottom: black 2px double;" valign="bottom" colspan="2"> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;"><font style="display: inline;">Percentage</font></font></div> </td> <td align="left" style="padding-bottom: 2px;" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> <tr bgcolor="#cceeff"> <td align="left" valign="bottom" width="76%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Net revenues from customers in the U.S.</font></div> </td> <td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></div> </td> <td align="right" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">974</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">84</font></div> </td> <td align="left" valign="bottom" width="1%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">%</font></div> </td> </tr> <tr bgcolor="white"> <td align="left" valign="bottom" width="76%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Net revenues from customers in Europe</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">--</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;--</font></div> </td> </tr> <tr bgcolor="#cceeff"> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="76%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Net revenues from customers in Asia</font></div> </td> <td align="right" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="border-bottom: black 2px solid;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" style="border-bottom: black 2px solid;" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">190</font></div> </td> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="border-bottom: black 2px solid;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" style="border-bottom: black 2px solid;" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">16</font></div> </td> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">%</font></div> </td> </tr> <tr bgcolor="white"> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="76%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="border-bottom: black 2px solid;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="border-bottom: black 2px solid;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="border-bottom: black 2px solid;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="border-bottom: black 2px solid;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> <tr bgcolor="#cceeff"> <td align="left" style="padding-bottom: 4px;" valign="bottom" width="76%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;Total</font></div> </td> <td align="right" style="padding-bottom: 4px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="border-bottom: black 4px double;" valign="bottom" width="1%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></div> </td> <td align="right" style="border-bottom: black 4px double;" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">1,164</font></div> </td> <td align="left" style="padding-bottom: 4px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" style="padding-bottom: 4px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="border-bottom: black 4px double;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" style="border-bottom: black 4px double;" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">100</font></div> </td> <td align="left" style="padding-bottom: 4px;" valign="bottom" width="1%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">%</font></div> </td> </tr> </table> </div> <div style="text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;"><font style="display: inline; font-weight: bold;">8.&#160; </font><font style="display: inline; font-weight: bold;">Net Loss Per Share</font></font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;"><font style="margin-left: 36pt;" ></font>Basic net loss per common share for the three months ended March 31, 2013 and 2012 was computed by dividing the net loss for the relevant period by the weighted average number of shares of common stock outstanding. Diluted loss per common share is computed by dividing net loss by the weighted average number of shares of common stock and common stock equivalents outstanding.</font></div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Potential common stock equivalents of approximately 309,000 and 11,500 outstanding stock options, 2.8 million and 3.2 million outstanding stock warrants under the treasury stock method and 11,000 and 52,000 shares issuable upon conversion of preferred stock are excluded from the diluted earnings per share calculation for the periods ended March 31, 2013 and 2012, respectively, due to their anti-dilutive effect.</font></font></div> </div> <div> <div align="left"> <table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0"> <tr> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="76%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; text-decoration: underline;">(in thousands, except per share amounts)</font></div> </td> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="border-bottom: 2px solid black; text-align: center;" valign="bottom" colspan="6"> <div style="text-align: center; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div style="text-align: center; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Three Months ended</font></font></div> </div> <div style="text-align: center; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">March 31,</font></div> </td> <td style="text-align: left; padding-bottom: 2px;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> </tr> <tr> <td style="padding-bottom: 2px;" valign="bottom" width="76%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="border-bottom: 2px solid black; text-align: center; text-indent: 0pt; margin-left: 0pt; margin-right: 0pt;" valign="bottom" colspan="2"> <div style="text-align: center; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">2013</font></div> </td> <td style="text-align: left; padding-bottom: 2px;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="border-bottom: 2px solid black; text-align: center; text-indent: 0pt; margin-left: 0pt; margin-right: 0pt;" valign="bottom" width="10%" colspan="2"> <div style="text-align: center; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">2012</font></div> </td> <td style="text-align: left; padding-bottom: 2px;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> </tr> <tr> <td align="left" valign="bottom" width="76%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">BASIC AND DILUTED</font></div> </td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td valign="bottom" colspan="2"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td valign="bottom" width="10%" colspan="2"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> </tr> <tr bgcolor="#cceeff"> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="76%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Weighted average number of </font>common shares outstanding</font></div> </div> </td> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="border-bottom: 2px solid black; text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="border-bottom: 2px solid black; text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">33,511</font></td> <td style="text-align: left; padding-bottom: 2px;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="border-bottom: 2px solid black; text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="border-bottom: 2px solid black; text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">32,809</font></td> <td style="text-align: left; padding-bottom: 2px;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> </tr> <tr bgcolor="white"> <td align="left" style="padding-bottom: 4px;" valign="bottom" width="76%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Number of shares for computation of</font>&#160;net loss per share</font></div> </div> </td> <td align="left" style="padding-bottom: 4px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="border-bottom: 4px double black; text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="border-bottom: 4px double black; text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">33,511</font></td> <td style="text-align: left; padding-bottom: 4px;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td align="left" style="padding-bottom: 4px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="border-bottom: 4px double black; text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="border-bottom: 4px double black; text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">32,809</font></td> <td style="text-align: left; padding-bottom: 4px;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="76%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> </tr> <tr bgcolor="white"> <td align="left" style="padding-bottom: 4px;" valign="bottom" width="76%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Net loss</font></div> </td> <td align="left" style="padding-bottom: 4px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="border-bottom: 4px double black; text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></td> <td style="border-bottom: 4px double black; text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">(3,570</font></td> <td style="text-align: left; padding-bottom: 4px;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">)</font></td> <td align="left" style="padding-bottom: 4px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="border-bottom: 4px double black; text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></td> <td style="border-bottom: 4px double black; text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">(1,588</font></td> <td style="text-align: left; padding-bottom: 4px;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">)</font></td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="76%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> </tr> <tr bgcolor="white"> <td align="left" style="padding-bottom: 4px;" valign="bottom" width="76%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Net loss per share - basic and diluted</font></div> </td> <td align="left" style="padding-bottom: 4px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="border-bottom: 4px double black; text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></td> <td style="border-bottom: 4px double black; text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">(0.11</font></td> <td style="text-align: left; padding-bottom: 4px;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">)</font></td> <td align="left" style="padding-bottom: 4px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="border-bottom: 4px double black; text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></td> <td style="border-bottom: 4px double black; text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">(0.05</font></td> <td style="text-align: left; padding-bottom: 4px;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">)</font></td> </tr> </table> </div> </div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;"><font style="display: inline; font-weight: bold;">9.&#160; </font><font style="display: inline; font-weight: bold;">Subsequent Events</font></font></div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">On April 1, 2013, warrant holders exercised warrants to purchase 55,000 shares of common stock using the net exercise provision allowed in the warrant and received 25,720 shares of our common stock.</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;">On April 3, 2013, the Company issued a warrant to an investor to purchase 40,000 shares of common stock at an exercise price of $1.00 per share. On April 4, 2013 the warrant holder paid $40,000 and exercised the warrant.</div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">On April 5, 2013, a warrant holder paid $120,244 in connection with a cash exercise of a warrant to purchase 80,000 shares of common stock with an exercise price of $1.38 per share and a warrant to purchase 3,145 shares of common stock with an exercise price of $3.13 per share.</font></div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">On April 16, 2013, Neonode Technologies AB renewed a lease with No Picnic for 2,853 square feet of office space located at Storgatan 23C, Stockholm, Sweden for approximately $14,000 per month including property tax (excluding VAT). The annual payment for this space equates to approximately $174,000 per year including property tax (excluding VAT). This lease is valid through April 15, 2014.</font></div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">On April 18, 2013, a warrant holder exercised a warrant to purchase 40,000 shares of common stock using the net exercise provision allowed in the warrant and received 30,663 shares of our common stock.</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">On May 3, 2013, a warrant holder paid $34,500 in connection with a cash exercise of a warrant to purchase 25,000 shares of common stock with an exercise price of $1.38 per share.</font></div> <div style="text-align: justify; text-indent: 18pt; display: block; margin-left: 18pt; margin-right: 0pt;"><font style="font-style: italic; display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Principles of Consolidation</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">The condensed consolidated balance sheet at December 31, 2012 and the condensed consolidated statements of operations, other comprehensive loss, and cash flows for the three months ended March 31, 2012 includes our accounts and the accounts of our wholly owned Swedish subsidiary Neonode Technologies AB (&#8220;NTAB&#8221;).&#160;&#160;All significant intercompany accounts and transactions have been eliminated.</font></font></div> </div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">The condensed consolidated balance sheet at March 31, 2013 and the condensed consolidated statements of operations, other comprehensive loss, and cash flows for the three months ended March 31, 2013&#160;&#160;include our accounts and the accounts of our wholly owned subsidiaries, NTAB, Neonode Americas Inc. (&#8220;NAI&#8221;), Neonode Japan Inc. (&#8220;NJKK&#8221;), NEON Technologies Inc. (&#8220;NTI&#8221;) and Neonode UI AB (&#8220;NUIAB&#8221;).&#160;&#160;All significant intercompany accounts and transactions have been eliminated.</font></font></div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Neonode management has made several strategic decisions to establish their presence in international markets that provide access to tier one customers and demonstrate Neonode&#8217;s long term commitment to these markets. NJKK was created in January 2013 to reach out to customers with global reach in electronics, automotive and home appliance markets.&#160;&#160;NUIAB was created to address particular opportunities that exist in this significant user interface arena as some aspects of our technology lends itself to ease of interacting with electronic devices. NTI and NAI were established to create a more focused organization with specific marketing, research and development goals. Furthermore, by creating separate entities, their performances can be directed and observed more clearly.</font></div> </div> </div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 36pt; margin-right: 0pt;"><font style="font-style: italic; display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Estimates</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;"><font style="margin-left: 36pt;" ></font>The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires making estimates and assumptions that affect, at the date of the financial statements, the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities and the reported amounts of revenue and expenses. Actual results could differ from these estimates. Significant estimates include, but are not limited to, collectibility of accounts receivable, recoverability of long-lived assets, the valuation allowance related to our deferred tax assets and the fair value of options and warrants issued for stock-based compensation.</font></div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 36pt; margin-right: 0pt;"><font style="font-style: italic; display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Concentration of Cash Balance Risks</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Cash balances are maintained at various banks in the U.S., Japan and Sweden. At times, deposits held with financial institutions in the United States of America may exceed the amount of insurance provided by the Federal Deposit Insurance Corporation (&#8220;FDIC&#8221;), which provides basic deposit coverage with limits up to $250,000 per owner. The Swedish government provides insurance coverage up to 100,000 euro per customer and covers deposits in all types of accounts. As of March 31, 2013, the Company has approximately $7.2 million in excess of insurance limits.</font></font></div> </div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 36pt; margin-right: 0pt;"><font style="font-style: italic; display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Accounts Receivable and Allowance for Doubtful Accounts&#160;&#160;</font></div> <div style="text-align: left; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Our accounts receivable are stated at net realizable value. Our policy is to maintain allowances for estimated losses resulting from the inability of our customers to make required payments. Credit limits are established through a process of reviewing the financial history and stability of each customer. Where appropriate, we obtain credit rating reports and financial statements of the customer when determining or modifying its credit limits. We regularly evaluate the collectibility of our trade receivable balances based on a combination of factors. When a customer&#8217;s account balance becomes past due, we initiate dialogue with the customer to determine the cause. If it is determined that the customer will be unable to meet its financial obligation, such as in the case of a bankruptcy filing, deterioration in the customer&#8217;s operating results or financial position or other material events impacting its business, we record a specific allowance to reduce the related receivable to the amount we expect to recover. Should all efforts fail to recover the related receivable, we will write-off the account. We also record an allowance based on certain other factors including the length of time the receivables are past due and historical collection experience with customers.&#160;&#160;We determined that an allowance for doubtful accounts was not necessary at March 31, 2013 and December 31, 2012.</font></div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 36pt; margin-right: 0pt;"><font style="font-style: italic; display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Property and Equipment</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Property and equipment are stated at cost, net of accumulated depreciation and amortization. Depreciation and amortization are computed using the straight-line method based upon estimated useful lives of the assets as follows:</font></div> <div style="text-indent: 0pt; display: block;">&#160;</div> <div align="center"> <table style="font-size: 10pt; width: 80%; font-family: times new roman;" cellspacing="0" cellpadding="0"> <tr> <td valign="top" width="26%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td valign="top" width="26%"> <div style="text-align: left; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;"><font style="display: inline; text-decoration: underline;">Estimated useful lives</font></font></font></div> </td> </tr> <tr bgcolor="#cceeff"> <td valign="top" width="26%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Computer equipment</font></div> </div> </td> <td valign="top" width="26%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">3 years</font></div> </div> </td> </tr> <tr bgcolor="white"> <td valign="top" width="26%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Furniture and fixtures</font></div> </div> </td> <td valign="top" width="26%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">5 years</font></div> </div> </td> </tr> </table> </div> <div style="text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Equipment purchased under capital leases is amortized on a straight-line basis over the estimated useful life of the asset or the term of the lease, whichever is shorter.</font></div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Upon retirement or sale of property and equipment, cost and accumulated depreciation and amortization are removed from the accounts and any gains or losses are reflected in the consolidated statement of operations. Maintenance and repairs are charged to expense as incurred.</font></div> <div style="text-align: left; text-indent: 0pt; display: block; margin-left: 36pt; margin-right: 0pt;"><font style="font-style: italic; display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Long-lived Assets</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">We assess any impairment by estimating the future cash flow from the associated asset in accordance with relevant accounting guidance. If the estimated undiscounted future cash flow related to these assets decreases or the useful life is shorter than originally estimated, we may incur charges for impairment of these assets.&#160;&#160;At March 31, 2013, we believe there is no impairment of our long-lived assets.</font></div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 36pt; margin-right: 0pt;"><font style="font-style: italic; display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Foreign Currency Translation and Transaction Gains and Losses</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">The functional currency of our foreign subsidiaries is the applicable local currency, the Swedish Krona and Japanese Yen. The translation from Swedish Krona and Japanese Yen to U.S. Dollars is performed for balance sheet accounts using current exchange rates in effect at the balance sheet date and for income statement accounts using a weighted-average exchange rate during the period. Foreign currency translation gains were $13,000 and $44,000 during the three months ended March 31, 2013 and 2012, respectively. Gains or losses resulting from translation are included as a separate component of accumulated other comprehensive loss. Gains or losses resulting from foreign currency transactions are included in general and administrative expense in the accompanying condensed consolidated statements of operations and were $37,000 and $62,000 during the three months ended March 31, 2013 and 2012, respectively.</font></div> <div style="text-indent: 0pt; display: block; margin-left: 36pt;"><font style="font-style: italic; display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Concentration of Credit and Business Risks</font></div> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Our accounts receivable as of March 31, 2013 was due from twelve customers, five of which accounted for 72% of our accounts receivable as of March 31, 2013. Our net revenues for the three months ended March 31, 2013 was earned from nine customers. Our customers are located in the U.S., Europe and Asia. Customers which accounted for 10% or more of our net revenues during the three months ended March 31, 2013 are as follows:</font></div> <div style="text-indent: 0pt; display: block;">&#160;</div> <div> <table style="font-size: 10pt; width: 100%; font-family: times new roman;" cellspacing="0" cellpadding="0"> <tr valign="top"> <td style="text-align: right; width: 63pt;"> <div style="text-align: right;"><font style="display: inline; font-family: times new roman;">&#9679;<font style="font-style: italic; display: inline;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></font></div> </td> <td> <div align="justify" style="text-indent: 0pt; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Kobo - 44%</font></div> </td> </tr> </table> </div> <div> <table style="font-size: 10pt; width: 100%; font-family: times new roman;" cellspacing="0" cellpadding="0"> <tr valign="top"> <td align="right" style="width: 63pt;"> <div><font style="font-style: italic; display: inline; font-size: 10pt; ; font-family: symbol, serif;"><font style="display: inline; font-family: times new roman;">&#9679;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></font></div> </td> <td> <div align="justify" style="text-indent: 0pt; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Sony Corporation -20%</font></div> </td> </tr> </table> </div> <div> <table style="font-size: 10pt; width: 100%; font-family: times new roman;" cellspacing="0" cellpadding="0"> <tr valign="top"> <td align="right" style="width: 63pt;"> <div><font style="font-style: italic; display: inline; font-size: 10pt; ; font-family: symbol, serif;"><font style="display: inline; font-family: times new roman;">&#9679;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></font></div> </td> <td> <div align="justify" style="text-indent: 0pt; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Netronix &#8211; 21%</font></div> </td> </tr> </table> </div> <div> <table style="font-size: 10pt; width: 100%; font-family: times new roman;" cellspacing="0" cellpadding="0"> <tr valign="top"> <td align="right" style="width: 63pt;"> <div><font style="font-style: italic; display: inline; font-size: 10pt; ; font-family: symbol, serif;"><font style="display: inline; font-family: times new roman;">&#9679;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></font></div> </td> <td> <div align="justify" style="text-indent: 0pt; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Barnes &amp; Noble &#8211; 10%</font></div> </td> </tr> </table> </div> <div style="text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Our accounts receivable as of December 31, 2012 was due from fifteen customers, none of which accounted for more than10% of our accounts receivable as of December 31, 2012. Our net revenues for the three months ended March 31, 2012 was earned from ten customers. Our customers are located in the U.S., Europe and Asia. Customers which accounted for 10% or more of our net revenues during the three months ended March 31, 2012 are as follows:</font></div> <div style="text-indent: 0pt; display: block;">&#160;</div> <div> <table style="font-size: 10pt; width: 100%; font-family: times new roman;" cellspacing="0" cellpadding="0"> <tr valign="top"> <td align="right" style="width: 63pt;"> <div><font style="font-style: italic; display: inline; font-size: 10pt; ; font-family: symbol, serif;"><font style="display: inline; font-family: times new roman;">&#9679;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></font></div> </td> <td> <div align="justify" style="text-indent: 0pt; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Amazon - 55%</font></div> </td> </tr> </table> </div> <div> <table style="font-size: 10pt; width: 100%; font-family: times new roman;" cellspacing="0" cellpadding="0"> <tr valign="top"> <td align="right" style="width: 63pt;"> <div><font style="font-style: italic; display: inline; font-size: 10pt; ; font-family: symbol, serif;"><font style="display: inline; font-family: times new roman;">&#9679;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></font></div> </td> <td> <div align="justify" style="text-indent: 0pt; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Sony Corporation -16%</font></div> </td> </tr> </table> </div> <div style="text-align: justify; text-indent: 18pt; display: block; margin-left: 18pt; margin-right: 0pt;"><font style="font-style: italic; display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Revenue Recognition</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 18pt; display: block; margin-left: 18pt; margin-right: 0pt;"><font style="font-style: italic; display: inline; font-family: times new roman; font-size: 10pt;">Licensing Revenues:</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">We derive revenue from the licensing of internally developed intellectual property (&#8220;IP&#8221;). We enter into IP licensing agreements that generally provide licensees the right to incorporate our IP components in their products with terms and conditions that vary by licensee. The IP licensing agreements generally include a nonexclusive license for the underlying IP. Fees under these agreements may include license fees relating to our IP and&#160;royalties payable following the distribution by our licensees of products incorporating the licensed technology. The license for our IP has standalone value and can be used by the licensee without maintenance and support. Neonode meets all the accounting requirements for revenue recognition as per unit royalty products are distributed or licensed by the Company&#8217;s customers.&#160; For technology license arrangements that do not require significant modification or customization of the underlying technology, we recognize technology license revenue when: (1) we enter into a legally binding arrangement with a customer for the license of technology; (2) the customer distributes or licenses the products; (3) the customer payment is deemed fixed or determinable and free of contingencies or significant uncertainties; and (4) collection is reasonably assured. Our customers report to us the quantities of products distributed or licensed by them after the end of the reporting period stipulated in the contract, generally 30 to 45 days after the end of the month or quarter.</font></font></div> </div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Explicit return rights are not offered to customers. There have been no returns through March 31, 2013.</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 18pt; display: block; margin-left: 18pt; margin-right: 0pt;"><font style="font-style: italic; display: inline; font-family: times new roman; font-size: 10pt;">Engineering Services:</font></div> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">We may sell engineering consulting services to our customers on a flat rate or hourly rate basis. We recognize revenue from these services when all of the following conditions are met: (1) evidence existed of an arrangement with the customer, typically consisting of a purchase order or contract; (2) our services were performed and risk of loss passed to the customer; (3) we completed all of the necessary terms of the contract; (4) the amount of revenue to which we were entitled was fixed or determinable; and (5) we believed it was probable that we would be able to collect the amount due from the customer. To the extent that one or more of these conditions has not been satisfied, we defer recognition of revenue.&#160;&#160;Generally, we recognize revenue as the engineering services stipulated under the contract are completed and accepted by our customers.</font></div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="font-style: italic; display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Advertising</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Advertising costs are expensed as incurred. Advertising costs for the quarters ended March 31, 2013 and 2012 amounted to approximately $124,000 and $197,000, respectively.</font></font></div> </div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="font-style: italic; display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Product Research and Development</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Research and development (&#8220;R&amp;D&#8221;) costs are expensed as incurred. R&amp;D costs consist mainly of personnel related costs in addition to some external consultancy costs such as testing, certifying and measurements.</font></div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="font-style: italic; display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Stock-Based Compensation Expense</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">We measure the cost of employee services received in exchange for an award of equity instruments, including stock options, based on the fair value of the award on the grant date, and recognize the value as compensation expense over the period the employee is required to provide services in exchange for the award, usually the vesting period, net of estimated forfeitures.</font></div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;We account for equity instruments issued to non-employees at their fair value. The measurement date for the fair value for the equity instruments issued is determined at the earlier of (i) the date at which a commitment for performance by the consultant or vendor is reached, or (ii) the date at which the consultant or vendor&#8217;s performance is complete. In the case of equity instruments issued to consultants, the fair value of the equity instruments is primarily recognized over the term of the consulting agreement. The fair value of the stock-based compensation is periodically re-measured and expense is recognized during the vesting term.</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">When determining stock-based compensation expense involving options and warrants, we determine the estimated fair value of options and warrants using the Black-Scholes option pricing model.</font></div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="font-style: italic; display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Income Taxes</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">We recognize deferred tax liabilities and assets for the expected future tax consequences of items that have been included in the consolidated financial statements or tax returns. We estimate income taxes based on rates in effect in each of the jurisdictions in which we operate. Deferred income tax assets and liabilities are determined based upon differences between the financial statement and income tax bases of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse. The realization of deferred tax assets is based on historical tax positions and expectations about future taxable income. Valuation allowances are recorded against net deferred tax assets when, in our opinion, realization is uncertain based on the &#8220;more likely than not&#8221; criteria of the accounting guidance.</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Based on the uncertainty of future pre-tax income, we fully reserved our net deferred tax assets as of March 31, 2013 and December 31, 2012. In the event we were to determine that we would be able to realize our deferred tax assets in the future, an adjustment to the deferred tax asset would increase income in the period such determination was made. The provision for income taxes represents the net change in deferred tax amounts, plus income taxes paid or payable for the current period.</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">We follow the relevant accounting guidance related to uncertain tax positions, which provisions include a two-step approach to recognizing, de-recognizing and measuring uncertain tax positions.&#160;&#160;As a result, we did not recognize a liability for unrecognized tax benefits.&#160;&#160;As of March 31, 2013 and December&#160;31, 2012, we had no unrecognized tax benefits.</font></div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="font-style: italic; display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Net Loss Per Share</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Net loss per share amounts have been computed based on the weighted-average number of shares of common stock outstanding during the period. Net loss per share, assuming dilution amounts from common stock equivalents, is computed based on the weighted-average number of shares of common stock and potential common stock equivalents outstanding during the period. The weighted-average number of shares of common stock and potential common stock equivalents used in computing the net loss per share for periods ended March 31, 2013 and 2012 exclude the potential common stock equivalents, as the effect would be anti-dilutive&#160;(See Note 8).</font></div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="font-style: italic; display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Comprehensive Income (Loss)</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Our comprehensive loss includes foreign currency translation gains and losses.&#160;&#160;The cumulative amount of translation gains and losses are reflected as a separate component of stockholder&#8217; equity in the condensed consolidated balance sheets as accumulated other comprehensive income.</font></div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="font-style: italic; display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Cash Flow Information</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Cash flows in foreign currencies have been converted to U.S. dollars at an approximate weighted-average exchange rate for the respective reporting periods. The weighted-average exchange rate for the consolidated statements of operations and comprehensive loss was 6.43 and 6.75 Swedish Krona to one U.S. Dollar for the three months ended March 31, 2013 and 2012, respectively. The exchange rate for the consolidated balance sheets was 6.52 and 6.52&#160;&#160;Swedish Krona to one U.S. Dollar as of March 31, 2013 and December 31, 2012, respectively.&#160;&#160;The weighted-average exchange rate for the consolidated statement of operations and comprehensive loss was 92.19 Japanese Yen to one U.S. Dollar for the three months ended March 31, 2013. The exchange rate for the consolidated balance sheet was 94.16 Japanese Yen to one U.S. Dollar as of March 31, 2013.</font></font></div> </div> <div style="text-indent: 0pt; display: block;">&#160;</div> <div align="left"> <table style="font-size: 10pt; width: 100%; font-family: times new roman;" cellspacing="0" cellpadding="0"> <tr> <td align="left" style="padding-bottom: 2px;" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="padding-bottom: 2px;" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td style="border-bottom: black 2px solid;" valign="bottom" colspan="2"> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Shares of Preferred Stock Not Exchanged as of March 31, 2013</font></div> </td> <td align="left" style="padding-bottom: 2px;" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="padding-bottom: 2px;" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td style="border-bottom: black 2px solid;" valign="bottom" colspan="2"> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Conversion Ratio</font></div> </td> <td align="left" style="padding-bottom: 2px;" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="padding-bottom: 2px;" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td style="border-bottom: black 2px solid;" valign="bottom" colspan="2"> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Shares of Common Stock after Conversion of all Outstanding Shares of Preferred Stock Not yet Exchanged at March 31, 2013</font></div> </td> <td align="left" style="padding-bottom: 2px;" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> <tr> <td align="left" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" colspan="2"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td align="left" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" colspan="2"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td align="left" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" colspan="2"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td align="left" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> <tr bgcolor="#cceeff"> <td style="padding-bottom: 4px;" valign="bottom" width="64%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Series B preferred stock</font></div> </div> </td> <td style="padding-bottom: 4px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td style="border-bottom: black 4px double;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td style="border-bottom: black 4px double;" valign="bottom" width="9%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">83</font></div> </div> </td> <td style="padding-bottom: 4px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td style="padding-bottom: 4px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td style="padding-bottom: 4px;" valign="bottom" width="9%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">132.07&#160;</font></div> </div> </td> <td style="padding-bottom: 4px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td style="padding-bottom: 4px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td style="border-bottom: black 4px double;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td style="border-bottom: black 4px double;" valign="bottom" width="9%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">10,962</font></div> </div> </td> <td style="padding-bottom: 4px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> </table> </div> <div align="center"> <table style="width: 50%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0"> <tr> <td align="left" valign="bottom" width="38%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td valign="bottom" width="10%" colspan="2"> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">For the three months</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> <tr> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="38%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td style="border-bottom: black 2px solid;" valign="bottom" width="10%" colspan="2"> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">ended</font></div> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">March 31,</font></div> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">2013</font></div> </td> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> <tr> <td align="left" valign="bottom" width="38%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="10%" colspan="2"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> <tr bgcolor="#cceeff"> <td align="left" valign="bottom" width="38%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;Annual dividend yield</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">-</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> <tr bgcolor="white"> <td align="left" valign="bottom" width="38%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;Expected life (years)</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">4.3</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> <tr bgcolor="#cceeff"> <td align="left" valign="bottom" width="38%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;Risk-free interest rate</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">0.65</font></div> </td> <td align="left" valign="bottom" width="1%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">%</font></div> </td> </tr> <tr bgcolor="white"> <td align="left" valign="bottom" width="38%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;Expected volatility</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">154</font></div> </td> <td align="left" valign="bottom" width="1%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">%</font></div> </td> </tr> </table> </div> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;">&#160;</div> <div align="center"> <table style="width: 80%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0"> <tr> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="56%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td style="border-bottom: black 2px double;" valign="bottom" width="10%" colspan="2"> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">2013</font></div> </td> <td style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td style="border-bottom: black 2px double;" valign="bottom" width="10%" colspan="2"> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">2012</font></div> </td> <td style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> <tr> <td align="left" valign="bottom" width="56%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="10%" colspan="2"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="10%" colspan="2"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> <tr bgcolor="#cceeff"> <td align="left" valign="bottom" width="56%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Product research and development</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></div> </td> <td align="right" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">60</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></div> </td> <td align="right" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">10</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> <tr bgcolor="white"> <td align="left" valign="bottom" width="56%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Sales and marketing</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">196</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">24</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> <tr bgcolor="#cceeff"> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="56%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">General and administrative</font></div> </td> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="border-bottom: black 2px solid;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" style="border-bottom: black 2px solid;" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">330</font></div> </td> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="border-bottom: black 2px solid;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" style="border-bottom: black 2px solid;" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">--</font></div> </td> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> <tr bgcolor="white"> <td align="left" style="padding-bottom: 4px;" valign="bottom" width="56%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Stock compensation expense</font></div> </td> <td align="left" style="padding-bottom: 4px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="border-bottom: black 4px double;" valign="bottom" width="1%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></div> </td> <td align="right" style="border-bottom: black 4px double;" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">586</font></div> </td> <td align="left" style="padding-bottom: 4px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="padding-bottom: 4px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="border-bottom: black 4px double;" valign="bottom" width="1%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></div> </td> <td align="right" style="border-bottom: black 4px double;" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">34</font></div> </td> <td align="left" style="padding-bottom: 4px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> </table> </div> <div style="text-indent: 0pt; display: block;">&#160;</div> <div align="center"> <table style="width: 80%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0"> <tr> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="68%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td style="border-bottom: black 2px solid;" valign="bottom" width="10%" colspan="2"> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Remaining unamortized</font></div> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">expense at</font></div> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">March 31,</font></div> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">2013</font></div> </td> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> <tr bgcolor="#cceeff"> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="68%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Stock-based compensation</font></div> </td> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="border-bottom: black 2px solid;" valign="bottom" width="1%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></div> </td> <td style="border-bottom: black 2px solid; text-align: right;" valign="bottom" width="9%"> <div style="text-align: right; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">3,060</font></div> </td> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> </table> </div> <div style="text-indent: 0pt; display: block;">&#160;</div> <div align="center"> <table style="width: 90%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0"> <tr> <td align="left" valign="bottom" width="47%"><font style="display: inline; font-family: times new roman; font-size: 10pt;"></font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td align="left" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="10%" colspan="2"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="10%" colspan="2"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> <tr> <td align="left" style="border-bottom: black 2px solid;" valign="bottom" width="47%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Description</font></div> </td> <td style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">&#160;</font></td> <td style="border-bottom: black 2px solid;" valign="bottom" width="9%"> <div align="center" style="text-indent: 9pt; display: block; margin-left: 0pt; margin-right: 1.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Issue&#160;&#160;Date</font></div> </td> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td style="border-bottom: black 2px solid;" valign="bottom" width="10%" colspan="2"> <div align="center" style="text-indent: 9pt; display: block; margin-left: 0pt; margin-right: 1.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Exercise Price</font></div> </td> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td style="border-bottom: black 2px solid;" valign="bottom" width="9%"> <div align="center" style="text-indent: 18pt; display: block; margin-left: 0pt; margin-right: 1.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Shares</font></div> </td> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td style="border-bottom: black 2px solid;" valign="bottom" width="10%" colspan="2"> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 1.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Expiration Date</font></div> </td> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> <tr> <td align="left" valign="bottom" width="47%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td align="left" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="10%" colspan="2"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="10%" colspan="2"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="47%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">August 2009 Employee Warrants</font></div> </div> </td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td valign="bottom" width="9%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">8/25/2009</font></div> </div> </td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td valign="bottom" width="1%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></div> </div> </td> <td valign="bottom" width="9%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">0.50</font></div> </div> </td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td valign="bottom" width="9%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;"><font style="display: inline; font-family: times new roman;">8</font>0,000</font></div> </div> </td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td valign="bottom" width="9%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">8/25/2016</font></div> </div> </td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> <tr bgcolor="white"> <td valign="bottom" width="47%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">2007 Debt Extension Warrants</font></div> </div> </td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td valign="bottom" width="9%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">9/22/2010</font></div> </div> </td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td valign="bottom" width="1%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></div> </div> </td> <td valign="bottom" width="9%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">1.00</font></div> </div> </td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td valign="bottom" width="9%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">16,000</font></div> </div> </td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td valign="bottom" width="9%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">9/22/2015</font></div> </div> </td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="47%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">September 2010 Repricing Warrant</font></div> </div> </td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td valign="bottom" width="9%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">9/28/2010</font></div> </div> </td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td valign="bottom" width="1%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></div> </div> </td> <td valign="bottom" width="9%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">1.38</font></div> </div> </td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td valign="bottom" width="9%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;"><font style="display: inline; font-family: times new roman;">4</font>,000</font></div> </div> </td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td valign="bottom" width="9%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">9/28/2013</font></div> </div> </td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> <tr bgcolor="white"> <td valign="bottom" width="47%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">October 2010 Repricing Warrants</font></div> </div> </td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td valign="bottom" width="9%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">10/18/2010</font></div> </div> </td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td valign="bottom" width="1%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></div> </div> </td> <td valign="bottom" width="9%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">1.38</font></div> </div> </td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td valign="bottom" width="9%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">2,078,433</font></div> </div> </td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td valign="bottom" width="9%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">10/18/2013</font></div> </div> </td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="47%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">October 2010 Employee Warrants</font></div> </div> </td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td valign="bottom" width="9%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">10/15/2010</font></div> </div> </td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td valign="bottom" width="1%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></div> </div> </td> <td valign="bottom" width="9%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">1.38</font></div> </div> </td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td valign="bottom" width="9%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">920,000</font></div> </div> </td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td valign="bottom" width="9%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">10/15/2013</font></div> </div> </td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> <tr bgcolor="white"> <td valign="bottom" width="47%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">December 2010 Employee Warrants</font></div> </div> </td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td valign="bottom" width="9%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">12/3/2010</font></div> </div> </td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td valign="bottom" width="1%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></div> </div> </td> <td valign="bottom" width="9%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">1.63</font></div> </div> </td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td valign="bottom" width="9%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">200,000</font></div> </div> </td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td valign="bottom" width="9%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">12/3/2015</font></div> </div> </td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="47%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">January 2011 Employee Warrant</font></div> </div> </td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td valign="bottom" width="9%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">1/21/2011</font></div> </div> </td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td valign="bottom" width="1%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></div> </div> </td> <td valign="bottom" width="9%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">2.00</font></div> </div> </td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td valign="bottom" width="9%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">20,000</font></div> </div> </td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td valign="bottom" width="9%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">1/21/2014</font></div> </div> </td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> <tr bgcolor="white"> <td valign="bottom" width="47%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">February 2011 Legal Advisor Warrant</font></div> </div> </td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td valign="bottom" width="9%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">2/22/2011</font></div> </div> </td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td valign="bottom" width="1%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></div> </div> </td> <td valign="bottom" width="9%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">2.50</font></div> </div> </td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td valign="bottom" width="9%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">80,000</font></div> </div> </td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td valign="bottom" width="9%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">2/22/2016</font></div> </div> </td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="47%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">March&#160;&#160;2011 Investor Warrants</font></div> </div> </td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td valign="bottom" width="9%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">3/9/2011</font></div> </div> </td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td valign="bottom" width="1%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></div> </div> </td> <td valign="bottom" width="9%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">3.13</font></div> </div> </td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td valign="bottom" width="9%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">602,009</font></div> </div> </td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td valign="bottom" width="9%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">3/9/2016</font></div> </div> </td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> <tr bgcolor="white"> <td valign="bottom" width="47%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">March&#160;&#160;2011 Investor Warrants</font></div> </div> </td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td valign="bottom" width="9%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">4/7/2011</font></div> </div> </td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td valign="bottom" width="1%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></div> </div> </td> <td valign="bottom" width="9%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">3.13</font></div> </div> </td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td valign="bottom" width="9%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">34,100</font></div> </div> </td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td valign="bottom" width="9%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">4/7/2016</font></div> </div> </td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="47%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">May 2011 Consultant Warrant</font></div> </div> </td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td valign="bottom" width="9%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">5/17/2011</font></div> </div> </td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td valign="bottom" width="1%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></div> </div> </td> <td valign="bottom" width="9%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">4.05</font></div> </div> </td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td valign="bottom" width="9%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">20,000</font></div> </div> </td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td valign="bottom" width="9%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">5/17/2014</font></div> </div> </td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> <tr bgcolor="white"> <td style="padding-bottom: 2px;" valign="bottom" width="47%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">September 2011 Employee Warrant</font></div> </div> </td> <td style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="padding-bottom: 2px;" valign="bottom" width="9%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">9/12/2011</font></div> </div> </td> <td style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td style="padding-bottom: 2px;" valign="bottom" width="1%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></div> </div> </td> <td style="padding-bottom: 2px;" valign="bottom" width="9%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">3.90</font></div> </div> </td> <td style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td style="border-bottom: black 2px solid;" valign="bottom" width="9%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">20,000</font></div> </div> </td> <td style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td style="padding-bottom: 2px;" valign="bottom" width="9%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">9/12/2014</font></div> </div> </td> <td style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> <tr bgcolor="#cceeff"> <td style="padding-bottom: 4px;" valign="bottom" width="47%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Total Warrants Outstanding</font></div> </div> </td> <td style="padding-bottom: 4px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="padding-bottom: 4px;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td style="padding-bottom: 4px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td style="padding-bottom: 4px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td style="padding-bottom: 4px;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td style="padding-bottom: 4px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td style="border-bottom: black 4px double;" valign="bottom" width="9%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div style="text-align: right; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">4,074,542</font></div> </div> </td> <td style="padding-bottom: 4px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td style="padding-bottom: 4px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td style="padding-bottom: 4px;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td style="padding-bottom: 4px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> </table> </div> <div align="left"> <table style="font-size: 10pt; width: 100%; font-family: times new roman;" cellspacing="0" cellpadding="0"> <tr> <td align="left" style="padding-bottom: 2px;" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="padding-bottom: 2px;" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td style="border-bottom: black 2px solid;" valign="bottom" colspan="6"> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">2013</font></div> </td> <td align="left" style="padding-bottom: 2px;" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> <tr> <td align="left" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td valign="bottom" colspan="2"> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Amount</font></div> </td> <td align="left" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td valign="bottom" colspan="2"> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Percentage</font></div> </td> <td align="left" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> <tr bgcolor="#cceeff"> <td align="left" valign="bottom" width="76%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Net revenues from customers in the U.S.</font></div> </td> <td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></div> </td> <td align="right" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">292</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">53</font></div> </td> <td align="left" valign="bottom" width="1%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">%</font></div> </td> </tr> <tr bgcolor="white"> <td align="left" valign="bottom" width="76%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Net revenues from customers in Europe</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">18</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">43</font></div> </td> <td align="left" valign="bottom" width="1%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">%&#160;</font></div> </td> </tr> <tr bgcolor="#cceeff"> <td align="left" valign="bottom" width="76%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Net revenues from customers in Asia</font></div> </td> <td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">238</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">44</font></div> </td> <td align="left" valign="bottom" width="1%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">%</font></div> </td> </tr> <tr bgcolor="white"> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="76%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="border-bottom: black 2px solid;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="border-bottom: black 2px solid;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="border-bottom: black 2px solid;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="border-bottom: black 2px solid;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> <tr bgcolor="#cceeff"> <td align="left" style="padding-bottom: 4px;" valign="bottom" width="76%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;Total</font></div> </td> <td align="right" style="padding-bottom: 4px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="border-bottom: black 4px double;" valign="bottom" width="1%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></div> </td> <td align="right" style="border-bottom: black 4px double;" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">548</font></div> </td> <td align="left" style="padding-bottom: 4px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" style="padding-bottom: 4px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="border-bottom: black 4px double;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" style="border-bottom: black 4px double;" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">100</font></div> </td> <td align="left" style="padding-bottom: 4px;" valign="bottom" width="1%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">%</font></div> </td> </tr> <tr bgcolor="white"> <td align="left" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" colspan="6"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td align="left" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> <tr bgcolor="white"> <td align="left" style="padding-bottom: 2px;" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="padding-bottom: 2px;" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td style="border-bottom: black 2px solid;" valign="bottom" colspan="6"> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">2012</font></div> </td> <td align="left" style="padding-bottom: 2px;" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> <tr bgcolor="white"> <td align="left" style="padding-bottom: 2px;" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="padding-bottom: 2px;" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td style="border-bottom: black 2px solid;" valign="bottom" colspan="2"> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Amount</font></div> </td> <td align="left" style="padding-bottom: 2px;" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="padding-bottom: 2px;" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td style="border-bottom: black 2px solid;" valign="bottom" colspan="2"> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Percentage</font></div> </td> <td align="left" style="padding-bottom: 2px;" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> <tr bgcolor="#cceeff"> <td align="left" valign="bottom" width="76%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Net revenues from customers in the U.S.</font></div> </td> <td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></div> </td> <td align="right" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">974</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">84</font></div> </td> <td align="left" valign="bottom" width="1%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">%</font></div> </td> </tr> <tr bgcolor="white"> <td align="left" valign="bottom" width="76%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Net revenues from customers in Europe</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">--</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;--</font></div> </td> </tr> <tr bgcolor="#cceeff"> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="76%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Net revenues from customers in Asia</font></div> </td> <td align="right" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="border-bottom: black 2px solid;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" style="border-bottom: black 2px solid;" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">190</font></div> </td> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="border-bottom: black 2px solid;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" style="border-bottom: black 2px solid;" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">16</font></div> </td> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">%</font></div> </td> </tr> <tr bgcolor="white"> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="76%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="border-bottom: black 2px solid;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="border-bottom: black 2px solid;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="border-bottom: black 2px solid;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="border-bottom: black 2px solid;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> <tr bgcolor="#cceeff"> <td align="left" style="padding-bottom: 4px;" valign="bottom" width="76%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;Total</font></div> </td> <td align="right" style="padding-bottom: 4px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="border-bottom: black 4px double;" valign="bottom" width="1%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></div> </td> <td align="right" style="border-bottom: black 4px double;" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">1,164</font></div> </td> <td align="left" style="padding-bottom: 4px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" style="padding-bottom: 4px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="border-bottom: black 4px double;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" style="border-bottom: black 4px double;" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">100</font></div> </td> <td align="left" style="padding-bottom: 4px;" valign="bottom" width="1%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">%</font></div> </td> </tr> </table> </div> <div> <div align="left"> <table style="width: 100%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0"> <tr> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="76%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; text-decoration: underline;">(in thousands, except per share amounts)</font></div> </td> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="border-bottom: black 2px solid; text-align: center;" valign="bottom" colspan="6"> <div style="text-align: center; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div style="text-align: center; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Three Months ended</font></font></div> </div> <div style="text-align: center; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">March 31,</font></div> </td> <td style="text-align: left; padding-bottom: 2px;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> </tr> <tr> <td style="padding-bottom: 2px;" valign="bottom" width="76%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="border-bottom: black 2px solid; text-align: center; text-indent: 0pt; margin-left: 0pt; margin-right: 0pt;" valign="bottom" colspan="2"> <div style="text-align: center; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">2013</font></div> </td> <td style="text-align: left; padding-bottom: 2px;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="border-bottom: black 2px solid; text-align: center; text-indent: 0pt; margin-left: 0pt; margin-right: 0pt;" valign="bottom" width="10%" colspan="2"> <div style="text-align: center; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">2012</font></div> </td> <td style="text-align: left; padding-bottom: 2px;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> </tr> <tr> <td align="left" valign="bottom" width="76%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">BASIC AND DILUTED</font></div> </td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td valign="bottom" colspan="2"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td valign="bottom" width="10%" colspan="2"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> </tr> <tr bgcolor="#cceeff"> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="76%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Weighted average number of </font>common shares outstanding</font></div> </div> </td> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="border-bottom: black 2px solid; text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="border-bottom: black 2px solid; text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">33,511</font></td> <td style="text-align: left; padding-bottom: 2px;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="border-bottom: black 2px solid; text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="border-bottom: black 2px solid; text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">32,809</font></td> <td style="text-align: left; padding-bottom: 2px;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> </tr> <tr bgcolor="white"> <td align="left" style="padding-bottom: 4px;" valign="bottom" width="76%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Number of shares for computation of</font>&#160;net loss per share</font></div> </div> </td> <td align="left" style="padding-bottom: 4px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="border-bottom: black 4px double; text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="border-bottom: black 4px double; text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">33,511</font></td> <td style="text-align: left; padding-bottom: 4px;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td align="left" style="padding-bottom: 4px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="border-bottom: black 4px double; text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="border-bottom: black 4px double; text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">32,809</font></td> <td style="text-align: left; padding-bottom: 4px;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="76%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> </tr> <tr bgcolor="white"> <td align="left" style="padding-bottom: 4px;" valign="bottom" width="76%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Net loss</font></div> </td> <td align="left" style="padding-bottom: 4px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="border-bottom: black 4px double; text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></td> <td style="border-bottom: black 4px double; text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">(3,570</font></td> <td style="text-align: left; padding-bottom: 4px;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">)</font></td> <td align="left" style="padding-bottom: 4px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="border-bottom: black 4px double; text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></td> <td style="border-bottom: black 4px double; text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">(1,588</font></td> <td style="text-align: left; padding-bottom: 4px;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">)</font></td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="76%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> </tr> <tr bgcolor="white"> <td align="left" style="padding-bottom: 4px;" valign="bottom" width="76%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Net loss per share - basic and diluted</font></div> </td> <td align="left" style="padding-bottom: 4px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="border-bottom: black 4px double; text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></td> <td style="border-bottom: black 4px double; text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">(0.11</font></td> <td style="text-align: left; padding-bottom: 4px;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">)</font></td> <td align="left" style="padding-bottom: 4px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td style="border-bottom: black 4px double; text-align: left;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></td> <td style="border-bottom: black 4px double; text-align: right;" valign="bottom" width="9%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">(0.05</font></td> <td style="text-align: left; padding-bottom: 4px;" valign="bottom" width="1%" nowrap="nowrap"><font style="display: inline; font-family: times new roman; font-size: 10pt;">)</font></td> </tr> </table> <font style="display: inline; font-family: times new roman; font-size: 10pt;"></font></div> </div> 250000 100000 0.55 0.16 0.20 0.44 0.10 0.21 0.10 P30D P45D 7200000 62000 37000 10 9 15 12 0.72 197000 124000 0 0 6.75 6.43 6.52 6.52 200000 320000 270094 40000 80000 40000 25000 1.00 1.38 1.38 83 480.63 132.07 10962 4 528 83 8 39790 929 One vote for each share One vote for each share 1-for-25 174798 266228 198512 4074542 1691544 4704636 1715200 15000 -200 38456 -590094 -38456 1.69 5.05 1.61 5.04 5.97 1.00 125.00 1.17 4.33 P4Y3M18D -40000 2009-08-25 2010-09-22 2010-09-28 2010-10-18 2010-10-15 2010-12-03 2011-01-21 2011-02-22 2011-03-09 2011-04-07 2011-05-17 2011-09-12 4074542 80000 16000 4000 2078433 920000 200000 20000 80000 602009 34100 20000 20000 2016-08-25 2015-09-22 2013-09-28 2013-10-18 2013-10-15 2015-12-03 2014-01-21 2016-02-22 2016-03-09 2016-04-07 2014-05-17 2014-09-12 2400000 1691544 P1Y P4Y P1Y P4Y P1Y P4Y 10000 24000 34000 586000 60000 196000 330000 120000 20000 198000 75000 1.63 3.90 2 1 15000 P24M 3.13 2853 7657 14000 174000 P3M P9M P3Y 2015-07-31 2013-04-15 2014-10-12 2014-12-31 2014-04-15 1 32809 33511 32809 33511 3200000 52000 11500 2800000 11000 309000 0 3145 9000 10000 167000 <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="font-style: italic; display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">Deferred Revenue</font></div> <div style="text-align: justify; text-indent: 0pt; display: block;">&#160;</div> <div style="text-align: justify; text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">From time-to-time the Company receives pre-payments from its customers related to future services or future license fee revenues.&#160;We defer the license fees until we have met all accounting requirements for revenue recognition as per unit royalty products are distributed or licensed by the Company&#8217;s customers and the engineering development fee revenue until such time as the engineering work has been completed and accepted by our customers.</font></div> <div style="display: block; margin-left: 0pt; text-indent: 36pt; margin-right: 0pt; text-align: justify;"><font style="display: inline; font-size: 10pt; font-family: times new roman;"></font>&#160;</div> <div style="text-align: center;"> <table style="font-size: 10pt; width: 50%; font-family: times new roman; text-align: center;" cellspacing="0" cellpadding="0"> <tr style="text-align: center;"> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="38%"> <div align="left" style="display: block; margin-left: 0pt; text-indent: 0pt; margin-right: 0pt;"><font style="display: inline; font-size: 10pt; font-family: times new roman; text-decoration: underline;"><font style="display: inline;">Year ending December 31,</font></font></div> </td> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-size: 10pt; font-family: times new roman;">&#160; </font></td> <td style="border-bottom: black 2px solid;" valign="bottom" width="10%" colspan="2"> <div align="center" style="display: block; margin-left: 0pt; text-indent: 0pt; margin-right: 0pt;"><font style="display: inline; font-size: 10pt; font-family: times new roman;">Total</font></div> </td> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-size: 10pt; font-family: times new roman;">&#160; </font></td> </tr> <tr bgcolor="#cceeff"> <td align="left" valign="bottom" width="38%"> <div align="left" style="display: block; margin-left: 18pt; text-indent: 0pt; margin-right: 0pt;"><font style="display: inline; font-size: 10pt; font-family: times new roman;">2013</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-size: 10pt; font-family: times new roman;">&#160; </font></td> <td align="left" valign="bottom" width="1%"> <div align="left" style="display: block; margin-left: 0pt; text-indent: 0pt; margin-right: 0pt;"><font style="display: inline; font-size: 10pt; font-family: times new roman;">$</font></div> </td> <td align="right" valign="bottom" width="9%"> <div align="right" style="display: block; margin-left: 0pt; text-indent: 0pt; margin-right: 0pt;"><font style="display: inline; font-size: 10pt; font-family: times new roman;">293</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-size: 10pt; font-family: times new roman;">&#160; </font></td> </tr> <tr bgcolor="white"> <td align="left" valign="bottom" width="38%"> <div align="left" style="display: block; margin-left: 18pt; text-indent: 0pt; margin-right: 0pt;"><font style="display: inline; font-size: 10pt; font-family: times new roman;">2014</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-size: 10pt; font-family: times new roman;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-size: 10pt; font-family: times new roman;">&#160; </font></td> <td align="right" valign="bottom" width="9%"> <div align="right" style="display: block; margin-left: 0pt; text-indent: 0pt; margin-right: 0pt;"><font style="display: inline; font-size: 10pt; font-family: times new roman;">255</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-size: 10pt; font-family: times new roman;">&#160; </font></td> </tr> <tr bgcolor="#cceeff"> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="38%"> <div align="left" style="display: block; margin-left: 18pt; text-indent: 0pt; margin-right: 0pt;"><font style="display: inline; font-size: 10pt; font-family: times new roman;">2015</font></div> </td> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-size: 10pt; font-family: times new roman;">&#160; </font></td> <td align="left" style="border-bottom: black 2px solid;" valign="bottom" width="1%"><font style="display: inline; font-size: 10pt; font-family: times new roman;">&#160; </font></td> <td align="right" style="border-bottom: black 2px solid;" valign="bottom" width="9%"> <div align="right" style="display: block; margin-left: 0pt; text-indent: 0pt; margin-right: 0pt;"><font style="display: inline; font-size: 10pt; font-family: times new roman;">23</font></div> </td> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-size: 10pt; font-family: times new roman;">&#160; </font></td> </tr> <tr bgcolor="white"> <td align="left" style="padding-bottom: 4px;" valign="bottom" width="38%"><font style="display: inline; font-size: 10pt; font-family: times new roman;">&#160; </font></td> <td align="left" style="padding-bottom: 4px;" valign="bottom" width="1%"><font style="display: inline; font-size: 10pt; font-family: times new roman;">&#160; </font></td> <td align="left" style="border-bottom: black 4px double;" valign="bottom" width="1%"> <div align="left" style="display: block; margin-left: 0pt; text-indent: 0pt; margin-right: 0pt;"><font style="display: inline; font-size: 10pt; font-family: times new roman;">$</font></div> </td> <td align="right" style="border-bottom: black 4px double;" valign="bottom" width="9%"> <div align="right" style="display: block; margin-left: 0pt; text-indent: 0pt; margin-right: 0pt;"><font style="display: inline; font-size: 10pt; font-family: times new roman;">571</font></div> </td> <td align="left" style="padding-bottom: 4px;" valign="bottom" width="1%"><font style="display: inline; font-size: 10pt; font-family: times new roman;">&#160; </font></td> </tr> </table> </div> 293000 255000 23000 571000 P3Y P2Y P1Y4M28D P1Y1M24D 3 years 5 years 6000 7007 86000 14000 174000 3000 36000 8000 93000 3185 2853 2723 <div style="text-indent: 0pt; display: block;"> <div style="text-align: left; text-indent: 0pt; margin-left: 36pt; margin-right: 0pt;"> <table style="text-align: center; width: 80%; font-family: times new roman; font-size: 10pt;" cellspacing="0" cellpadding="0"> <tr style="text-align: center;"> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="44%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td style="border-bottom: 2px solid black;" valign="bottom" width="34%" colspan="10"> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">March 31, 2013</font></div> </td> <td style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;">&#160;</font></td> </tr> <tr> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="44%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Outstanding and exercisable</font></div> </td> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td style="border-bottom: 2px solid black;" valign="bottom" width="10%" colspan="2"> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Warrants</font></div> </td> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td style="border-bottom: 2px solid black;" valign="bottom" width="10%" colspan="2"> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Weighted </font></div> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Average </font></div> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Exercise Price</font></div> </td> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td style="border-bottom: 2px solid black;" valign="bottom" width="10%" colspan="2"> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Weighted </font></div> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Average</font></div> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Remaining </font></div> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Contractual Life</font></div> </td> <td style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="44%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">January 1, 2013</font></div> </div> </td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td valign="bottom" width="9%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">4,704,636</font></div> </div> </td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td valign="bottom" width="1%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></div> </div> </td> <td valign="bottom" width="9%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">1.61</font></div> </div> </td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td valign="bottom" width="9%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">1.41</font></div> </div> </td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> </tr> <tr bgcolor="white"> <td valign="bottom" width="44%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;&#160;&#160;Issued</font></div> </div> </td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td valign="bottom" width="9%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">--</font></div> </div> </td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td valign="bottom" width="9%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">--</font></div> </div> </td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td valign="bottom" width="9%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">--</font></div> </div> </td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="44%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;&#160;&#160;Expired/forfeited</font></div> </div> </td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td valign="bottom" width="9%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">(40,000</font></div> </div> </td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">)&#160; </font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td valign="bottom" width="9%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">1.00</font></div> </div> </td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td valign="bottom" width="9%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">--</font></div> </div> </td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> </tr> <tr bgcolor="white"> <td style="padding-bottom: 2px;" valign="bottom" width="44%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;&#160;&#160;Exercised</font></div> </div> </td> <td style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td style="border-bottom: 2px solid black;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td style="border-bottom: 2px solid black;" valign="bottom" width="9%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">(590,094</font></div> </div> </td> <td style="padding-bottom: 2px;" valign="bottom" width="1%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">)</font></div> </div> </td> <td style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td style="border-bottom: 2px solid black;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td style="border-bottom: 2px solid black;" valign="bottom" width="9%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">1.17</font></div> </div> </td> <td style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td style="border-bottom: 2px solid black;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td style="border-bottom: 2px solid black;" valign="bottom" width="9%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">--</font></div> </div> </td> <td style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> </tr> <tr bgcolor="#cceeff"> <td style="padding-bottom: 4px;" valign="bottom" width="44%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Outstanding and exercisable, March 31, 2013</font></div> </div> </td> <td style="padding-bottom: 4px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td style="border-bottom: 4px double black;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td style="border-bottom: 4px double black;" valign="bottom" width="9%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">4,074,542</font></div> </div> </td> <td style="padding-bottom: 4px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td style="padding-bottom: 4px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td style="border-bottom: 4px double black;" valign="bottom" width="1%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></div> </div> </td> <td style="border-bottom: 4px double black;" valign="bottom" width="9%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">1.69</font></div> </div> </td> <td style="padding-bottom: 4px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td style="padding-bottom: 4px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td style="border-bottom: 4px double black;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td style="border-bottom: 4px double black;" valign="bottom" width="9%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">1.15</font></div> </div> </td> <td style="padding-bottom: 4px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> </tr> </table> </div> </div> <div align="left" style="text-indent: 36pt; display: block; margin-left: 0pt; margin-right: 0pt;">&#160;</div> <div align="left"> <table style="font-size: 10pt; width: 100%; font-family: times new roman;" cellspacing="0" cellpadding="0"> <tr> <td align="left" style="padding-bottom: 2px;" valign="bottom"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 1.6pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;&#160;</font></div> </td> <td align="left" style="padding-bottom: 2px;" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td style="border-bottom: black 2px solid;" valign="bottom" colspan="2"> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 3.6pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Number of Options Outstanding</font></div> </td> <td align="left" style="padding-bottom: 2px;" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="padding-bottom: 2px;" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td style="border-bottom: black 2px solid;" valign="bottom" colspan="2"> <div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 3.6pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Weighted Average Exercise Price</font></div> </td> <td align="left" style="padding-bottom: 2px;" valign="bottom"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> <tr bgcolor="#cceeff"> <td align="left" valign="bottom" width="76%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 1.6pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Outstanding at January 1, 2013</font></div> </td> <td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">1,715,200</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></div> </td> <td align="right" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">5.04</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> <tr bgcolor="white"> <td align="left" valign="bottom" width="76%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 1.6pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Granted</font></div> </td> <td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">15,000</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">5.97</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> <tr bgcolor="#cceeff"> <td align="left" valign="bottom" width="76%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 1.6pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Cancelled or expired</font></div> </td> <td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">(200</font></div> </td> <td align="left" valign="bottom" width="1%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">)&#160;</font></div> </td> <td align="right" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">125.00</font></div> </td> <td align="left" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> <tr bgcolor="white"> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="76%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 1.6pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Exercised</font></div> </td> <td align="right" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="border-bottom: black 2px solid;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" style="border-bottom: black 2px solid;" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">(38,456</font></div> </td> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">)&#160;</font></div> </td> <td align="right" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="border-bottom: black 2px solid;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" style="border-bottom: black 2px solid;" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">4.33</font></div> </td> <td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> <tr bgcolor="#cceeff"> <td align="left" style="padding-bottom: 4px;" valign="bottom" width="76%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 1.6pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Outstanding at March 31, 2013</font></div> </td> <td align="right" style="padding-bottom: 4px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="border-bottom: black 4px double;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" style="border-bottom: black 4px double;" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">1,691,544</font></div> </td> <td align="left" style="padding-bottom: 4px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="right" style="padding-bottom: 4px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> <td align="left" style="border-bottom: black 4px double;" valign="bottom" width="1%"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">$</font></div> </td> <td align="right" style="border-bottom: black 4px double;" valign="bottom" width="9%"> <div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0.8pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">5.05</font></div> </td> <td align="left" style="padding-bottom: 4px;" valign="bottom" width="1%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160; </font></td> </tr> </table> </div> <div style="text-indent: 0pt; display: block;"><font style="display: inline; font-family: times new roman; font-size: 10pt;"></font>&#160;</div> 68000 68000 1.54 0.0065 P10Y P5Y P7Y P10Y 103000 120000 1.00 0.84 0.16 1.00 0.53 0.43 0.44 55000 25720 June 2008 March 2011 P3Y <div style="text-indent: 0pt; display: block;">&#160;</div> <div align="center"> <table style="font-size: 10pt; width: 80%; font-family: times new roman;" cellspacing="0" cellpadding="0"> <tr> <td valign="top" width="26%"><font style="display: inline; font-family: times new roman; font-size: 10pt;">&#160;</font></td> <td valign="top" width="26%"> <div style="text-align: left; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;"><font style="display: inline; text-decoration: underline;">Estimated useful lives</font></font></font></div> </td> </tr> <tr bgcolor="#cceeff"> <td valign="top" width="26%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Computer equipment</font></div> </div> </td> <td valign="top" width="26%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">3 years</font></div> </div> </td> </tr> <tr bgcolor="white"> <td valign="top" width="26%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">Furniture and fixtures</font></div> </div> </td> <td valign="top" width="26%"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: times new roman; font-size: 10pt;">5 years</font></div> </div> </td> </tr> </table> </div> 30663 3 13 -1588000 -3570000 8100000 5296000 3060000 -1544000 -3557000 0 25000 576000 0.50 1.00 1.38 1.38 1.38 1.63 2.00 2.50 3.13 3.13 4.05 3.90 167000 92.19 94.16 270094 266228 198512 320000 2014-04-15 0 5 500000 0 Neonode will contribute to TI the NRE as follows: For each of the first one million units: $0.08 per unit and For the next eight million units: $0.05 per unit. 0.08 0.05 217600 2000000 58000000 80000 EX-101.SCH 6 neond-20130331.xsd 001 - Document - Document and Entity Information link:presentationLink link:definitionLink link:calculationLink 002 - Statement - Condensed Consolidated Balance Sheets link:presentationLink link:definitionLink link:calculationLink 003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) link:presentationLink link:definitionLink link:calculationLink 004 - Statement - Condensed Consolidated Statements of Operations (Unaudited) link:presentationLink link:definitionLink link:calculationLink 005 - Statement - Condensed Consolidated Statements of Comprehensive Loss (Unaudited) link:presentationLink link:definitionLink link:calculationLink 006 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) link:presentationLink link:definitionLink link:calculationLink 007 - Disclosure - Interim Period Reporting link:presentationLink link:definitionLink link:calculationLink 008 - Disclosure - Summary of Significant Accounting Policies link:presentationLink link:definitionLink link:calculationLink 009 - Disclosure - Stockholders' Equity link:presentationLink link:definitionLink link:calculationLink 010 - Disclosure - Deferred Revenue link:presentationLink link:definitionLink link:calculationLink 011 - Disclosure - Stock-Based Compensation link:presentationLink link:definitionLink link:calculationLink 012 - Disclosure - Commitments and Contingencies link:presentationLink link:definitionLink link:calculationLink 013 - Disclosure - Segment Information link:presentationLink link:definitionLink link:calculationLink 014 - Disclosure - Net Loss Per Share link:presentationLink link:definitionLink link:calculationLink 015 - Disclosure - Subsequent Events link:presentationLink link:definitionLink link:calculationLink 016 - Disclosure - Summary of Significant Accounting Policies (Policies) link:presentationLink link:definitionLink link:calculationLink 017 - Disclosure - Summary of Significant Accounting Policies (Tables) link:presentationLink link:definitionLink link:calculationLink 018 - Disclosure - Stockholders' Equity (Tables) link:presentationLink link:definitionLink link:calculationLink 019 - Disclosure - Stock-Based Compensation (Tables) link:presentationLink link:definitionLink link:calculationLink 020 - Disclosure - Commitments and Contingencies (Tables) link:presentationLink link:definitionLink link:calculationLink 021 - Disclosure - Segment Information (Tables) link:presentationLink link:definitionLink link:calculationLink 022 - Disclosure - Net Loss Per Share (Tables) link:presentationLink link:definitionLink link:calculationLink 023 - Disclosure - Summary of Significant Accounting Policies (Details) link:presentationLink link:definitionLink link:calculationLink 024 - Disclosure - Summary of Significant Accounting Policies (Details Textual) link:presentationLink link:definitionLink link:calculationLink 025 - Disclosure - Stockholders' Equity (Details) link:presentationLink link:definitionLink link:calculationLink 026 - Disclosure - Stockholders' Equity (Details Textual) link:presentationLink link:definitionLink link:calculationLink 027 - Disclosure - Deferred Revenue (Details) link:presentationLink link:definitionLink link:calculationLink 028 - Disclosure - Stock-Based Compensation (Details) link:presentationLink link:definitionLink link:calculationLink 029 - Disclosure - Stock-Based Compensation (Details 1) link:presentationLink link:definitionLink link:calculationLink 030 - Disclosure - Stock-Based Compensation (Details 2) link:presentationLink link:definitionLink link:calculationLink 031 - Disclosure - Stock-Based Compensation (Details 3) link:presentationLink link:definitionLink link:calculationLink 032 - Disclosure - Stock-Based Compensation (Details 4) link:presentationLink link:definitionLink link:calculationLink 033 - Disclosure - Stock-Based Compensation (Details Textual) link:presentationLink link:definitionLink link:calculationLink 034 - Disclosure - Commitments and Contingencies (Details) link:presentationLink link:definitionLink link:calculationLink 035 - Disclosure - Commitments and Contingencies (Details Textual) link:presentationLink link:definitionLink link:calculationLink 036 - Disclosure - Segment Information (Details) link:presentationLink link:definitionLink link:calculationLink 037 - Disclosure - Segment Information (Details Textual) link:presentationLink link:definitionLink link:calculationLink 038 - Disclosure - Net Loss Per Share (Details) link:presentationLink link:definitionLink link:calculationLink 039 - Disclosure - Net Loss Per Share (Details Textual) link:presentationLink link:definitionLink link:calculationLink 040 - Disclosure - Subsequent Events (Details) link:presentationLink link:definitionLink link:calculationLink EX-101.CAL 7 neond-20130331_cal.xml EX-101.DEF 8 neond-20130331_def.xml EX-101.LAB 9 neond-20130331_lab.xml EX-101.PRE 10 neond-20130331_pre.xml XML 11 R39.htm IDEA: XBRL DOCUMENT v2.4.0.6
Net Loss Per Share (Details Textual)
3 Months Ended
Mar. 31, 2013
Mar. 31, 2012
Stock Option [Member]
   
Net Loss Per Share (Textual)    
Antidilutive securities excluded from computation of earnings per share 309,000 11,500
Warrant [Member]
   
Net Loss Per Share (Textual)    
Antidilutive securities excluded from computation of earnings per share 2,800,000 3,200,000
Convertible Preferred Stock [Member]
   
Net Loss Per Share (Textual)    
Antidilutive securities excluded from computation of earnings per share 11,000 52,000
XML 12 R33.htm IDEA: XBRL DOCUMENT v2.4.0.6
Stock-Based Compensation (Details Textual) (USD $)
0 Months Ended 3 Months Ended 0 Months Ended 3 Months Ended 0 Months Ended 3 Months Ended 0 Months Ended 3 Months Ended
Mar. 16, 2012
Mar. 31, 2013
Plan
Mar. 31, 2012
Mar. 11, 2013
Stock Options [Member]
Mar. 31, 2013
Stock Options [Member]
Mar. 19, 2013
Stock Options [Member]
Dec. 03, 2010
Warrant [Member]
Mar. 31, 2013
Warrant [Member]
Mar. 31, 2012
Warrant [Member]
Mar. 31, 2013
1998 Non-Officer Stock Option Plan [Member]
Mar. 31, 2013
1998 Non-Officer Stock Option Plan [Member]
Minimum [Member]
Mar. 31, 2013
1998 Non-Officer Stock Option Plan [Member]
Maximum [Member]
Mar. 31, 2013
2006 Equity Incentive Plan [Member]
Mar. 31, 2013
2006 Equity Incentive Plan [Member]
Minimum [Member]
Mar. 31, 2013
2006 Equity Incentive Plan [Member]
Maximum [Member]
Mar. 31, 2013
2001 Non-Employee Director Stock Option Plan [Member]
Mar. 31, 2013
2001 Non-Employee Director Stock Option Plan [Member]
Minimum [Member]
Mar. 31, 2013
2001 Non-Employee Director Stock Option Plan [Member]
Maximum [Member]
Sep. 12, 2011
Three Year Stock Purchase Warrants [Member]
Mar. 31, 2013
Three Year Stock Purchase Warrants [Member]
Mar. 31, 2012
Three Year Stock Purchase Warrants [Member]
Stock-Based Compensation (Textual)                                          
Stock option expiration date                   June 2008           March 2011          
Options outstanding, vested and expected to vest, outstanding, number         1,691,544                                
Options outstanding, vested and expected to vest, aggregate intrinsic value         $ 2,400,000                                
Additional common stock authorized for issuance as incentive stock options       2,000,000                                  
Common stock issued upon exercise of warrants, value       167,000                                  
Common stock issued upon exercise of warrants, Shares       38,456 (38,456)     (590,094)                          
Intrinsic value related to options exercised           58,000,000                              
Stock option vesting period                     1 year 4 years   1 year 4 years   1 year 4 years      
Stock option expiration period                   10 years     10 years       5 years 7 years      
Warrant issued in period             120,000                       20,000    
Exercise price of warrants per share             $ 1.63                       $ 3.90    
Fair value of warrants             198,000                       75,000    
Amortized period of warrants             24 months                            
Compensation expense related to the vesting of stock options   576,000 0           25,000                        
Fair value of warrants granted included in product research and development expenses                                       $ 10,000 $ 9,000
Number of equity incentive plans   2                                      
Number of non-employee director stock option plan   1                                      
Options granted to purchase of common stock to employee   15,000                                       
Stock options, grant date fair value   $ 80,000                                      
Recognition period of unamortized expense related to stock options and warrants   3 years                                      
Common stock purchase due to exercise of warrant by warrant holders excluding CFO     270,094                                    
Common stock received due to net exercise provision of warrant 266,228   198,512                                    
Common stock purchase due to exercise of warrant by CFO 320,000                                        
XML 13 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; word-wrap: break-word; } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 14 R25.htm IDEA: XBRL DOCUMENT v2.4.0.6
Stockholders' Equity (Details)
3 Months Ended
Mar. 31, 2013
Series A Preferred Stock [Member]
 
Schedule of conversion of preferred stock issued to common stock  
Conversion Ratio 480.63
Series B Preferred Stock [Member]
 
Schedule of conversion of preferred stock issued to common stock  
Shares of Preferred Stock Not Exchanged as of March 31, 2013 83
Conversion Ratio 132.07
Shares of Common Stock after Conversion of all Outstanding Shares of Preferred Stock Not yet Exchanged at March 31, 2013 10,962
XML 15 R37.htm IDEA: XBRL DOCUMENT v2.4.0.6
Segment Information (Details Textual)
3 Months Ended
Mar. 31, 2013
Segment
Segment Information (Textual)  
Number of reportable segments 1
XML 16 R9.htm IDEA: XBRL DOCUMENT v2.4.0.6
Stockholders' Equity
3 Months Ended
Mar. 31, 2013
Stockholders' Equity [Abstract]  
Stockholders' Equity
3.  Stockholders’ Equity
 
On February 29, 2012, the Company filed a Certificate of Correction with the Secretary of State of Delaware effectively reducing the amount of its authorized shares from 848,000,000 shares of Common Stock and 2,000,000 shares of Preferred Stock to 70,000,000 shares of Common Stock and 1,000,000 shares of Preferred Stock. This correction reflects the new capital structure of the Company following its 1-for-25 reverse split that became effective at the close of business on March 25, 2011.
 
On May 1, 2012, the Company began trading its common stock on the NASDAQ Stock Market under trading symbol NEON.
 
Common Stock
 
During the three months ended March 31, 2013, warrant holders (excluding our CFO) exercised warrants to purchase 270,094 shares of common stock using the net exercise provision allowed in the warrant and received 198,512 shares of our common stock.
 
On February 26, 2013, David Brunton, our CFO, exercised warrants to purchase 320,000 shares of common stock using the net exercise provision allowed in the warrant and received 266,228 shares of our common stock.
 
On March 16, 2012, John Reardon, a member of our board of directors, exercised a warrant to purchase 200,000 shares of common stock using the net exercise provision allowed in the warrant and received 174,798 shares of our common stock.
 
Preferred Stock
 
On March 21, 2013, Series A Preferred stockholders exchanged 83 shares of Series A Preferred stock for 39,790 shares of our common stock, eliminating all Series A Preferred shares outstanding.
 
 On February 27, 2013, Series B Preferred stockholders exchanged 4 shares of Series B Preferred stock for 528 shares of our common stock.
 
On March 21, 2013, Series B Preferred stockholders exchanged 8 shares of Series B Preferred stock for 929 shares of our common stock.
 
The terms of the Series A and Series B Preferred stock are as follows:
 
Dividends and Distributions.
     
 
Series A Preferred:
The holders of shares of Series A Preferred stock are entitled to participate with the holders of our common stock with respect to any dividends declared on the common stock in proportion to the number of shares of common stock issuable upon conversion of the shares of Series A Preferred stock held by them.
     
 
Series B Preferred:
The holders of shares of Series B Preferred stock are entitled to participate with the holders of our common stock with respect to any dividends declared on the common stock in proportion to the number of shares of common stock issuable upon conversion of the shares of Series B Preferred stock held by them.
     
Liquidation Preference.
     
 
Series A Preferred:
In the event of any liquidation, dissolution, or winding up of our operations, either voluntary or involuntary, subject to the rights of any other series of Preferred stock to be established by the Board of Directors (the “Senior Preferred Stock”), the holders of Series A Preferred stock shall be entitled to receive, after any distribution to the holders of Senior Preferred Stock and prior to and in preference to any distribution to the holders of common stock, $0.001 for each share of Series A Preferred stock then outstanding.
     
 
Series B Preferred:
In the event of any liquidation, dissolution, or winding up of our operations, either voluntary or involuntary, subject to the rights of the Series A Preferred stock and Senior Preferred Stock, the holders of Series B Preferred stock shall be entitled to receive, after any distribution to the holders of Senior Preferred Stock and prior to and in preference to any distribution to the holders of common stock, $0.001 for each share of Series B Preferred stock then outstanding.
     
Voting.
 
     
The holders of shares of Series A Preferred stock and Series B Preferred stock shall have one vote for each share of Series A Preferred stock and Series B Preferred stock held by them.
     
Conversion.
 
 
Initially, each share of Series A Preferred stock and each share of Series B Preferred stock was convertible into one share of our common stock.  Any modification to the conversion rate requires shareholder approval. On March 31, 2009, our shareholders approved a resolution to increase the authorized share capital, and to increase the conversion ratio to 480.63 shares of common stock for each share of Series A Preferred stock and to 132.07 shares of our common stock for each shares of Series B Preferred stock, thus completing the restructuring begun in December 2008.
 
On April 24, 2009, we initiated the process of allowing the shareholders of our preferred stock to convert the Series A and B Preferred stock to shares of our common stock. In order to convert the preferred stock to common stock each preferred stock shareholder is required to submit the preferred stock certificate to our transfer agent and request conversion to common stock. The conversion to common stock is not mandatory and shareholders who own preferred stock may choose not to convert their preferred stock to shares of our common stock.  The following table summarizes the Preferred stock not yet converted as of March 31, 2013.
 
   
Shares of Preferred Stock Not Exchanged as of March 31, 2013
   
Conversion Ratio
   
Shares of Common Stock after Conversion of all Outstanding Shares of Preferred Stock Not yet Exchanged at March 31, 2013
 
                   
Series B preferred stock
   
83
     
132.07 
     
10,962
 
EXCEL 17 Financial_Report.xls IDEA: XBRL DOCUMENT begin 644 Financial_Report.xls M[[N_34E-12U697)S:6]N.B`Q+C`-"E@M1&]C=6UE;G0M5'EP93H@5V]R:V)O M;VL-"D-O;G1E;G0M5'EP93H@;75L=&EP87)T+W)E;&%T960[(&)O=6YD87)Y M/2(M+2TM/5].97AT4&%R=%]B.6%A-SDS,%\W-V,Y7S1A.#-?8C(P8E]F.&8Q M,S(W-#DV834B#0H-"E1H:7,@9&]C=6UE;G0@:7,@82!3:6YG;&4@1FEL92!7 M96(@4&%G92P@86QS;R!K;F]W;B!A'!L;W)E&UL;G,Z=CTS1")U&UL;G,Z;STS1")U&UL/@T*(#QX.D5X8V5L5V]R:V)O;VL^#0H@(#QX M.D5X8V5L5V]R:W-H965T5]);F9O#I%>&-E;%=O#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/D-O;F1E;G-E9%]#;VYS;VQI9&%T961?4W1A=&5M M93$\+W@Z3F%M93X-"B`@("`\>#I7;W)K#I%>&-E;%=O#I%>&-E;%=O5]O9E]3:6=N:69I8V%N=%]!8V-O=6YT/"]X.DYA;64^#0H@("`@/'@Z5V]R M:W-H965T4V]U#I%>&-E;%=O3PO>#I.86UE M/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/D1E9F5R#I7;W)K#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/D-O;6UI=&UE;G1S7V%N9%]#;VYT:6YG96YC:65S/"]X M.DYA;64^#0H@("`@/'@Z5V]R:W-H965T4V]U#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I. M86UE/DYE=%],;W-S7U!E#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/E-U8G-E<75E;G1?179E;G1S/"]X.DYA;64^#0H@ M("`@/'@Z5V]R:W-H965T4V]U#I%>&-E;%=O5]O9E]3:6=N:69I M8V%N=%]!8V-O=6YT,3PO>#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/E-U;6UA#I7;W)K#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/E-T;V-K0F%S961?0V]M<&5N#I.86UE M/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/D-O;6UI=&UE;G1S7V%N M9%]#;VYT:6YG96YC:65S7SPO>#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/E-E9VUE;G1?26YF;W)M871I;VY?5&%B;&5S/"]X.DYA;64^ M#0H@("`@/'@Z5V]R:W-H965T4V]U#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I. M86UE/E-U;6UA#I7;W)K#I%>&-E;%=O5]$971A:6QS/"]X.DYA;64^ M#0H@("`@/'@Z5V]R:W-H965T4V]U#I%>&-E;%=O5]$971A:6QS7U1E/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H965T4V]U M#I%>&-E;%=O#I%>&-E;%=O#I% M>&-E;%=O#I.86UE M/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/E-T;V-K0F%S961?0V]M M<&5N#I7;W)K#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/E-T;V-K0F%S961?0V]M<&5N#I7;W)K#I%>&-E;%=O#I%>&-E;%=O#I.86UE M/E-E9VUE;G1?26YF;W)M871I;VY?1&5T86EL#I.86UE/@T*("`@(#QX M.E=O#I%>&-E;%=O M#I.86UE/E-E9VUE;G1?26YF;W)M871I;VY?1&5T M86EL#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE M/DYE=%],;W-S7U!E#I%>&-E;%=O#I%>&-E;%=O M#I.86UE/@T*("`@(#QX.E=O M#I%>&-E;%=O#I!8W1I=F53:&5E M=#X-"B`@/'@Z4')O=&5C=%-T#I0#I0#I0&UL/CPA6V5N9&EF M72TM/@T*/"]H96%D/@T*("`\8F]D>3X-"B`@(#QP/E1H:7,@<&%G92!S:&]U M;&0@8F4@;W!E;F5D('=I=&@@36EC'1087)T M7V(Y86$W.3,P7S'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T* M("`@("`@/'1R(&-L87-S/3-$2!# M96YT3PO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^,#`P,#`X-S`U,#QS<&%N/CPO'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L M87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$2!&:6QE3PO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^06-C96QE2!#;VUM M;VX@4W1O8VLL(%-H87)E'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S7!E.B!T97AT+VAT;6P[(&-H87)S M970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@ M:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M M;#L@8VAA'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$7!E.B!T97AT+VAT M;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@ M("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$ M)W1E>'0O:'1M;#L@8VAAF5D/"]T9#X-"B`@("`@("`@/'1D(&-L M87-S/3-$;G5M<#XW,"PP,#`L,#`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T* M("`@("`@/'1R(&-L87-S/3-$F5D/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XT-#0L-30Q/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S3X-"CPO:'1M;#X- M"@T*+2TM+2TM/5].97AT4&%R=%]B.6%A-SDS,%\W-V,Y7S1A.#-?8C(P8E]F M.&8Q,S(W-#DV834-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO8CEA M83'0O:'1M;#L@8VAA'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$7!E.B!T97AT+VAT;6P[(&-H M87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U% M5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O M:'1M;#L@8VAA2!T7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI M(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS M1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA7!E/3-$=&5X="]J879A'!E;G-E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XU M.#8\'!E;G-E6%B;&4@86YD(&%C8W)U960@97AP96YS97,\+W1D/@T*("`@ M("`@("`\=&0@8VQA'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S M/3-$2!A;F0@97%U:7!M96YT/"]T9#X-"B`@("`@ M("`@/'1D(&-L87-S/3-$;G5M/B@R."D\&-H86YG92!R871E(&-H86YG97,@;VX@ M8V%S:#PO=&0^#0H@("`@("`@(#QT9"!C;&%S&5S('!A:60\+W1D/@T*("`@("`@("`\=&0@8VQA3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R M=%]B.6%A-SDS,%\W-V,Y7S1A.#-?8C(P8E]F.&8Q,S(W-#DV834-"D-O;G1E M;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO8CEA83'0O:'1M;#L@8VAA'0^/&1I=B!A;&EG;CTS1&QE9G0@3H@8FQO8VL[(&UA6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@ M=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L\+V9O M;G0^/"]D:78^#0H\9&EV('-T>6QE/3-$)W1E>'0M86QI9VXZ(&IU'0M:6YD96YT.B`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`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`S-G!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P M=#L@;6%R9VEN+7)I9VAT.B`P<'0[)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y M.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UE6QE/3-$)V1I3H@8FQO8VL[(&UA3H@:6YL:6YE.R!F;VYT+69A M;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SX\9F]N M="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UE M6QE/3-$)W1E>'0M86QI9VXZ(&IU'0M:6YD96YT.B`S-G!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN M+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`P<'0[)SX\9F]N="!S='EL93TS M1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UE6QE/3-$)V1I3H@8FQO8VL[(&UA6QE/3-$)W1E>'0M86QI9VXZ M(&IU'0M:6YD96YT.B`S-G!T.R!D:7-P;&%Y.B!B;&]C:SL@ M;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`P<'0[)SXF(S$V,#L\ M+V1I=CX-"CQD:78@3L@=&5X M="UI;F1E;G0Z(#,V<'0[(&1I3H@ M8FQO8VL[(&UA3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@ M=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SY.96]N;V1E(&UA M;F%G96UE;G0@:&%S(&UA9&4@2X\+V9O;G0^/"]D:78^#0H\+V1I=CX-"CPO M9&EV/@T*/&1I=B!S='EL93TS1"=T97AT+6%L:6=N.B!J=7-T:69Y.R!T97AT M+6EN9&5N=#H@,S9P=#L@9&ES<&QA>3H@8FQO8VL[(&UA6QE/3-$)W1E>'0M86QI9VXZ(&IU'0M:6YD96YT.B`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`P<'0[(&1I6QE/3-$)W1E>'0M86QI9VXZ(&IU'0M:6YD96YT.B`S-G!T M.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I M9VAT.B`P<'0[)SX-"CQD:78@3L@=&5X="UI;F1E;G0Z(#,V<'0[(&1I6QE/3-$ M)V1I2!E>&-E M960@=&AE(&%M;W5N="!O9B!I;G-U&EM871E;'D@ M)#6QE/3-$)W1E M>'0M:6YD96YT.B`P<'0[(&UA6QE.B!I=&%L:6,[(&1I6QE/3-$)W1E>'0M86QI9VXZ M(&QE9G0[('1E>'0M:6YD96YT.B`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`@=VED M=&@],T0R-B4^#0H\9&EV('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('1E M>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1I3H@:6YL:6YE M.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P M<'0[('1E>'0M9&5C;W)A=&EO;CH@=6YD97)L:6YE.R<^17-T:6UA=&5D('5S M969U;"!L:79E6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I M3H@8FQO8VL[(&UA3H@:6YL M:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z M(#$P<'0[)SY#;VUP=71E6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1I3H@8FQO M8VL[(&UA6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1I6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)W1E>'0M86QI M9VXZ(&IU'0M:6YD96YT.B`S-G!T.R!D:7-P;&%Y.B!B;&]C M:SL@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`P<'0[)SX\9F]N M="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UE MF5D(&]N(&$@ M3H@8FQO8VL[(&UA3H@:6YL:6YE.R!F;VYT M+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF M(S$V,#L\+V9O;G0^/"]D:78^#0H\9&EV('-T>6QE/3-$)W1E>'0M86QI9VXZ M(&IU'0M:6YD96YT.B`S-G!T.R!D:7-P;&%Y.B!B;&]C:SL@ M;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`P<'0[)SX\9F]N="!S M='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UEF%T:6]N(&%R92!R M96UO=F5D(&9R;VT@=&AE(&%C8V]U;G1S(&%N9"!A;GD@9V%I;G,@;W(@;&]S M6QE/3-$)W1E>'0M86QI9VXZ(&IU'0M:6YD M96YT.B`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`V,W!T.R<^#0H\9&EV/CQF;VYT('-T>6QE/3-$)V9O;G0M3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@ M;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(SDV-SD[)B,Q-C`[)B,Q M-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[/"]F;VYT M/CPO9&EV/@T*/"]T9#X-"CQT9#X-"CQD:78@86QI9VX],T1J=7-T:69Y('-T M>6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&UA3H@:6YL M:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z M(#$P<'0[)SY3;VYY($-O6QE/3-$)W=I9'1H.B`V,W!T.R<^#0H\9&EV/CQF;VYT('-T M>6QE/3-$)V9O;G0M3H@:6YL:6YE.R!F M;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[ M)SXF(SDV-SD[)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[ M)B,Q-C`[)B,Q-C`[/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT9#X-"CQD:78@ M86QI9VX],T1J=7-T:69Y('-T>6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&UA M3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W M(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SY.971R;VYI>"`F(S@R,3$[(#(Q M)3PO9F]N=#X\+V1I=CX-"CPO=&0^#0H\+W1R/@T*/"]T86)L93X-"CPO9&EV M/@T*/&1I=CX-"CQT86)L92!S='EL93TS1"=W:61T:#H@,3`P)3L@9F]N="UF M86UI;'DZ('1I;65S(&YE=R!R;VUA;CL@9F]N="US:7IE.B`Q,'!T.R<@(&-E M;&QS<&%C:6YG/3-$,"!C96QL<&%D9&EN9STS1#`^#0H\='(@=F%L:6=N/3-$ M=&]P/@T*/'1D(&%L:6=N/3-$3H@8FQO8VL[(&UA3H@ M:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I M>F4Z(#$P<'0[)SY/=7(@86-C;W5N=',@6QE/3-$)W1E>'0M:6YD96YT.B`P M<'0[(&1I6QE/3-$)W=I9'1H.B`Q,#`E.R!F;VYT+69A;6EL>3H@=&EM97,@ M;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)R`@8V5L;'-P86-I;F<],T0P M(&-E;&QP861D:6YG/3-$,#X-"CQT6QE.B!I=&%L:6,[(&1I2!S='EL93TS1"=T97AT+6EN9&5N=#H@,'!T M.R!M87)G:6XM;&5F=#H@,'!T.R!M87)G:6XM6QE/3-$)V1IF]N("T@-34E/"]F M;VYT/CPO9&EV/@T*/"]T9#X-"CPO='(^#0H\+W1A8FQE/@T*/"]D:78^#0H\ M9&EV/@T*/'1A8FQE('-T>6QE/3-$)W=I9'1H.B`Q,#`E.R!F;VYT+69A;6EL M>3H@=&EM97,@;F5W#0H@6QE/3-$)W=I9'1H.B`V,W!T.R<^ M#0H\9&EV/CQF;VYT('-T>6QE/3-$)V9O;G0M3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F M;VYT+7-I>F4Z(#$P<'0[)SXF(SDV-SD[)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q M-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[/"]F;VYT/CPO9&EV/@T*/"]T M9#X-"CQT9#X-"CQD:78@86QI9VX],T1J=7-T:69Y('-T>6QE/3-$)W1E>'0M M:6YD96YT.B`P<'0[(&UA3H@:6YL:6YE.R!F;VYT+69A M;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SY3;VYY M($-O3L@=&5X="UI;F1E;G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA M6QE/3-$)W1E>'0M86QI9VXZ(&IU'0M M:6YD96YT.B`Q.'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#$X M<'0[(&UA3H@8FQO8VL[(&UA6QE/3-$)V9O;G0M3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N M.R!F;VYT+7-I>F4Z(#$P<'0[)SY,:6-E;G-I;F<@4F5V96YU97,Z/"]F;VYT M/CPO9&EV/@T*/&1I=B!S='EL93TS1"=T97AT+6%L:6=N.B!J=7-T:69Y.R!T M97AT+6EN9&5N=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SLG/B8C,38P.SPO9&EV M/@T*/&1I=B!S='EL93TS1"=T97AT+6%L:6=N.B!J=7-T:69Y.R!T97AT+6EN M9&5N=#H@,S9P=#L@9&ES<&QA>3H@8FQO8VL[(&UA6QE/3-$)W1E>'0M86QI M9VXZ(&IU'0M:6YD96YT.B`S-G!T.R!D:7-P;&%Y.B!B;&]C M:SL@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`P<'0[)SX\9F]N M="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UE M6QE/3-$ M)V1I2`H)B,X,C(P.TE0)B,X,C(Q.RDN(%=E(&5N=&5R(&EN M=&\@25`@;&EC96YS:6YG(&%G6%L=&EE2!T:&4@0V]M<&%N>28C.#(Q-SMS(&-U2!A2!T:&5M(&%F=&5R('1H M92!E;F0@;V8@=&AE(')E<&]R=&EN9R!P97)I;V0@3H@8FQO8VL[(&UA3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O M;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SY%>'!L:6-I="!R971U3H@8FQO8VL[(&UA6QE/3-$)V9O;G0M3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@ M;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SY%;F=I;F5E6QE/3-$)W1E>'0M86QI9VXZ M(&IU'0M:6YD96YT.B`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`T*('-T>6QE/3-$)V1I&EM871E;'D@)#$R-"PP,#`@ M86YD("0Q.33H@8FQO8VL[(&UA3L@=&5X="UI;F1E;G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[)SXF(S$V M,#L\+V1I=CX-"CQD:78@3L@ M=&5X="UI;F1E;G0Z(#,V<'0[(&1I6QE/3-$)V1I M'!E;G-E9"!A2!O9B!P97)S M;VYN96P@6EN9R!A;F0@;65A3L@=&5X="UI;F1E;G0Z(#!P=#L@ M9&ES<&QA>3H@8FQO8VL[)SXF(S$V,#L\+V1I=CX-"CQD:78@3L@=&5X="UI;F1E;G0Z(#,V<'0[(&1I6QE/3-$)V9O;G0M3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT M+7-I>F4Z(#$P<'0[(&9O;G0M=V5I9VAT.B!B;VQD.R<^4W1O8VLM0F%S960@ M0V]M<&5N6QE M/3-$)W1E>'0M86QI9VXZ(&IU'0M:6YD96YT.B`P<'0[(&1I M6QE/3-$)W1E M>'0M86QI9VXZ(&IU'0M:6YD96YT.B`S-G!T.R!D:7-P;&%Y M.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`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`P<'0[(&1I6QE/3-$)W1E>'0M86QI9VXZ(&IU'0M M:6YD96YT.B`S-G!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P M=#L@;6%R9VEN+7)I9VAT.B`P<'0[)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y M.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UE65A"!AF%T:6]N(&ES('5N8V5R=&%I;B!B87-E9"!O;B!T:&4@)B,X,C(P.VUO6QE/3-$)W1E M>'0M86QI9VXZ(&IU'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)W1E>'0M86QI M9VXZ(&IU'0M:6YD96YT.B`S-G!T.R!D:7-P;&%Y.B!B;&]C M:SL@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`P<'0[)SX\9F]N M="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UE M2!O9B!F=71U"!I;F-O;64L('=E(&9U;&QY M(')E3H@8FQO8VL[(&UA3H@:6YL:6YE.R!F;VYT M+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SY7 M92!F;VQL;W<@=&AE(')E;&5V86YT(&%C8V]U;G1I;F<@9W5I9&%N8V4@"!P;W-I=&EO;G,N)B,Q-C`[)B,Q-C`[07,@82!R97-U;'0L('=E(&1I9"!N M;W0@F5D('1A>"!B96YE9FET6QE/3-$ M)W1E>'0M86QI9VXZ(&IU'0M:6YD96YT.B`S-G!T.R!D:7-P M;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`P M<'0[)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M M:6QY.B!T:6UE3L@=&5X="UI;F1E;G0Z(#,V<'0[(&1I6QE/3-$)V9O;G0M3H@:6YL:6YE M.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P M<'0[(&9O;G0M=V5I9VAT.B!B;VQD.R<^3F5T($QO6QE/3-$)W1E>'0M86QI9VXZ(&IU'0M:6YD96YT.B`S-G!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z M(#!P=#L@;6%R9VEN+7)I9VAT.B`P<'0[)SX\9F]N="!S='EL93TS1"=D:7-P M;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UE&-L=61E('1H92!P;W1E;G1I86P@8V]M;6]N('-T M;V-K(&5Q=6EV86QE;G1S+"!A3H@8FQO8VL[(&UA6QE M/3-$)W1E>'0M86QI9VXZ(&IU'0M:6YD96YT.B`P<'0[(&1I M6QE/3-$)W1E M>'0M86QI9VXZ(&IU'0M:6YD96YT.B`S-G!T.R!D:7-P;&%Y M.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`P<'0[ M)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY M.B!T:6UE2!T6QE M/3-$)W1E>'0M86QI9VXZ(&IU'0M:6YD96YT.B`P<'0[(&1I M6QE/3-$)W1E M>'0M86QI9VXZ(&IU'0M:6YD96YT.B`S-G!T.R!D:7-P;&%Y M.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`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`@/&AE860^#0H@("`@/$U% M5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O M:'1M;#L@8VAA3QB6QE/3-$)V1I3H@:6YL:6YE M.R!F;VYT+7=E:6=H=#H@8F]L9#LG/E-T;V-K:&]L9&5R3L@=&5X="UI;F1E;G0Z(#!P=#L@9&ES<&QA>3H@8FQO M8VL[)SXF(S$V,#L\+V1I=CX-"CQD:78@3L@=&5X="UI;F1E;G0Z(#,V<'0[(&1I6QE/3-$)V1I6QE/3-$)W1E>'0M86QI9VXZ(&IU'0M:6YD96YT.B`P<'0[ M(&1I6QE/3-$ M)W1E>'0M86QI9VXZ(&IU'0M:6YD96YT.B`S-G!T.R!D:7-P M;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`P M<'0[)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M M:6QY.B!T:6UE2`Q+"`R,#$R+"!T:&4@0V]M<&%N>2!B96=A;B!T6UB;VP@3D5/3BX\+V9O;G0^/"]D:78^#0H\9&EV('-T>6QE/3-$ M)W1E>'0M86QI9VXZ(&IU'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)W1E>'0M M86QI9VXZ(&IU'0M:6YD96YT.B`P<'0[(&1I6QE.B!I=&%L:6,[(&1I3H@8FQO8VL[(&UA3H@:6YL:6YE.R!F;VYT+69A;6EL M>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SY$=7)I;F<@ M=&AE('1H&-L=61I;F<@;W5R($-&3RD@97AE3L@=&5X="UI;F1E;G0Z(#!P=#L@9&ES<&QA M>3H@8FQO8VL[)SXF(S$V,#L\+V1I=CX-"CQD:78@3L@=&5X="UI;F1E;G0Z(#,V<'0[(&1I6QE/3-$)V1I&5R8VES92!P6QE M/3-$)W1E>'0M86QI9VXZ(&IU'0M:6YD96YT.B`P<'0[(&1I M6QE/3-$)W1E M>'0M86QI9VXZ(&IU'0M:6YD96YT.B`S-G!T.R!D:7-P;&%Y M.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`P<'0[ M)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY M.B!T:6UE3H@8FQO8VL[(&UA3L@=&5X="UI;F1E;G0Z(#!P=#L@9&ES<&QA>3H@8FQO M8VL[)SXF(S$V,#L\+V1I=CX-"CQD:78@3L@=&5X="UI;F1E;G0Z(#,V<'0[(&1I6QE/3-$)V1I3H@8FQO8VL[(&UA3H@ M:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I M>F4Z(#$P<'0[)SXF(S$V,#M/;B!&96)R=6%R>2`R-RP@,C`Q,RP@4V5R:65S M($(@4')E9F5R&-H86YG960@-"!S:&%R97,@ M;V8@4V5R:65S($(@4')E9F5R3H@ M8FQO8VL[(&UA3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@ M=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SY/;B!-87)C:"`R M,2P@,C`Q,RP@4V5R:65S($(@4')E9F5R&-H M86YG960@."!S:&%R97,@;V8@4V5R:65S($(@4')E9F5R3H@8FQO8VL[(&UA3H@:6YL:6YE M.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P M<'0[)SY4:&4@=&5R;7,@;V8@=&AE(%-E6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E3H@:6YL:6YE.R!F M;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R<^)B,Y-C6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I M6QE/3-$)V9O;G0M9F%M:6QY.B!T:6UE6QE/3-$)V1I6QE/3-$)V9O;G0M9F%M:6QY.B!T:6UE6QE/3-$)V9O;G0M9F%M:6QY M.B!T:6UE6QE/3-$)V9O M;G0M9F%M:6QY.B!T:6UE6QE/3-$)V9O;G0M9F%M:6QY.B!T:6UE6QE/3-$)W1E>'0M:6YD96YT.B`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`@=VED=&@],T0Q,B4^#0H\9&EV(&%L:6=N/3-$;&5F="!S M='EL93TS1"=T97AT+6EN9&5N=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R M9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`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`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`@=VED=&@],T0Q,B4^#0H\9&EV(&%L:6=N/3-$;&5F="!S='EL93TS M1"=T97AT+6EN9&5N=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE M9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`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`P M<'0[(&1I6QE/3-$)V9O;G0M9F%M:6QY.B!T:6UE M6QE/3-$ M)V1I6QE/3-$)V9O M;G0M9F%M:6QY.B!T:6UE6QE M/3-$)V9O;G0M9F%M:6QY.B!T:6UE6QE/3-$)V9O;G0M9F%M:6QY.B!T:6UE6QE/3-$)V9O;G0M9F%M:6QY.B!T:6UE6QE/3-$)W1E M>'0M86QI9VXZ(&IU'0M:6YD96YT.B`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`P<'0[(&1I6QE/3-$)V1I6QE/3-$)VUA2P@96%C:"!S:&%R92!O9B!397)I97,@02!02!M;V1I9FEC871I;VX@ M=&\@=&AE(&-O;G9EF5D('-H87)E(&-A<&ET86PL(&%N9"!T;R!I;F-R96%S92!T:&4@8V]N=F5R M3L@=&5X="UI;F1E;G0Z M(#,V<'0[(&1I6QE/3-$)V1I65T(&-O;G9E6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1IF4Z(#$P<'0[('=I9'1H.B`Q,#`E.R!F;VYT+69A;6EL>3H@ M=&EM97,@;F5W(')O;6%N.R<@8V5L;'-P86-I;F<],T0P(&-E;&QP861D:6YG M/3-$,#X-"CQT#LG('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS M1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UE#LG M('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI M;F4[(&9O;G0M9F%M:6QY.B!T:6UE6QE/3-$)W1E M>'0M:6YD96YT.B`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`P<'0[(&1I M6QE/3-$)V1I65T($5X8VAA;F=E9"!A="!-87)C:"`S,2P@,C`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`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS M1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA7!E/3-$=&5X="]J879A3L@=&5X="UI;F1E;G0Z(#!P M=#L@9&ES<&QA>3H@8FQO8VL[(&UA3H@:6YL:6YE.R!F M;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[ M(&9O;G0M=V5I9VAT.B!B;VQD.R<^/&9O;G0@3H@ M:6YL:6YE.R<^-#PO9F]N=#XN)B,Q-C`[($1E9F5R6QE/3-$)W1E>'0M86QI9VXZ(&IU'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)W1E>'0M86QI9VXZ(&IU'0M M:6YD96YT.B`S-G!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P M=#L@;6%R9VEN+7)I9VAT.B`P<'0[)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y M.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UE2P@ M;V8@9&5F97)R960@96YG:6YE97)I;F<@9&5V96QO<&UE;G0@9F5E2!O=7(@8W5S=&]M97)S+CPO9F]N=#X\+V1I=CX\'0O:F%V87-C3X- M"B`@("`\=&%B;&4@8VQA6QE/3-$)W1E>'0M86QI9VXZ(&IU'0M:6YD96YT M.B`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`P<'0[(&1I6QE/3-$)W1E>'0M86QI9VXZ(&IU'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)V9O;G0M M3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@ M=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M=V5I9VAT M.B!B;VQD.R<^4W1O8VL@3W!T:6]N3L@=&5X="UI;F1E;G0Z(#!P=#L@ M9&ES<&QA>3H@8FQO8VL[)SXF(S$V,#L\+V1I=CX-"CQD:78@3L@=&5X="UI;F1E;G0Z(#!P=#L@9&ES<&QA M>3H@8FQO8VL[(&UA3H@:6YL:6YE.R!F;VYT+69A;6EL M>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SY!3L@=&5X="UI;F1E;G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA M6QE/3-$)W=I M9'1H.B`Q,#`E.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT M+7-I>F4Z(#$P<'0[)R!C96QL6QE/3-$)V9O;G0M M9F%M:6QY.B!T:6UE6QE/3-$)W1E>'0M86QI9VXZ(&QE M9G0[)R!W:61T:#TS1#0E/CQF;VYT('-T>6QE/3-$)V1I6QE/3-$)V9O;G0M9F%M:6QY.B!T:6UE6QE/3-$)V9O;G0M9F%M:6QY.B!T:6UE6QE/3-$)W1E M>'0M86QI9VXZ(&QE9G0[)R!W:61T:#TS1#0E/CQF;VYT('-T>6QE/3-$)V1I M6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E6QE/3-$)W1E>'0M86QI9VXZ(&-E M;G1E6QE/3-$ M)W1E>'0M86QI9VXZ(&IU'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1I6QE/3-$)V9O;G0M9F%M:6QY.B!T M:6UE6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[)R!W:61T M:#TS1#0E/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.B!T:6UE6QE/3-$)V9O;G0M9F%M:6QY.B!T M:6UE6QE/3-$)V9O;G0M9F%M M:6QY.B!T:6UE6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[ M)R!W:61T:#TS1#0E/CQF;VYT('-T>6QE/3-$)V1I6QE/3-$)V9O;G0M9F%M:6QY.B!T:6UE6QE/3-$)V1I65E($1I6QE/3-$)W1E>'0M:6YD96YT.B`S-G!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R M9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`P<'0[)SX\9F]N="!S='EL M93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UE2!O9B!T:&4@8V]M M8FEN960@86-T:79I='D@=6YD97(@86QL(&]F('1H92!S=&]C:R!O<'1I;VX@ M<&QA;G,@:7,@3H@8FQO8VL[)SXF M(S$V,#L\+V1I=CX-"CQD:78@86QI9VX],T1L969T/@T*/'1A8FQE('-T>6QE M/3-$)W=I9'1H.B`Q,#`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`Q+C9P M=#LG/CQF;VYT('-T>6QE/3-$)V1I2`Q+"`R,#$S/"]F;VYT/CPO9&EV/@T*/"]T9#X- M"CQT9"!A;&EG;CTS1')I9VAT('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E M/CQF;VYT('-T>6QE/3-$)V1I6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W M(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXQ+#6QE/3-$)V1I6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@ M=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXD/"]F;VYT/CPO M9&EV/@T*/"]T9#X-"CQT9"!A;&EG;CTS1')I9VAT('9A;&EG;CTS1&)O='1O M;2!W:61T:#TS1#DE/@T*/&1I=B!A;&EG;CTS1')I9VAT('-T>6QE/3-$)W1E M>'0M:6YD96YT.B`P<'0[(&1I3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F M;VYT+7-I>F4Z(#$P<'0[)SXU+C`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`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`P+CAP=#LG/CQF;VYT('-T>6QE M/3-$)V1I3H@8FQO8VL[(&UA3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W M(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L@/"]F;VYT/CPO=&0^ M#0H\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O M;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\ M=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)3X- M"CQD:78@86QI9VX],T1R:6=H="!S='EL93TS1"=T97AT+6EN9&5N=#H@,'!T M.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I M9VAT.B`P+CAP=#LG/CQF;VYT('-T>6QE/3-$)V1I3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N M.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\+W1R M/@T*/'1R(&)G8V]L;W(],T1W:&ET93X-"CQT9"!A;&EG;CTS1&QE9G0@#LG('9A;&EG;CTS1&)O='1O;2!W M:61T:#TS1#6QE/3-$)W1E>'0M M:6YD96YT.B`P<'0[(&1I3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT M+7-I>F4Z(#$P<'0[)SY%>&5R8VES960\+V9O;G0^/"]D:78^#0H\+W1D/@T* M/'1D(&%L:6=N/3-$#LG('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$ M)V1I6QE/3-$)V)O"!S;VQI9"!B;&%C:SLG('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#DE M/@T*/&1I=B!A;&EG;CTS1')I9VAT('-T>6QE/3-$)W1E>'0M:6YD96YT.B`P M<'0[(&1I3H@:6YL:6YE M.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P M<'0[)SXH,S@L-#4V/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!A;&EG;CTS M1&QE9G0@#LG('9A;&EG;CTS M1&)O='1O;2!W:61T:#TS1#$E/@T*/&1I=B!A;&EG;CTS1&QE9G0@3H@8FQO8VL[(&UA#LG('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T M>6QE/3-$)V1I6QE/3-$)V)O"!S;VQI9"!B;&%C:SLG('9A;&EG;CTS1&)O='1O;2!W:61T M:#TS1#DE/@T*/&1I=B!A;&EG;CTS1')I9VAT('-T>6QE/3-$)W1E>'0M:6YD M96YT.B`P<'0[(&1I3H@ M:6YL:6YE.R!F;VYT+69A;6EL>3H-"B!T:6UE3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT M+7-I>F4Z(#$P<'0[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\+W1R/@T*/'1R M(&)G8V]L;W(],T0C8V-E969F/@T*/'1D(&%L:6=N/3-$;&5F="!S='EL93TS M1"=P861D:6YG+6)O='1O;3H@-'!X.R<@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$-S8E/@T*/&1I=B!A;&EG;CTS1&QE9G0@3H@8FQO8VL[(&UA6QE/3-$)W!A M9&1I;F6QE/3-$)V1I6QE M/3-$)W1E>'0M:6YD96YT.B`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`P<'0[ M(&1I3H@:6YL:6YE.R!F M;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[ M)SXD/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!A;&EG;CTS1')I9VAT('-T M>6QE/3-$)V)O"!D;W5B;&4@8FQA8VL[)R!V86QI M9VX],T1B;W1T;VT@=VED=&@],T0Y)3X-"CQD:78@86QI9VX],T1R:6=H="!S M='EL93TS1"=T97AT+6EN9&5N=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R M9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`P+CAP=#LG/CQF;VYT('-T M>6QE/3-$)V1I6QE/3-$)W!A9&1I;F6QE/3-$)W1E M>'0M:6YD96YT.B`P<'0[(&1I3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O M;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L\82!N86UE/3-$9FES7W5N M:61E;G1I9FEE9%]T86)L95\R,CX\+V$^/"$M+45&4&QA8V5H;VQD97(M+3XF M(S$V,#L\+V9O;G0^/"]D:78^#0H\9&EV('-T>6QE/3-$)W1E>'0M:6YD96YT M.B`P<'0[(&1I6QE/3-$)W1E>'0M M86QI9VXZ(&IU'0M:6YD96YT.B`S-G!T.R!D:7-P;&%Y.B!B M;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`P<'0[)SX\ M9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T M:6UE3H@ M8FQO8VL[)SXF(S$V,#L\+V1I=CX-"CQD:78@3L@=&5X="UI;F1E;G0Z(#,V<'0[(&1I6QE/3-$)V1I3L@ M=&5X="UI;F1E;G0Z(#,V<'0[(&1I3H@8FQO8VL[(&UA6QE/3-$)W1E>'0M86QI9VXZ(&IU M'0M:6YD96YT.B`P<'0[(&1I6QE M/3-$)V1I&5R M8VES92!O9B!S=&]C:R!O<'1I;VYS(&EN=&\@,S@L-#4V('-H87)E&5R8VES92X\+V9O;G0^/"]D:78^#0H\+V1I=CX- M"CQD:78@3L@=&5X="UI;F1E M;G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[)SXF(S$V,#L\+V1I=CX-"CQD:78@ M3L@=&5X="UI;F1E;G0Z(#,V M<'0[(&1I6QE/3-$)V1I3L@=&5X="UI;F1E;G0Z(#,V<'0[(&1I M3H@8FQO8VL[ M(&UA6QE/3-$)W1E>'0M86QI9VXZ(&IU'0M:6YD96YT.B`S M-G!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN M+7)I9VAT.B`P<'0[)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[ M(&9O;G0M9F%M:6QY.B!T:6UE6QE/3-$)V1I65E(&1U3L@=&5X="UI M;F1E;G0Z(#,V<'0[(&1I3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM M97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SX\9F]N="!S='EL93TS M1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UE3H@ M8FQO8VL[(&UA6QE/3-$)W=I9'1H.B`W-24[(&9O;G0M9F%M:6QY.B!T:6UE6QE/3-$ M)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1I M3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O M;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L\+V9O;G0^/"]T9#X-"CQT M9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q,"4@8V]L6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[ M(&1I6QE/3-$)V1I#LG('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#8S)3X-"CQD:78@ M86QI9VX],T1L969T('-T>6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1I#LG('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT M('-T>6QE/3-$)V1I6QE/3-$)V1I3H@8FQO8VL[(&UA3H@:6YL:6YE.R!F M;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[ M)SXF(S$V,#M!;FYU86P@9&EV:61E;F0@>6EE;&0\+V9O;G0^/"]D:78^#0H\ M+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T M>6QE/3-$)V1I6QE/3-$)V1I3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM M97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXM/"]F;VYT/CPO=&0^ M#0H\=&0@6QE/3-$)W1E>'0M:6YD96YT.B`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`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`[ M/"]D:78^#0H\9&EV('-T>6QE/3-$)W1E>'0M86QI9VXZ(&IU'0M:6YD96YT.B`S-G!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z M(#!P=#L@;6%R9VEN+7)I9VAT.B`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`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`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`P M<'0[(&1I6QE/3-$)V1I3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W M(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L@/"]F;VYT/CPO=&0^ M#0H\=&0@86QI9VX],T1L969T('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E M/@T*/&1I=B!A;&EG;CTS1&QE9G0-"B!S='EL93TS1"=T97AT+6EN9&5N=#H@ M,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN M+7)I9VAT.B`P<'0[)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[ M(&9O;G0M9F%M:6QY.B!T:6UE3H@8FQO8VL[ M(&UA3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@ M;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXQ,#PO9F]N=#X\+V1I=CX- M"CPO=&0^#0H\=&0@86QI9VX],T1L969T('9A;&EG;CTS1&)O='1O;2!W:61T M:#TS1#$E/CQF;VYT('-T>6QE/3-$)V1I6QE/3-$)W1E>'0M:6YD96YT.B`P M<'0[(&1I6QE/3-$)V1I6QE/3-$)V1I6QE M/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$ M)V1I3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@ M=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L@/"]F M;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('9A;&EG;CTS1&)O='1O;2!W M:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)V1I6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1I6QE/3-$)W!A9&1I;F#LG M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)V1I M6QE/3-$)V)O"!S;VQI9"!B;&%C:SLG('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#DE/@T* M/&1I=B!A;&EG;CTS1')I9VAT('-T>6QE/3-$)W1E>'0M:6YD96YT.B`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`P<'0[)SX\ M9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T M:6UE6QE/3-$)W!A9&1I M;F#LG('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT M('-T>6QE/3-$)V1I6QE/3-$)W1E>'0M:6YD96YT.B`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`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`R<'@@'0M86QI9VXZ(')I9VAT.R<@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$.24^#0H\9&EV('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!T M97AT+6EN9&5N=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z M(#!P=#L@;6%R9VEN+7)I9VAT.B`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`P<'0[(&1I6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('1E>'0M:6YD M96YT.B`P<'0[(&UA6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E#LG('9A;&EG;CTS M1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)V1I6QE/3-$)V)O M"!S;VQI9"!B;&%C:SLG('9A;&EG;CTS1&)O='1O M;2!W:61T:#TS1#,T)2!C;VQS<&%N/3-$,3`^#0H\9&EV(&%L:6=N/3-$8V5N M=&5R('-T>6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1I3H@:6YL:6YE.R!F M;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[ M(&9O;G0M=V5I9VAT.B!B;VQD.R<^)B,Q-C`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`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`P<'0[(&1I3H@8FQO8VL[(&UA3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O M;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXD/"]F;VYT/CPO9&EV/@T*/"]D:78^ M#0H\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#DE/@T*/&1I M=B!S='EL93TS1"=T97AT+6EN9&5N=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@ M;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`P<'0[)SX-"CQD:78@ M86QI9VX],T1R:6=H="!S='EL93TS1"=T97AT+6EN9&5N=#H@,'!T.R!D:7-P M;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`P M<'0[)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M M:6QY.B!T:6UE3H@:6YL:6YE M.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P M<'0[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$,24^/&9O;G0@3H@:6YL:6YE.R!F M;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[ M)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$,24^/&9O;G0@3H@:6YL:6YE.R!F;VYT M+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF M(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$.24^#0H\9&EV('-T>6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)W1E>'0M:6YD96YT M.B`P<'0[(&1I6QE/3-$)V1I6QE/3-$)W1E>'0M:6YD96YT M.B`P<'0[(&1I6QE/3-$)V1I6QE/3-$)V1I6QE/3-$)V1I6QE/3-$)V1I6QE/3-$)V1I6QE/3-$)V1I6QE/3-$)V1I6QE/3-$)V1I6QE/3-$)V1IF4Z(#$P<'0[)SXF(S$V,#L\+V9O;G0^/"]T9#X-"CPO M='(^#0H\='(@8F=C;VQO6QE/3-$)W1E M>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1I3H@ M:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I M>F4Z(#$P<'0[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@3H@:6YL M:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z M(#$P<'0[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$.24^#0H\9&EV('-T>6QE/3-$)W1E>'0M:6YD96YT.B`P M<'0[(&1I6QE/3-$)W1E M>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1I3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W M(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L@/"]F;VYT/CPO=&0^ M#0H\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O M;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\ M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^#0H\9&EV('-T>6QE/3-$ M)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)W1E>'0M:6YD96YT.B`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`P<'0[(&1I6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I M6QE/3-$)V1I#LG('9A;&EG;CTS1&)O='1O;2!W:61T M:#TS1#$E/@T*/&1I=B!S='EL93TS1"=T97AT+6EN9&5N=#H@,'!T.R!D:7-P M;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`P M<'0[)SX-"CQD:78@86QI9VX],T1L969T('-T>6QE/3-$)W1E>'0M:6YD96YT M.B`P<'0[(&1I6QE/3-$)V1I3H@:6YL:6YE.R!F;VYT M+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF M(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@3H@:6YL:6YE.R!F;VYT+69A;6EL M>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L@ M/"]F;VYT/CPO=&0^#0H\=&0@6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I M6QE/3-$)V1I3H@:6YL:6YE.R!F;VYT+69A;6EL M>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L@ M/"]F;VYT/CPO=&0^#0H\=&0@#LG('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$ M)V1I6QE/3-$)V1I6QE M/3-$)V)O"!S;VQI9"!B;&%C:SLG('9A;&EG;CTS M1&)O='1O;2!W:61T:#TS1#DE/@T*/&1I=B!S='EL93TS1"=T97AT+6EN9&5N M=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R M9VEN+7)I9VAT.B`P<'0[)SX-"CQD:78@86QI9VX],T1R:6=H="!S='EL93TS M1"=T97AT+6EN9&5N=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE M9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`P<'0[)SX\9F]N="!S='EL93TS1"=D M:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UE6QE/3-$)W!A9&1I;F6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1I3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W M(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L@/"]F;VYT/CPO=&0^ M#0H\=&0@6QE/3-$ M)V1I3H@8FQO8VL[(&UA M3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W M(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXT+#`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`P<'0[ M(&1I6QE/3-$)W1E>'0M86QI9VXZ(&IU'0M:6YD96YT.B`S-G!T M.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I M9VAT.B`P<'0[)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O M;G0M9F%M:6QY.B!T:6UE&5R8VES M960@=V%R3H@8FQO8VL[(&UA3H@:6YL:6YE.R!F;VYT+69A M;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SY/;B!& M96)R=6%R>2`R-BP@,C`Q,RP@1&%V:60@0G)U;G1O;BP@;W5R($-&3RP@97AE M3H@8FQO8VL[ M)SXF(S$V,#L\+V1I=CX-"CQD:78@86QI9VX],T1C96YT97(^#0H\=&%B;&4@ M6QE/3-$)W1E>'0M:6YD96YT.B`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`Y<'0[ M(&1I3H@:6YL:6YE.R!F M;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[ M(&9O;G0M=V5I9VAT.B!B;VQD.R<^17AE3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM M97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L@/"]F;VYT M/CPO=&0^#0H\=&0@6QE/3-$)W1E>'0M:6YD96YT.B`Q.'!T.R!D:7-P M;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`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`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`P<'0[(&1I3H@8FQO8VL[(&UA3H@:6YL:6YE.R!F;VYT+69A M;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXD/"]F M;VYT/CPO9&EV/@T*/"]D:78^#0H\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O M;2!W:61T:#TS1#DE/@T*/&1I=B!S='EL93TS1"=T97AT+6EN9&5N=#H@,'!T M.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I M9VAT.B`P<'0[)SX-"CQD:78@86QI9VX],T1R:6=H="!S='EL93TS1"=T97AT M+6EN9&5N=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P M=#L@;6%R9VEN+7)I9VAT.B`P<'0[)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y M.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UE3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O M;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\ M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^#0H\9&EV('-T>6QE/3-$ M)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1I3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N M.R<^.#PO9F]N=#XP+#`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`P<'0[(&1I3H@8FQO M8VL[(&UA3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM M97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXR,#`W($1E8G0@17AT M96YS:6]N(%=A6QE/3-$ M)V1I6QE/3-$)W1E M>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1I6QE/3-$)V1I6QE/3-$)W1E>'0M:6YD96YT.B`P M<'0[(&1I6QE/3-$)V1I3H@8FQO8VL[(&UA3H@8FQO8VL[(&UA3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N M.R!F;VYT+7-I>F4Z(#$P<'0[)SXQ+C`P/"]F;VYT/CPO9&EV/@T*/"]D:78^ M#0H\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT M('-T>6QE/3-$)V1I6QE/3-$)V1I6QE/3-$)V1I6QE/3-$)V1I6QE/3-$ M)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1I M3H@ M:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I M>F4Z(#$P<'0[)SXF(S$V,#L\+V9O;G0^/"]T9#X-"CQT9"!V86QI9VX],T1B M;W1T;VT@=VED=&@],T0Y)3X-"CQD:78@3H@8FQO8VL[(&UA3H@8FQO8VL[(&UA3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F M;VYT+7-I>F4Z(#$P<'0[)SXY+S(X+S(P,3`\+V9O;G0^/"]D:78^#0H\+V1I M=CX-"CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O M;G0@3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM M97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L@/"]F;VYT M/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^#0H\9&EV M('-T>6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I3H@8FQO8VL[(&UA3H@:6YL:6YE.R!F;VYT+69A;6EL M>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXD/"]F;VYT M/CPO9&EV/@T*/"]D:78^#0H\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!W M:61T:#TS1#DE/@T*/&1I=B!S='EL93TS1"=T97AT+6EN9&5N=#H@,'!T.R!D M:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT M.B`P<'0[)SX-"CQD:78@86QI9VX],T1R:6=H="!S='EL93TS1"=T97AT+6EN M9&5N=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@ M;6%R9VEN+7)I9VAT.B`P<'0[)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I M;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UE3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N M.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^#0H\9&EV('-T>6QE/3-$)W1E M>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1I3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R<^ M-#PO9F]N=#XL,#`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`P M<'0[(&1I6QE/3-$)V1I3H@8FQO8VL[(&UA3H@8FQO8VL[(&UA3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N M.R!F;VYT+7-I>F4Z(#$P<'0[)SXQ+C,X/"]F;VYT/CPO9&EV/@T*/"]D:78^ M#0H\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT M('-T>6QE/3-$)V1I3H@8FQO8VL[(&UA3H@8FQO8VL[(&UA3H@ M:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I M>F4Z(#$P<'0[)SXQ,"\Q."\R,#$S/"]F;VYT/CPO9&EV/@T*/"]D:78^#0H\ M+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T M>6QE/3-$)V1I6QE/3-$)W1E>'0M:6YD M96YT.B`P<'0[(&1I3H@8FQO8VL[(&UA3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N M.R!F;VYT+7-I>F4Z(#$P<'0[)SY/8W1O8F5R(#(P,3`@16UP;&]Y964@5V%R M3H@ M:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I M>F4Z(#$P<'0[)SXF(S$V,#L\+V9O;G0^/"]T9#X-"CQT9"!V86QI9VX],T1B M;W1T;VT-"B!W:61T:#TS1#DE/@T*/&1I=B!S='EL93TS1"=T97AT+6EN9&5N M=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R M9VEN+7)I9VAT.B`P<'0[)SX-"CQD:78@86QI9VX],T1R:6=H="!S='EL93TS M1"=T97AT+6EN9&5N=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE M9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`P<'0[)SX\9F]N="!S='EL93TS1"=D M:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UE3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@ M=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L@/"]F M;VYT/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^#0H\ M9&EV('-T>6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I3H@8FQO8VL[(&UA3H@:6YL:6YE.R!F;VYT+69A M;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXD/"]F M;VYT/CPO9&EV/@T*/"]D:78^#0H\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O M;2!W:61T:#TS1#DE/@T*/&1I=B!S='EL93TS1"=T97AT+6EN9&5N=#H@,'!T M.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I M9VAT.B`P<'0[)SX-"CQD:78@86QI9VX],T1R:6=H="!S='EL93TS1"=T97AT M+6EN9&5N=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P M=#L@;6%R9VEN+7)I9VAT.B`P<'0[)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y M.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UE3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O M;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\ M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^#0H\9&EV('-T>6QE/3-$ M)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1I3H@ M8FQO8VL[(&UA3H@8FQO8VL[(&UA3H@:6YL:6YE.R!F M;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[ M)SXQ,"\Q-2\R,#$S/"]F;VYT/CPO9&EV/@T*/"]D:78^#0H\+W1D/@T*/'1D M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)V1I M6QE/3-$)W1E>'0M:6YD M96YT.B`P<'0[(&1I6QE/3-$)V1I3H@8FQO8VL[(&UA6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[ M(&1I6QE/3-$)V1I3H@8FQO8VL[(&UA3H@8FQO8VL[(&UA3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F M;VYT+7-I>F4Z(#$P<'0[)SXR,#`L,#`P/"]F;VYT/CPO9&EV/@T*/"]D:78^ M#0H\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT M('-T>6QE/3-$)V1I6QE/3-$)V1I6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I M6QE/3-$)V1I2`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`P M<'0[(&1I3H@:6YL:6YE.R!F;VYT+69A M;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V M,#L@/"]F;VYT/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M.24^#0H\9&EV('-T>6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)W1E>'0M:6YD96YT.B`P M<'0[(&1I3H@:6YL:6YE M.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P M<'0[)SXR,"PP,#`\+V9O;G0^/"]D:78^#0H\+V1I=CX-"CPO=&0^#0H\=&0@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F M;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT M+7-I>F4Z(#$P<'0[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$.24^#0H\9&EV('-T>6QE/3-$)W1E>'0M:6YD M96YT.B`P<'0[(&1I6QE M/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$ M)V1I6QE/3-$)V1I6QE/3-$)W1E>'0M:6YD96YT.B`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`P<'0[(&1I3H@8FQO8VL[(&UA3H@:6YL:6YE M.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P M<'0[)SXD/"]F;VYT/CPO9&EV/@T*/"]D:78^#0H\+W1D/@T*/'1D('9A;&EG M;CTS1&)O='1O;2!W:61T:#TS1#DE/@T*/&1I=B!S='EL93TS1"=T97AT+6EN M9&5N=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@ M;6%R9VEN+7)I9VAT.B`P<'0[)SX-"CQD:78@86QI9VX],T1R:6=H="!S='EL M93TS1"=T97AT+6EN9&5N=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN M+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`P<'0[)SX\9F]N="!S='EL93TS M1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UE3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM M97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L@/"]F;VYT M/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^#0H\9&EV M('-T>6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1I6QE/3-$)V1I6QE/3-$)V1I6QE/3-$ M)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1I M6QE/3-$)V1I M6QE/3-$)W1E>'0M M:6YD96YT.B`P<'0[(&1I6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE M/3-$)V1I3H@:6YL:6YE.R!F;VYT+69A;6EL M>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L@ M/"]F;VYT/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^ M#0H\9&EV('-T>6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I3H@8FQO8VL[(&UA3H@:6YL:6YE.R!F;VYT M+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXD M/"]F;VYT/CPO9&EV/@T*/"]D:78^#0H\+W1D/@T*/'1D('9A;&EG;CTS1&)O M='1O;2!W:61T:#TS1#DE/@T*/&1I=B!S='EL93TS1"=T97AT+6EN9&5N=#H@ M,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN M+7)I9VAT.B`P<'0[)SX-"CQD:78@86QI9VX],T1R:6=H="!S='EL93TS1"=T M97AT+6EN9&5N=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z M(#!P=#L@;6%R9VEN+7)I9VAT.B`P<'0[)SX\9F]N="!S='EL93TS1"=D:7-P M;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UE3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W M(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L@/"]F;VYT/CPO=&0^ M#0H\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^#0H\9&EV('-T>6QE M/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1I3H@8FQO8VL[(&UA3H@8FQO8VL[(&UA3H@:6YL:6YE M.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P M<'0[)SXS+SDO,C`Q-CPO9F]N=#X\+V1I=CX-"CPO9&EV/@T*/"]T9#X-"CQT M9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X\9F]N="!S='EL93TS1"=D M:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UE6QE/3-$ M)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1I M3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM M97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L@/"]F;VYT M/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^#0H\9&EV M('-T>6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I3H@8FQO8VL[(&UA3H@:6YL:6YE.R!F;VYT+69A;6EL M>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXD/"]F;VYT M/CPO9&EV/@T*/"]D:78^#0H\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!W M:61T:#TS1#DE/@T*/&1I=B!S='EL93TS1"=T97AT+6EN9&5N=#H@,'!T.R!D M:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT M.B`P<'0[)SX-"CQD:78@86QI9VX],T1R:6=H="!S='EL93TS1"=T97AT+6EN M9&5N=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@ M;6%R9VEN+7)I9VAT.B`P<'0[)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I M;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UE3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N M.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^#0H\9&EV('-T>6QE/3-$)W1E M>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1I6QE/3-$)V1I6QE/3-$)V1I6QE/3-$)V1I6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I3H@8FQO8VL[(&UA3H@:6YL:6YE M.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P M<'0[)SY-87D@,C`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`P<'0[(&1I3H@8FQO8VL[(&UA3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N M.R!F;VYT+7-I>F4Z(#$P<'0[)SXD/"]F;VYT/CPO9&EV/@T*/"]D:78^#0H\ M+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#DE/@T*/&1I=B!S M='EL93TS1"=T97AT+6EN9&5N=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R M9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`P<'0[)SX-"CQD:78@86QI M9VX],T1R:6=H="!S='EL93TS1"=T97AT+6EN9&5N=#H@,'!T.R!D:7-P;&%Y M.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`P<'0[ M)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY M.B!T:6UE3H@:6YL:6YE.R!F M;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[ M)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$.24^#0H\9&EV('-T>6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I M6QE/3-$)W1E>'0M:6YD M96YT.B`P<'0[(&1I6QE/3-$)V1I6QE/3-$ M)V1I6QE/3-$)W!A9&1I;F6QE/3-$)W1E>'0M:6YD96YT M.B`P<'0[(&1I3H@8FQO8VL[(&UA3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F M;VYT+7-I>F4Z(#$P<'0[)SY397!T96UB97(@,C`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`P<'0[)SX-"CQD:78@86QI9VX],T1R:6=H M="!S='EL93TS1"=T97AT+6EN9&5N=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@ M;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`P<'0[)SX\9F]N="!S M='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UE#LG('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE M/3-$)V1I6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1I6QE/3-$)W!A9&1I;F3H@ M:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I M>F4Z(#$P<'0[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@#LG('9A;&EG;CTS1&)O='1O;2!W:61T:#TS M1#DE/@T*/&1I=B!S='EL93TS1"=T97AT+6EN9&5N=#H@,'!T.R!D:7-P;&%Y M.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`P<'0[ M)SX-"CQD:78@86QI9VX],T1R:6=H="!S='EL93TS1"=T97AT+6EN9&5N=#H@ M,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN M+7)I9VAT.B`P<'0[)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[ M(&9O;G0M9F%M:6QY.B!T:6UE3H@:6YL:6YE M.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P M<'0[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\+W1R/@T*/'1R(&)G8V]L;W(] M,T0C8V-E969F/@T*/'1D('-T>6QE/3-$)W!A9&1I;F6QE/3-$ M)W1E>'0M:6YD96YT.B`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`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`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$'0^/&1I=B!S='EL93TS1"=T97AT+6%L M:6=N.B!J=7-T:69Y.R!T97AT+6EN9&5N=#H@,'!T.R!D:7-P;&%Y.B!B;&]C M:SL@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`P<'0[)SX\9F]N M="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UE M3L@=&5X="UI;F1E;G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[)SXF M(S$V,#L\+V1I=CX-"CQD:78@3L@=&5X="UI;F1E;G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA6QE/3-$ M)V9O;G0M3H@:6YL:6YE.R!F;VYT+69A M;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SY.;VXM M4F5C=7)R:6YG($5N9VEN965R:6YG($1E=F5L;W!M96YT($-O&%S($EN2!422X@5&AE M(%1)($%324,@:7,@9&5S:6=N871E9"!A6QE/3-$)W1E>'0M M86QI9VXZ(&IU'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)W1E>'0M86QI9VXZ M(&IU'0M:6YD96YT.B`P<'0[(&1I3L@=&5X="UI;F1E;G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA M6QE/3-$)V1I'!E;G-E(')E;&%T960@=&\@=&AI6QE/3-$)W1E>'0M86QI9VXZ(&IU'0M:6YD96YT.B`P<'0[ M(&1I6QE/3-$)W1E>'0M86QI9VXZ(&IU'0M:6YD96YT.B`Q.'!T M.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#$X<'0[(&UA6QE/3-$)W1E>'0M86QI9VXZ(&IU'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)W1E>'0M86QI9VXZ(&IU'0M:6YD M96YT.B`S-G!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@ M;6%R9VEN+7)I9VAT.B`P<'0[)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I M;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UE"`H97AC;'5D M:6YG(%9!5"DN(%1H92!A;FYU86P@<&%Y;65N="!F;W(@=&AI&EM871E;'D@)#DS+#`P,"!P97(@>65A&-L=61I;F<@5D%4*2X@5&AI6QE/3-$)W1E>'0M M86QI9VXZ(&IU'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)W1E>'0M86QI9VXZ M(&IU'0M:6YD96YT.B`S-G!T.R!D:7-P;&%Y.B!B;&]C:SL@ M;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`P<'0[)SX\9F]N="!S M='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UE&EM871E;'D@)#$T+#`P,"!P97(@;6]N=&@@ M:6YC;'5D:6YG('!R;W!E"`H97AC;'5D:6YG(%9!5"DN(%1H92!A M;FYU86P@<&%Y;65N="!F;W(@=&AI&EM871E;'D@)#$W-"PP,#`@<&5R('EE87(@:6YC;'5D:6YG('!R;W!E"`H97AC;'5D:6YG(%9!5"DN(%1H:7,@;&5A2`D,30L,#`P('!E&-L=61I;F<@5D%4*2X\+V9O M;G0^/"]D:78^#0H\9&EV('-T>6QE/3-$)W1E>'0M86QI9VXZ(&IU'0M:6YD96YT.B`S-G!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE M9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`P<'0[)SX\9F]N="!S='EL93TS1"=D M:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UE3L@=&5X="UI;F1E;G0Z(#,V M<'0[(&1I6QE/3-$)V1I65A6QE/3-$)W1E>'0M86QI9VXZ(&IU'0M:6YD96YT.B`P<'0[ M(&1I6QE/3-$ M)W1E>'0M86QI9VXZ(&IU'0M:6YD96YT.B`S-G!T.R!D:7-P M;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`P M<'0[)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M M:6QY.B!T:6UE6\L M($IA<&%N+B!4:&4@;&5A6UE;G0@9F]R('1H:7,@ M3H@8FQO8VL[(&UA3H@8FQO M8VL[(&UA3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM M97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SX\9F]N="!S='EL93TS M1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UE&EM871E;'D@)#$R,"PP,#`@86YD("0Q M,#,L,#`P+"!R97-P96-T:79E;'DL(&9O6QE/3-$)W1E>'0M M86QI9VXZ(&IU'0M:6YD96YT.B`S-G!T.R!D:7-P;&%Y.B!B M;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`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`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`P<'0[(&1I6QE/3-$)V1I3H@:6YL:6YE M.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P M<'0[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\+W1R/@T*/'1R(&)G8V]L;W(] M,T1W:&ET93X-"CQT9"!A;&EG;CTS1&QE9G0@#LG('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#8X)3X\9F]N M="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UE M#LG('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T M>6QE/3-$)V1I6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE M/3-$)V1I#LG('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE M/3-$)V1I'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$6QE/3-$)V1I6QE/3-$)V1I M6QE/3-$)W1E>'0M86QI9VXZ(&IU'0M:6YD96YT.B`P<'0[ M(&1I6QE/3-$ M)W1E>'0M86QI9VXZ(&IU'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1I6QE/3-$)VUA6QE/3-$)V1I2!G96]G3H@8FQO8VL[)SXF(S$V,#L\+V1I=CX-"CQD M:78@86QI9VX],T1L969T/@T*/'1A8FQE('-T>6QE/3-$)V9O;G0M6QE/3-$)V1I6QE/3-$)V1I6QE/3-$)V)O"!S;VQI9#LG('9A;&EG;CTS1&)O='1O;2!C;VQS<&%N/3-$-CX- M"CQD:78@86QI9VX],T1C96YT97(@3H@8FQO8VL[(&UA3H@:6YL:6YE.R!F M;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[ M(&9O;G0M=V5I9VAT.B!B;VQD.R<^,C`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`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`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`P<'0[)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O M;G0M9F%M:6QY.B!T:6UE6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1I6QE/3-$)V1I6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE M/3-$)V1I3H@:6YL:6YE.R!F M;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[ M)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('9A;&EG M;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)V1IF4Z(#$P<'0[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX] M,T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)3X-"CQD:78@86QI M9VX],T1R:6=H="!S='EL93TS1"=T97AT+6EN9&5N=#H@,'!T.R!D:7-P;&%Y M.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`P<'0[ M)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY M.B!T:6UE#LG('9A;&EG;CTS1&)O M='1O;2!W:61T:#TS1#6QE/3-$ M)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1I M#LG('9A;&EG;CTS1&)O M='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)V1I6QE/3-$)V)O"!S;VQI M9#LG('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#DE/@T*/&1I=B!A;&EG;CTS M1')I9VAT('-T>6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1I#LG('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF M;VYT('-T>6QE/3-$)V1I#LG('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT M('-T>6QE/3-$)V1I6QE/3-$)V)O"!S;VQI9#LG('9A;&EG;CTS1&)O='1O;2!W M:61T:#TS1#DE/@T*/&1I=B!A;&EG;CTS1')I9VAT('-T>6QE/3-$)W1E>'0M M:6YD96YT.B`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`P<'0[(&1I6QE/3-$)V1I3H@8FQO8VL[(&UA3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F M;VYT+7-I>F4Z(#$P<'0[)SXU-#@\+V9O;G0^/"]D:78^#0H\+W1D/@T*/'1D M(&%L:6=N/3-$;&5F="!S='EL93TS1"=P861D:6YG+6)O='1O;3H@-'!X.R<@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F M;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI M9VX],T1R:6=H="!S='EL93TS1"=P861D:6YG+6)O='1O;3H@-'!X.R<@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT M+7-I>F4Z(#$P<'0[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX] M,T1L969T('-T>6QE/3-$)V)O"!D;W5B M;&4[)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X\9F]N="!S='EL93TS M1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UE6QE/3-$)V)O"!D;W5B;&4[)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)3X-"CQD M:78@86QI9VX],T1R:6=H="!S='EL93TS1"=T97AT+6EN9&5N=#H@,'!T.R!D M:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT M.B`P<'0[)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M M9F%M:6QY.B!T:6UE6QE M/3-$)W!A9&1I;F6QE/3-$)W1E>'0M:6YD M96YT.B`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`Q,'!T.R<^)B,Q-C`[(#PO9F]N=#X\+W1D/@T*/'1D(&%L M:6=N/3-$;&5F="!S='EL93TS1"=P861D:6YG+6)O='1O;3H@,G!X.R<@=F%L M:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V1I6QE/3-$)V)O"!S;VQI9#LG('9A;&EG;CTS1&)O='1O;2!C;VQS M<&%N/3-$-CX-"CQD:78@86QI9VX],T1C96YT97(@3H@8FQO8VL[(&UA3H@ M:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I M>F4Z(#$P<'0[(&9O;G0M=V5I9VAT.B!B;VQD.R<^,C`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`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`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`P<'0[)SX\9F]N="!S M='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UE6QE/3-$)W1E M>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1I6QE/3-$)V1I M6QE/3-$)W1E>'0M:6YD96YT M.B`P<'0[(&1I6QE/3-$)V1I3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@ M;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L@/"]F;VYT/CPO M=&0^#0H\=&0@86QI9VX],T1L969T('9A;&EG;CTS1&)O='1O;2!W:61T:#TS M1#$E/CQF;VYT('-T>6QE/3-$)V1I6QE/3-$)V1I6QE/3-$)W1E>'0M M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1I#LG('9A;&EG;CTS1&)O='1O M;2!W:61T:#TS1#6QE/3-$)W1E M>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1I#LG('9A;&EG;CTS1&)O='1O M;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)V1I6QE/3-$)V)O"!S;VQI9#LG M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#DE/@T*/&1I=B!A;&EG;CTS1')I M9VAT('-T>6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1I#LG('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT M('-T>6QE/3-$)V1I#LG('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T M>6QE/3-$)V1I"!S;VQI9#LG('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E M/CQF;VYT('-T>6QE/3-$)V1I3H@8FQO8VL[(&UA3H@ M:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I M>F4Z(#$P<'0[)SXQ-CPO9F]N=#X\+V1I=CX-"CPO=&0^#0H\=&0@86QI9VX] M,T1L969T('-T>6QE/3-$)W!A9&1I;F6QE M/3-$)W1E>'0M:6YD96YT.B`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`P<'0[)SX\9F]N="!S='EL93TS1"=D:7-P M;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UE#LG M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)V1I M3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O M;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\ M=&0@86QI9VX],T1R:6=H="!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C M:R`T<'@@9&]U8FQE.R<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^#0H\ M9&EV(&%L:6=N/3-$3H@8FQO8VL[(&UA3H@:6YL:6YE.R!F;VYT M+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXQ M,#`\+V9O;G0^/"]D:78^#0H\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!S='EL M93TS1"=P861D:6YG+6)O='1O;3H@-'!X.R<@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$,24^#0H\9&EV(&%L:6=N/3-$;&5F="!S='EL93TS1"=T97AT+6EN M9&5N=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@ M;6%R9VEN+7)I9VAT.B`P<'0[)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I M;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UE3H@8FQO8VL[)SXF(S$V,#L\+V1I=CX\'0O:F%V M87-C3X-"B`@("`\=&%B M;&4@8VQA6QE/3-$)W1E>'0M86QI9VXZ(&IU M'0M:6YD96YT.B`P<'0[(&1I6QE M/3-$)V1I3H@:6YL:6YE M.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P M<'0[)SX\9F]N="!S='EL93TS1"=M87)G:6XM;&5F=#H@,S9P=#LG(#X\+V9O M;G0^0F%S:6,@;F5T(&QO6QE/3-$)V1I3H@8FQO8VL[(&UA M6QE/3-$)W1E>'0M86QI9VXZ(&IU'0M:6YD96YT.B`S-G!T M.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I M9VAT.B`P<'0[)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O M;G0M9F%M:6QY.B!T:6UE6QE/3-$)V1I6QE/3-$)W=I9'1H.B`Q,#`E.R!F;VYT M+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)R!C M96QL3H@8FQO8VL[(&UA M3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W M(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[('1E>'0M9&5C;W)A=&EO;CH@=6YD M97)L:6YE.R<^*&EN('1H;W5S86YD6QE/3-$)W!A9&1I;F6QE/3-$)V)O"!S;VQI9"!B;&%C:SL@=&5X="UA;&EG;CH@8V5N=&5R.R<@=F%L M:6=N/3-$8F]T=&]M(&-O;'-P86X],T0V/@T*/&1I=B!S='EL93TS1"=T97AT M+6%L:6=N.B!C96YT97([('1E>'0M:6YD96YT.B`P<'0[(&1I'0M:6YD96YT M.B`P<'0[(&1I6QE/3-$)V1I3H@:6YL:6YE.R!F;VYT+69A M;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SY4:')E M92!-;VYT:',@96YD960\+V9O;G0^/"]F;VYT/CPO9&EV/@T*/"]D:78^#0H\ M9&EV('-T>6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E3H@8FQO8VL[(&UA3H@:6YL:6YE M.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P M<'0[)SY-87)C:"`S,2P\+V9O;G0^/"]D:78^#0H\+W1D/@T*/'1D('-T>6QE M/3-$)W1E>'0M86QI9VXZ(&QE9G0[('!A9&1I;F3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM M97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L\+V9O;G0^ M/"]T9#X-"CPO='(^#0H\='(^#0H\=&0@#LG('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#6QE M/3-$)V1I'0M:6YD96YT.B`P<'0[(&UA'0M:6YD96YT.B`P<'0[(&1I6QE/3-$ M)V1I#LG('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS M1&YO=W)A<#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M M9F%M:6QY.B!T:6UE3H@:6YL:6YE.R!F;VYT+69A;6EL M>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L\ M+V9O;G0^/"]T9#X-"CQT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B`R<'@@ M'0M86QI9VXZ(&-E;G1E6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E3H@8FQO8VL[(&UA3H@:6YL:6YE.R!F M;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[ M)SXR,#$R/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!S='EL93TS1"=T97AT M+6%L:6=N.B!L969T.R!P861D:6YG+6)O='1O;3H@,G!X.R<@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$,24@;F]W6QE M/3-$)V1I3H@:6YL:6YE.R!F M;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[ M)SXF(S$V,#L\+V9O;G0^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8V]L M3H@:6YL:6YE.R!F;VYT M+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF M(S$V,#L\+V9O;G0^/"]T9#X-"CQT9"!S='EL93TS1"=T97AT+6%L:6=N.B!L M969T.R<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W6QE/3-$)V1I3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@ M=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L\+V9O M;G0^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q,"4@8V]L M3H@:6YL:6YE.R!F;VYT M+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF M(S$V,#L\+V9O;G0^/"]T9#X-"CQT9"!S='EL93TS1"=T97AT+6%L:6=N.B!L M969T.R<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W6QE/3-$)V1I3H@8FQO M8VL[(&UA6QE/3-$)V1I6QE/3-$)W!A9&1I;F6QE/3-$)V1I3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N M.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L\+V9O;G0^/"]T9#X-"CQT9"!S M='EL93TS1"=B;W)D97(M8F]T=&]M.B`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`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`\+V9O;G0^ M/"]T9#X-"CQT9"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T.R!P861D:6YG M+6)O='1O;3H@-'!X.R<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W M6QE/3-$)V1I3H@:6YL:6YE.R!F;VYT+69A;6EL M>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L\ M+V9O;G0^/"]T9#X-"CQT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B`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`],T1N;W=R87`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`P<'0[(&1I6QE/3-$)V1I3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W M(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L\+V9O;G0^/"]T9#X- M"CQT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B`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`@("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@ M(#PO8F]D>3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%]B.6%A-SDS M,%\W-V,Y7S1A.#-?8C(P8E]F.&8Q,S(W-#DV834-"D-O;G1E;G0M3&]C871I M;VXZ(&9I;&4Z+R\O0SHO8CEA83'0O:'1M;#L@8VAA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/&1I=B!S='EL93TS1"=T97AT M+6%L:6=N.B!J=7-T:69Y.R!T97AT+6EN9&5N=#H@,'!T.R!D:7-P;&%Y.B!B M;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`P<'0[)SX\ M9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T M:6UE6QE M/3-$)V1I3H@:6YL:6YE.R!F M;VYT+7=E:6=H=#H@8F]L9#LG/E-U8G-E<75E;G0@179E;G1S/"]F;VYT/CPO M9F]N=#X\+V1I=CX-"CQD:78@3L@=&5X="UI;F1E;G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA6QE/3-$)W1E>'0M86QI9VXZ(&IU'0M:6YD96YT M.B`S-G!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R M9VEN+7)I9VAT.B`P<'0[)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI M;F4[(&9O;G0M9F%M:6QY.B!T:6UE&5R M8VES960@=V%R&5R8VES92!P3L@=&5X="UI;F1E;G0Z(#!P M=#L@9&ES<&QA>3H@8FQO8VL[)SXF(S$V,#L\+V1I=CX-"CQD:78@3L@=&5X="UI;F1E;G0Z(#,V<'0[(&1I M3L@ M=&5X="UI;F1E;G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[)SXF(S$V,#L\+V1I M=CX-"CQD:78@3L@=&5X="UI M;F1E;G0Z(#,V<'0[(&1I6QE/3-$)V1I6QE M/3-$)W1E>'0M86QI9VXZ(&IU'0M:6YD96YT.B`S-G!T.R!D M:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT M.B`P<'0[)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M M9F%M:6QY.B!T:6UE3L@=&5X="UI;F1E;G0Z(#,V<'0[(&1I6QE/3-$)V1I&EM871E;'D@)#$T+#`P,"!P97(@;6]N=&@@:6YC;'5D M:6YG('!R;W!E"`H97AC;'5D:6YG(%9!5"DN(%1H92!A;FYU86P@ M<&%Y;65N="!F;W(@=&AI&EM871E M;'D@)#$W-"PP,#`@<&5R('EE87(@:6YC;'5D:6YG('!R;W!E"`H M97AC;'5D:6YG(%9!5"DN(%1H:7,@;&5A6QE/3-$)W1E M>'0M86QI9VXZ(&IU'0M:6YD96YT.B`S-G!T.R!D:7-P;&%Y M.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`P<'0[ M)SXF(S$V,#L\+V1I=CX-"CQD:78@3L@=&5X="UI;F1E;G0Z(#,V<'0[(&1I6QE M/3-$)V1I3H@8FQO8VL[(&UA3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F M;VYT+7-I>F4Z(#$P<'0[)SY/;B!-87D@,RP@,C`Q,RP@82!W87)R86YT(&AO M;&1E&5R8VES92!O9B!A('=A&5R8VES92!P7!E.B!T97AT+VAT;6P[(&-H M87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U% M5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O M:'1M;#L@8VAA2!/9B!3:6=N:69I8V%N="!! M8V-O=6YT:6YG(%!O;&EC:65S(%M!8G-T6QE/3-$)W1E>'0M86QI9VXZ(&IU'0M:6YD96YT.B`Q M.'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#$X<'0[(&UA6QE/3-$)W1E>'0M86QI9VXZ(&IU'0M:6YD96YT.B`P M<'0[(&1I6QE M/3-$)W1E>'0M86QI9VXZ(&IU'0M:6YD96YT.B`S-G!T.R!D M:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT M.B`P<'0[)SX-"CQD:78@3L@ M=&5X="UI;F1E;G0Z(#,V<'0[(&1I6QE/3-$)V1I M2!O=VYE9"!3 M=V5D:7-H('-U8G-I9&EA2!A8V-O=6YT3L@=&5X="UI;F1E M;G0Z(#,V<'0[(&1I3H@8FQO8VL[ M(&UA3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@ M;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SX\9F]N="!S='EL93TS1"=D M:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UE2!O=VYE9"!S=6)S:61I87)I97,L($Y404(L($YE;VYO9&4@ M06UE2!A8V-O=6YT6QE/3-$)W1E>'0M86QI9VXZ(&IU'0M:6YD96YT M.B`S-G!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R M9VEN+7)I9VAT.B`P<'0[)SXF(S$V,#L\+V1I=CX-"CQD:78@3L@=&5X="UI;F1E;G0Z(#,V<'0[(&1I3H@8FQO8VL[(&UA3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT M+7-I>F4Z(#$P<'0[)SY.96]N;V1E(&UA;F%G96UE;G0@:&%S(&UA9&4@2X\ M+V9O;G0^/"]D:78^#0H\+V1I=CX-"CPO9&EV/CQS<&%N/CPO6QE/3-$)W1E>'0M M86QI9VXZ(&IU'0M:6YD96YT.B`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`P<'0[(&1I6QE/3-$)W1E>'0M86QI9VXZ(&IU M'0M:6YD96YT.B`S-G!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R M9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`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`S-G!T.R!D:7-P;&%Y.B!B M;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`P<'0[)SX\ M9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T M:6UEF%B;&4@=F%L M=64N($]U2!A;F0@2!A="!-87)C:"`S,2P@,C`Q,R!A;F0@1&5C96UB M97(@,S$L(#(P,3(N/"]F;VYT/CPO9&EV/CQS<&%N/CPO'0^/&1I=B!S='EL M93TS1"=T97AT+6%L:6=N.B!J=7-T:69Y.R!T97AT+6EN9&5N=#H@,'!T.R!D M:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#,V<'0[(&UA2!A;F0@17%U:7!M96YT/"]F;VYT/CPO9&EV/@T*/&1I=B!S='EL93TS1"=T M97AT+6%L:6=N.B!J=7-T:69Y.R!T97AT+6EN9&5N=#H@,'!T.R!D:7-P;&%Y M.B!B;&]C:SLG/B8C,38P.SPO9&EV/@T*/&1I=B!S='EL93TS1"=T97AT+6%L M:6=N.B!J=7-T:69Y.R!T97AT+6EN9&5N=#H@,S9P=#L@9&ES<&QA>3H@8FQO M8VL[(&UA3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM M97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SY02!A;F0@ M97%U:7!M96YT(&%R92!S=&%T960@870@8V]S="P@;F5T(&]F(&%C8W5M=6QA M=&5D(&1E<')E8VEA=&EO;B!A;F0@86UOF%T:6]N+B!$97!R96-I871I M;VX@86YD(&%M;W)T:7IA=&EO;B!A3H@8FQO8VL[(&UA3H@:6YL M:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z M(#$P<'0[)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M M9F%M:6QY.B!T:6UE6QE/3-$)V1I6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I3H@8FQO8VL[(&UA3H@:6YL:6YE.R!F;VYT+69A M;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SY#;VUP M=71E6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1I3H@8FQO8VL[(&UA6QE M/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$ M)V1I6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)W1E>'0M86QI9VXZ(&IU'0M:6YD96YT.B`S-G!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE M9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`P<'0[)SX\9F]N="!S='EL93TS1"=D M:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UEF5D(&]N(&$@3H@8FQO M8VL[(&UA3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM M97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L\+V9O;G0^ M/"]D:78^#0H\9&EV('-T>6QE/3-$)W1E>'0M86QI9VXZ(&IU'0M:6YD96YT.B`S-G!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z M(#!P=#L@;6%R9VEN+7)I9VAT.B`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`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$3H@8FQO8VL[(&UA3L@=&5X M="UI;F1E;G0Z(#,V<'0[(&1I6QE/3-$)V1I6QE/3-$)W1E>'0M M86QI9VXZ(')I9VAT.R!W:61T:#H@-C-P=#LG/@T*/&1I=B!S='EL93TS1"=T M97AT+6%L:6=N.B!R:6=H=#LG/CQF;VYT('-T>6QE/3-$)V1I6QE/3-$)V9O;G0M6QE/3-$)W=I9'1H.B`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`P<'0[(&1I3H@=&EM97,@;F5W(')O;6%N.R<@ M8V5L;'-P86-I;F<],T0P(&-E;&QP861D:6YG/3-$,#X-"CQT6QE.B!I=&%L:6,[ M(&1I6UB;VPL('-E3H@ M:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R<^)B,Y-C6QE/3-$)V1I6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&UA3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT M+7-I>F4Z(#$P<'0[)SY3;VYY($-O3L@=&5X="UI;F1E;G0Z M(#$X<'0[(&1I6QE.B!I M=&%L:6,[(&1I6QE M/3-$)W1E>'0M86QI9VXZ(&IU'0M:6YD96YT.B`P<'0[(&1I M6QE/3-$)W1E M>'0M86QI9VXZ(&IU'0M:6YD96YT.B`Q.'!T.R!D:7-P;&%Y M.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#$X<'0[(&UA6QE/3-$)W1E>'0M86QI9VXZ(&IU'0M:6YD M96YT.B`P<'0[(&1I6QE/3-$)W1E>'0M86QI9VXZ(&IU'0M:6YD96YT.B`S M-G!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN M+7)I9VAT.B`P<'0[)SX-"CQD:78@3L@=&5X="UI;F1E;G0Z(#,V<'0[(&1I6QE M/3-$)V1I2!P6EN9R!)4"X@1F5E2!I;F-L=61E(&QI8V5N6%B;&4@9F]L;&]W M:6YG('1H92!D:7-T2!T:&4@;&EC96YS964@=VET:&]U="!M86EN=&5N M86YC92!A;F0@6%L='D@<')O9'5C=',@87)E(&1I2!L:6-E;G-E(&%R6UE;G0@:7,@9&5E M;65D(&9I>&5D(&]R(&1E=&5R;6EN86)L92!A;F0@9G)E92!O9B!C;VYT:6YG M96YC:65S(&]R('-I9VYI9FEC86YT('5N8V5R=&%I;G1I97,[(&%N9"`H-"D@ M8V]L;&5C=&EO;B!I6QE/3-$)W1E>'0M86QI9VXZ(&IU'0M:6YD96YT.B`S-G!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z M(#!P=#L@;6%R9VEN+7)I9VAT.B`P<'0[)SX\9F]N="!S='EL93TS1"=D:7-P M;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UE6QE/3-$)W1E>'0M86QI9VXZ(&IU'0M:6YD96YT M.B`P<'0[(&1I6QE/3-$)W1E>'0M86QI9VXZ(&IU'0M:6YD96YT.B`Q.'!T M.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#$X<'0[(&UA3L@=&5X="UI;F1E;G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N M.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L\+V9O;G0^/"]D:78^#0H\9&EV M('-T>6QE/3-$)W1E>'0M86QI9VXZ(&IU'0M:6YD96YT.B`S M-G!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN M+7)I9VAT.B`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`P<'0[(&1I6QE/3-$)W1E>'0M86QI9VXZ(&IU M'0M:6YD96YT.B`S-G!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R M9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`P<'0[)SX-"CQD:78@3L@=&5X="UI;F1E;G0Z(#,V<'0[ M(&1I6QE/3-$)V1I3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@ M=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SY!9'9E2`D,3(T+#`P,"!A M;F0@)#$Y-RPP,#`L(')E2X\+V9O;G0^/"]F;VYT/CPO9&EV M/@T*/"]D:78^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M("`@/'1R(&-L87-S/3-$'0^/&1I=B!S='EL93TS1"=T M97AT+6%L:6=N.B!J=7-T:69Y.R!T97AT+6EN9&5N=#H@,S9P=#L@9&ES<&QA M>3H@8FQO8VL[(&UA3L@=&5X="UI;F1E;G0Z(#!P=#L@9&ES M<&QA>3H@8FQO8VL[)SXF(S$V,#L\+V1I=CX-"CQD:78@6QE/3-$)V1I'!E;G-E9"!A2!O9B!P97)S;VYN96P@6EN9R!A;F0@;65A'!E;G-E/"]T M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\9&EV('-T>6QE/3-$)W1E M>'0M86QI9VXZ(&IU'0M:6YD96YT.B`S-G!T.R!D:7-P;&%Y M.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`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`S-G!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R M9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`P<'0[)SX\9F]N="!S='EL M93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UE3L@=&5X="UI;F1E M;G0Z(#,V<'0[(&1I6QE/3-$)V1I2!I;G-T2!I;G-T6QE/3-$)W1E>'0M86QI9VXZ(&IU'0M M:6YD96YT.B`P<'0[(&1I6QE/3-$)W1E>'0M86QI9VXZ(&IU'0M:6YD96YT M.B`S-G!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R M9VEN+7)I9VAT.B`P<'0[)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI M;F4[(&9O;G0M9F%M:6QY.B!T:6UE'0^/&1I=B!S='EL93TS1"=T M97AT+6%L:6=N.B!J=7-T:69Y.R!T97AT+6EN9&5N=#H@,S9P=#L@9&ES<&QA M>3H@8FQO8VL[(&UA6QE/3-$)W1E>'0M86QI9VXZ(&IU'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)W1E>'0M86QI9VXZ(&IU'0M:6YD96YT.B`S-G!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z M(#!P=#L@;6%R9VEN+7)I9VAT.B`P<'0[)SX\9F]N="!S='EL93TS1"=D:7-P M;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UE65A"!AF%T:6]N(&ES('5N8V5R=&%I;B!B87-E9"!O;B!T:&4@)B,X,C(P.VUO M6QE/3-$ M)W1E>'0M86QI9VXZ(&IU'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)W1E>'0M M86QI9VXZ(&IU'0M:6YD96YT.B`S-G!T.R!D:7-P;&%Y.B!B M;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`P<'0[)SX\ M9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T M:6UE2!O9B!F=71U"!I;F-O;64L('=E(&9U M;&QY(')E3H@:6YL:6YE.R!F M;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[ M)SY792!F;VQL;W<@=&AE(')E;&5V86YT(&%C8V]U;G1I;F<@9W5I9&%N8V4@ M"!P;W-I=&EO;G,N)B,Q-C`[)B,Q-C`[07,@82!R97-U;'0L('=E(&1I M9"!N;W0@F5D('1A>"!B96YE9FET3L@=&5X="UI;F1E;G0Z(#,V M<'0[(&1I6QE/3-$)V9O;G0M3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O M;6%N.R!F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M=V5I9VAT.B!B;VQD.R<^3F5T M($QO3H@8FQO M8VL[(&UA3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM M97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SY.970@;&]S'0^/&1I=B!S='EL93TS1"=T97AT M+6%L:6=N.B!J=7-T:69Y.R!T97AT+6EN9&5N=#H@,S9P=#L@9&ES<&QA>3H@ M8FQO8VL[(&UA6QE/3-$)W1E>'0M M86QI9VXZ(&IU'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)W1E>'0M86QI9VXZ M(&IU'0M:6YD96YT.B`S-G!T.R!D:7-P;&%Y.B!B;&]C:SL@ M;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`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`S M-G!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN M+7)I9VAT.B`P<'0[)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[ M(&9O;G0M9F%M:6QY.B!T:6UE6QE/3-$)V1I&-H86YG92!R871E(&9O3X- M"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%]B.6%A-SDS,%\W-V,Y7S1A M.#-?8C(P8E]F.&8Q,S(W-#DV834-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z M+R\O0SHO8CEA83'0O:'1M M;#L@8VAA'0^/&1I=B!S='EL93TS1"=T97AT+6EN9&5N=#H@ M,'!T.R!D:7-P;&%Y.B!B;&]C:SLG/B8C,38P.SPO9&EV/@T*/&1I=B!A;&EG M;CTS1&-E;G1EF4Z(#$P<'0[ M('=I9'1H.B`X,"4[(&9O;G0M9F%M:6QY.B!T:6UE3H@8FQO8VL[(&UA3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O M;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y M.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UE6QE/3-$)V1I6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[ M(&1I3H@8FQO8VL[(&UA3H@ M:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I M>F4Z(#$P<'0[)SY#;VUP=71E6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I M6QE/3-$)V1I3H@ M8FQO8VL[(&UA6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1I3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R M=%]B.6%A-SDS,%\W-V,Y7S1A.#-?8C(P8E]F.&8Q,S(W-#DV834-"D-O;G1E M;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO8CEA83'0O:'1M;#L@8VAA'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L M87-S/3-$6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I3H@=&EM97,@;F5W(')O;6%N.R<@8V5L;'-P86-I;F<] M,T0P(&-E;&QP861D:6YG/3-$,#X-"CQT#LG('9A;&EG;CTS1&)O='1O M;3X\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY M.B!T:6UE#LG('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS M1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UE6QE/3-$)W1E>'0M:6YD96YT.B`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`P<'0[(&1I6QE/3-$)V1I65T($5X8VAA;F=E9"!A M="!-87)C:"`S,2P@,C`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`P<'0[(&1I3H@8FQO8VL[(&UA3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F M;VYT+7-I>F4Z(#$P<'0[)SY397)I97,@0B!P#LG('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF M;VYT('-T>6QE/3-$)V1I6QE/3-$)V)O"!D;W5B;&4[)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X\9F]N="!S M='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UE6QE M/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1I#LG('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T M>6QE/3-$)V1I6QE/3-$)W!A9&1I;F6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[ M(&1I6QE/3-$)V1I6QE/3-$)W!A9&1I;F3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM M97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L@/"]F;VYT M/CPO=&0^#0H\=&0@6QE/3-$)V1I6QE/3-$)V)O"!D;W5B M;&4[)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)3X-"CQD:78@3H@8FQO8VL[(&UA3H@8FQO M8VL[(&UA3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM M97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXQ,"PY-C(\+V9O;G0^ M/"]D:78^#0H\+V1I=CX-"CPO=&0^#0H\=&0@#LG('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT M('-T>6QE/3-$)V1I'0O:F%V M87-C3X-"B`@("`\=&%B M;&4@8VQA2!O9B!A M;&P@3PO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/&1I=B!S='EL93TS1"=T97AT M+6EN9&5N=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SLG/@T*/&1I=B!S='EL93TS M1"=T97AT+6%L:6=N.B!L969T.R!T97AT+6EN9&5N=#H@,'!T.R!M87)G:6XM M;&5F=#H@,S9P=#L@;6%R9VEN+7)I9VAT.B`P<'0[)SX-"CQT86)L92!S='EL M93TS1"=T97AT+6%L:6=N.B!C96YT97([('=I9'1H.B`X,"4[(&9O;G0M9F%M M:6QY.B!T:6UE6QE/3-$ M)W!A9&1I;F3H@:6YL:6YE.R!F;VYT+69A M;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V M,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('-T>6QE/3-$)W!A M9&1I;F#LG('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT M('-T>6QE/3-$)V1I#LG('9A;&EG M;CTS1&)O='1O;2!W:61T:#TS1#0T)3X-"CQD:78@86QI9VX],T1L969T('-T M>6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE M/3-$)V1I#LG('9A;&EG;CTS1&)O='1O M;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)V1I6QE/3-$)V)O"!S;VQI9"!B;&%C:SLG('9A;&EG;CTS1&)O='1O;2!W:61T M:#TS1#$P)2!C;VQS<&%N/3-$,CX-"CQD:78@86QI9VX],T1C96YT97(@3H@8FQO8VL[(&UA3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O M;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SY787)R86YT6QE/3-$)W!A9&1I;F6QE M/3-$)V1I3H@:6YL:6YE.R!F;VYT M+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SY7 M96EG:'1E9"`\+V9O;G0^/"]D:78^#0H\9&EV(&%L:6=N/3-$8V5N=&5R('-T M>6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE M/3-$)V1I6QE/3-$)W1E>'0M:6YD96YT.B`P M<'0[(&1I6QE/3-$)V1I3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT M+7-I>F4Z(#$P<'0[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX] M,T1L969T('-T>6QE/3-$)W!A9&1I;F6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1I6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1I3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT M+7-I>F4Z(#$P<'0[)SXF(S$V,#L\+V9O;G0^/"]T9#X-"CPO='(^#0H\='(@ M8F=C;VQO6QE/3-$)W1E>'0M:6YD96YT M.B`P<'0[(&1I6QE/3-$)V1I2`Q+"`R,#$S/"]F;VYT/CPO9&EV/@T*/"]D:78^#0H\ M+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T M>6QE/3-$)V1I6QE M/3-$)V1I3H@8FQO8VL[(&UA6QE/3-$)W1E>'0M:6YD M96YT.B`P<'0[(&1I6QE M/3-$)W1E>'0M:6YD96YT.B`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`P<'0[(&1I3H@8FQO8VL[(&UA3H@:6YL:6YE.R!F;VYT+69A M;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V M,#LF(S$V,#LF(S$V,#M%>'!I3H@8FQO8VL[ M(&UA3H@8FQO8VL[(&UA3H@:6YL:6YE.R!F;VYT+69A M;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXH-#`L M,#`P/"]F;VYT/CPO9&EV/@T*/"]D:78^#0H\+W1D/@T*/'1D('9A;&EG;CTS M1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)V1I3H@8FQO8VL[(&UA3H@8FQO8VL[(&UA3H@ M:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I M>F4Z(#$P<'0[)SXQ+C`P/"]F;VYT/CPO9&EV/@T*/"]D:78^#0H\+W1D/@T* M/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$ M)V1I6QE/3-$)V1I6QE/3-$)W1E>'0M:6YD96YT M.B`P<'0[(&1I6QE/3-$)V1I6QE/3-$)W!A9&1I;F3H@8FQO8VL[(&UA3H@8FQO8VL[(&UA3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O M;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXH-3DP+#`Y-#PO9F]N=#X\+V1I=CX- M"CPO9&EV/@T*/"]T9#X-"CQT9"!S='EL93TS1"=P861D:6YG+6)O='1O;3H@ M,G!X.R<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^#0H\9&EV('-T>6QE M/3-$)W1E>'0M:6YD96YT.B`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`P<'0[(&1I M6QE/3-$)W1E>'0M:6YD M96YT.B`P<'0[(&1I6QE/3-$)V1I6QE/3-$)W!A9&1I;F3H@:6YL:6YE.R!F;VYT+69A;6EL M>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L@ M/"]F;VYT/CPO=&0^#0H\=&0@6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I M6QE/3-$)V1I6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[ M(&1I6QE/3-$)W1E>'0M M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1I3H@:6YL M:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z M(#$P<'0[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@#LG('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E M/CQF;VYT('-T>6QE/3-$)V1I6QE/3-$)V)O"!D M;W5B;&4@8FQA8VL[)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X\9F]N M="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UE M6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1I3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM M97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L\+V9O;G0^ M/"]T9#X-"CPO='(^#0H\+W1A8FQE/@T*/"]D:78^#0H\+V1I=CX\6QE/3-$)V1I6QE/3-$)W1E>'0M:6YD96YT.B`P M<'0[(&1I6QE/3-$)V1I6QE M/3-$)W!A9&1I;F3H@:6YL:6YE.R!F;VYT M+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF M(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('-T>6QE/3-$ M)W!A9&1I;F6QE/3-$)W1E M>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1I6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1I3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F M;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\+W1R/@T* M/'1R/@T*/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1B;W1T;VT@=VED=&@] M,T0S."4^/&9O;G0@3H@:6YL:6YE.R!F;VYT+69A M;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V M,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('9A;&EG;CTS1&)O M='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)V1I3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@ M;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L\+V9O;G0^/"]T M9#X-"CQT9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,24^/&9O;G0@3H@:6YL:6YE.R!F;VYT+69A;6EL M>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L@ M/"]F;VYT/CPO=&0^#0H\+W1R/@T*/'1R(&)G8V]L;W(],T0C8V-E969F/@T* M/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0S."4^ M#0H\9&EV(&%L:6=N/3-$;&5F="!S='EL93TS1"=T97AT+6EN9&5N=#H@,'!T M.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I M9VAT.B`P<'0[)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O M;G0M9F%M:6QY.B!T:6UE6QE/3-$)V1I6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1I6QE/3-$)V1I6QE/3-$)W1E>'0M:6YD96YT.B`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`P M<'0[(&1I6QE/3-$)V1I3H@:6YL M:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z M(#$P<'0[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1R:6=H M="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)3X-"CQD:78@86QI9VX],T1R M:6=H="!S='EL93TS1"=T97AT+6EN9&5N=#H@,'!T.R!D:7-P;&%Y.B!B;&]C M:SL@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`P<'0[)SX\9F]N M="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UE M6QE/3-$)W1E>'0M M:6YD96YT.B`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`P<'0[(&1I6QE M/3-$)V1I2!O9B!S=&]C:RUB M87-E9"!C;VUP96YS871I;VX@97AP96YS93PO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/&1I=B!A;&EG;CTS1&QE9G0@3H@8FQO8VL[(&UA6QE/3-$)W=I9'1H.B`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`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`P<'0[(&1I6QE/3-$)V1I3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT M+7-I>F4Z(#$P<'0[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX] M,T1L969T('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/@T*/&1I=B!A;&EG M;CTS1&QE9G0@3H@ M8FQO8VL[(&UA3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@ M=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXD/"]F;VYT/CPO M9&EV/@T*/"]T9#X-"CQT9"!A;&EG;CTS1')I9VAT('9A;&EG;CTS1&)O='1O M;2!W:61T:#TS1#DE/@T*/&1I=B!A;&EG;CTS1')I9VAT('-T>6QE/3-$)W1E M>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1I3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@ M;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L@/"]F;VYT/CPO M=&0^#0H\=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@] M,T0Y)3X-"CQD:78@86QI9VX],T1R:6=H="!S='EL93TS1"=T97AT+6EN9&5N M=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R M9VEN+7)I9VAT.B`P<'0[)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI M;F4[(&9O;G0M9F%M:6QY.B!T:6UE6QE/3-$ M)V1I3H@:6YL:6YE.R!F;VYT+69A M;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V M,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B M;W1T;VT@=VED=&@],T0Y)3X-"CQD:78@86QI9VX],T1R:6=H="!S='EL93TS M1"=T97AT+6EN9&5N=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE M9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`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`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`P<'0[)SX\9F]N="!S='EL93TS M1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UE6QE/3-$)W!A9&1I;F#LG M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)V1I M6QE/3-$)W1E M>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1I3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT M+7-I>F4Z(#$P<'0[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\+W1R/@T*/"]T M86)L93X-"CPO9&EV/@T*/&1I=B!S='EL93TS1"=T97AT+6EN9&5N=#H@,'!T M.R!D:7-P;&%Y.B!B;&]C:SLG/B8C,38P.SPO9&EV/@T*/&1I=B!A;&EG;CTS M1&-E;G1E3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)R!C96QL M6QE/3-$)V1I3H@:6YL M:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z M(#$P<'0[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N M.R!F;VYT+7-I>F4Z(#$P<'0[)SYE>'!E;G-E(&%T/"]F;VYT/CPO9&EV/@T* M/&1I=B!A;&EG;CTS1&-E;G1E3H@8FQO8VL[(&UA M3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W M(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXR,#$S/"]F;VYT/CPO9&EV/@T* M/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@#LG('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T M>6QE/3-$)V1I#LG('9A;&EG;CTS M1&)O='1O;2!W:61T:#TS1#8X)3X-"CQD:78@86QI9VX],T1L969T('-T>6QE M/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$ M)V1I#LG('9A;&EG;CTS1&)O='1O;2!W:61T M:#TS1#$E/CQF;VYT('-T>6QE/3-$)V1I6QE/3-$)W1E M>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1I3H@8FQO8VL[(&UA3H@:6YL:6YE.R!F M;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[ M)SXS+#`V,#PO9F]N=#X\+V1I=CX-"CPO=&0^#0H\=&0@86QI9VX],T1L969T M('-T>6QE/3-$)W!A9&1I;F6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)W=I9'1H.B`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`R<'@@ M6QE/3-$)V1I3H@:6YL M:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z M(#$P<'0[(&9O;G0M=V5I9VAT.B!B;VQD.R<^)B,Q-C`[/"]F;VYT/CPO=&0^ M#0H\=&0@6QE/3-$)W1E>'0M:6YD96YT.B`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`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`P<'0[(&1I3H@8FQO8VL[(&UA3H@:6YL:6YE.R!F;VYT+69A M;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXD/"]F M;VYT/CPO9&EV/@T*/"]D:78^#0H\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O M;2!W:61T:#TS1#DE/@T*/&1I=B!S='EL93TS1"=T97AT+6EN9&5N=#H@,'!T M.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I M9VAT.B`P<'0[)SX-"CQD:78@86QI9VX],T1R:6=H="!S='EL93TS1"=T97AT M+6EN9&5N=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P M=#L@;6%R9VEN+7)I9VAT.B`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`\+V9O;G0^ M/"]D:78^#0H\+V1I=CX-"CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$,24^/&9O;G0@3H@:6YL:6YE.R!F;VYT M+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF M(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,24^#0H\9&EV('-T>6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I3H@8FQO8VL[(&UA3H@:6YL:6YE M.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P M<'0[)SXD/"]F;VYT/CPO9&EV/@T*/"]D:78^#0H\+W1D/@T*/'1D('9A;&EG M;CTS1&)O='1O;2!W:61T:#TS1#DE/@T*/&1I=B!S='EL93TS1"=T97AT+6EN M9&5N=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@ M;6%R9VEN+7)I9VAT.B`P<'0[)SX-"CQD:78@86QI9VX],T1R:6=H="!S='EL M93TS1"=T97AT+6EN9&5N=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN M+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`P<'0[)SX\9F]N="!S='EL93TS M1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UE3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM M97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L@/"]F;VYT M/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^#0H\9&EV M('-T>6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1I6QE/3-$)V1I6QE/3-$)V1I6QE/3-$ M)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1I M3H@ M:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I M>F4Z(#$P<'0[)SXF(S$V,#L\+V9O;G0^/"]T9#X-"CQT9"!V86QI9VX],T1B M;W1T;VT@=VED=&@],T0Y)3X-"CQD:78@3H@8FQO8VL[(&UA3H@8FQO8VL[(&UA3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F M;VYT+7-I>F4Z(#$P<'0[)SXY+S(X+S(P,3`\+V9O;G0^/"]D:78^#0H\+V1I M=CX-"CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O M;G0@3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM M97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L@/"]F;VYT M/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^#0H\9&EV M('-T>6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I3H@8FQO8VL[(&UA3H@:6YL:6YE.R!F;VYT+69A;6EL M>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXD/"]F;VYT M/CPO9&EV/@T*/"]D:78^#0H\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!W M:61T:#TS1#DE/@T*/&1I=B!S='EL93TS1"=T97AT+6EN9&5N=#H@,'!T.R!D M:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT M.B`P<'0[)SX-"CQD:78@86QI9VX],T1R:6=H="!S='EL93TS1"=T97AT+6EN M9&5N=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@ M;6%R9VEN+7)I9VAT.B`P<'0[)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I M;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UE3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N M.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^#0H\9&EV('-T>6QE/3-$)W1E M>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1I3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R<^ M-#PO9F]N=#XL,#`P/"]F;VYT/CPO9&EV/@T*/"]D:78^#0H\+W1D/@T*/'1D M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)V1I M6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1I3H@:6YL:6YE.R!F;VYT M+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF M(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,24^#0H\9&EV('-T>6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I3H@8FQO8VL[(&UA3H@:6YL:6YE M.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P M<'0[)SXD/"]F;VYT/CPO9&EV/@T*/"]D:78^#0H\+W1D/@T*/'1D('9A;&EG M;CTS1&)O='1O;2!W:61T:#TS1#DE/@T*/&1I=B!S='EL93TS1"=T97AT+6EN M9&5N=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@ M;6%R9VEN+7)I9VAT.B`P<'0[)SX-"CQD:78@86QI9VX],T1R:6=H="!S='EL M93TS1"=T97AT+6EN9&5N=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN M+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`P<'0[)SX\9F]N="!S='EL93TS M1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UE3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM M97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L@/"]F;VYT M/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^#0H\9&EV M('-T>6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1I6QE/3-$)V1I6QE/3-$)V1I3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@ M;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L@/"]F;VYT/CPO M=&0^#0H\+W1R/@T*/'1R(&)G8V]L;W(],T0C8V-E969F/@T*/'1D('9A;&EG M;CTS1&)O='1O;2!W:61T:#TS1#0W)3X-"CQD:78@3H@8FQO8VL[(&UA3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@ M=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L@/"]F M;VYT/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^#0H\ M9&EV('-T>6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I3H@8FQO8VL[(&UA3H@:6YL:6YE.R!F;VYT+69A M;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXD/"]F M;VYT/CPO9&EV/@T*/"]D:78^#0H\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O M;2!W:61T:#TS1#DE/@T*/&1I=B!S='EL93TS1"=T97AT+6EN9&5N=#H@,'!T M.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I M9VAT.B`P<'0[)SX-"CQD:78@86QI9VX],T1R:6=H="!S='EL93TS1"=T97AT M+6EN9&5N=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P M=#L@;6%R9VEN+7)I9VAT.B`P<'0[)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y M.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UE3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O M;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\ M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^#0H\9&EV('-T>6QE/3-$ M)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1I3H@ M8FQO8VL[(&UA3H@8FQO8VL[(&UA3H@:6YL:6YE.R!F M;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[ M)SXQ,"\Q-2\R,#$S/"]F;VYT/CPO9&EV/@T*/"]D:78^#0H\+W1D/@T*/'1D M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)V1I M6QE/3-$)W1E>'0M:6YD M96YT.B`P<'0[(&1I6QE/3-$)V1I3H@8FQO8VL[(&UA6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)W1E>'0M:6YD96YT.B`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`P<'0[(&1I6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1I6QE/3-$)V1I6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I3H@8FQO8VL[(&UA3H@:6YL:6YE.R!F;VYT M+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SY* M86YU87)Y(#(P,3$@16UP;&]Y964@5V%R3H@8FQO8VL[(&UA6QE M/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1I3H@8FQO8VL[(&UA3H@8FQO8VL[(&UA3H@:6YL:6YE M.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P M<'0[)SXR,"PP,#`\+V9O;G0^/"]D:78^#0H\+V1I=CX-"CPO=&0^#0H\=&0@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F M;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT M+7-I>F4Z(#$P<'0[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$.24^#0H\9&EV('-T>6QE/3-$)W1E>'0M:6YD M96YT.B`P<'0[(&1I6QE M/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$ M)V1I6QE/3-$)V1I6QE/3-$)W1E>'0M:6YD96YT.B`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`P<'0[(&1I3H@8FQO8VL[(&UA3H@:6YL:6YE M.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P M<'0[)SXD/"]F;VYT/CPO9&EV/@T*/"]D:78^#0H\+W1D/@T*/'1D('9A;&EG M;CTS1&)O='1O;2!W:61T:#TS1#DE/@T*/&1I=B!S='EL93TS1"=T97AT+6EN M9&5N=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@ M;6%R9VEN+7)I9VAT.B`P<'0[)SX-"CQD:78@86QI9VX],T1R:6=H="!S='EL M93TS1"=T97AT+6EN9&5N=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN M+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`P<'0[)SX\9F]N="!S='EL93TS M1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UE3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM M97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L@/"]F;VYT M/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^#0H\9&EV M('-T>6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1I6QE/3-$)V1I6QE/3-$)V1I3H@8FQO8VL[(&UA3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N M.R!F;VYT+7-I>F4Z(#$P<'0[)SY-87)C:"8C,38P.R8C,38P.S(P,3$@26YV M97-T;W(@5V%R3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N M.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L\+V9O;G0^/"]T9#X-"CQT9"!V M86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)3X-"CQD:78@3H@8FQO8VL[(&UA M3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W M(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXS+SDO,C`Q,3PO9F]N=#X\+V1I M=CX-"CPO9&EV/@T*/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@=VED=&@] M,T0Q)3X\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M M:6QY.B!T:6UE3H@ M8FQO8VL[(&UA6QE/3-$)W1E>'0M:6YD96YT M.B`P<'0[(&1I6QE/3-$ M)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1I M3H@ M8FQO8VL[(&UA3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@ M=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXV,#(L,#`Y/"]F M;VYT/CPO9&EV/@T*/"]D:78^#0H\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O M;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)V1I6QE/3-$)V1I6QE/3-$ M)V1I6QE/3-$)W1E>'0M M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1I6QE/3-$)V1I6QE/3-$)W1E>'0M:6YD96YT M.B`P<'0[(&1I6QE/3-$ M)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1I M3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM M97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L@/"]F;VYT M/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^#0H\9&EV M('-T>6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I3H@8FQO8VL[(&UA3H@:6YL:6YE.R!F;VYT+69A;6EL M>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXD/"]F;VYT M/CPO9&EV/@T*/"]D:78^#0H\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!W M:61T:#TS1#DE/@T*/&1I=B!S='EL93TS1"=T97AT+6EN9&5N=#H@,'!T.R!D M:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT M.B`P<'0[)SX-"CQD:78@86QI9VX],T1R:6=H="!S='EL93TS1"=T97AT+6EN M9&5N=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@ M;6%R9VEN+7)I9VAT.B`P<'0[)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I M;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UE3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N M.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^#0H\9&EV('-T>6QE/3-$)W1E M>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1I6QE/3-$)V1I6QE/3-$)V1I6QE/3-$)V1I6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I3H@8FQO8VL[(&UA3H@:6YL:6YE M.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P M<'0[)SY-87D@,C`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`P<'0[(&1I3H@8FQO8VL[(&UA3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N M.R!F;VYT+7-I>F4Z(#$P<'0[)SXD/"]F;VYT/CPO9&EV/@T*/"]D:78^#0H\ M+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#DE/@T*/&1I=B!S M='EL93TS1"=T97AT+6EN9&5N=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R M9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`P<'0[)SX-"CQD:78@86QI M9VX],T1R:6=H="!S='EL93TS1"=T97AT+6EN9&5N=#H@,'!T.R!D:7-P;&%Y M.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`P<'0[ M)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY M.B!T:6UE3H@8FQO8VL[(&UA3H@8FQO8VL[(&UA3H@ M:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I M>F4Z(#$P<'0[)SXR,"PP,#`\+V9O;G0^/"]D:78^#0H\+V1I=CX-"CPO=&0^ M#0H\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O M;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\ M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N M.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^#0H\9&EV('-T>6QE/3-$)W1E M>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1I6QE/3-$)V1I#LG('9A;&EG;CTS M1&)O='1O;2!W:61T:#TS1#0W)3X-"CQD:78@3H@8FQO8VL[(&UA65E(%=A M#LG('9A;&EG;CTS1&)O='1O;2!W:61T M:#TS1#$E/CQF;VYT('-T>6QE/3-$)V1I#LG('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#DE/@T*/&1I=B!S='EL M93TS1"=T97AT+6EN9&5N=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN M+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`P<'0[)SX-"CQD:78@86QI9VX] M,T1R:6=H="!S='EL93TS1"=T97AT+6EN9&5N=#H@,'!T.R!D:7-P;&%Y.B!B M;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`P<'0[)SX\ M9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T M:6UE3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@ M=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L@/"]F M;VYT/CPO=&0^#0H\=&0@#LG M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/@T*/&1I=B!S='EL93TS1"=T M97AT+6EN9&5N=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z M(#!P=#L@;6%R9VEN+7)I9VAT.B`P<'0[)SX-"CQD:78@86QI9VX],T1L969T M('-T>6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1I6QE/3-$ M)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1I3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W M(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L@/"]F;VYT/CPO=&0^ M#0H\=&0@6QE/3-$ M)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1I6QE/3-$)W!A9&1I;F3H@ M:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I M>F4Z(#$P<'0[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@#LG('9A;&EG;CTS1&)O='1O;2!W:61T:#TS M1#DE/@T*/&1I=B!S='EL93TS1"=T97AT+6EN9&5N=#H@,'!T.R!D:7-P;&%Y M.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`P<'0[ M)SX-"CQD:78@86QI9VX],T1R:6=H="!S='EL93TS1"=T97AT+6EN9&5N=#H@ M,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN M+7)I9VAT.B`P<'0[)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[ M(&9O;G0M9F%M:6QY.B!T:6UE3H@:6YL:6YE M.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P M<'0[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\+W1R/@T*/'1R(&)G8V]L;W(] M,T0C8V-E969F/@T*/'1D('-T>6QE/3-$)W!A9&1I;F6QE/3-$ M)W1E>'0M:6YD96YT.B`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`P<'0[(&1I3H@ M8FQO8VL[(&UA3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@ M=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M=V5I9VAT M.B!B;VQD.R<^-"PP-S0L-30R/"]F;VYT/CPO9&EV/@T*/"]D:78^#0H\+W1D M/@T*/'1D('-T>6QE/3-$)W!A9&1I;F3H@:6YL:6YE.R!F;VYT+69A;6EL M>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L@ M/"]F;VYT/CPO=&0^#0H\=&0@#LG('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#DE/CQF;VYT('-T>6QE/3-$ M)V1I6UE;G0@07=A6QE/3-$)W1E>'0M:6YD96YT.B`S M-G!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN M+7)I9VAT.B`P<'0[)SXF(S$V,#L\+V1I=CX-"CQD:78@86QI9VX],T1L969T M/@T*/'1A8FQE('-T>6QE/3-$)V9O;G0M6QE/3-$)W!A9&1I;F3H@:6YL:6YE M.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P M<'0[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@6QE/3-$)V1I6QE/3-$)V1I6QE/3-$)V1I6QE M/3-$)V)O"!S;VQI9#LG('9A;&EG;CTS M1&)O='1O;2!C;VQS<&%N/3-$,CX-"CQD:78@86QI9VX],T1C96YT97(@3H@8FQO8VL[(&UA6QE/3-$)V1I3H@8FQO8VL[(&UA3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT M+7-I>F4Z(#$P<'0[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX] M,T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)3X-"CQD:78@86QI M9VX],T1R:6=H="!S='EL93TS1"=T97AT+6EN9&5N=#H@,'!T.R!D:7-P;&%Y M.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`P+CAP M=#LG/CQF;VYT('-T>6QE/3-$)V1I3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT M+7-I>F4Z(#$P<'0[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX] M,T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X\9F]N="!S='EL M93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UE6QE/3-$)V1I6QE/3-$)V1I6QE/3-$)V1I6QE/3-$)W1E>'0M:6YD96YT M.B`P<'0[(&1I3H@:6YL M:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z M(#$P<'0[)SY'6QE/3-$)V1I6QE/3-$)W1E M>'0M:6YD96YT.B`P<'0[(&1I3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F M;VYT+7-I>F4Z(#$P<'0[)SXQ-2PP,#`\+V9O;G0^/"]D:78^#0H\+W1D/@T* M/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X\ M9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T M:6UE6QE/3-$)V1I6QE/3-$)W1E>'0M:6YD96YT.B`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`Q+C9P=#LG/CQF;VYT('-T>6QE/3-$)V1I3H@:6YL:6YE.R!F M;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[ M)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('9A;&EG M;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)V1I3H@ M8FQO8VL[(&UA6QE/3-$ M)W1E>'0M:6YD96YT.B`P<'0[(&1I3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N M.R!F;VYT+7-I>F4Z(#$P<'0[)SXI)B,Q-C`[/"]F;VYT/CPO9&EV/@T*/"]T M9#X-"CQT9"!A;&EG;CTS1')I9VAT('9A;&EG;CTS1&)O='1O;2!W:61T:#TS M1#$E/CQF;VYT('-T>6QE/3-$)V1I6QE/3-$)V1I6QE/3-$)V1I6QE/3-$)W!A9&1I;F6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@ M;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SY%>&5R8VES960\+V9O;G0^ M/"]D:78^#0H\+W1D/@T*/'1D(&%L:6=N/3-$#LG('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E M/CQF;VYT('-T>6QE/3-$)V1I6QE/3-$ M)V)O"!S;VQI9#LG('9A;&EG;CTS1&)O M='1O;2!W:61T:#TS1#DE/@T*/&1I=B!A;&EG;CTS1')I9VAT('-T>6QE/3-$ M)W1E>'0M:6YD96YT.B`P<'0[(&1I3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N M.R!F;VYT+7-I>F4Z(#$P<'0[)SXH,S@L-#4V/"]F;VYT/CPO9&EV/@T*/"]T M9#X-"CQT9"!A;&EG;CTS1&QE9G0@#LG('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/@T*/&1I=B!A;&EG M;CTS1&QE9G0@3H@ M8FQO8VL[(&UA#LG('9A;&EG;CTS1&)O='1O;2!W:61T M:#TS1#$E/CQF;VYT('-T>6QE/3-$)V1I6QE/3-$)V)O"!S;VQI9#LG('9A;&EG M;CTS1&)O='1O;2!W:61T:#TS1#DE/@T*/&1I=B!A;&EG;CTS1')I9VAT('-T M>6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W M(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXT+C,S/"]F;VYT/CPO9&EV/@T* M/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@#LG('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T M>6QE/3-$)V1I#LG('9A;&EG;CTS M1&)O='1O;2!W:61T:#TS1#6QE M/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O M;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SY/=71S=&%N9&EN9R!A="!-87)C:"`S M,2P@,C`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`P+CAP=#LG M/CQF;VYT('-T>6QE/3-$)V1I#LG('9A;&EG;CTS1&)O='1O;2!W:61T M:#TS1#$E/CQF;VYT('-T>6QE/3-$)V1I#LG('9A;&EG;CTS1&)O='1O;2!W:61T:#TS M1#$E/CQF;VYT('-T>6QE/3-$)V1I6QE/3-$)V1I3H@8FQO8VL[(&UA3H@:6YL:6YE.R!F;VYT+69A M;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V M,#L@/"]F;VYT/CPO=&0^#0H\+W1R/@T*/"]T86)L93X-"CPO9&EV/@T*/&1I M=B!S='EL93TS1"=T97AT+6EN9&5N=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SLG M/CQF;VYT('-T>6QE/3-$)V1I7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T* M#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O M;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA2!O9B!F=71U6QE/3-$)V1I'0M86QI9VXZ(&IU3H@8FQO8VL[(&UA M'0M:6YD96YT.B`P<'0[(&UA3H@:6YL:6YE.R!F;VYT M+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE'0M9&5C;W)A=&EO;CH@=6YD97)L:6YE.R<^/&9O;G0@3H@:6YL:6YE.R<^665A6QE M/3-$)W!A9&1I;F6QE/3-$ M)V1I6QE/3-$)V1I M3H@ M=&EM97,@;F5W(')O;6%N.R<^5&]T86P\+V9O;G0^/"]D:78^#0H\+W1D/@T* M/'1D(&%L:6=N/3-$;&5F="!S='EL93TS1"=P861D:6YG+6)O='1O;3H@,G!X M.R<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@3H@:6YL:6YE.R!F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY M.B!T:6UE'0M:6YD96YT.B`P<'0[(&UA3H@:6YL:6YE.R!F;VYT+7-I>F4Z(#$P<'0[(&9O M;G0M9F%M:6QY.B!T:6UE3H@:6YL:6YE.R!F;VYT M+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE'0M:6YD M96YT.B`P<'0[(&UA3H@:6YL:6YE.R!F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY M.B!T:6UE6QE/3-$)V1I6QE/3-$)V1I3H@:6YL:6YE.R!F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE M3H@8FQO8VL[(&UA6QE/3-$ M)V1I3H@=&EM97,@;F5W(')O;6%N.R<^,C`Q-#PO9F]N=#X\+V1I=CX-"CPO=&0^ M#0H\=&0@86QI9VX],T1L969T('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E M/CQF;VYT('-T>6QE/3-$)V1I3H@=&EM97,@;F5W(')O;6%N.R<^)B,Q-C`[(#PO M9F]N=#X\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1B;W1T;VT@ M=VED=&@],T0Q)3X\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O M;G0M6QE/3-$)V1I6QE M/3-$)V1I3H@=&EM97,@;F5W(')O;6%N.R<^,C4U/"]F;VYT/CPO9&EV/@T*/"]T M9#X-"CQT9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,24^/&9O;G0@3H@:6YL:6YE.R!F;VYT+7-I>F4Z M(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE3H@8FQO8VL[(&UA6QE/3-$)V1I3H@=&EM97,@;F5W(')O;6%N.R<^,C`Q-3PO9F]N=#X\ M+V1I=CX-"CPO=&0^#0H\=&0@86QI9VX],T1L969T('-T>6QE/3-$)W!A9&1I M;F3H@:6YL:6YE.R!F;VYT+7-I M>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE#LG('9A M;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)V1I6QE/3-$ M)W!A9&1I;F3H@:6YL:6YE.R!F;VYT+7-I M>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE6QE/3-$)W!A M9&1I;F3H@8FQO8VL[(&UA'0M:6YD96YT.B`P<'0[ M(&UA3H@ M:6YL:6YE.R!F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B!T:6UE6QE/3-$)V)O"!D;W5B M;&4[)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)3X-"CQD:78@86QI9VX] M,T1R:6=H="!S='EL93TS1"=D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z M(#!P=#L@=&5X="UI;F1E;G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`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`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`P M<'0[(&1I6QE/3-$)V1I6QE/3-$)V1I3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@ M;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L@/"]F;VYT/CPO M=&0^#0H\+W1R/@T*/'1R(&)G8V]L;W(],T0C8V-E969F/@T*/'1D(&%L:6=N M/3-$;&5F="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W-B4^#0H\9&EV(&%L M:6=N/3-$;&5F="!S='EL93TS1"=T97AT+6EN9&5N=#H@,'!T.R!D:7-P;&%Y M.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`P<'0[ M)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY M.B!T:6UE3H@8FQO8VL[(&UA3H@:6YL:6YE.R!F;VYT M+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXR M.3(\+V9O;G0^/"]D:78^#0H\+W1D/@T*/'1D(&%L:6=N/3-$;&5F="!V86QI M9VX],T1B;W1T;VT@=VED=&@],T0Q)3X\9F]N="!S='EL93TS1"=D:7-P;&%Y M.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UE6QE M/3-$)V1I6QE/3-$)W1E>'0M M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1I6QE/3-$)W1E>'0M:6YD96YT.B`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`P<'0[)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O M;G0M9F%M:6QY.B!T:6UE3H@8FQO8VL[(&UA3H@:6YL:6YE.R!F;VYT+69A M;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SY.970@ M3H@:6YL M:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z M(#$P<'0[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1R:6=H M="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)3X-"CQD:78@86QI9VX],T1R M:6=H="!S='EL93TS1"=T97AT+6EN9&5N=#H@,'!T.R!D:7-P;&%Y.B!B;&]C M:SL@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`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`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`P<'0[)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O M;G0M9F%M:6QY.B!T:6UE6QE/3-$)W!A9&1I;F6QE/3-$)W1E>'0M M:6YD96YT.B`P<'0[(&1I6QE/3-$)V1I6QE/3-$)V1I3H@:6YL:6YE.R!F;VYT+69A M;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V M,#L@/"]F;VYT/CPO=&0^#0H\=&0@86QI9VX],T1L969T('9A;&EG;CTS1&)O M='1O;2!C;VQS<&%N/3-$-CX\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI M;F4[(&9O;G0M9F%M:6QY.B!T:6UE3H@:6YL:6YE M.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P M<'0[)SXF(S$V,#L@/"]F;VYT/CPO=&0^#0H\+W1R/@T*/'1R(&)G8V]L;W(] M,T1W:&ET93X-"CQT9"!A;&EG;CTS1&QE9G0@#LG('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=D M:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UE#LG('9A M;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[ M(&9O;G0M9F%M:6QY.B!T:6UE6QE/3-$)W1E>'0M M:6YD96YT.B`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`P<'0[(&1I6QE/3-$)V1I6QE/3-$ M)W1E>'0M:6YD96YT.B`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`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`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`P<'0[(&1I6QE/3-$ M)V1I#LG('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT M('-T>6QE/3-$)V1I6QE/3-$)W1E>'0M:6YD96YT.B`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`P<'0[)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I M;FQI;F4[(&9O;G0M9F%M:6QY.B!T:6UE6QE/3-$)W!A9&1I;F6QE M/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I6QE/3-$ M)V1I7!E.B!T97AT+VAT;6P[(&-H87)S970] M(G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T M<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@ M8VAA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T* M("`@("`@/'1R(&-L87-S/3-$6QE/3-$)W!A9&1I;F&-E<'0@<&5R M('-H87)E(&%M;W5N=',I/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!A;&EG M;CTS1&QE9G0@#LG('9A;&EG M;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)V1I6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E3H@8FQO8VL[(&UA6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E3H@8FQO8VL[(&UA3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F M;VYT+7-I>F4Z(#$P<'0[)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI M;F4[(&9O;G0M9F%M:6QY.B!T:6UE#LG('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS M1&YO=W)A<#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M M9F%M:6QY.B!T:6UE6QE/3-$)V1I3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@ M=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L\+V9O M;G0^/"]T9#X-"CQT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`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`P<'0[(&1I6QE M/3-$)V1I6QE/3-$)W1E M>'0M86QI9VXZ(&QE9G0[)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N M;W=R87`],T1N;W=R87`^/&9O;G0@3H@:6YL:6YE M.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P M<'0[)SXF(S$V,#L\+V9O;G0^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@ M=VED=&@],T0Q)3X\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O M;G0M9F%M:6QY.B!T:6UE6QE/3-$)W1E M>'0M86QI9VXZ(&QE9G0[)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N M;W=R87`],T1N;W=R87`^/&9O;G0@3H@:6YL:6YE M.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P M<'0[)SXF(S$V,#L\+V9O;G0^/"]T9#X-"CPO='(^#0H\='(@8F=C;VQO6QE/3-$)W!A9&1I;F6QE/3-$)W1E>'0M:6YD M96YT.B`P<'0[(&1I6QE/3-$)V1I3H@:6YL:6YE.R!F;VYT M+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SY7 M96EG:'1E9"!A=F5R86=E(&YU;6)E#LG M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)V1I M3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@ M;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L\+V9O;G0^/"]T M9#X-"CQT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`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`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`],T1N;W=R87`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`P<'0[(&1I6QE/3-$)V1I M3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@;F5W(')O M;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L\+V9O;G0^/"]T9#X-"CQT M9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`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`],T1N;W=R87`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`P<'0[ M(&1I6QE/3-$)V1I3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@ M=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L\+V9O M;G0^/"]T9#X-"CQT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`T M<'@@9&]U8FQE.R!T97AT+6%L:6=N.B!L969T.R<@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$,24^/&9O;G0@3H@:6YL:6YE.R!F M;VYT+69A;6EL>3H@=&EM97,@;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[ M)SXD/"]F;VYT/CPO=&0^#0H\=&0@F4Z(#$P<'0[)SXF(S$V,#L\+V9O;G0^/"]T9#X-"CQT9"!S='EL M93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`T<'@@9&]U8FQE.R!T97AT+6%L M:6=N.B!L969T.R<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@ M3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@ M;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SXD/"]F;VYT/CPO=&0^#0H\ M=&0@#LG('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E M(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI M;F4[(&9O;G0M9F%M:6QY.B!T:6UE3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@=&EM97,@ M;F5W(')O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)SX\+V9O;G0^/"]D:78^#0H\ M+V1I=CX\'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T* M("`@("`@/'1R(&-L87-S/3-$'1U2!A;F0@97%U:7!M96YT/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D M(&-L87-S/3-$=&5X=#X\65A'0O M:F%V87-C3X-"B`@("`\ M=&%B;&4@8VQAF]N(%M-96UB97)=/&)R/CPO=&@^#0H@ M("`@("`@(#QT:"!C;&%S2!#;W)P;W)A=&EO;B!;365M8F5R73QB"!;365M8F5R73QB2!O M9B!3:6=N:69I8V%N="!!8V-O=6YT:6YG(%!O;&EC:65S("A497AT=6%L*3PO M'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$ M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S M/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^-#4@9&%Y2!T2!T'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S&-H86YG92!R871E(&9O M7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\ M:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E M;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$65T($5X8VAA;F=E9"!A="!-87)C:"`S,2P@,C`Q,SPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S3X-"CPO:'1M;#X- M"@T*+2TM+2TM/5].97AT4&%R=%]B.6%A-SDS,%\W-V,Y7S1A.#-?8C(P8E]F M.&8Q,S(W-#DV834-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO8CEA M83'0O:'1M;#L@8VAA'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S M/3-$&5R8VES92!O9B!W87)R86YT M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^3VYE('9O=&4@9F]R M(&5A8V@@'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T* M("`@("`@/'1R(&-L87-S/3-$F5D/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X-"CPO:'1M;#X-"@T*+2TM M+2TM/5].97AT4&%R=%]B.6%A-SDS,%\W-V,Y7S1A.#-?8C(P8E]F.&8Q,S(W M-#DV834-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO8CEA83'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R M'1U86PI/"]S=')O;F<^/"]T9#X-"B`@("`@ M("`@/'1D(&-L87-S/3-$=&5X=#X\'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T* M("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X-"CPO M:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%]B.6%A-SDS,%\W-V,Y7S1A.#-? M8C(P8E]F.&8Q,S(W-#DV834-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O M0SHO8CEA83'0O:'1M;#L@ M8VAA2!O9B!A;&P@3PO'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$&5R8VES92!0&5R8VES92!0'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S7!E.B!T M97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE M860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT M96YT/3-$)W1E>'0O:'1M;#L@8VAA'0^)FYB'!E8W1E9"!L:69E("AY96%R65A'!E8W1E9"!V;VQA=&EL:71Y/"]T M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ-30N,#`E/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D M>3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%]B.6%A-SDS,%\W-V,Y M7S1A.#-?8C(P8E]F.&8Q,S(W-#DV834-"D-O;G1E;G0M3&]C871I;VXZ(&9I M;&4Z+R\O0SHO8CEA83'0O M:'1M;#L@8VAA'!E;G-E/"]S=')O;F<^/"]T M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\'!E;G-E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$ M;G5M<#XD(#4X-CQS<&%N/CPO'!E;G-E M(&]F('-T;V-K+6)A2!O9B!S=&]C:RUB87-E9"!C;VUP96YS M871I;VX@97AP96YS93PO'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R M/@T*("`@("`@/'1R(&-L87-S/3-$'0^ M)FYB3X-"CPO:'1M;#X-"@T*+2TM+2TM/5]. M97AT4&%R=%]B.6%A-SDS,%\W-V,Y7S1A.#-?8C(P8E]F.&8Q,S(W-#DV834- M"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO8CEA83'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R2!O9B!A M;&P@3PO'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^)FYB'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$&5R8VES M960\+W1D/@T*("`@("`@("`\=&0@8VQA'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S M/3-$&5R8VES92!0'0^)FYB'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'!I'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$&5R8VES960\+W1D/@T*("`@("`@("`\=&0@8VQA&5R8VES92!0&5R8VES86)L93PO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^,2!Y M96%R(#$@;6]N=&@@,C0@9&%Y65A'0O M:F%V87-C3X-"B`@("`\ M=&%B;&4@8VQA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M("`@/'1R(&-L87-S/3-$'1E;G-I;VX@ M5V%R'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'!I'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^ M4V5P(#(X+`T*"0DR,#$S/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R M/@T*("`@("`@/'1R(&-L87-S/3-$'0^3V-T(#$X+`T*"0DR,#$P/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$&5R8VES92!0'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L M87-S/3-$'!I'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L M87-S/3-$&5R8VES92!0'0^ M1&5C(#,L#0H)"3(P,34\'0^2F%N(#(Q+`T*"0DR,#$Q/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$&5R8VES92!0'0^1F5B(#(R+`T*"0DR,#$Q/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$&5R8VES92!0'!I'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$&5R8VES92!0'0^36%R(#DL#0H) M"3(P,38\2!O9B!O=71S=&%N9&EN9R!W87)R86YT'0^07!R(#'!I'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L M87-S/3-$'!I2`Q-RP-"@D),C`Q-#QS M<&%N/CPO'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA65E($1I'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^2G5N92`R M,#`X/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^36%R8V@@,C`Q,3QS<&%N/CPO'!E8W1E9"!T;R!V97-T+"!O=71S=&%N9&EN9RP@;G5M8F5R/"]T9#X- M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M&5R8VES92!O9B!W87)R M86YT&5R8VES92!O9B!W M87)R86YT'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$65A65A'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^,2!Y96%R/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^-"!Y96%R'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^-2!Y96%R65A'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%SF5D('!E M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^,C0@;6]N=&AS/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T* M("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$2!I;F-E;G1I=F4@<&QA;G,\+W1D/@T*("`@("`@("`\=&0@8VQAF5D(&5X<&5N M'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^,R!Y96%R&5R8VES92!O9B!W87)R86YT(&)Y('=A M&-L=61I;F<@0T9//"]T9#X-"B`@("`@("`@/'1D M(&-L87-S/3-$=&5X=#X\'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'1087)T7V(Y M86$W.3,P7S'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA6UE;G1S('5N9&5R(&YO;BUC86YC96QL M86)L92!O<&5R871I;F<@;&5A'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M("`@/'1R(&-L87-S/3-$'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^3F5O;F]D M92!W:6QL(&-O;G1R:6)U=&4@=&\@5$D@=&AE($Y212!A'0@96EG:'0@;6EL;&EO;B!U;FET M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$ M'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S2!T87@@*&5X8VQU9&EN9R!6050I+"!N970\+W1D/@T*("`@ M("`@("`\=&0@8VQA'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M,R!M;VYT:',\'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$'!I65A'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T* M("`@("`@/'1R(&-L87-S/3-$'1E;F1E9"!L96%S92!P97)I;V0@=6YD97(@'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^07!R(#$U+`T*"0DR,#$T/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA2!O9B!N970@'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T* M("`@("`@/'1R(&-L87-S/3-$2!G96]G'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R M/@T*("`@("`@/'1R(&-L87-S/3-$'0^)FYB'0^)FYB2!O9B!N970@ M3X-"CPO:'1M;#X-"@T*+2TM M+2TM/5].97AT4&%R=%]B.6%A-SDS,%\W-V,Y7S1A.#-?8C(P8E]F.&8Q,S(W M-#DV834-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO8CEA83'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R M'1U86PI/"]S=')O;F<^/"]T M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%]B M.6%A-SDS,%\W-V,Y7S1A.#-?8C(P8E]F.&8Q,S(W-#DV834-"D-O;G1E;G0M M3&]C871I;VXZ(&9I;&4Z+R\O0SHO8CEA83'0O:'1M;#L@8VAA'0O:F%V87-C3X-"B`@ M("`\=&%B;&4@8VQA'1U86PI/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X M=#X\'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$&-L=61E9"!F'1U86PI/"]S=')O;F<^/"]T9#X- M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA2`P,RP@,C`Q,SQB'1U86PI/"]S=')O;F<^/"]T9#X-"B`@ M("`@("`@/'1D(&-L87-S/3-$=&5X=#X\&5R8VES97,\+W1D/@T*("`@("`@("`\=&0@8VQA M&5R8VES92!O9B!W M87)R86YT'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S&5R8VES92!P'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R M/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M("`@/'1R(&-L87-S/3-$&-L=61I;F<@ M5D%4*2P@;F5T/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\2!U&5R8VES M92!P7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\>&UL M('AM;&YS.F\],T0B=7)N.G-C:&5M87,M;6EC XML 18 R29.htm IDEA: XBRL DOCUMENT v2.4.0.6
Stock-Based Compensation (Details 1)
3 Months Ended
Mar. 31, 2013
Summary of assumptions used to value stock options granted to employees  
Annual dividend yield   
Expected life (years) 4 years 3 months 18 days
Risk-free interest rate 0.65%
Expected volatility 154.00%
XML 19 R28.htm IDEA: XBRL DOCUMENT v2.4.0.6
Stock-Based Compensation (Details) (Stock Options [Member], USD $)
0 Months Ended 3 Months Ended
Mar. 11, 2013
Mar. 31, 2013
Stock Options [Member]
   
Summary of all stock option plans / warrant activity    
Number of Options/Warrants Outstanding, Beginning Balance   1,715,200
Number of Options/Warrants Outstanding, Granted   15,000
Number of Options/Warrants Outstanding, Cancelled or expired   (200)
Number of Options/Warrants Outstanding, Exercised 38,456 (38,456)
Number of Options/Warrants Outstanding, Ending Balance   1,691,544
Weighted Average Exercise Price, Outstanding, Beginning Balance   $ 5.04
Weighted Average Exercise Price, Granted   $ 5.97
Weighted Average Exercise Price, Expired   $ 125.00
Weighted Average Exercise Price, Exercised   $ 4.33
Weighted Average Exercise Price, Outstanding, Ending Balance   $ 5.05
XML 20 R30.htm IDEA: XBRL DOCUMENT v2.4.0.6
Stock-Based Compensation (Details 2) (Warrant [Member], USD $)
In Thousands, unless otherwise specified
3 Months Ended
Mar. 31, 2013
Mar. 31, 2012
Summary of stock-based compensation expense    
Share-based compensation expense $ 586 $ 34
Remaining unamortized expense of stock-based compensation 3,060  
Product research and development [Member]
   
Summary of stock-based compensation expense    
Share-based compensation expense 60 10
Sales and marketing [Member]
   
Summary of stock-based compensation expense    
Share-based compensation expense 196 24
General and administrative [Member]
   
Summary of stock-based compensation expense    
Share-based compensation expense $ 330   
XML 21 R31.htm IDEA: XBRL DOCUMENT v2.4.0.6
Stock-Based Compensation (Details 3) (Warrant [Member], USD $)
3 Months Ended 12 Months Ended
Mar. 31, 2013
Dec. 31, 2012
Warrant [Member]
   
Summary of all stock option plans / warrant activity    
Number of Options/Warrants Outstanding, Beginning Balance 4,704,636  
Warrants, Issued     
Warrants, Expired/forfeited (40,000)  
Number of Options/Warrants Outstanding, Exercised (590,094)  
Number of Options/Warrants Outstanding, Ending Balance 4,074,542 4,704,636
Weighted Average Exercise Price, Outstanding, Beginning Balance $ 1.61  
Weighted Average Exercise Price, Issued     
Weighted Average Exercise Price, Expired/forfeited $ 1.00  
Weighted Average Exercise Price, Exercised $ 1.17  
Weighted Average Exercise Price, Outstanding, Ending Balance $ 1.69 $ 1.61
Weighted Average Remaining Contractual Life, Outstanding and exercisable 1 year 1 month 24 days 1 year 4 months 28 days
Weighted Average Remaining Contractual Life, Issued     
Weighted Average Remaining Contractual Life, Expired/forfeited     
Weighted Average Remaining Contractual Life, Exercised     
XML 22 R8.htm IDEA: XBRL DOCUMENT v2.4.0.6
Summary of Significant Accounting Policies
3 Months Ended
Mar. 31, 2013
Summary Of Significant Accounting Policies [Abstract]  
Summary of Significant Accounting Policies
2.   Summary of Significant Accounting Policies
 
Principles of Consolidation
 
The condensed consolidated balance sheet at December 31, 2012 and the condensed consolidated statements of operations, other comprehensive loss, and cash flows for the three months ended March 31, 2012 includes our accounts and the accounts of our wholly owned Swedish subsidiary Neonode Technologies AB (“NTAB”).  All significant intercompany accounts and transactions have been eliminated.
 
The condensed consolidated balance sheet at March 31, 2013 and the condensed consolidated statements of operations, other comprehensive loss, and cash flows for the three months ended March 31, 2013  include our accounts and the accounts of our wholly owned subsidiaries, NTAB, Neonode Americas Inc. (“NAI”), Neonode Japan Inc. (“NJKK”), NEON Technologies Inc. (“NTI”) and Neonode UI AB (“NUIAB”).  All significant intercompany accounts and transactions have been eliminated.
 
Neonode management has made several strategic decisions to establish their presence in international markets that provide access to tier one customers and demonstrate Neonode’s long term commitment to these markets. NJKK was created in January 2013 to reach out to customers with global reach in electronics, automotive and home appliance markets.  NUIAB was created to address particular opportunities that exist in this significant user interface arena as some aspects of our technology lends itself to ease of interacting with electronic devices. NTI and NAI were established to create a more focused organization with specific marketing, research and development goals. Furthermore, by creating separate entities, their performances can be directed and observed more clearly.
 
Estimates
 
The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires making estimates and assumptions that affect, at the date of the financial statements, the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities and the reported amounts of revenue and expenses. Actual results could differ from these estimates. Significant estimates include, but are not limited to, collectibility of accounts receivable, recoverability of long-lived assets, the valuation allowance related to our deferred tax assets and the fair value of options and warrants issued for stock-based compensation.
 
Concentration of Cash Balance Risks
 
Cash balances are maintained at various banks in the U.S., Japan and Sweden. At times, deposits held with financial institutions in the United States of America may exceed the amount of insurance provided by the Federal Deposit Insurance Corporation (“FDIC”), which provides basic deposit coverage with limits up to $250,000 per owner. The Swedish government provides insurance coverage up to 100,000 euro per customer and covers deposits in all types of accounts. As of March 31, 2013, the Company has approximately $7.2 million in excess of insurance limits.
 
Accounts Receivable and Allowance for Doubtful Accounts  
 
Our accounts receivable are stated at net realizable value. Our policy is to maintain allowances for estimated losses resulting from the inability of our customers to make required payments. Credit limits are established through a process of reviewing the financial history and stability of each customer. Where appropriate, we obtain credit rating reports and financial statements of the customer when determining or modifying its credit limits. We regularly evaluate the collectibility of our trade receivable balances based on a combination of factors. When a customer’s account balance becomes past due, we initiate dialogue with the customer to determine the cause. If it is determined that the customer will be unable to meet its financial obligation, such as in the case of a bankruptcy filing, deterioration in the customer’s operating results or financial position or other material events impacting its business, we record a specific allowance to reduce the related receivable to the amount we expect to recover. Should all efforts fail to recover the related receivable, we will write-off the account. We also record an allowance based on certain other factors including the length of time the receivables are past due and historical collection experience with customers.  We determined that an allowance for doubtful accounts was not necessary at March 31, 2013 and December 31, 2012.
 
Property and Equipment
 
Property and equipment are stated at cost, net of accumulated depreciation and amortization. Depreciation and amortization are computed using the straight-line method based upon estimated useful lives of the assets as follows:
 
 
Estimated useful lives
Computer equipment
3 years
Furniture and fixtures
5 years
 
Equipment purchased under capital leases is amortized on a straight-line basis over the estimated useful life of the asset or the term of the lease, whichever is shorter.
 
Upon retirement or sale of property and equipment, cost and accumulated depreciation and amortization are removed from the accounts and any gains or losses are reflected in the consolidated statement of operations. Maintenance and repairs are charged to expense as incurred.
 
Long-lived Assets
 
We assess any impairment by estimating the future cash flow from the associated asset in accordance with relevant accounting guidance. If the estimated undiscounted future cash flow related to these assets decreases or the useful life is shorter than originally estimated, we may incur charges for impairment of these assets.  At March 31, 2013, we believe there is no impairment of our long-lived assets.
 
Foreign Currency Translation and Transaction Gains and Losses
 
The functional currency of our foreign subsidiaries is the applicable local currency, the Swedish Krona and Japanese Yen. The translation from Swedish Krona and Japanese Yen to U.S. Dollars is performed for balance sheet accounts using current exchange rates in effect at the balance sheet date and for income statement accounts using a weighted-average exchange rate during the period. Foreign currency translation gains were $13,000 and $44,000 during the three months ended March 31, 2013 and 2012, respectively. Gains or losses resulting from translation are included as a separate component of accumulated other comprehensive loss. Gains or losses resulting from foreign currency transactions are included in general and administrative expense in the accompanying condensed consolidated statements of operations and were $37,000 and $62,000 during the three months ended March 31, 2013 and 2012, respectively.
  
Concentration of Credit and Business Risks
 
Our accounts receivable as of March 31, 2013 was due from twelve customers, five of which accounted for 72% of our accounts receivable as of March 31, 2013. Our net revenues for the three months ended March 31, 2013 was earned from nine customers. Our customers are located in the U.S., Europe and Asia. Customers which accounted for 10% or more of our net revenues during the three months ended March 31, 2013 are as follows:
 
        
Kobo - 44%
●        
Sony Corporation -20%
●        
Netronix – 21%
●        
Barnes & Noble – 10%
 
Our accounts receivable as of December 31, 2012 was due from fifteen customers, none of which accounted for more than10% of our accounts receivable as of December 31, 2012. Our net revenues for the three months ended March 31, 2012 was earned from ten customers. Our customers are located in the U.S., Europe and Asia. Customers which accounted for 10% or more of our net revenues during the three months ended March 31, 2012 are as follows:
 
●        
Amazon - 55%
●        
Sony Corporation -16%
 
Revenue Recognition
 
Licensing Revenues:
 
We derive revenue from the licensing of internally developed intellectual property (“IP”). We enter into IP licensing agreements that generally provide licensees the right to incorporate our IP components in their products with terms and conditions that vary by licensee. The IP licensing agreements generally include a nonexclusive license for the underlying IP. Fees under these agreements may include license fees relating to our IP and royalties payable following the distribution by our licensees of products incorporating the licensed technology. The license for our IP has standalone value and can be used by the licensee without maintenance and support. Neonode meets all the accounting requirements for revenue recognition as per unit royalty products are distributed or licensed by the Company’s customers.  For technology license arrangements that do not require significant modification or customization of the underlying technology, we recognize technology license revenue when: (1) we enter into a legally binding arrangement with a customer for the license of technology; (2) the customer distributes or licenses the products; (3) the customer payment is deemed fixed or determinable and free of contingencies or significant uncertainties; and (4) collection is reasonably assured. Our customers report to us the quantities of products distributed or licensed by them after the end of the reporting period stipulated in the contract, generally 30 to 45 days after the end of the month or quarter.
Explicit return rights are not offered to customers. There have been no returns through March 31, 2013.
 
Engineering Services:
 
We may sell engineering consulting services to our customers on a flat rate or hourly rate basis. We recognize revenue from these services when all of the following conditions are met: (1) evidence existed of an arrangement with the customer, typically consisting of a purchase order or contract; (2) our services were performed and risk of loss passed to the customer; (3) we completed all of the necessary terms of the contract; (4) the amount of revenue to which we were entitled was fixed or determinable; and (5) we believed it was probable that we would be able to collect the amount due from the customer. To the extent that one or more of these conditions has not been satisfied, we defer recognition of revenue.  Generally, we recognize revenue as the engineering services stipulated under the contract are completed and accepted by our customers.  
 
Deferred Revenue
 
From time-to-time the Company receives pre-payments from its customers related to future services or future license fee revenues. We defer the license fees until we have met all accounting requirements for revenue recognition as per unit royalty products are distributed or licensed by the Company’s customers and the engineering development fee revenue until such time as the engineering work has been completed and accepted by our customers.
 
Advertising
 
Advertising costs are expensed as incurred. Advertising costs for the quarters ended March 31, 2013 and 2012 amounted to approximately $124,000 and $197,000, respectively.
Product Research and Development
 
Research and development (“R&D”) costs are expensed as incurred. R&D costs consist mainly of personnel related costs in addition to some external consultancy costs such as testing, certifying and measurements.
 
Stock-Based Compensation Expense
 
We measure the cost of employee services received in exchange for an award of equity instruments, including stock options, based on the fair value of the award on the grant date, and recognize the value as compensation expense over the period the employee is required to provide services in exchange for the award, usually the vesting period, net of estimated forfeitures.
 
 We account for equity instruments issued to non-employees at their fair value. The measurement date for the fair value for the equity instruments issued is determined at the earlier of (i) the date at which a commitment for performance by the consultant or vendor is reached, or (ii) the date at which the consultant or vendor’s performance is complete. In the case of equity instruments issued to consultants, the fair value of the equity instruments is primarily recognized over the term of the consulting agreement. The fair value of the stock-based compensation is periodically re-measured and expense is recognized during the vesting term.
 
When determining stock-based compensation expense involving options and warrants, we determine the estimated fair value of options and warrants using the Black-Scholes option pricing model.
 
Income Taxes
 
We recognize deferred tax liabilities and assets for the expected future tax consequences of items that have been included in the consolidated financial statements or tax returns. We estimate income taxes based on rates in effect in each of the jurisdictions in which we operate. Deferred income tax assets and liabilities are determined based upon differences between the financial statement and income tax bases of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse. The realization of deferred tax assets is based on historical tax positions and expectations about future taxable income. Valuation allowances are recorded against net deferred tax assets when, in our opinion, realization is uncertain based on the “more likely than not” criteria of the accounting guidance.
 
Based on the uncertainty of future pre-tax income, we fully reserved our net deferred tax assets as of March 31, 2013 and December 31, 2012. In the event we were to determine that we would be able to realize our deferred tax assets in the future, an adjustment to the deferred tax asset would increase income in the period such determination was made. The provision for income taxes represents the net change in deferred tax amounts, plus income taxes paid or payable for the current period.
 
We follow the relevant accounting guidance related to uncertain tax positions, which provisions include a two-step approach to recognizing, de-recognizing and measuring uncertain tax positions.  As a result, we did not recognize a liability for unrecognized tax benefits.  As of March 31, 2013 and December 31, 2012, we had no unrecognized tax benefits.
  
Net Loss Per Share
 
Net loss per share amounts have been computed based on the weighted-average number of shares of common stock outstanding during the period. Net loss per share, assuming dilution amounts from common stock equivalents, is computed based on the weighted-average number of shares of common stock and potential common stock equivalents outstanding during the period. The weighted-average number of shares of common stock and potential common stock equivalents used in computing the net loss per share for periods ended March 31, 2013 and 2012 exclude the potential common stock equivalents, as the effect would be anti-dilutive (See Note 8).
 
Comprehensive Income (Loss)
 
Our comprehensive loss includes foreign currency translation gains and losses.  The cumulative amount of translation gains and losses are reflected as a separate component of stockholder’ equity in the condensed consolidated balance sheets as accumulated other comprehensive income.
 
Cash Flow Information
 
Cash flows in foreign currencies have been converted to U.S. dollars at an approximate weighted-average exchange rate for the respective reporting periods. The weighted-average exchange rate for the consolidated statements of operations and comprehensive loss was 6.43 and 6.75 Swedish Krona to one U.S. Dollar for the three months ended March 31, 2013 and 2012, respectively. The exchange rate for the consolidated balance sheets was 6.52 and 6.52  Swedish Krona to one U.S. Dollar as of March 31, 2013 and December 31, 2012, respectively.  The weighted-average exchange rate for the consolidated statement of operations and comprehensive loss was 92.19 Japanese Yen to one U.S. Dollar for the three months ended March 31, 2013. The exchange rate for the consolidated balance sheet was 94.16 Japanese Yen to one U.S. Dollar as of March 31, 2013.
XML 23 R32.htm IDEA: XBRL DOCUMENT v2.4.0.6
Stock-Based Compensation (Details 4) (USD $)
3 Months Ended
Mar. 31, 2013
Summary of outstanding warrants to purchase common stock  
Shares 4,074,542
August 2009 Employee Warrants [Member]
 
Summary of outstanding warrants to purchase common stock  
Issue Date Aug. 25, 2009
Exercise Price $ 0.50
Shares 80,000
Expiration Date Aug. 25, 2016
2007 Debt Extension Warrants [Member]
 
Summary of outstanding warrants to purchase common stock  
Issue Date Sep. 22, 2010
Exercise Price $ 1.00
Shares 16,000
Expiration Date Sep. 22, 2015
September 2010 Repricing Warrant [Member]
 
Summary of outstanding warrants to purchase common stock  
Issue Date Sep. 28, 2010
Exercise Price $ 1.38
Shares 4,000
Expiration Date Sep. 28, 2013
October 2010 Repricing Warrants [Member]
 
Summary of outstanding warrants to purchase common stock  
Issue Date Oct. 18, 2010
Exercise Price $ 1.38
Shares 2,078,433
Expiration Date Oct. 18, 2013
October 2010 Employee Warrants [Member]
 
Summary of outstanding warrants to purchase common stock  
Issue Date Oct. 15, 2010
Exercise Price $ 1.38
Shares 920,000
Expiration Date Oct. 15, 2013
December 2010 Employee Warrants [Member]
 
Summary of outstanding warrants to purchase common stock  
Issue Date Dec. 03, 2010
Exercise Price $ 1.63
Shares 200,000
Expiration Date Dec. 03, 2015
January 2011 Employee Warrant [Member]
 
Summary of outstanding warrants to purchase common stock  
Issue Date Jan. 21, 2011
Exercise Price $ 2.00
Shares 20,000
Expiration Date Jan. 21, 2014
February 2011 Legal Advisor Warrant [Member]
 
Summary of outstanding warrants to purchase common stock  
Issue Date Feb. 22, 2011
Exercise Price $ 2.50
Shares 80,000
Expiration Date Feb. 22, 2016
March 2011 Investor Warrants [Member]
 
Summary of outstanding warrants to purchase common stock  
Issue Date Mar. 09, 2011
Exercise Price $ 3.13
Shares 602,009
Expiration Date Mar. 09, 2016
March 2011 Investor Warrants One [Member]
 
Summary of outstanding warrants to purchase common stock  
Issue Date Apr. 07, 2011
Exercise Price $ 3.13
Shares 34,100
Expiration Date Apr. 07, 2016
May 2011 Consultant Warrant [Member]
 
Summary of outstanding warrants to purchase common stock  
Issue Date May 17, 2011
Exercise Price $ 4.05
Shares 20,000
Expiration Date May 17, 2014
September 2011 Employee Warrant [Member]
 
Summary of outstanding warrants to purchase common stock  
Issue Date Sep. 12, 2011
Exercise Price $ 3.90
Shares 20,000
Expiration Date Sep. 12, 2014
XML 24 R40.htm IDEA: XBRL DOCUMENT v2.4.0.6
Subsequent Events (Details) (USD $)
0 Months Ended 1 Months Ended 0 Months Ended
Mar. 31, 2013
May 03, 2013
Subsequent Event [Member]
Apr. 03, 2013
Subsequent Event [Member]
Apr. 04, 2013
Subsequent Event [Member]
Apr. 05, 2013
Subsequent Event [Member]
Apr. 16, 2013
Subsequent Event [Member]
sqft
Apr. 18, 2013
Subsequent Event [Member]
Apr. 01, 2013
Subsequent Event [Member]
Apr. 16, 2013
Subsequent Event [Member]
Month [Member]
Apr. 16, 2013
Subsequent Event [Member]
Annual [Member]
Subsequent Events (Textual)                    
Warrants exercised to purchase common stock               55,000    
Common stock shares received on warrants exercises               25,720    
Proceeds from exercise of warrants   $ 34,500   $ 40,000 $ 120,244          
Common stock issuable upon exercise of warrants 270,094 25,000 40,000   80,000   40,000      
Warrants, exercise price   $ 1.38 $ 1.00   $ 1.38          
Additional cash exercise price per share         $ 3,145          
Warrant exercised to purchase common stock one         3.13          
Area of leased space (in square feet)           2,853        
Lease payment including property tax (excluding VAT), net                 $ 14,000 $ 174,000
Lease expiration date           Apr. 15, 2014        
Common stock issued to related party using exercise provision             30,663      
XML 25 R2.htm IDEA: XBRL DOCUMENT v2.4.0.6
Condensed Consolidated Balance Sheets (USD $)
In Thousands, unless otherwise specified
Mar. 31, 2013
Dec. 31, 2012
Current assets:    
Cash $ 7,582 $ 9,097
Accounts receivable 812 2,123
Prepaid expenses and other current assets 731 550
Total current assets 9,125 11,770
Deposit 68 68
Property and equipment, net 328 330
Total assets 9,521 12,168
Current liabilities:    
Accounts payable 321 539
Accrued expenses 984 804
Deferred revenue 2,920 2,725
Total current liabilities 4,225 4,068
Total liabilities 4,225 4,068
Stockholders' equity:    
Common stock, 70,000,000 shares authorized with par value $0.001per share; 33,875,625 and 33,331,182 shares issued and outstanding at March 31, 2013 and December 31, 2012, respectively 34 33
Additional paid - in capital 147,429 146,677
Accumulated other comprehensive income 18 5
Accumulated deficit (142,185) (138,615)
Total stockholders' equity 5,296 8,100
Total liabilities and stockholders' equity 9,521 12,168
Series A Preferred Stock
   
Stockholders' equity:    
Preferred stock, value      
Series B Preferred Stock
   
Stockholders' equity:    
Preferred stock, value      
XML 26 R6.htm IDEA: XBRL DOCUMENT v2.4.0.6
Condensed Consolidated Statements of Cash Flows (Unaudited) (USD $)
In Thousands, unless otherwise specified
3 Months Ended
Mar. 31, 2013
Mar. 31, 2012
Cash flows from operating activities:    
Net loss $ (3,570) $ (1,588)
Adjustments to reconcile net loss to net cash (used in) provided by operating activities:    
Stock-based compensation expense 586 34
Depreciation and amortization 32 18
Changes in operating assets and liabilities:    
Accounts receivable 1,316 2,273
Prepaid expenses and other current assets (186) (26)
Accounts payable and accrued expenses (36) (199)
Deferred revenue 195 11
Net cash (used in) provided by operating activities (1,663) 523
Cash flows from investing activities:    
Purchase of property and equipment (28) (201)
Net cash used in investing activities (28) (201)
Cash flows from financing activities:    
Proceeds from stock option exercises 167   
Net cash provided by financing activities 167   
Effect of exchange rate changes on cash 9 45
Net decrease (increase) in cash (1,515) 367
Cash at beginning of period 9,097 12,940
Cash at end of period 7,582 13,307
Supplemental disclosure of cash flow information:    
Income taxes paid $ 11 $ 22
XML 27 R35.htm IDEA: XBRL DOCUMENT v2.4.0.6
Commitments and Contingencies (Details Textual) (USD $)
0 Months Ended 3 Months Ended 12 Months Ended 3 Months Ended 0 Months Ended 1 Months Ended 1 Months Ended 1 Months Ended 0 Months Ended
Jan. 24, 2010
Mar. 31, 2013
Mar. 31, 2012
Dec. 31, 2011
Vasakronan Fastigheter AB, Linnegatan 89 [Member]
Dec. 31, 2011
Vasakronan Fastigheter AB, Linnegatan 89 [Member]
Month [Member]
Mar. 31, 2013
Vasakronan Fastigheter AB, Linnegatan 89D [Member]
sqft
Mar. 31, 2013
Vasakronan Fastigheter AB, Linnegatan 89D [Member]
Month [Member]
Mar. 31, 2013
Vasakronan Fastigheter AB, Linnegatan 89D [Member]
Annual [Member]
Apr. 16, 2013
No Picnic [Member]
Apr. 30, 2012
No Picnic [Member]
Apr. 15, 2012
No Picnic [Member]
sqft
Apr. 30, 2012
No Picnic [Member]
Month [Member]
Apr. 30, 2012
No Picnic [Member]
Annual [Member]
Mar. 31, 2012
2350 Mission Investors LLC [Member]
Mar. 22, 2012
2350 Mission Investors LLC [Member]
sqft
Mar. 31, 2012
2350 Mission Investors LLC [Member]
Month [Member]
Mar. 31, 2012
2350 Mission Investors LLC [Member]
Annual [Member]
Oct. 12, 2012
Space Design Inc. [Member]
Oct. 12, 2012
Space Design Inc. [Member]
Month [Member]
Oct. 12, 2012
Space Design Inc. [Member]
Annual [Member]
Commitments and Contingencies (Textual)                                        
Non-recurring engineering development costs contributed to TI $ 500,000   $ 0                                  
Description of NRE cost contributed to TI   Neonode will contribute to TI the NRE as follows: For each of the first one million units: $0.08 per unit and For the next eight million units: $0.05 per unit.                                    
NRE cost contributed for each of first one milion unit, Per unit $ 0.08                                      
NRE cost contributed for next eight milion unit, Per unit $ 0.05                                      
Non recurring expense included in product research and development   217,600                                    
Area of leased space (in square feet)           2,723         2,853       3,185          
Initial lease payment (including property tax and excluding VAT)         6,000   8,000 93,000       14,000 174,000     7,007 86,000   3,000 36,000
Lease payment including property tax (excluding VAT), net                               7,657        
Operating lease notice period       3 months   9 months                            
Lease extended period if not terminated           3 years                            
Lease expiration date           Dec. 31, 2014       Apr. 15, 2013       Jul. 31, 2015       Oct. 12, 2014    
Operating leases period                           3 years       2 years    
Extended lease period under same terms and conditions                 Apr. 15, 2014                      
Rent expenses   $ 120,000 $ 103,000                                  
XML 28 R22.htm IDEA: XBRL DOCUMENT v2.4.0.6
Net Loss Per Share (Tables)
3 Months Ended
Mar. 31, 2013
Net Loss Per Share [Abstract]  
Basic and diluted for net loss per share
(in thousands, except per share amounts)
 
Three Months ended
March 31,
 
   
2013
   
2012
 
BASIC AND DILUTED
           
Weighted average number of common shares outstanding
    33,511       32,809  
Number of shares for computation of net loss per share
    33,511       32,809  
                 
Net loss
  $ (3,570 )   $ (1,588 )
                 
Net loss per share - basic and diluted
  $ (0.11 )   $ (0.05 )
XML 29 R36.htm IDEA: XBRL DOCUMENT v2.4.0.6
Segment Information (Details) (USD $)
In Thousands, unless otherwise specified
3 Months Ended
Mar. 31, 2013
Mar. 31, 2012
Summary of net revenues by geographic region    
Net revenues $ 548 $ 1,164
Revenues percentage, Total 100.00% 100.00%
U.S. [Member]
   
Summary of net revenues by geographic region    
Net revenues 292 974
Revenues percentage, Total 53.00% 84.00%
Europe [Member]
   
Summary of net revenues by geographic region    
Net revenues 18   
Revenues percentage, Total 43.00%   
Asia [Member]
   
Summary of net revenues by geographic region    
Net revenues $ 238 $ 190
Revenues percentage, Total 44.00% 16.00%
XML 30 R24.htm IDEA: XBRL DOCUMENT v2.4.0.6
Summary of Significant Accounting Policies (Details Textual)
3 Months Ended 12 Months Ended 3 Months Ended 12 Months Ended 3 Months Ended
Mar. 31, 2013
USD ($)
Customer
Mar. 31, 2012
USD ($)
Customer
Dec. 31, 2012
USD ($)
Customer
Mar. 31, 2012
Amazon [Member]
Mar. 31, 2013
KOBO Inc [Member]
Mar. 31, 2013
Sony Corporation [Member]
Mar. 31, 2012
Sony Corporation [Member]
Mar. 31, 2013
Barnes and Noble [Member]
Mar. 31, 2013
Netronix [Member]
Mar. 31, 2013
Minimum [Member]
Dec. 31, 2012
Minimum [Member]
Mar. 31, 2013
Maximum [Member]
Mar. 31, 2013
US [Member]
USD ($)
Mar. 31, 2013
Sweden [Member]
EUR (€)
Summary of Significant Accounting Policies (Textual)                            
Basic deposit coverage limits per owner and customer                         $ 250,000 € 100,000
Entity-Wide Revenue, Major Customer, Percentage       55.00% 44.00% 20.00% 16.00% 10.00% 21.00%          
Percentage of net revenues earned from major customers                     10.00%      
Days of reporting period stipulated in the contract                   30 days   45 days    
Excess of insurance limits 7,200,000                          
Impairment of long-lived assets 0                          
Gains or (losses) resulting from foreign currency transactions 37,000 62,000                        
Foreign currency translation gain (loss) 13,000 44,000                        
Accounts receivable due, Number of aggregate customers 12   15                      
Accounts receivable, Number of major customer 5   0                      
Revenue earned, Number of customers 9 10                        
Percentage of accounts receivable due by five major customers 72.00%                          
Advertising costs 124,000 197,000                        
Unrecognized tax benefits $ 0   $ 0                      
Weighted-average exchange rate for consolidated statements of operations (Swedish Krona to one U.S. Dollar) 6.43 6.75                        
Exchange rate for the consolidated balance sheets (Swedish Krona to one U.S. Dollar) 6.52   6.52                      
Weighted-average exchange rate for consolidated statements of operations (Japanese Yen to one U.S. Dollar) 92.19                          
Exchange rate for the consolidated balance sheets (Japanese Yen to one U.S. Dollar) 94.16                          
XML 31 Show.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.1.0.1 * */ var moreDialog = null; var Show = { Default:'raw', more:function( obj ){ var bClosed = false; if( moreDialog != null ) { try { bClosed = moreDialog.closed; } catch(e) { //Per article at http://support.microsoft.com/kb/244375 there is a problem with the WebBrowser control // that somtimes causes it to throw when checking the closed property on a child window that has been //closed. So if the exception occurs we assume the window is closed and move on from there. bClosed = true; } if( !bClosed ){ moreDialog.close(); } } obj = obj.parentNode.getElementsByTagName( 'pre' )[0]; var hasHtmlTag = false; var objHtml = ''; var raw = ''; //Check for raw HTML var nodes = obj.getElementsByTagName( '*' ); if( nodes.length ){ objHtml = obj.innerHTML; }else{ if( obj.innerText ){ raw = obj.innerText; }else{ raw = obj.textContent; } var matches = raw.match( /<\/?[a-zA-Z]{1}\w*[^>]*>/g ); if( matches && matches.length ){ objHtml = raw; //If there is an html node it will be 1st or 2nd, // but we can check a little further. var n = Math.min( 5, matches.length ); for( var i = 0; i < n; i++ ){ var el = matches[ i ].toString().toLowerCase(); if( el.indexOf( '= 0 ){ hasHtmlTag = true; break; } } } } if( objHtml.length ){ var html = ''; if( hasHtmlTag ){ html = objHtml; }else{ html = ''+ "\n"+''+ "\n"+' Report Preview Details'+ "\n"+' '+ "\n"+''+ "\n"+''+ objHtml + "\n"+''+ "\n"+''; } moreDialog = window.open("","More","width=700,height=650,status=0,resizable=yes,menubar=no,toolbar=no,scrollbars=yes"); moreDialog.document.write( html ); moreDialog.document.close(); if( !hasHtmlTag ){ moreDialog.document.body.style.margin = '0.5em'; } } else { //default view logic var lines = raw.split( "\n" ); var longest = 0; if( lines.length > 0 ){ for( var p = 0; p < lines.length; p++ ){ longest = Math.max( longest, lines[p].length ); } } //Decide on the default view this.Default = longest < 120 ? 'raw' : 'formatted'; //Build formatted view var text = raw.split( "\n\n" ) >= raw.split( "\r\n\r\n" ) ? raw.split( "\n\n" ) : raw.split( "\r\n\r\n" ) ; var formatted = ''; if( text.length > 0 ){ if( text.length == 1 ){ text = raw.split( "\n" ) >= raw.split( "\r\n" ) ? raw.split( "\n" ) : raw.split( "\r\n" ) ; formatted = "

"+ text.join( "

\n" ) +"

"; }else{ for( var p = 0; p < text.length; p++ ){ formatted += "

" + text[p] + "

\n"; } } }else{ formatted = '

' + raw + '

'; } html = ''+ "\n"+''+ "\n"+' Report Preview Details'+ "\n"+' '+ "\n"+''+ "\n"+''+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+'
'+ "\n"+' formatted: '+ ( this.Default == 'raw' ? 'as Filed' : 'with Text Wrapped' ) +''+ "\n"+'
'+ "\n"+' '+ "\n"+'
'+ "\n"+' '+ "\n"+'
'+ "\n"+''+ "\n"+''; moreDialog = window.open("","More","width=700,height=650,status=0,resizable=yes,menubar=no,toolbar=no,scrollbars=yes"); moreDialog.document.write(html); moreDialog.document.close(); this.toggle( moreDialog ); } moreDialog.document.title = 'Report Preview Details'; }, toggle:function( win, domLink ){ var domId = this.Default; var doc = win.document; var domEl = doc.getElementById( domId ); domEl.style.display = 'block'; this.Default = domId == 'raw' ? 'formatted' : 'raw'; if( domLink ){ domLink.innerHTML = this.Default == 'raw' ? 'with Text Wrapped' : 'as Filed'; } var domElOpposite = doc.getElementById( this.Default ); domElOpposite.style.display = 'none'; }, LastAR : null, showAR : function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }, toggleNext : function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }, hideAR : function(){ Show.LastAR.style.display = 'none'; } }
XML 32 R7.htm IDEA: XBRL DOCUMENT v2.4.0.6
Interim Period Reporting
3 Months Ended
Mar. 31, 2013
Interim Period Reporting [Abstract]  
Interim Period Reporting
1.   Interim Period Reporting
 
The accompanying unaudited interim condensed consolidated financial statements, include all adjustments, consisting of normal recurring adjustments that are, in the opinion of management, necessary for a fair presentation of the financial position and results of operations and cash flows for the interim periods presented. The results of operations for the three months ended March 31, 2013 are not necessarily indicative of expected results for the full 2013 fiscal year.
 
The accompanying condensed consolidated financial statements as of March 31, 2013 and for the three months ended March 31, 2013 and 2012 have been prepared by us, pursuant to the rules and regulations of the Securities and Exchange Commission (SEC). Certain information and footnote disclosures normally contained in financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted.  These condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto contained in our Annual Report on Form 10-K for the fiscal year ended December 31, 2012.
 
Operations
 
Neonode Inc. (“we”, “us”, “our”, the “Company”), develops and licenses MultiSensing™ touch user interfaces and optical multi-touch solutions. The cornerstone of our interface solutions is zForce®, our patented touch technology. Neonode licenses its MultiSensing touch technology to Original Equipment Manufacturers (“OEMs”) and Original Design Manufacturers (“ODMs”) who embed Neonode technology into devices that they produce and sell.
XML 33 R3.htm IDEA: XBRL DOCUMENT v2.4.0.6
Condensed Consolidated Balance Sheets (Parenthetical) (USD $)
Mar. 31, 2013
Dec. 31, 2012
Common stock, shares authorized 70,000,000 70,000,000
Common stock, par value $ 0.001 $ 0.001
Common stock, shares issued 33,875,625 33,331,182
Common stock, shares outstanding 33,875,625 33,331,182
Series A Preferred Stock
   
Preferred stock, shares authorized 444,541 444,541
Preferred stock, par value $ 0.001 $ 0.001
Preferred stock, shares issued 0 83
Preferred stock, shares outstanding 0 83
Preferred stock, liquidation preference $ 0.001 $ 0.001
Series B Preferred Stock
   
Preferred stock, shares authorized 54,425 54,425
Preferred stock, par value $ 0.001 $ 0.001
Preferred stock, shares issued 83 95
Preferred stock, shares outstanding 83 95
Preferred stock, liquidation preference $ 0.001 $ 0.001
XML 34 R17.htm IDEA: XBRL DOCUMENT v2.4.0.6
Summary of Significant Accounting Policies (Tables)
3 Months Ended
Mar. 31, 2013
Summary Of Significant Accounting Policies [Abstract]  
Estimated useful lives of property and equipment
 
 
Estimated useful lives
Computer equipment
3 years
Furniture and fixtures
5 years
ZIP 35 0001213900-13-002263-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001213900-13-002263-xbrl.zip M4$L#!!0````(`"Y"J$)739#\T:D``*;E"0`2`!P`;F5O;F0M,C`Q,S`S,S$N M>&UL550)``-70HI15T**475X"P`!!"4.```$.0$``.Q=Z9.C1I;_[@C_#XPV MPO/%*G'H[NJ:4%T]97<=4ZKV$;L;%5F0DG(:)7("U5)/Q/[MFPE(`@0")$`@ MX7#8)2#S7;_W\N7!X_P?\ZG*O4.B(PU_K`EG?(V#6-84A,;NO=&O>/ MBQ]_./];OKV&==?SN(Z"'J:="XT_ M[C\/Y0F<@CK"N@&P3/GRL(6VB+)NLFZ#=*TI"IUMK>PGW(T4."-09I8-;==K M`"(3386-$9"-.IS/5("!H9'%+?WM[DS63&R0A5>;.I3/QMI[P[G)S";6>:%. M#>=N:A)"X1?6UKD;TEB!*+@=O1'2!,[E27`;=B>D$<+O4#>"F]GW0AIB@&0] MN)UUBS43-IOI2`YN1&^$-3%F)*0-O1/2R-3K8P!FJW8CH+]9UG=NA$@U5[=@ M[8_//E\P#;(%8O0N@S\+$LR)^KKE&L]PQ%E.U7<@N-WU&C.BS2`Q$-1=SFYW M8"QFM+6.IC-U=6U"X.ACS8HR]64T.9OK2HUK+*/5E88-.#>X(90-%NB<0&:' M*MFYB:CS.`^^7IFZH4U?Q6;]%X!9KWQMW0!B`QF+]6^DL"LC!`EG">R5;VFY MJ[M?:Q<\^Z?;X5O\>9(?_T= M$`*P<0^G;Y#DHU)'(W`\I5>7%Q1*DD9`)".'%TY!]+X]BCK^TO>P7KM87O;( M<-X([,ZE-Q?EF-:UAP5C:2KFM"[;KN_N9RH'XI6M]K+5AB=:(3:))_K,FZXG M2L+*NH4*8)L0EX3T(6[K@'8^A#.F`^'UB28]#V!J`_R%CASP3PC(T-#DKT\F MD2=TJ'$@HY<#]VZ!:A?6(-B/(U?F<8LF*#UJU\SB5F75G*SJBW"679-$N`T@ MI!7A;O^\<<4WB@)@Y8PO&GN`T$F-"=0!T\X8,I$MUAP9Z\)?`ODTUGK2;WM+=)!:.W M-7-;>;&[#]+DDK1+H2>%5W_>)A0W;]O000$*A<:=,9 MQ1!@LW@79G]'QN0.*^@=*13,-W-9-=D*Z'`""+16*AVDZ0.L/&FZ0:"!B-7R M$F(X0H9^N7A!A@H?1^MN;+^VH/8XNM3H_.)Q=$V;R89&2I)''$IM*R?>JKW, MQRT#5""^6EON!FJ2%)<-O06[K!3137CAUG.+Y'.H/UG;4V2]'S M697+X7X)1MI0&?-Q$C&#B9IT;V5>)?&09,._I;0LAG^?TEX'5!`%J::!WN$0 MRB9!#%%VJ(;*+=&F++:;AA7:'T) M.TKSG>WOO*GPB3@9BK6H42%QA<0('9TT-N_!OS5BIV"0.)!R?CUB6`X0;:SI;=G^%,(\9GA.U##\]0AX#(DP$5 M`+Y#59LQ5=[,69?.\%'FTUU9ZV^-VQB*W&??LV#'U4[88X9056E8HW:F-+]" M@_Y=N4MB=XG28N4KQ^`K]GM#*K7R0)DBC'2#`#;X5PZ3V&%BJ;+RFCSF!.6% M:V7;"-M6!X+S.Q!<'!2LCLX5\LC!YJ&++([..2>3/,Y0';')_XA-*D>PLG"2 MM`%R2L>A=T%0)!]%.PI]:E`=8$P[J;":#E;=VCPIL#IGUEOUP2P!5A^T)R1C M='R#K5>P+)#@SZ>:=:&573[%5W;-R:Z;'MY,ZN'-NL1G-QSM!8532I=B8Z6, M.=+Q@_)($Z,\49E_-E0L6%("C[(1'Y;#&9#A-=31F":NQS=X!HF7"RQ8B8U$ ML+!JAM2@0]1:T*-8>Q_Y;0[E4`1%? MGQF(G=5"C*;FM!P>N6)[O>GKX;^8VWTYV;3:T#\>V_JKH!0KS/F6'C.M@N)& M^.K%@"L5Z/KCR-KX=TXSLA/_@S*^3ALJE/N48:AT.:PL%\:\ET=MWD#ICLF\ MRV(\S_`=8A.Z,NG5H$55,'-*[K#W,&Y-PR3P,Y+9T M$P/!\I$;/$884KIX['H5X1AA$%?BL@-!;-=OX9M5I/QP%X]/&/FNA%7QW M7L9?G1R4?*M#KM>32Y)-A2P1;0J2CZ&ENL`G,K3D63U/^=1=K[)S)OD&-5HO MNWS#Y9W5RM:!`K9$]9_0C\7LCGHG@42Y\X<"C^$E@$1**6BYHTJ14]`JHN4` MWW)'P"+#MXJ^WC>JI4)MOVXJ+=FNM93/:^A25;S[J(MWGR;NKJKBW24HWEU< M;!YW3E[@O+BD>"AWDEO@1+.@>*A.R13HE$QI4%.=YSX^FU:??CAI6_^JO97> MR&L93MJZ3T2C'1D+5L7.&&"%+?U91_LN%ZM!W9YV0;*Z5P[;QQ#-LZ@9)&.% MC0ALW)IT%LZ2'GK_%LW97R5)\A+!(US,DT:(*[<#\W+G=F[^3]JFSKS86;)] M),]H/+%?I1Z88SJ2TJSH9:*9.L#*`\)P696Y7$5;0X5CC0[22!KA9:0[$0."-!'"IZ03XE'`IA$TE:("43,+7PC@4K\#,=`'2CO2-?(<<$FN<@5=@*Q<\^^ M<[BAQ67!^",;G9((6^%E#[R4YAO=*4$FS\]SEQ,UFY&:]J*;*GN7\+B&I@2R M5FB)O8)WS#EP0GE/&C55?"M-PI&@ MG'*4J!56]L3**56/WP-,D>P4K9+\*:+V2$O*'Q:V.9>7+RYN`T[F7@*"(2NB M]Z"]J249?,//Z`9)<](6KTJ4PF*5*"T-@LPZ[HEKD&\'/#*I5+)AE9.&G]#:FS%9/7? ME[LO0TC>D0S7)>0]I>=559,=]3]#61MC]!TJ3Q8K5YK.RLD_PYE&C,]TRF"! M\!GJD.TJT]FF:_9P,V==+M=X2KS-D;7^UKB-HJ?9NB>,P0JBH-:]3. ME.97:-"_*W=)["Y16JQ\Y1A\Y1/$D-`4%"L#98HPT@T"V.!?.4QBAXFERLIK M#K/_\``-HF$T+P=HPW<>O'*(0-G0C@H$L62KT)`4#66M_Y812F+3K^K/98G$,E6K*2(2 MJVHY.V1'1Q8*=\R:J@AX2-P=0>`[!.ZJ>!>$._L[,7=89N*]P^.,=*%"5C&N M<%@K>W3+'6M57$N$M5/!U(G9^V5"(/P3`CNG>#*)/`%ZR8H`!9D^CEPGA0+[ MF\1%_7C:YB=^W3I(ZQ._&SIXM>LF>$_#/<,QVZ8K]M%A9#'>W\Y_UL>'#V6U MZFM-N7R=IZCFK3Z^5&KS5M]2*M"WE`X%@JK4>@%*K1?/^%7E]",V;E4(/==" MZ,4#0%77/,>ZYB4Q_Y&.[` M%*H2WSF6^"ZK^4M3KJ,,%;N+"(*J`'=.!;B+9_RJGO;))(15">6#EU`NZ-F* MX4U1[9KP;,7PYIBL5M79#-B?/62=S4,!H<05&0Y5OJ`8IJHJG!;0:':IA5=> MJ`]FRV-.YIMNU?@V;M[=X=5WO1PF#!'&9RBZH5_8LAT>WLO)HH5TA('>/%MJ9>;3;GG'6I!^T)R1C))?#J`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`JA4-8"*6^N)W`LN%C/.`,YIT`93:DG?:SQM0NIR7=Y MH25YE+"%*N-O]585T"=;N'`EE2XNV.#O8J%.M=/C>QT:.,X;[HZ3$5JI>BNA M3JLK;B5$[<1>&=&?H0S1.WA3X0,T'$RD(:DHB)*'@6T$TV$LGF:Z@K@37U99 M/*0XGS<<8.71F$`RT'5HZ"GJK=7B/>S%()LJES'A)0G[<)FZU@2AT_'J+0W: M\731$\16/-)/1*/IN[%@"9Q!E<1*@ELO[5#$I:$%2?)C)YQ>.GS%TY`D=G?B MRU9D*O@0A78WP$A)J<5$1$L4HH@Y4><)+%C(23.`2+W`^.:EM"\O<0TO).>% MF%#YC,`;4A$[1Y2B:KI\T\].,+$4.(J)E.X.'/E>%4QST.[X0EDPJ;282;'Z M;KA8+9:+\'S!Q(K]VNI6P=JYR!4/RF)/S).9W+##YZKC_+#32RQ7-D&YR?M& MYNW!+YLXW!1]@2\V$UFK8">R^POMFU.X:L#_!E0S>+EF,Q#N]FT$']-S'?4Q M4C_6##HTUAKY[[A1";6^&XJE%:'::8B\Q0[)L M3DV5+2U:RPM4FS,")VQ7]!W>85F;PL^:KM]J!*(QML.VO'BA`ZA.&[%2*P#R5"9<_@T^;R8/J(*9!NWDJX1D:@&8^R@T@F"8_NHL*T;33E-/N/IOBXT1:&[#Y^N<7^`[>`]T50%$MW^:%TV*S!1 M5-/C<,=5FR0,>H<^>R]A8!H3C:#O4(FE0#YJ`V-C*K*=:,KL"5'L"0=E;_]D M,U"H9K/9:@J%E2DJY0J4J=5LBJV\14HMORV0F5++C+,TTQ,@C\1B4+%RSB=( MK,;Y3>%<9Y9<$K)#%&<\'VJT,+X/)FF,Z4VQ)4USBGDDDA;(IK9'W^FZ>=@1 MKRMMCSDVA[G*L5/X[$7$SO3DR'9HBTBH#B#&3N9(!U;Q#@4=W$="3A'E(U$F MWI*%1`?UFX,*E(D'Q9+H,Z)35\5:8[%O0"P7/A4,9/HP,F:6,&0OX^'3OP+) M>#@[;APY37N9J-OL^E=BMM!,D[7():(.?R#.Q.)Q%K`HF1EG^\V,=W.+&.13 MY39XD3=[;I//=R(/JM-_!*$K;K'X9K:\$T=Q,2A)W4ZK[5Z-VH6CQ*EN"HH* M.\^_,V\IJBR$-^<`3IRW.B)/1;>;OFTAN^M=R:V'U?57*(!J#:M?AA&[*YW< M6'%>07-?_T0TYL+(_KK9NFA>!\YAH$Z5HUJ\TW7@<.7?VCV5BL^=+@ES= M[T,WZF1#.QY9JCY=?R+:*&13/Y&P/=^Q`U?GN].,\FE)C$/S&>J0?4-P@!77 MH5/GQ9_])6]W.SYD;2&7)E^1,)#\XU=,QH905>D(3Y^CE+Y"]JIE:MKJ]+Q. M$4XK-8ZBWJ[C6SMP]`EB2&BLPLI`F2)LO:IMH'>8FJ)Z/9]#;2>8+F^1T&J) MNS+W.&.OVJZ5FD+2*#:[WF,P&S3V92#J6#+?2\"`ZS09T::,(,(F?=9II&'] M$HXTXIPZ>P%SJ-\C3&?+QN*.,D?3)(C^\756M0!-ZG5ZA5':[0[!XB7U%%3&>]%,4"\#3KIL!(5C82DK"S/&"[7 M22Z!CF0V+"+5-$)6(+9J)WC-1J1`X,]XUX0Z@G"Z/,9:5[)Y%(2=>/P=LD^U M0F7P3D$\A@\FR\,?1U8SUU+!?NH-7JL0NWQOS?-NC.0B2HQEEY9;_?N+DO3\ M,K!JV="^DI^Y3A0RFMYT-!LV"Z&(J(`EY:R(I1]#A9&A-*PV^UO4-\$()I,* M(U$SP6X[(2?7D*I;1M9U^K<*'9T.IJRVS/>4%.1;+XE#-`,F(U]YWXM)"E8" MJ:JOH?W_.[Q9GR2%/%04.Y)_G(^DFP&?D:\V2,)&OKPGG]Y2)2GD;E$,>@FF MS%SD>SEI1\N_*37Y"14YDHJR1DDR^=[G3V$F* M8-Q',6WVHF#N6]Y)Q!\K]P3TR1/16"5*Y7+QA8YTU!3+584X)URU<4 M*S[MS#B.#,'M=AH\.U^YT%^T@4QGV@2&%@%*(23SONI4L6EGQG%4\8QN"@R' M&,9>S$@9R'6_CN,3SXSE*"3[E+P;Q_1Q&4+%6C)R"F/?S"&14=C:Y][?90T5 MBKWWM%'P*Y2Y5(38^5.4VX001%YL-G.48N=Z_=NDD)JM74P1@L);A`&6]W;: M+0<94B4-Z`;0]BWBC$93I?/QF+D]849QG8,!'S#JB$9']CT7%=Z"F MLU;?]*8428AGR'34.\RI\!S\A%V4UI]:I;#NT=XLB1J7>H9<1^9%+=\F?;I\ M#ZB'$+*@SA"_%HH0X85BSS=>Q"*=,J\Q)QR2Q,>!1;:\!I^`C574]T!JW:4L M<")675MJK%!+=GM?=O_[D=YQKVM-VJYI;^T9HJGMRJN"V2^4WJ6JR5]C,7+Q MDVI\4-`[!U0TQA]K*AP9-4XW%BJDHS-M44>8?1:DS_$SXP.G('VF@D6?>V,4 M/G!30,8(UUDKYPGG"F$;''VN+K7IQ=I/8^,#(S2B7"P[7W6%L(HP_,"QF_41 MF"*57C30E([P&'[C:*("L'-71]]AGQ,L0M:%;]"F\Z:IBDU&./L)3&,/2\W$54864MI]K@5*QJUETS[' M=@W0:/&!\XA@628_&3+H\V4".2!3YY@!S(("=2I@*HAMV2''W-0%%+:`:'FE MKJGL%1CZ8V1G=$"E[#B'$_6?:2-9-17:IZIR8+770F^PMLB:?'':B,,:H;[* M$2B;A!4Y=#_+&1-@<(!`UAO]`3EMAC!;P:<-J23`KIGX,Y5-AKH.R(**1CC` MC0`BW(Q`G=ZUE_QI`]9^S>I,TZU25-S_M_>OS6WCR`(P_#U5^0]\2JID M15=?DIVI`AH:QY#8X+UN`CD/ M&S0-Q&'V6/+E<.0S9HQA`T:!P0"=`^-WC#`SNNV&@3($EPM(">,UP1;"E`/; MHO`@')8]3T#C8PG8:89`V6,$PBBMGM!B);@SC@:3QMC9$)M'#/F(OD-P&:&1CW4R,"]II$?A"! M(6J$'@WJ1PX+!)4_1(Z@1\$/M\AVW/[#)Z0-86`:@QU@(RKC[>W5Q;NF<<%\ MK#8%R!LBQ\:L,_2\$,B5X198CH=]8`+!U`ZOV$0UJI"!,Y$2@P\/(&;]@8D) M@$]V.*+/D4N28@*RP;(GN)0''CD'H\/O;,(%%*WF#Y?$%85(TQ+/Q\"CEJE@ M*]DOP+DWMD/DVZPS#G::6Q"YMS<8>9$#VX`BP"28X)W_1B[O>T,+0B"E4,U! M+X!>1"W*0>8SV,\4.KW(-WCK8'$`&S#-9\`\T.O1OQ*AD(@"05.@\)*G(UFL MH*].<^='X@M(B/;I2CCX(XL`F9$C7##@WR!*0IC:4D8O5OU*0MT*UZQ68%>1=`XPGBG/GTL?A9;0#XW?0,^Q;#+4!)9\_WSOM`*-Y$1Q/ M4LYWL.T:4@TQ@NPP_0BYM[!X_(& MJ`8$L6,DESZ_FVX$\&!-<3](;\JXM_1JN,1+ED`-+WL]1`#KP`'>/%P:VR+":T8]G(*IZ(WB`!9.'7`'"=#?B^6&?+3/][G,H!304FP M-GL(^^N&Y_$9_HR$$#*7LDI%L MDR'W:1U:*?Q\.833^UNBL\)N7,3Z'DBU(O6LW>]!80?]WG3'BISV_!3,-#'N M38<,H6#$6&B`P)=:NS0&.R3UP\4C*)9$RA4]HRMP^,<`E:`?1?6`/;!1>\@2\DR<@ M&JCGGU('Z->[\T_J`9HI4\\=L*@4,4CZA3#?9\!,XH0#Q5YDCDW-;-%*W$)> M:F+/0EG\H22"JBJ87$=L9#B0RB$SNEG\*IW&ZTN16'J`J&@8*!P:L1@1;J!@ MWJKZ>GZ=-G_D*[^9("(RGO_M7_^:>>'JYFM:3LV_='<]9RC(>?ZXGI-K?UR7 M6+`=E!91$K%4#T$H*3ZYMP%J#.`C?!&S3Y91PKP=,SMDT4#@83[`F#/\0;NG? M3#="C8:$+[P"OX`(]")Z/X&"O,,/CG=/5V'XB(TLRJS0]US;0BD;P:,>70$A MR"-XSS`G$\]?M("5OTBX?O+1R3;S@"`BN`"^H8CFM^#$<.`C(&<.<(>TLANG`8S02 M"BE`-.$B6;MT>P!^[ZZY[#R_-IZ8SQ*ZX&OBRS-,.'3@QR$VUB8__X/IRLP? M&ANAPW4(K,&<#;Q*HTH/@A[B6@_&@V/\('`M1R8WYFN\L"711H7 M)AM7>W4XI.4S[Z]@.6.\::J6,5]^-]K\[K\QYE03U('YW6%\P9]YB<:OX9`3 ML8-,L=>*/J.X?3S$?N!H3%($\;<9!-%XPO4N'LA`D9H-@WMO#=2XY^,2U!`* MNKXE1RR*C'&L_)J\B3'WT,?90@WE"A:?0N\K0(5"+/N%6+'.FL,7:3OX#!,E M.9K&N15&=$3QP`.+;CP'-BS,-X:PQ^)(C!'13#DA$_P(/1]$:13&$0^HD?+C M"8-$'#P!;(*5O)FQ4NO'.8`HMBT/58?D,3RKCQP;Y2I?-4?CH^E$XM+:`3.% M#DV?.?(XQ&-J(+*'C-!\5C%&^X,!)8\4H$=V41(@\L3#OO&:@DHQHOD38/F_ MHWN3FU=)-FVAUZLEB;^HKOR^\(`(W#"1'Q@?:7P2!O1W._A1,-AO"CX""`MVEH2LX!&PP2.Y17H"L.HK$Y!2&-J2C<44)BG.O5*>G,Q5,+E\[YE. M,=`4?CII=@R@)`=QA1;;,UF:*<3SE3-"_AHAU+VF;,>BY'O10]@CJ"0DW(#U&Z; M/5&`2LHL&-DPGS_ED1ZA`@PYBR0T3>-/C!3D4@IL&U@52&G06>]IX1:'AV=P M"ZV?:[&9II.P36)Y^C1B+DA2=(39+H5O^\;8`^V?(F%QB9:Z8`"&B9A3'V0E MXRHX$]I[VTV,/M,"Q`2T MZ98N'.!L.B8#!.'.49Q:,3N#1#CSYH$8=><.A>JM$U&HZ@1!G22^U`!1T`WFJQ2(5G<)JKL%TP8WA7.S!SBU9;:3* M&")>$X*'Y\NPQ&IAOX2*10JM+([V3.L5EA=0;E$H#`797!NMB;C>%W?U*86^ MFL;ELI\-WN-D/*%BB%$@A09>/^'"CW!-<"Y@A5(A=J()BH-82X$#!YD8?5SQ M&2W=5:C1(,\''UXH8!P]*LQ7_`DA278QU9,]"$QPG@W`&$ M82D&^CPQ!P/Q69G15_X>H#I(D(7>Y(U!`/SRIG/\\XOD%X:#W*#MV8@HOR>& M+W>`AS,QT@=0HP;,IZ%2]S%I#EG+[%;WYWV*CGSC_@$.9\__Y/- MEEM9S,;-,6"5XJZG%+_1G_WF+#]#YLM@_]0CGE/2E&&[E\#TU93[*Q)A&8IEPGQK/? ML,P)VE^@#YF4Y!5(55LZB]):-5Y0@,HL?009*O60I31J0\:R8NR7^('F$G-W](`S MEQQ"O"#`Q+1]/B3PE?_`@R%$N`=W/&)9CLP8X5I%(+W$I4Y974Y?D@B:3^5AU!\XQ.1IA?G4RB"(0@\%"4RL"FK8(;/ M'/:(D59*B-L#=JJ&)^B28N;8Q:.ZA)-I(,K;!?)T5$_/ MY#!$)[3[^A4\Q%.BG6DR,_GB,6B!Y(N0/?PV3L$./W#CB;/S(&;]U33T/7-L M.)MYW0R$R?5F!L;KIKE0,>W5WI.($3TZ#-FDPU#Z>COY7A\A>,H@P' MO$P%<>=,FX*I$JUR-N9!Y4<4H3Q>%P4E6E4RYP'O,3Q7B%15\5V4+;ARXF$F M8F3Z6@H4V$,1L\UUY50;Q5B)%0IRGJ)=BY(?>9PO;4?W)-F.XTYAV[';RYH7 M$O(;*]5KGF\O?9C-QQ'S*!CF& M<&TU0Y(/K21,^OSL5Q-D*-3Y*D+7"(^F#&RS:5PDZ8T9JVRW?N8!9'Y<_2D% M_WIRU6/F]_+:[W=KDNGN=^^Z4/S_EZ,]@-^*4CX8`[KB;*_R?OU0`9RGH M/#L^.=M(;L]N23%_;7I/K/Z=MYA=_LCM7NYTU3^RE&GI0E<$WAM"/PKHZ((SW$9 MSW;[H]%I:QK7-%X;&O^$IDC`*1S_,[YZ2'@JQ;=W*=5UX$4^@W>^(&'*YAW: MPY`JKB=&KRLJ_6:9@V0'XI41V86KK-_YA(3-#>#.G`$O]*4K2F[&!.V?;PO9:<*]68J7`]<=D+_SBSOP;6K M5P>\`KCG$6S4]0&U)X'RM36B:@>-U,/ZV,68E";MX]V;K&\6Q]I0\ M:$T4@Q1M\"@]&TN@Q7'`:HFZW"7E MYV394M&[A+=_XCCZRZ9_C`@SSX,+'QQ7/T*.KB^EO3^(S+ MX;'[(K0O&5O$`]*H\3",0D0<$2#IR17#2A)F\[VIZ5!!NXDY)46-VT'2?!I@ M5(A]3[64<*D4^QJ$"**P/%(0`FNF@H:M++!4A$!+UZ4A(GS(@Y4>(0C M$<&1I.TGYPP:AU@;":N[&AQ?TV39:#W&2.*MT>)U"WAG>@51'8FLB@08V90J M^"K01%7R'E2"'WA4>D!`GRHN2T5%J.$AKT+!)Y)A\R(/0Z&L9+ZX!@4,]C^6 M!8A$#A8S^6"\;;^C.A,)DYJ&PQZ(PN^QZR*2?P*ZJ!^95/209"Y'1]CB.3\: M;SOOTA5`$BP'"I8YA\OM@->Z,Z^)DC*\P`BCP#?[F6^4K/H05S(:HJ]`+?^( MO5XH@T$MW^N*0A;(-A_IO;>]=VKY"1OYS@P\''A*M2PQ#6#&%\)+R"!?1GP- M?V/G05Y<4N6KY<0U-LQA*'-RL##N4*E*254Z>9M9.+S1-FNE8OOZAD#.E$HL##R77[,!'%)3@\K M>XKJRHE#[(["JI-:\JXG7@_BHD8SX2G54K^JHN=>N3`[8^0GO&4^EN::K M@\WVE3.""A%V=0/1E>PS1JR*@-E`;+G4BQ*Y3+F/0Q"5/``9)!WH&%B$BSY2 M&J2HSB5/REEU.&#)\%3W"Q4/6:PXUJX499*J8K*0'ZD,%5C49*B`/"/!B^6( M9D]2]9!K8%%&+(+$V\8J+:+-..\35H*J(ZH$0O+S,Q97GX"+PBD)$:=$-SOX MP8L#4\G[((C36N+I^:G[Q&.:'49I-LF2DP))7).6I=$2*'KO9DIO2HS"/-S] MC^6GJ&H]GI`.&]"U0^8Y+@[D_CLEEV6`!<;P#3A4[WFU+-2B<%#9=E;6T!*G MN`K/0+5TDFIQ=QP'P`K4T0`'I"N:Y%HBC-O@VK*#""\918(?RQH'0ULD]%`! MY936F:`A,WGGG_+0GE';XMK3@3BY$_*/=UE1!F)[(MZ/N,B.V$B>ELF+>@L# M8'DYK2*%2X[39"^>LX*%W!X=9Y>R,K=PYU1+FRCAX?*91`$\>A1Z1W&1.EGG MEM^V,NK-?22K67+Q044>%?4_SA`4V8,Q>V)%0?Z58LK'EYL*S_TIY89J1@VY MFR"T'10,I&B.,;?'<AZ(\4IRPA:T=D)^#@9+J M39FB^PO[82`Z8O!,>#SJT`7T9/KD#D+=/9Q2FQ,_$OVNDC+:U$%)]EEJ).6W MYWLQD9.##\I_?L!V3)3!WQ!%CN+;H%%\*1>D^C+%R>)Q:3!QXT#ZN5P?W8B( M&O\@).0U;;SLV=7&D#6,*(C(KT40<*$AIHCK"R=56>#=(:."?\4*CQ*2U,%X MJ8.C;?VNZ1M'7H>>4RSVA(5)U':7DH3.CY`J9`:&,,#SQ?W MB]8(?8?P\:V=.?RBUU/FN#JE'<1F<].X3K=-6(KK9!;1,6Y>S&2^CRT$@9!L M9YI(FD$B2-3*@8KK/@Y[X#LX/]>B%G*B_`E(#N$J]]F1V/^!VJN/XS>&1PDF ME_('(3MLY:200W&V)\K"C4L*DCQZSB-=;62T$12.=+7%B'(RK.Y"F!24_^28 M`,BM-?*PZ01_&(D5PXXQPH(YA[W[>U1-KWD%H3OS65>O*D(-352Z5,_.V=:F MHEY=?/11,YFDTAV^@B(9Q#JC)D,8]Q>RL8A/2L(;U(I#<\4VLSLG^32Z"(K@ M<8""BV4YJ1")(5%L9\M2X5_4*9P?!_\%^1V`R(_;`<97BKQ,$<.N$P(5R00+ M^[[ZJ6XQ2I<)WLJ5H^.>A4^X_'0C*J4,EIN:ZYZ7!%S4G59()N::M`>$GIDU MRXW",LO)&GD$7P*6]`!8PA&&[G4_$*J0:`,F+Q^S6KK:"M:5SCOXA.Q\%,0G MJ17*$E#W&*274`[=M?+5-XU_SS>7E75:L3XCGLQ4TXNW*LL""J_8T?XAS[XW M@:,$VS^IJ[&#)&@K;0\IOA.ZM77L'XQL#1,C%E.F!F4^*L>D/9;9JD"DR- MN^((A)DN9@O""#CUL86]D84TY$MJD'$_P$TBX2"B*^;?$_/`RJF(J)0@8C`9 MZ8<.MC@B@N@?0Q_&YD#P.1G?`9403"KT<9'J8\WE0,29,D*B,,IM=P8>WNVZ M84R<*$@/,C%MN@U,`HI%@($H)RCJ^&E>V?XPY]%$(N)S![6F@@`?XC\?PO'"51R&EGE``RGR]V7E8&A33/Z;G M;8?GQDCP*-0G-3RZOAY-1[CI@\+`1JDU\3#ZT*:;MNPI5ZWN;I=S4]:.+7=* M3NW.;Z[P?@)$J^[Q*5UJP+T[JR%HQ)%"W$Q*%#5X[XAOWB-+..GM+6/&5QC6 M.'UWV!K*'B7H1:K4L7#XO$69^NZ@MZ"H,C3SI:2E;D<.GE7%M,D9006G,S6J M.U+MJ7@U#I\$<2\;::83RY+*V,32(Z"55"/FY#Y!>I6RBE*G"I.3[;>JSK;P M2APTV>V3\[%AQF4MFY!0Z155%T,7H0&[@ M4L.#@6AX(%IY)_%^J_H-2&=%$OTWETL9+%":L@?*7R4_0TRCX^:XV>/JSW'S MI#_3\`&3EURF]GC(7;EK<7N#NU&NMRSHJ5T.=WS\T&:"XX MF;;:I?R;=-9IML_F>F]LO#>;;0*'I-=L'Z^$)+,.^B9!KO]X'P5'#Z8Y^7"; MI$B?QRZH;QYFR++@#@38)Q14O[Y^]8_XC>1H#Z[H/$?-^](.+,!KY+/X));L`X1U.LHWHGZ[1J?V;T?8?9CYTQ*+C5A:&AC.J-I7%`8+!9NH`"%"P_. M.5Y-(,[VO,7F82$.!0_3XY M,(5Q3RZ+T]XIQ;UC('QB]%]PN_HV-OH[&0]]\^7-`'\.Y,U)*\]@[=6#H20D MGTF,#F$UR!N*I[B1*486671%)&[H8A3'.;>X_O812-*C3E]>?AJPR[9(X+QG MECE6,"E#N5`@T;#WLB<)`,*E9Z=/N]H^;)NA(%[YW9P:[2PNN6!13F0 MVYCVX'$S\.OY[>7Y_T\0&&S/#Q;*!%?Q9C`=@R`TOE[=?*W8AJTN)_#2#>ND M+R?F\6HAN(0<<;E&&Y>&C&,SQ-%NO.6N4HJ6BWSCXO/-.U`IF6_9`5.BWC`< M6Y8(Z*#-3N=4 M$\6NSU<4&>UC><3^YHUR+?9&"C\N5A&?*$5LQX M)U,29$ZAVX$$.>DU3LXTL>S[;)]1S0\:QX4R9"<^PV\9=8P]5\P@Y0(DB%U" M`^.TJ]#_HM?(:=0]`VYI+>$6X&K'YL%B&+OC.)GCB=>3V^3#9K)B@VI2!_;) M##5\6DT-O7EBF'N+B*&O#]D7XND/XO;YY&=LA4$)1J M^=D-,SG4,`?!\\N;_L^+-99]7CDJ%!RWTESB]4ZW1I"+.8/58,$XP!UL4.=- MYK[MJQMQ26YM+VTJ7SC@MV672O7HK!#9)?=+"]LRS!!=\82U)*\ZFP[:G1>< M_+2[]\G+NAUJOY?9O3ETOIS7Z#..IYSL.$]\+UX>MR181KU!JG6IX-F%!AH\ M\/I54M8472FF']J6/:%@%7GUIPPZJ^WQAT0P!%6W`6"F&!\QR3#^),TZ] M:KO4BP'#6WCU'O+,K`K^Q<1_4CXH[9$'WP1*=?D- M_;526$Z6U,Z"?6`Y55Z$FKQ@I[58 PP8''TXNISM^3:*H63:3&ER0G-`QF M4S[;([SA\B!AG]=+XQ\;1A#=_UA/@JU?Z0N6"[-49BZZY_SR=#=?];!L>C\ MFG=QU.[\FE^B/K\.\/PZ-$^./A_YF/_VPJU87!.TECU[V"J,@U,\KUVM?66- M*0=5%_3Z%0_0?#/'V1L$.RP+GN2:$17UP&H%CYZH>9#3:EXZ]NXOEK2XJ).X MT*I*#<7<17PE70=UY3W%?RN?%P6.[VN7R]O3J(3K7';B+CIOK[$K+^_XO<:9 MF--H?Z*V7E1&R^;E^475H/C5^2R3K/+*[A3[H_!")HI[00D'H6)&HAE8P(?G M6@0OT_5H.DTCSJ+AV>VM,YZMK#PS3:3!M#Q_HG;::Q]U%42]K:B@P7KO;:;9.EJ3OS(RYU)^$CJE)"GY"KD(6ID)U MO!"_1;5DACSM66Y?BLP%@4SF[^,$N\[G)V6XY+QEZ6+8Z`!;;?BSHV9.JA;: M-:EB_)P>'W/T3-N_(+H?V]E#6TKY(Y0\D<_KAV)W<_-!MDS!P8"V53Z=@8E7 M3EO\.X*$]>1AYP9FZ/E3&C>%\:<1S/_DSH$X-J>&-?*P$A".D,:5G;E%RW+T M%A2L2XH5B02O:(PMTO['>,&CV9U%2*9,8D344LU3VFTIMVV=_*=*#D5[VE?* MVD+=/TNBB?>.[KTP],8?C,[D&6:0EV+\VSUH/,9*?;[2P(MI[TG0Q.#>8Z,U M!-J@FH;SH*^,EA-YD>576XUM81^TK\/95G!R4_1*>9ZN=TE7^Q>IM`AT>-\H[3F6'P6HYBG'07BH9\$R MWVYJ564#O.+PS;+NOAV`-4)EV>'36ZVW6F_UJI,G*8SS?Y;%V'#X)K64!8=J M+^M0??U*WBL=]Y:%AA:C"57ZCBAVA<_XVU;I/TNUH77V*KY7S;X`+),B#O`; M`R^Z=UCMEW'V`FQ##U2%;TY76@@UYY`J@EYNZ#9!K.;3%1O`[X=S1T)HKBTM MZ/I(UJR^G-5;C;/CSD$R^-)8ML*A6H1AI7M9WEYD:@.S2V&`?,?$M>B%.Y>5 MSA&^:AIZJ)?:&R4JPI#(-01V5[")+FJ\B@O.U^BM^,1X)/Y/H(L8,(E#O1G@ M6?BB+;](MV!L4*<(N6F.;6%#7F/(:@@V$?WGC72QGY;.).>6=,#'<;1A1 MXR[E+=&6C/>]L0#'WIBB_EP,^`L];/@%\_W4:IZEX6LUC_/`QUQ`.V,4(#<` M^!QO0AT?U9EM/Z3NHG+RIO$GXR-0*$X*6&QWZ,1H&[.0+G?,N!&BC(-*EIQ@ MQ?(>,"X,5\![HD?P$;9R:CKA%*/$!A'V.\/XPCAU$TMW^1*$N!B#:) M%"1I@QK<1DY(?:APL+C[4-,X!YDJGTS]-@,##0N3\^9_%#H^OP!:J>FJ78A` MG&)G>5BYB%L?\R:"H$A'<5M)&M29H@C,:D+(EX3M>2D6%5?L8\2H\0A(H2[2 MLMD1B%1;'(?,I_;GF*2/O>QMO@Q$,17GF8C"!B!LY2CT&Z!#2;27RWO@/;QL MD,S$8Y[K3`U>DQ%>C7!3F/^(:S4#0H#`J(IZ/%TD99T%9;[U-MYRS""P MAS:/96.D9`.%8Z@ZB>2*M:W808X4_5U8SZ:EXM>XX;MVR#C?E5(MU&?@["QZ-^^P_TGN)--@,N'!;5D)5G$-F0?+H M@B*EQ>4*8T)#^^SLU/CJN4)OYH^]DX?L*O'HO>\<1U+R80NZ'>BBPP%X5"W?K=0%;_1 M>\K;[Y6PR$<17`IVF>D$'BD5F)3K@CB-[:!,&XC4C,R1B+NS/3A7")0#T+R MO-VI75YQ`_+=MC='E>#,6.S?)U[B9KI"/)R9SO%8!,$ MEH%B%A#"VG>`I5Q2>F\V75--!-_;[FFCUS_>1O)M0>1:2]%BHJQ+.@PQD3LZ MH-?L[JW,=ID(8@LORH(E+ZU/5!/U:282HHAJ[F+/N63E4EIL1H)R_R+ M*KNTS!UW<7S6;O1[6]WS5I_0-IDB.UT8 MCFX:KCG&W#,[^"MR;82'2KK\10OYJY,T$7AORK_^GZ.CJ\_?@*A%B\6CH_EQ MB\R769J%5YER?7$/W'9<5@13D#YYIC]("C/A5W$+6Y&EY,8Y!ZGZ1$HK7"P> M9`=!1`6'S$"I3I(NZ<,3H%)9^%C1K1.7W.,-+E=5[MEQ_E.5=QF3)\V'!Y\] M8.=3VPU]VPUL*UUQ*M:E9K8G'(%=06V'$U.C016B1!D^]HSE#WF-*?QZW@[! M_+6?.LV>W-%"BS!MB^^2[/L&,VZ9V;E;,5ZBOQ(A=Z8*.5''$FMC,IMZ?+L* MEV#=S_;Q"<9UB5*=3TH!.['#$2U?*5!5X/V*UWEF&5$J`=9Q7!Y_=L9(D15?0#[=G),&\<+S6:4E[64:I8D?+$^ M[`Q-R`)^LV3(.UR3`C]5D?$H4<$B7DE5V,^2>+ZW&"&!>T MAT4O(V`^5%MYB.Z29NGXM%*GTAA$OB3LU4Q-!X"IE.6 MAVMX26A[0'W8^11*P<[4*I&#K)D1K(.!SJKB%T4= M+F74LCA,%6>@6]A?JBQ!=IL)=MM8VF/)_[L2$R?%Q+/7%>!%SKYQJUJYY7A5^_ M$J?&FGN9(0]$;:[%NPSGXY-O3GYYP_]]\5W/W4-ZDRO[`^?UTD8YK!0$V\;N MU$]@9&G4!8D+8UT"J:P,T6)BY65>J<5"+DCS\'XU-U:K!P6D#=:,V<]=%[ND MP#KP"GA@3&WFK)LF4&J>WX2*RPEV7,]W>3C)+@`_V@F:*R,L-JSX43-1<27O MH!U[R(RW4V;ZP3LM*LH(]@N*BEXSPZXX)&&A-0N.ON]V\.-HB%<:-A(C!JWX M9KAN:]W_>G\A(HTD?_^L?_X^>8X:V8X=3S;G= M[Y6/E8L.S2Y)G,HN]N].;=\&T/ICVZ60)U!H>'P4;^#6[J,'N74:=Z).-0') M?E%IXF&<.^'(BQY&V%_1@A=@V@&4-'<0R!K-D]+E=$K`R$[E(\S1%IY?L'KQQAS\>8R>"R7EC M6`$77>.+]8_-9WL,9F-HQ<%7LE#.]NE*0<,?V8^DX5_,M[/]T_2IWW&UD%M4L-3K5Y4^ M.78QYN4:T8$-4'O\$(7[$R( M'CK[!A6)\MO%AM^XQB6S*&;2Z-*^MJ@%,T>,T>[P`,]X!S%I9J[M.R45-(^[ M>"9PS,Y$G2Z*SXZ'I=#^]EEF;+\XI-8)+95=<$WY(Z5L8+RJ" MR^EDZ_0$C3>--8B_0TA*HML[/`PWCA[,"#G/"&E7P]F1!,$)$2$.:@=(\1%\;P>2\,3D:AJ%HL+]U&XEZ1EG MDI@STS#L(`;9IO1')QIP00TB?!!9(>9V,.(6'&T`:K;C35!VQ^,--T@K41-& MLN3)PER/F1R2.'<3WHDWV5;30=82-4KNAQ(F+[ZA\\Z9XL-BJCRLO=)G54*& M6^0_J;&,N5N68+0YI4O#*:#WYL],8>Q.\$#C`>NQ*>X.$HI6I(EL<@R*59(J M0;J1T@HY$#;HLL5(7'H7TK4%,V.`'S$.F(TA$V8CPL5\4Z0)!L@G0\]Q MO*?`>$L#@:4)0`3O\O1\K+0;5_^U1B?'=;,53BO1E5/Z5?O'):BB49?2:DNC MCG/6U*E?V/'F8<85)H`*@ZYI-T6[G0.AW6TCX$MYDI08WUO$HK_P?7/=,%PA M4#4QE*=Y4']/E6UW>L!]6^$A6_/PJPHUE*SWS"YWN-JM2W>)F>.Z]D>I+:C9 MC#AS;5Y>@M.LN#!HL*ZL6'1`<2V4CEO3$0Y_'H0%=G)-M[^2H!Z"O#G;JD-0 M);91@ZJ98S.GYU9M'DJ\B\6WOLEUMU;IL_J?S&6^Z=!I;0[&MFL'(5ZB/ZZ; MQ5>7&[ZL=>@&8343@=WN5@9)S#);5@CA#NBG]$V+JMH'K+RNV6TQ6`MAW#_=1=?EJG)37=:AI8*6"EM94@?9 M,_0EBT_4-UC]^+0$6UL7*Z(R);*QM/W^Y-5W*@^"B421&R?IKA!AE0UOEGE4 MYJHXK\JN,,YIJ^L"-^\_7VWQM>>[''GT5%J=791/>8CTLQL7<:7)8UUK)Q_* M##67FI:QAL63D8[-ARA[A]9NH[5=>&E5^4J7W=L\>=_/TCVS:EZD:^.ETNRI MQMT]+P7SX-(`GFN8!M[:XS(,A!#+P=@!S_YWII@)GYE>']?G2`";J=3!J]I0 M`_-G>PS@!4:WV>+5W0HM&M/KEV['ULH@KSII+BYM8@+I#8)TV\O-JY3+,IB\JD]2=7>F(3QL M(Z\CQ8L`2;@??&8BJ"85X!1ESN)M(70)@).AL$8C#C[T_"&S"01?%)"9+09I MXX[XU-*;D`&;%7H`*/82,4.LT)@4#4K70)MX07@D,S8R'VW/ MI^)K3\RAPC8QG/)7G"2C"BA?E1^7'Z;E2M2NKY?E8[,?C4\C*27&IS!0"E3V:G4_!C_*4*,FI[#.-B*5:3-X?UO(B M!Q3VD>D^Q"5/.'7(C7ZB)\0V)[P0S+='C_?.Y16^!)7Q-6&A.W<@YS.C($5R M8N;0"S$=',-\1$JFX\3%L$R4+X(0 M`Q8B2XXPS-J9QM["VA*KV.>D@H+9_6ET]U75X2V%37%5[`E[YIA=C, M^HL]7%<$EU9:K658K@B$R6U`%K_EE39.?S/="%VL.=T8I>V!N/KDJR1T2P-' M=D2^E0K#[S5.6KW&<7=EBHZFW!>!3@O>38/2-B%8+2Y6U4=J'K>UI-#0:98J MD*5ZU66I#4V0C(($V@#91?>>:VHB5UGRTC+Q,&7BZOHMFF0U=)JA-$-IZ#1# MU9:AB@TDT!<'92*@Y7K[U?/$]MG@OCV7>T) MM]S0:;9:Z2VL'$_5GFC+#9UFJ3*H\J52Y#/<[\5DEV@=?RT=G\<%;Z?;ES8Z M;?>QM+58A1;/JPR)_AE8$F66EEL++;7VR8%S2(5! MU\RMF7MW-F-I^6-#@S+S9FC!(I?6:-;%$!K&>B4U-J'0TA?87RC[UFY0 M4?5E:!F^,O6E==)K]'N=:C+*ZU<[T],.B,OU0;-@+[;+K]'":_>).&?5E%M: M:FG=1+/W:N=1OY[LO8:%N;Q*?'&%26M<`_8R*58,#X5EZP%4]=G%J.BTNVS MTT:_W5'F0.C4>73QX*W]#*[QF=W[5-NBRUX=[9/AON+9#_IV>IPK/M['.T\-H_[4[S=$>D MS+^8+\[Z"6M=8_EK4ZV1K?K6_E3H^)N@XQST4R,<77#6X2VR3>*H]'FQJE;X MTA)P)=9O3#/BG!(LJ$[T(@/=-(W06H&?4(*T`,%<*PIEM-MZ7"\+H% MYS>-(9#'X,Z]X'O7C"Y98/GV9(,.F>6Y]U^TMC4(ON@8DQRZ\]E&NO/>"82J MKF0YF"[-\%`+0&\;5[5MX>2*D(XN%OXRDJ5]NF/ZD-?U6U/(+3FX-&54I_SZ M2TB1B>WS3GN'>N1H+TX9#2!M#6MKN(H8UG2KZ;94&"ZF2-.0^92O*ZVD+3(R4;QV?M.!T7.X1Z66I!H"ZE$6#_,>K(U((O7 MKW9,&,?:IBD?=#4@W/TH&-MESY:8-O3%SS[(Z)9-0C:^9SYF.K6,[VSBVY:2 M%U99ZM*"9W>"YU1;-EJ8:,NF)%AO-[NGA\>+FBQV?_>3+D6NS:3R0:>Y(*>V MLEV1T!+3AK[ZV4.-&"OT%IM(^O9'2YU9E:SUOJV-)"U,M)%4%JQK(TF31590 M1Z-U56,VI*NO@#:NVUSN*D_KU]IR;.&Y.EKXT9+$VW< ME`3KVKC19)'E^^[H=)T20J?I-J^"<7BFC;ZT*6PS+IFE!+8=KF6CQ4Y>L=-Y MW]5FC98EVJPI"=;;S>/::@":++9)Q-5F3?F@TW2;4[_0&3O:KMEB.WXS7=ZL MK-5NSYDUE24M+75V)77>=]HH==J5)0UMU6BKID8,V=&%".I"%J]?%6O7:+.F M?-#5DG!WH6#TZDJY^K)F]T24M&!&J^8+>S`=XWSP:`>>KTT;+7D6')BB!(HV M;;0\T:9-";#>T56H-5EDE-_5ADT)H=-DFU.].+RJT?J^IL#M^-WTK9%B#<1_ MD:ES[3ZR($RL'!V7IN70#(J[[\^TE:-%B[9R2H+U;K.^@>F:+#;&\7&KTSCD MCF@EA4[3;3[UXO"L''U]HVV<2MDXHA-"/<50[_V)MG*T<-%63DFPKJT<3199 M9-%KM/5=3MF@TV2;3[LX/"-'7^44:N:(`+4+SPTB)P1;1D>G:9&3C>+^^[:V M:+0:[9JFWJKR4*GW6B+YI#(5JH7.NT&EB'@FYB#@>T^'/'5?#`Z MD^>/;[2U4T1KT()+#6RR8>4PAS:!7`NSE5VZV@5D\I26J%:?@EN`KN773JPL MS><[V))N\VP[3;OZ+'[O^0/FJY`;@>?8`]@?$_9G>]IZ_>I0J:L`2Z[Z]'4H MH&M9FU.GVLY`K"I5K7Y]YP!G^;."TTG#@,T;J(P M"$T7<;X+(EVZ?:6V)I="?E8"]BHSTC7HFF#VHKL#Y,;`B^X=5ICR7L11H8Y- MX'PPZ.&/1O4.C%ZC==)K]'N=>IX/A\`T6E2]D-;[/C1!-,WSR#_>1\'1@VE. M/ES:@>5X0>2SF^&%-YXP-S!#VW._,\<,V>#""\+@=F3Z[),9L,$WO_B&'@M?'=DB_G[OPIAL"XIAKV2Q(9HG?-"QX`#Y\9\-?WESP MO__J_G[U5[=]]+OI'V'OGS>_+A%H_XV"T!Y.JRC2CIM9B3*&@D`#5&(CA<(5 MTF]K)&6IK<7.D-Z&[O$:^\`1BW_#5H#]8%O*Z%MPU5?//?K.K,CW`<_&E0NP M,$9_7[)'YG@3W`R#F*!N^-^W+R*+XLOTUU?FN=Z`$>.!D#(#X]H-0C_B['CM M6DWC+7_ZM--I?;R[CC^T/[XSX"'FLP$@*/1@"./<-1V/J,BV6(J8SA]\QN@O M=;CXV]2HGFO$I=Y[#8.Z6#V-8"+C[AJG8@\^"FE#P"[?;9]\#.AGQV%6&(&Y M/?&]"?/#:0+?9`),1)+>N)TPRQ[:%BPR'O'"]JW(GH'Q]OHB!=Z`+PL>OY\" M1$WC;D20X8.&'<#O`9`HC0?H_/JUW6JU";\60'#/T.DM7C78L^5$@0WC30V` M$&"#@X@!67E#N;JF\0<0MV^$,`D@>TR_X8<8=PWY*$[NW0-_T-PP'IXUOGT? MAR?PL37[U%D M(R#D2V_&X#W9CJ/"Q-^G)[]?(:Z&GN-X3\&'N@F=L[,]2YW/GF\PTQK)G1C: M?A#"'C$#1G&0^B/7#@'1&1+AIU:S=6H`W]`SN]Z*$B`*$>0"G`8I+#,8,A`= M_;VA0Q^'^_OKVN5"=01RU!@#M*,`A.$`A!DE=1O=-IT]W8;Q$YPMC6,N/%%4 ML6RYH9I]-6-S# MB(&2A8\.X63H-$XZ72/X&U11.$,9X_PW'*)R&TR`,PQ8*U?T0N.+[;H,5"\8 MZO3LLF'>,X<\G!JBB(PQO@<[WTRGI9'BZ$),*H8&4$.NN MH?ELO"5%D;[_]_G=.ZYRFJY+2BYW3M#H)(4X9`R@#F'5J/BFYSSKQI-.01JM M,2<,SG$'?Z`O:(`")C+B?K-"JH#.3L@U#==VA?@!*1,BVF!\VQOP!9`J:()8 M),40-&.@*BZD"%.N@4XHE'2P2B[)$%Z0K$/@/H0!QB2=V!;:MH72#P$F@2SU M93N6K33;WJ59[;CK!@TIWW:,=I^?(HD%,LMP:0-1Y3PXNK[9E@OV%^>TTWYN M3@/.\CFC=;H7.1D-B'+_G-8^Z17*:E[T,$JCOMLTDMTXYE]QV`2J0>"EN`IM M``(%E`9X)S58#[Z4IF9@CB7_D.D*BHDME([OB`.?C4W;#7`["L)TD6Q90J99 M=C5>JX4"/7(=L].1TN&)S0J"1)RK,J'3[;>,W^T@0/M+UDX*C"]?+HAVNXWV M:3^OD$B-=>$Y#GM@QB?G<0!2(K)#9K3/6O"GZ8:F<>&8OMDP+LZ-LWZKWS/^ MN#WGC&^#R6<#YW,8)?\#=_UT`D1^DA!Y`ZG5WPWO4?'A2+.< MAEW.[;]%P%/B7.UO)XU.CU/"2)^#!5#ZC15ZJ/FTE]'ZDS='Z;>T5]Q32%[6 MAO$[LW]XQJ?(=D@F=C\WC/91^_2H8]R.[/&]"38:/(2JCG?T(X(?6_TCV,^> M<>?]F'I/6*0P,Y!GA6*[Y8#X!N?>.VD?'QK]0^9T9^!0&/NGS@1O& M;^;$=#GIS?'!#(EUTZ)_.6G/X*ZW'75W#YFZUXB6*R$?[=*QM\@#DN5MD`X? MTG@X-^,0>#]LNM/$N3*K\/#H:WKKIW:+>*"!KIX)LT+R[3>(C'U&??.$\RB# M0/,&>51=;I92%:H):GM5/SL:TJY6.E/@>R'A+IKL7!9QL5;$^_'I;(!?Q>*U";0!BG9RJG_@E$Q#T7S_0KL8V/CJU1+2@NDPHJ# M5%+<;:50596Z-]:V-LE1DX*P),2_^4+*L'/YY%+^)&%M+Q:>9EU%,=@_65D% MKX[^LXGGXTM;IZ=6D$WSC3F?NWHRMX?;0C8_1W,9 MR6P"M-APX]H=>OZ8[C?F2;&@Z]>#S&:18\I!YU-]WV3B>1D@_%)!B3O`H'4, MV_2);_D-(]_8A@&JDC7"6U,+'O9MRL3CL66A%UFCP/(9AL+K(-P+388&(P,F1)Q.'3?!<%,P_A'WTQLP/XF`D$8O] M1_.VV3"N(HP'I=?.`]NL6,A.3<@1*8W?MU/H(I'7!/.4\([>91CI^\C<"*:_ MGQH/S'OPS0D0'7S]@)&5&U#'VP%,1W'\*V[WE^[-UANM'EZ*4J'>X,]=%HOK M^W9KY?W]6M?UQ=AV+Z[(5!WX;"6<-._$(9&A2\;WV<<5O\]>I$=L>Z-9*4*8 M<4O49%55!WYKWJQ%K$DNW?&<,H+74?1K12F5!EZ3>6XR_\9\7)7YP`Z3U(L/ MOSHYKH$?]JMJL@SA2<4*5:S/K;RU)78FZ@BM[?:P%H[TSMG*JJ$5#9^H+RN6 M!-0#X([^#L,7*RU0?UX'+T7'2AZ"\L$=WK47S14"]0#$7?M4$]PA@?KZE>:. M-5IC:V5@D3*0-TO[)>.;#T%KP+OQK4S=J@:(Y@LS7.T<+>62E@;^Y5Y3+61P MI[N5BE)]\M9\6MXE:3Y-=*6MT@"WH.Y*G^[[\:ILHSR5A-/J(LUK*`0+65)) M.ES5F=KJL@[--9IKRA4RL4ER42V<$PERMRATM-S`*7V&UCHLG>3LU5NMW46^ M8WX,UL*>ZO=VX?>H$#=IL5#B-6E.5>Y06ZT7XM1*GQ$O$E!2(A:J)'RSZ4R[ MA;7:J-R+NV[9*E^_*KT!^.*;I#/[EF;V;14J7"E">'%NU;Q:`*\N5#@/,`=* MI_I5%WA-Y_GI7.?ZZ5P_G>NWKB%7(T^"SO5;A)FSD_H7YZX;*Y8$U`/@CM,= M,D>E!:K.]=.Y?EK#1!1UX,S)"_.EC2Q31'+U*U=>F5Z;OP5/"-^;H2 M:'5?1"/MVWD\!28_V@'I$PCCQ3')@ MGSGLT02H86K;HQ?P:TX],(#YR'SS`5Z,QO<`G#?D@`7XEX0T1'[VHC`(`0B8 MJ6EP&`,7`;`X%(2'W!_HYL.#:H*:8*89'$3GM;,EK,6P-XGPNM M"6IW,.8W+X3EVJ:SA'B'ACF9^-ZS/39#YDR-;NNLT6JUB.3;[48?_E0(7#+E M!'M'!R`BFJ<&0.1@ZU=\H]OLQ)_G7WLR?=_$62/8!R&`?&;"*3\53XQ9.`)I M(2:7T\+>V_=VU=7'A< M[`R8Y?E$4Q\XZ2>9;&_5IL<-I%4V"15Z-"FC,WBW`^/GY=W%*PWA;-,W]MIS M(U@@60A\GNVX3NY^QJDA!BE2-=SW?%4YH^Y(`_U=T4"WDHL5QFY\L*S)ZQDK MQ@5\--9E>,/UGGQS\LL;_N^+"X!EG9=UO$6%A7,&)^;BO/RI[]65`AOT5J^M M`-"\4B"O2'RT?JXKWZQ;N:BV?+/LX#R$?,Q%GNI/Y[?7%\;YUTOC\OK+'W=7 MEVL23*E%S(JSL1P"<([7JL165:.`)1)?4T/10K9VN795%?X[&_//Q==&*4I1 M[Z12MT-K^3)VK0B_?E4=57BE;'AI6;#9LH@17B3RN-MM]-OMC<5TY17D@S8L M-3<5S4V=QFGK['"YJ>BDN7(%]6L]:+9@PFRT#-Z3\\`;?F_N#=/T$I-1*AXI MR(X4*U@E>OD0Y@UE71+96R\9OGQ=]5&)5A%>V82XYJ=R<.N!^6XU26N2KAE)U]L(WXD=*ZS153:HUI)?7`9E)+M76CE^ M"\;F249":]65XXPP=M\[<:M;Q=E,;G)IY M]L(\K?[!,<\:Y<#FZWDM+-"E5O&ZC>X#]G<$9_G5(U8CT56\\M;<.BN\BE>R M%P;?C'GB6*RQ[',7BJKT5<(:0#>N<3[Q;<<0Q64:LF*.,8)]PH9$[)GYEAVP M05)+)_2,2>1;(S-@1K^O%LJ9K6(5!6JY+CF4,?&]1YL*Z)B.XSW!V*)7LIP< M-5>?6J)`D;J3 MG(S@0+('QD]B0MS=A*R4IYMUW[N=LG!?TH.9C?UVI]7H]'K(:W#8N5@X"C;[ MR0Y'\(9E!J-DL[%&ETI!,JD6&W,&"&;J-=J^_P03=)E!> M0I5%BH02;OHR/;Y6"TT.J&-)WE^9YWH#9MPQ:^1ZCO=@PSCGG^#`@,%(]CD, M*8F(Y:MG?+,MU[8H9KS3..UWC>#OB"I2,CB3\#@9#I&(L-H8,V#))F7/UP:H3FL_&6EXC#[_]]?O>N:=R-D"G#L0$`&JA),0J?O M[*0GR:Q39OIK3`JCH#CVO>AA)+'.A4JO5/QT",*\?;I0FB='9[8$ M77ZL%Z*2=5N-X^.N5LEV2PF_F]-$R5MPJ'=[5#!SFS.]LU2%SWVF+]YRI>;V M(O-;M='!^J:4.TKM^09_6=-=F^GMTY7[SQ_)20!\1_%OH($0IK:4T8NM,/+- M!VEO3QR^=2G<'10/UH/K=S$FJA;`-K!F/#.LF$*P9K7IF"[J/B/4A4#GN00) M3[EVHMILA^1^N'B$((1_QK*P+RH;IBC4Z\%;/$O/9R-X$^O0XD55@]>V1MDT MA),F*>"]JC)X1^@U5.(`-"_+HD*E,83Q%^(\>@)!">J1]^3"2*BRV3!E`!+( M'MBF/UVH1[[E)'W:Z;0^?KT[_Q1_;']\ISC!DK_.'<<(@,YLT"-1N-I8OLH2 M!GD:3!"^@4E".C!&)F#DGH$BR1Q[;+N(S^U*]&IFJQ2S9=1U+@>G=;.H7##? M!KP7\QPP&)AOP%*)$7<^9J!/F(%Q[5K--.N=7ZN&%W_%#_"0$SPN25C2`9HGWP,0,Z@ M-1.\G M4)`!\N!X(#[%(S:R")@ZON?:%DJY"![UJ-`]@CR"]]!%XM@D;B4,6:Q*#)V" M"[TK@X&/2)F8?FAC:7[`RP2;!$6N':(4(0RR9SL(N9&,+AJ%WZ.`^1SW0_3; M@&GDF@9,$1!<5+$_EI.AE$Y3PP%!'("U$#!G2#MKZRJ>PZH)XF5VI MVI]_!.QF>`6B8TS^MI>Z&.9RJGP&9XR9:IF7Y;^)S]5F"?5+D/'$6*(#R1!T M!=>RZ8R(543N$$(NL\.I<.)PU8.[A6.GP0-S\7QQ2#5ADS#Q_/T!X@XMIY#8 M`"82NAH(A+\C&WU%8_,'CL9B7J%KG2"(QKQ;"Y>4)C4?::#&2ZU04"+`:/AW M%N@-T4$]7`0<>=6&-'Q$T1.B"(A`I8@HFG<*@="@A^A0X.8 MA%,.[R!<+S10V^-'3P.+9J)TMPG6*2U:*HS<^8HQ,2B2+0_5@N0Q/(>/''+. M\E5S-#Z:3L0)A=RZ="#ZS)%''1Y!`]F_!J\(%(S1_I@@K7$,QFT.OJOX:QP, M("Z1GR64$V@XP-0*DU1@Q$)IU#B="W MP;*PPXA+E56GSMB<4K,B$3+"9397D$'T$ST+JR;N_?<9H$';Z9(#`>:_?/+" M\R>B05+*PO]\>7V1=B(\C6Q0?<7(@8BL%ZLRN!1^$'?-),@#(YJ@:/VITV_% MM[+H!_'Y):]T1#[@JR[IT?'@R4KB@?E@[18?BT6^Q[L0"O-(]`G$?F0)JFV2 M]D8XG7`,RB,$]H4^IWT]Z?@AM#MGKI=/E`YK:'H]D\F80CQ?^4;.RW^\WT30 MJ_KZ]_A@#.Y\,)G/W<$-&B3G8MG)[^?R#/SL^9=>=!\.(T<^Q2?0!\C,`2+1 M8R18))J+44DGOT2F(1_/,K8W.VAX0+,.Y\QW::SZ9GUEQWS&-6P2Y7CQ#S:Z M`Y8__DCZ7=/`=R><"6SR"$GYGZB.W(,LU5G>%)4%0BU&2R#N=P@B/M%-*3@@ M]N?0R#^8M"(&,MX%Q-,%?+1#*4?-63>&B$PQ46!*&03ZNLV>9$A#T<(O#XW-W!C<7N/J;:7,) MHR:6S4\CYH)41N^8C:'IAH=106`V3/$#+M%2%PS`(%8>T.,$TFUJ)I`6("6CG]+*!->?4$#<57%O=@;R#] M3` M0G1KTPZXNK&.0.'W]BC]P8A[.5._`0 M]'L,P6%X/?-$F^?Y&,D3>]X20XU\HH/(8K*_,3&=LMW63`Z@4<[\.2#2G;D#8?J50]1J^D$7KP$U<:, MZ<]B/K$21XP@/B5`#4=TF/L`A(/L`U).@!.?Z20').%Q!R_Q-NB$3LP7GDMK M]VWR?1,=QA(GT_,+P,^27FH!*.@&\E2+12IZBM%D=QG*'W1>9U_CS5VCYS&! MB]1C5/WHFX@!_`:\',*@5R!WR8&KC>=5H34B>!*W-,;:0=G+NU!24FAE$JTS M.HKE!6&#-!5NP$3CB`LHL')`.-C"J>62\\X/Q25&$TV]Q3_3'''#]B02$N^W M<.%'N";9$9J+,.KXG&@\<'BA0$!'6WS>2Y\9:D?(F,&'-4ED:VH0>7V\;YJ: M)*^V8YZC>M&?^71E>^;-NS'+C,/0F\3IAIV]U(.9WX(%E3.R0-NS05(1#]'* M,0DG2SI/7V6RT0JGP1(/PO:EBO)OOJ[L__&""TX_D=GK7K%E"RI8:ST/9Y["2&(I@.T<8D MT]9LD'G)S<.\IB79CC"!AR$6L9\[%G),A7+17:2-[JZPNI2])F`['EO8F;.B8<"*!]>SSTU&<9>I9EQQ= MZ+#&^P8;L$RQ>_&\Y+7'4`F2!4).\'L[!3?\<(RGS4YCF/5LT]#WS+'A',77 M?8+(]68&QHNIN6BT/!)I$^FB2J?/G@_\YEZ@"'3A&26Y`N0;?72X;-6.[^52 M2F#2D*@T%.314:3@UO@GG7CX[1A`*(2;SVJ-B%YA8D:A1,U.8QI-HHWTDVVBG9C,&D2]/"+Q!]`9-0S)`C'L5 M*US%HRR+GT`JRHI&/_5X%0YEN)5Y=O0BW@]2E@7>W8*D,TA;-*)EW@5<=GBODLJKI+LH87#GQ,!,Q,H4M!0KLH8@MY\KQ`(,@ M*),(9Y-:J]"(<<\H`(V(8KT$2!Z/3-O1/4FVX[A3V';D.+PV/GQF*A\D,7`8 M]L8#8O"OS<^H-8^CESY[YB.6>8P,;LTG$3F1.W"Y@GZK@[':%\:J9<2H4N`% MAG]PZ??$G$,*LZ?D\[/\NC,.QT/AN-AO;]>=8'=;A5[@YWRMZ<<\1GLQDL$2U".N[D2#41=X>TY M2T'GV?')V49R>W9+BOEKTWM<]6]%@@NIMD2(OZ@L^Y=W[QE'1J_W\\9WUBMO M&,K+%N)[0G2\0XLY8CL%0UWIS/*"Z1CTB`;HO[X]W`E[:2[9ADMN/7>:RKP! MK54SC&88S3`+&.8KHSH/ST86<`SG]#T"CC'X'_&5P\) M6>6@]BY/'1T(DL_`GZ\TF++QA_8PQ%I8BI'O8G6B!48^V;UX*49V\"IK?SX] M8W.#OS-G\(T`:!\7 MSS"IBF^+[M/2!23HT/S.+._!M775\1RW=`)EAH*S-;6&%X[[J`#N><"@;>'] M/*AR`N5KJV?5#K"IARFTBS$I@]W'BT]9LRX.9W1BHI'U0WF4H"C>2:9'R"AS MGAK.R"!IM1+2];?X`Q8ZQFQ_2B_%5SWC^ILRB?D`!@8/S*!$^J2DH"PSRY]E MC$7T)YH\#4??('=A*H<%' M3,B_G\:S\8"F1:`F4,K*UB:9F-@CAP?$\&%B2Y!G,U*$RO6WIO$9E\,3&T0L M93*V","D4>-A&(73."(>U9,KAI4DS.9[4].A(H43.>X2G`;EUG@SPV4HK,<0^I"!5!8!BH(`3330:N;EP#DU<2I M6BN5CQ55MN3\M#U8OG<\$[@>1%0^MQE7UL8J'@&O497$T//Z&E03AB,1P9&D M[2?G#%JJ6`(+J_$:'%_39-EHRL9(HA*WR;H%O*+45>P1PA(?6<4B,`HL5:!7 MH(DJ'SZH!#_PJ"J$@#Y5#)CJO<"?LD`(GTCF%(@D%86RDOGB\B`PV/]8%B`2 M.5AGYH/QMOV.2H`D3(J-L!Z(PN]!-A+Y)Z#'36)DL15)YG)TA"V>\Z/QMO,N M79PEP7*@8)ESN-P.>*T[\YKL;D6U7Q@%"=K/?*-D08ZXR-00'1=J24_+YI.E MRBV[HL8(LLU'>N]M[YU:&<1&OC,##P>>4GU2S)&8<5FL5U;`3 M[]P=Q;$GM?==3[P>Q/6F9F*#JJ5^547/O7)A=L;(:7G+?"IKOG--5T?Z[2M% M!Q6B@&$-*F6?,;I7!!<'8LNE7I3(94H,'8*HY,':(.E`Q\#Z:/212;*AXR`+4L7:E*)-4_)2%_$AEJ,"B)D,%_QD)7JP4-7N2JH=< M`VMO8GTJAPI*`HBA4,;-I.T:-:(GE4!(?G[&XNH3<%$X)>'TE`6(P_^TPRFI*EIS4KN*:M*Q:ET#1>S=3855B%.;A=Q%8&8RZ M#.`)Z5!OZ"#['!<'\D!EJ43@HU2H#_5*6-Q.GN`K/ M0+5TDD)^=QP'P`K4@0('I/NBY(Z$DX*RSR-1S8L$/Y:J#H:VR*"BHM@IK3-! M0V:VU#_EH3VCML7UQ`-Q5%VH7!H"BO"X2 M)&J5L17.+M4S=CYX!-W*1M/IP@N*S^WUU`3MI=G5U5!"$91T M+LJ:\NR702IIVYA_5MID0KE?D;4B)*3H8C/3([C32U)CVF>4)[,RRV6UY9#( ME16B(NUOYPUESMW!9=).YHKC9*=UF*LK6;YQ^]/XKC;C4;!W4.)F%XSZ?5&7 M(]4I^CT.*[I4O:,K.5MY3SPKU$+RE3F4VPEJ7H`M?)TX.9P_B:GH`ZZR(%]3 M%RG4O@F](Z+D,"YMS$ST?_"*R[GTA97,JO+V M+;8"_H1%7RZ4#B`WU#D$AKBF"SF0-UAV8KQ$[BXI8F7/;O:&+*&$041F;4$`1 M'3(JAK9$U-2#I`[&F9,L],_XZH:(9)X-9&^H$*]'W"-)?H%(ZK=]A0'X391R M./$D?TE]"J?(KQ;/ERXK+RH(8`M!:G$Y--[:[Y).9.AXX/&5:@=+G$3I4BBO MCN+CEHI,@2$]\'QQO6"-T'4`']_:F<,O>CUU#:5.:0>QV=\TKM,%[9?B.IE% M-`&;%S.9[V-7."`D&WUK4M(,$D&B5E53/'?QK2??P?FY%G4%$Y4B0'((3YG/ MCL3^#]3V:QR_,3Q*8*N4/PA9Q=SR)63L/V>[52S$(DAT7UGB_S@7]3[ MF9\8_P41'\"I$/>%BR\=>-$7AF7^!2J2"19V^_13K3Z4LOZ\@2='QST+GW#Y MZ2Y"2E$A-S77/:_1MJ@GJ1!>S#5I#P@],VN6&X55:I,U\AB?!"SI4K"$5P^O M$_Q`:$NBAY.\GLAJY&DK6%?:IN`3LFU-$!^V5B@+ZMQC&$]".70;PU??-/X] MWU)4EKG$@GEX>%.%)-YG*@LHO(1#$XDN+[P)G#;8NT==C1TD81UIDTEQQM"] MCF/_8&2.F'AW'RI>&)XQH_T!(/AI1JBQF?C%,BKGW<]BJE3LV5QG0C.E.! MY6B@@(??CL?PO/!D1R$%AJ.Q?&DAD?/U*/I M""]Z4!C8*#$F'L8&V71MECWEJM7=[7)NBJFWY4[)J=WYS17.28!H54``)3,, MN/-E-02-.$J)FRB)D@3O'?'->V0))[V]9X[+6<+*&@Q7S-7JEWD>UE5-9C\!%19-U/9N2.M MFZKTXO!)!.:RD69Z3"PI`4PDBA78QY(1M3 MD*-C1HZA/U/5(UT,]..V*55^'XC*[Z*%\Q,\%E:K'[W#6"%M=YOQOE6LN,\.6@]CL" MU'XGZRQ9"7U^S]ILH.B"DVNK7=9OMLK@G!QGNSV29P2'K-]O%*2#(K M3&\6;)OW\$L.REN,2X@<=C.\(,9%3]'-\)LO7(,4:G9-H0-WW@79!?35'3H" M"SA+BVIM3!7._HW@M#;_S!Z$R>8099-8=_NX>X M'&.>G&8:2E8:>#'M/>5/Q>#>8XP``FT0P\Z#CJE$L-'P1>=-)HF)[MFYR??% MM("%8:.Q]R%F;X.8&6UTXTH(N$&F/%HE@>I$0)4&7E/_0L>'/-Z,[W@D:HJN M"/":HE?*'36ZVW6F_UJI/'N'\`Y'G^+V_^S[(8&P[3Y747'*J] MK$.5.S]^>7/<^WF)S[L8/2C;2U-^A8MK5XP:IW["\$2A(='U6$Y?7+8NM,E. MM7]^>7I,Z&$`7>A:>*W<0#)LG% MWWA]XW,LET&O\PSC($Z;.\=H:/[=-K?L:2^WLIGJU;BX">^OO`B?WX9B;L87 MD$[WM`2TDQ/6,I#Y$A6N]7.-KD)HS,\9D3NKA%M%]S7W#<0Z]RJE9K)-%E*& MG=KBHK*^G$KA="M8L[*+BR]%Z[K`?=[UEHF5-[WV+;5<+3&^\X*:(1]W"W=M M,+S>==(Z-%[I*QXEB=QUL=$5K`.+^0^,J#U`5O31' M-:6WA<+G:62'[.!%SY6LWN380V:\Q7)/*U-QJTH*E03U`$1/K[F5HE_B;=2: MSPK\8:_C(^JC1WU`6<#[*-64'"H)Z@$(H%;SN+\[DJLTJV[>_USK6@MUK41Y?&^N9+CHPO*=EVB\\]31 MS]W!GZ*`>0&7^SO;WWQ)][EB"TY?++9@D_N'_G&I)&*U+U)RW(FN#%&KWZ7H M!M=JU2>`"H.N:3=%NROC"&M"`-O>`I?R)"DQOO4M<%DP7"%0-3&4QS$N!5ZE MK5#91M=?T.U5NXNJOL,_;;:%!^";.FYIZJX6J)H1:\F([;HR8M'74[50.6Y- M1[3H@TE_,"QN7-/MKR2HAR!OSHXUQ6E0-7-DNCQW>&%;SL-XM0=@FYNU2I_5 M_V0N\TV'-]0=8!_L(/2I%\LV1%)5%_F"=6R<`%FJ):6%U*9K>C$1^/I5D?CK M=KND$.DG]TXB"M-'NO: M.OE09J@MY6D9&]8U3PUAE!R7W49KN^#2JO+5_NV>N)9Y<:G)2KYS-`:JF=X, MSQU'/'N.3=_M<+JO4N5G92M5WCO9(9VM);1?D@\*@?2L!!Q;)J3J)*EJ8%C3 MK:;;4F%XW;8!F^KY\NS;N:+?/-V1>LJ_F.^M?B#:I1MU='H<.GB9>[@7D*&3&R?1^X=ZH&S;8&>G3INJFBV:5NX MO*!J6UC[<"J(54VW>[K2S^V@*?[RM=*WO.?10Q2$1J?5.C.NQA/'FS)FR&NP M55K54AVKU">Y[J2]&8I/WW?Z[Y%8*DL:FS<2UI)DNWB134CBT!GR]:L-ATX8N4(G-A^3"_O4YK0:K=8!$EJYH=-LD$]A::],1:PJY:Z3_*V- MI$VCZELGQB6[#XVKYY"Y`7J=M8VD14XVBL_>=SHH<@[WL-2"1-M()<)ZNWF( MBJLFBU5D<:PMFO)!I\DVIWJQLE]L52E77_SL)?N334(VOF>^@:JJ\9U-?!OS M@Z1A4UGJTH)G=X+G5-LU6IAHNZ8D6&\WNZ>'QXN:+'9_\Y.NT:7-I/)!I[D@ MI[:RLAQ.52EW%Q<_2=%TK=GP,6^LT%ML).G;'RUWYGJ7O6]K,TF;2=I,*@O6 MM9FDR2(KJ*/1.CEM]+JU51"K"IVFW+PJ1FU)5U\![=VVT95,`[/L-'9.H5MQB6SE,`V;==HL;-* M['3>=[59HV6)-FMRS_3ZU:X-F^/:Z@"U)HP=W]FTM&%30N@TW>;4,'3.CK9L MMMB.WTPW,OTI&C;M.<.FLJ2EIM3N.0>Z*5%#I-M_G4B\.S<_0%CK9QM(U3#@+JO3_1-HX6+=K&*0G6 MM8VCR2*++'J-MK[+*1MTFFSS:1>'9^*4XRJG)IK([Z8(4+OPW"!R0K!D='2: M%CG9*.Z_;VN+1LL1;='L'^NO7RW0`IJMVJ;>:L+0B3?:ICDDLI4*ADZ\@64( M^";F8&"[#T=\-1^,SN3YXQMM[Q31'+3@4@.;;%@Y#*)-(-?";&6?KG8!N3RE M):K5I^`6H&OYM1,[2_/Y#K:DVSS;3M.N/HO?>_Z`^3'D]XYI_4#XCTXZI/78<"NN:&G!K5=N9A5:EJO0NQ!:OL:>MQL[WB7SPQ/LN]YPSX-'=> M:#IQ$*!Q$X5!:+J(\UT0Z=+M*[4MN13RLQ*P5YF1KD'7!+-'S1W@-P9>=.^P MDB@KZM@$S@>#'OYH5._`Z#5:)[U&O]>IY_EP"$RC1=4+:;WO0Q.$TCR/_..] MRSQW\.$V&@-S3V^&YXXC5+)S*[0?[7!ZAV_>@;3XA&+AU]>O_A$%1P^F.?EP M:XW8('+8S?`[>V1NQ#Y-?S?_Z_D740#(8'[P:?J=33P_!+S=LH4&)Z3);0A^*'U M\PITOS$LYCC!Q+0`W%_>M/AGL>WX6;4A4A22I8_G,I)>G$:J#ORF7C2P_V"C MX8OC;-/*`E)E?H6-JSP-LVI#"#/V_>)5E0WP"L"WD',Z%><<&O-\[$6K[ZXK MMF5EAZ_>)/6-^0BP^<#J1%;KN5"7+46JR"?'LW9PM=R:-.97%AH^UWT#8PA/ M&I;4?6%8(QPQXX_F;7,S2A`W#"4V,7)N]5QH0@5W>F7XP"9[..<*JN+=4N=L MI4-FI$@EM)PR MI$*@'H"X:Y]J@M.@:M[(PDI/JP*+5($E03(;*`7:)[%$+3@/;%/[(TH$Z@%( MODZW_FJ!YH[J<,?K5^7BC][*N.R#U0SVX238)*Y=J@HE89/-%U(N=D^M8]/D MJ!HNJ22Q<'6FMKJL0W.-YIIR10!L$D%;"U,\02XE.VUE=EQ0PAMT4MG"@H4G.PR)*0EY MUXT52P+J`7#'J8X7*Y'3M%97UCJIK&*@'H"X.SK2!*=!70?4"L6#U?@T3G"R M'@<7'VJ6*Y2[TKC>==975<,6:QTDFR/,9)->(E74$=JK6\G4,2I7\VD5EJ3Y M-.'3XQ=BTTJ?[CH/;A/AH85@[9941@NN9M16EW5HKM%_OROZDJ!#9HVUE8`:%XID%6:!%-J$;/B;"R'`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`+@?R3>0^P2R/;^LX>;,\]?[:# MO_ZX?6-$KLU'^>/V\HTQ8)8]-IT`ZV7\VNFWX/^2Q61"LB=0;Z\44*_^^#X# M:KNU)JA7;FB'TS_M`1.U5%*55)(>ASG*G73^2E=A(7CEIQN7_?D6U#XNS8*ZA2RHTRKW@O[EW>=<2:]7[I5\ M`EG)`A".7SV0BCG)K>2[`U:7[[GV1^/\>[(^1,DZ+LUI@,6N1$TK M&,3V!K>A/8D<$\[,:Q?A]4TK^XR9W91%B_CU6[=U*0'-/>4>H#2?4U#V^MM` M>?5LL0!>HA/1="WVQ1[;89#O=%ZL)ASUW_QZTA&G[]*95&;[[/D,U,J+R/>9 M:TWOX+$`H(7#_I^F[7[Q@N`3&\(S=^9SGO-JJ19SW$EI!FM,O3N(ER`4(.Z> M;`,QWP3!89S!/DUY//S-,"4ZUD2M?$V%]OKK9U2^Y-;GF;5P&+MY8#S;#,1S MRZ+*9M^9Q>Q'U-$O(W;^\."S!V"TI4#.R-!7+"$P4A]_L1<-EQY;F00_>RYT87M26!8,,O6@.0X MP'(#PNE(YE>?\_1J..Q&>&)_!W('07T;PK]4>/-F>#-AO)PB:K(7WGCBLQ%@ MUWYD*+/7I*,,ZCYNGL3RHBBH7F2=*[CXN-GK[F*="\Y7=4PZ:QT:IKTVQ6+`OFKAP6/.B?4M8+QP3U<`_31\>"&_\[[AU\KR]95;DVZ'-@@O31Z0#83H1> M3NF"8X-OYI0H!JCDFQ>$/@MMG]Z4K/]I>F>'Z,%+AN'J.>,K^>29_N!F>`FO M6:'G!W.F$<]`G/6MS3JLMD/6?O#>.3[ZS.ZYG?)B>+\8V6SXV7;!LK!-YV8X MM"WFYT-ZMU-!I&32?< M%)[Y/M]N]RJXV:W^CI!Q6D%DM$\U9:AL\KLYW0$RZ):G4&38=)7S(;G1D0]= M/3/?L@/VS0>9G;E6;H<5(A-`S_\+=,"_Z,B9T6W:35QR/C@+6E$!C+U\1=W3 M/:^H`((LM8/ MOD;F`S]\2B;$7W(*Y=BNV0!LQ=V?FAI6`,91`.K8=U3*"EG=^8K599@/O=-6 M\SA>WU(0][F25?N4L9)VM]-LG>1>22Q(XY\$%'S;^-=@PF8;:7NANW;K[%BQ M[59"FF-9UT$0+5J3$!B=D\1ZV,FR>BN7)*#>2>4,F"V?; M9"6[67^_<[IG#!0H0A8*R+(N:#.)7X+U%$2B&VUH]^SDK%4?'&Q$`V>=LTTP MD)[JWQY>_"ZQ&HHYXG_%FYA'+V140(N9UHA'C"<+6`S6'H'/WH>B@*Z2:IJ2S*$>9:X5\T1FQ""[#S.K9.>OV>HMH7OH;R(8BV M48R84W`?\VI^33)Z#NP/KNW\\B;T(_;F??D6L,$VI_WC.UA&D5BZ>I[8(NY! MSK$7+!T5R@D9JYA3R+F)=!GY20`L`:;"+IW$V3@0!F*[0#1T3WO]XQGU?BU` M=[#,[3@ZO. MW0O,@DDO\=*$N0/,8M@H3V7507Z_&N#[=0"^8_XX5]P0I@O_I_M[^_1R9O-V M`M%>)?W.?1PST<$[7U!R9[;Q5.2.-Z4,1EY*6_7.ZW6V5'KE.ZSBX*_1+BX9/?AU7.(.6.>.[_V=NL( MEM_IU'+MMVP2TDH54KAC[GBXPM[,)WSP:,=>'XF2CIU/53@$6LTAP^>V1'C(D@CHPO'R@$C(ZD> M)_#1.THR$6J&CWE6@5&"R`G-..DGC8O^4;N>N,C2OG+(TK.C=KD$!P]HO78# ML([).1"3=>+W)Y.(;'XLR;).&%CN6+@76D7I$5B0'9@O\5AOPMJ;L,P`71GA MJ)&^&=+7LWQSY)GK7=A@%]:RN%=66CDY[76WM[GT/BRW;U=F/>F#8..#8`TW M0\ZZ0WH;UMZ&]1P<>?9!;\,&V["!9T6KJ#O:B[5<.BMVX;B%%TIZ&W:V#5FM M"#)WHMMK:W[8<"/R>['T`;%'$Z[2)_76D0A)T,'^8P3:QS)&H.!EE`\SJR(& M^C)BH/:86#]^H"OC!VJ/F[6C";HRFN`P4;-$M'1E;$'M,;-VI$%?1AK4'C7K MQQWT9-Q![7&S813"L8Q"J#V"UHY).)8Q"1HU&1$*QS)"X0"PLUZ\0D_&*]0> M,YM$+_1D]$(9L2/BN/\-=,\&/(2;A[Y[^)5JO\F^-]=NZ-M@!5@4-;^31.+9 M'ES4TZ7(L/6-E[M?G%>[<%#>]16"4_H?'#ZN8)"O!.TWQW2_FF..M*]>S,:R M7)N"1WQ4E$[\CN!D=MMK_Z<`!&8LIMI(FFWV=PA($I7I-`%M@9N#HQOI2<5^ MHO8CTQ23'RLO0"OGCN-9V),T>X(UFNK]I?12%\+UEOF/P"0+8.*DJ)F^9X_`+#9CS!PN3UH+;HG&V=V&MT?A/YC+?=`"-YX,QB+0@1-/FD6V, MRR7YR@7B9>/-[99F<]5P:F;D'3.Y.9K;/#HDB"Q>: M,S*JNRU1;JQJT;>B-<#2:@A)AR91_ZNU34&$=J<@SU(6_"^"F';GZ)9-$#'M MM!9]-_(9^P\(-#*[OD4@V&"N]>+8=HVMH@-1%M2EA4_H08UK?RQO3;D\ND_Z+XWM'17VR5<9<2.*759JLHB+]I4+>G&T%4B/ M"Y'9;9X5(3US(3/=>R_#A;)N]W)\1UW/]=?/<"#,-OG+FF@>G-5.Y"*`:\\" MMWI:15;B#W.[HPH!O-&0Y'`SO$CZ;MQY1--.+Z(S2;8-?7!7[]U>K]+P!?.I+1ZV:YE+'9I6B*J=](1F01-.TX* MW'X%RM;XS+P9?F&XU[<3<[E`/2Y@<7\/PUD5]+0?+VT.'/44N0$I;**E2;\' MWQ/3_2O+[FDE2$EU]WPS?43.G8?/^*858ANB1$(+AWR`0;$R>B3XXEC"$!-" M^[-/:[2F_'$8:91'C3GN*R$52U=3R+(WWJ_MEME.^\4JM\YSUP6:R+/0DS57 MRFE\YK&O7@@'_!(S\/-_KI3BV.U<%/QO,S!_^)YKNI_-(`2V9R'SS^]CD=F- M)>82:#8'>>[R9W.0E9"M;V?K04V_48C[0!X(^X2V^Q\);08@*N&+G]50H*4] M(@L39S+._^2HJ\279H&S%;@MR9[YP/WJ?;,MUU9A[&*DGAHZ732,8"O<6&%^ M&.ELNF2!_0!H52'M49!W9P>0[H9*. MR.!?4T\6KV59(:OG4B&:*1LW>`7]I.))W?ZOO[P_DB"'8+?$%XSP/\N1O:`WS.?F2)+<+[A;+! M9]\;HTD9A>*6Y,KT71@A@%.1A@4#+G+S-*CM_+7E3)^FV0.L>>6`X:S=SDPX M:R%(J!]6+WCC4AO$Y&8=XS625R-9\7_EO#%#UT\-T-HMD43HG-9%(NP6JUM* MA'9;(WD'$J';.MLM7J_'$]/V44^^&7[QP(J'@0?G0<#"X/]CSN"SY_^1+T!C M>?2#LH1<,R:N`VXKX^/2>YJZCEGD!):NZP*\P`MOG7!_VKVX1/EJ2)-5Q==, MB5]<.//7:%?1*?AR]TRY=U@-8,&+Z1:\F'9K[=6LZ-M)`^RK2VS&@HY/T@$B MZT*I+O$[YM5%3$1&D?$N9+[X)5^SF/_7"3\.[$-)^-$8V,'$,:\Z`3RWQ8P@$(2CO\5D)UWM` M!/[]^M7:6&EE((6OUQQ//OY?^[BU[0P%XWU+'-.8>%C1HT>A=X3_&N&(&7A\ MF>[4\)G%X&`(C(G/CB;\XC8B[F!_"@@U%T1N@9PPB[Y1@!CPL, M#,^77P%A4*#AD#%X@?8O:";(_9,!J\'V$@3*LP'P8V@[QA,S1N8C,\8L-$S' M,4S+PG,4+7Z\K[!])L"#&<7PN`#)6H8)RX#1D;D!)5/3":>P+F\06?`2'"JX M,:%OWZ-)CU`+$`;&_51%"@?XM-,^^:AB`"Q_>HJYL'6,H2B`Y<0QM>JBQ7J" MR!H1ZA&RV5>?//\'+#6(.!N*S`H6?$UJ@3?SMES>X3V_D2V+,HWLO!#K]8'0F MSS#[HWB4?_N&+^:7-]W3G]^D$94UY)KDL;U4S4T(?&+0&3SNCO\`W#Y@/@V5 M:SYZ"'4ND`?DSI358XQNNS'/X(L/O_?AH-BM:?^\.\Z)F<687]7,.L2T]YX/ M>(TAOW=,$#4`OQ%XCCU8LHK6ST#J'E*^BZ$DF<3&:;L"Y$9CWGD@C@^1&MZ' M?DI*W3_`QGK^+V_^#XY(-APND4V[$S_MTQJ!6]12A,7_: M;`L)M(6(.5N`&/%6-3#3.:LK>2^4:$\C.V0'+,]Z-=WP2H)Z""*FWZ\IQ6VA M-+V005<.";05/515PUZPCHV-KU(M*2V0-EU3/<3=5@I55:E[8VUKP8)[>01A M28A_\X648>?6D4NP&&/@1?<.6[FF`[87M\5@+<1@_Z2]`SE8>FY*R<'W=.F@ M?)Z[0RKD6FA)JE-J5#G>9<0N(M]G"P*(EG68S:I$==9=EJNT`H(-8+]V[YX\ M=.MG1]VO"WZ_OPGX"1";K4"&@Q2SAHUV0(5B@T44`3@(B4T@7U6E8B;(_#L; MFS;&C2GY+%_L(>/!)MM7P5J<@KT-=)2'PC!^;,CL<*=PSJ!]=>&8`O/$E&2V M3#"V@+*8U*MOG=4`ILHTW*\NTW"_H`ZRDOF0@TKNF#_NY$CL7%Z)#JN"]G[O MG%[.5)O8[S+*B,5UF`NQV/Z]TRL/%K_Y'I!K.,4PQ!!+:_\=V;PH70`J#L88 M_1&P8>1\H;"D7`&-BT;\-(VQPL-UF1__)O'3-:9XT"3H60N^EU_8Y\B'@PR. M(_C]L_V,?\7],/J%K6UQHG=*,\Q>5N'IW-MEZQ_G3&%/KZPP;)2L0D.KE:M" M0Z61D;N^P6E):&.K_/$]U;*H'@IV4.9BMT@H0E'D49?,NK5G5;9\J M%2D6P;GE6MK]K0JGY"BZM>,%%%ZN9/F23CIK+BGQZZJI2]\]Q_GL^61&;A_8 MGR_E9FF8//K:E]P3\+N$11D!BX+K,R+;97S]Z>KX^KG?H%=7MJA,=4B/ICHQGC2+%U'ECDZI;0" M9I-+!H$(C6CY5 M>AU:/AVJ?*KK\N+K]]INH.)),S`6J;*6YC9FY8ITGMSF8_%;7FG3]#?3C4Q_ M:N1T8BPEM'*??)6$;B[X?`_DFPYL+SG]]AHGK5[CN'NL*;>4T&G!NP#%*Y-: M-B%8+2Y68+W=/%Z9"*,EA89.L]0:+-6K!$N]?E6D$9*12*M-D*T-PHR_>%I0 M%0A,2T4M%>,QCXXTR6KH-$-IAJHMR98;.LU0]66H#75V?7&P-ZU=I,O#)HE\ M^W_9:C5:K53&Z?5=[PBTW=)JM5GH+*\=3M2?:MW[8BO])&I^T^EK86J]#B>94AT3\#2^)L99W_77&)EFX+ M;24MM[3OVJ(@S2;K9/#IQ'*@RZ9F^MENS.:BPM?VQH4F;>#2U8Y-*R MY]JHW+P80L-8KZ3&)A1:7,WZ?YT#9Y0* M@[XMC^MC9L%>;)=?HT77[A-QSK34JBKH6C/1[+W*=;2RK60UV7L-^W)1PZGT MIZSV4[G*E.ZXPNE,@PUU7-EI(;=ZP(N6;DZA:>POJNI!\RM4I)9!G=U560.U MW5I9!'6MFJT!#"PU`<0(=$$)4&7E,S'S,N%B:+_KU,<;P7)XDM>JTO4-Y.CO=3Z'?' MQU[*NQT::Y976MK(MMPF59X]+A>HR]&:K^UO`698\W2GAECCI-UO=%8'7==\ M.\L%:QZT[MS[NEO"VZYI=[V9LM]LK0P'K"@_KA.S?4!JP3^QMOOJ2.G#D&PE M`?4@1`T<_CFR&&N^E^6"M39HK0F+])MG*\-<*[J3VDQ?@,$+TT4G/AL8GF\P M7JQ`'\XE`O4@),_;G=KE%3<@E5(&->;,E;%/:5(G-[BS7O@,LY9+2>[/IFFHB^MYV3QN]_LH6"CMJ MB:7U%"TFRKHD+2;4=)-F=\,;[&JWS=O"B[))&&M-7"PSD1#K9?9M(BE?/C:X M0$F9Q*)794TY1&6>1=5$5K8;QV?M1K^WU3UO]0E="7-T?=-[\>G[9:K03*15-M M#X[,'2H^[[I/K`Q//QIFCSRS9SB5Y2_]-FT M_7^;3L1@]&C,]^/J><*LD`W^[3DPC&.'T^]FR/+D1"GKFD0^4Q?6>?-KN]GO M*;2P>Y!WAJ'O=O#CL\_8-4;GLR`L`#^]-[^VFJW6<7]'&,H">0X_]ZLGNY^= M[$;N0%RF1"8!B!R`N`&UTJ?YCOGC]@99=G^:"%`H$NR,Y\#^X-H.R#\_8F_> MXWI.-Z4L4O;!X;TLG'PUW>$A5[Y'2AC'(UCW/0U:F+4F,\I MU)S4%#57?T<@KZ]=S'6R']E>6$5*O2\,GCYW!]_A8=/!4\0-\DCR)0I%"PZZ M5C=U@F?.4@082Q0)!*/3R@<&1_!W]LCK,8E1D'OH(PN(9 MMI__K]L0SC+<[G\R[\$W)R/;,ATBK3]NEP,'-DSOQ8"[90^SW__3]Z))<#.\ M\"(X*FT6T!/=XK[E=KHC@FSNQ5A]KLO M!EP!A#FSF%X%%I.;;'LY18;058,X2N+.^Q;YU@B$,)Q@8\\E!2!S>1=1$'KC MOUKMH_.)7&%T'["_(YCG"B8-D[H3Z>_GEA#@F1C,G`S]?BLA_GQP)NM2OJ0# M-_C.+`8']^#&G1TJ>)'5=?HGG7AUZT";K#'1&2Z!L%+NBAU8!+]%+C/@L#Z5 M0"^9?GOG*OXA:`HK+-$\!F-,=UG^1;MC0F\0^V,[Q MRU57OA@H/?YHU'R\E,O,B;A!`2UQV7%!Y#B`^;3;SR:4/*0$1$3 M&0YRT?Q.+?ZP^'9@LYZ7^3=?%Y3\B%9Y!`+&8%(HKMJ@7&V7]!ZLL0==8\I, M/X-G\B)^G3AHO4,;[-#GR`=U!,P*JNT]M)_Q[RTV3._#AM?+A7+*HGM:J89N MH3=FVEW701"APBHTUV\FC/U'`.J6-&5@PD<[6&0)"`.L?;HC`ZS;.C[N9AA@ M^<%.5LWKHX&Q3C##\9+'M+ED0^;[;"`,=,5)'"_LF\\FW$D$1TU8!?5A01='#:;J7GGY]F&R#R8:'?.3M>`PCI(KAE_B.P2O:5S%?/!2F& M][]X^Q+<>:'IJ+]?>$'XU0O_PT)AG8,EKEK>^=:U_&)XV9I!.J41OY=5J6C$ M]WPV@E=!WG.:`^*[&=Z9SX6P5*^76M^2Z8J#:C6[$;_EABH^/&(,SWIK_@W; M`0(O'4NT/?Y4S^%Z<^\8[,THGORABK>W9*M:)9].CHN!/=$P@,-OA@)YN<[A M"\<,@OB5&_\[JJ>T!>?1`QR1=T_>W\9(NV7UX]1PB5WKN1DM0[]5>9`FW;!(2P,K&W#'W.YO`+$`B M2QAGR:*ZIR^ZJ!LK]%8N:=V-*N.:MF*?%U\2J'X9I+?EFA);ZD76)&JT*DNZ M5WRCQ#CPAPU_9!5V>=9OLL#CPI#K)DN?`F#.M>4(Z$ M-54'O0-""1P:9]%BEKE/LI;34X+87$;OSY#;&Y/UI*O[X_X1K MYMER(KQ?OQC9;/C9=DW7LDU'A)FL2=_9031`<&>]#"=ND8!F8D(&Z-`$7UDX MYQQ>+JND<_LX_U*/CSN=TXREYH=D%PM9<\/:9Z?]=J?X5:S:[_P4N/[.=$4$ M#[^; M__7\I39>1 M0Z=W!.82@M=:ZI+KMU3"7C+9YA!MYO3,! M7[_"D-Z`&4^VX]`;_&TC](R[:R,<,>/K]RO##(RAYSC>4_#!^(PU24UKA$V3 M\/>A[0,./#C2QS`&7GKB4N'!GUK-UJD!N@-]03?N^"Z^XP(L!ND?62_UXY>: M$C$YUYQKOQ9I'ZN(:(G;,(D=73YO+OA`=R\;/AFG;WG#SXCF;IU MCDRGC1[F+-@6SEE(5JF\8ST?<$%N.CPZ^3P*1YZ/ET=+3YUUVA`N.V./CO$( MFKV(W-VB"L&=6)Y20.<:^0_L`8NR7I=H]NVSC1"7=3-Q6AC:5JVG2*11HX7@ M6D1#SUA@]"/&<,<)Q.OS5[8,`$X[+19;:RX$<`A8_'^.CN`$\$+7@P/FEED4 M*W]TA`AV;/?'AZ'X[0M\,)[IJQ`(Y)!2*,PG'QX__[IZ:GY M?.\[3<]_>`_UP,VP?[^X?M1SV-A`"F%AT$I`]!W.VWC';M MDF&>$CDRH)M_OD'\`64 M15@8Q=PGQ(P_(>K`):)N!(P)]<]G8V`2NLSOJ1$(VV%L)>T^;59F).P=YK+7 M7LOMKS[=Y^;Y\A/\-G6HVE#-3"VIT>A4TC^#,9=4R3G4+YQYN?[/%G&8BFS0 M;F9X/@:A'FXP3RC,;>?_1G0<(EPL3<;4;A)SF!TS\/>6Z0*5AG.WVK&GE.GP7BP!B%1'XA6+*(%,?AK(L<+$F MG,$`$)Y_"Q-@D<4`RA*H"3U9\-^KP69LW"GN?1_Q`#TC=>U4#X:X2&M<^F8. M#T/.8B1_DB`"`]S-II4&<+:K-W9Z-H`[F?M]G\Y1W.!R^I*=DC%5&E)VYL^2 MJ`DOF?A=S/I8I*)0^Q/F&QP85&,!(V"23N"282J"*R[E!1<(DZA(6N[#=NEB5&%*WH`AEX)\3P2@;RB7#L>92 MCYHF%3;"-2')QNI2T]:>N2+ECT8EA#9X79G_FQT_GJPKUC@ MXCSD9::P=:,EK:7U-"0MY[S0Z;E4^%.7,LD'>FLN[N,YQ^@9BG9\GI[1:\DA M_8?`^<*-X`-C15UI5?Y<(%YO= ME7:N.WT-;G[R:E4R8W(C(_3F/;-A1SE2M9#\)RS7!TC]^-(K*T%X44(#YT>81>[STB.H$! M%\F>U3V9@;RFC`M<7%PR!0*D/F)?U3)?>UR#&G'\9@+S?2Q3>2H51>DC])DS M]ZI&7@4AL3&FEYWA8G%\B;G7&^8WQ27O1P0ZRMM2M[6+S5:E+5 M4$X-B_7!5JH[7$S6CX8EV>8$9XSF8IPI41>V4Z!OEV"WVPKV-1+?RTBKWO+A M:!#;9KLU7%3Q;K:*BZ(H_W[,^N&SQ?&]4:KL(;Q-_:MJN%JX?7WPKL%W,9D6 MO]@7ZF\2+@T^<<$*;KV?'Y8'JG MY2=(W3>NF2<4+3EY^(H5Z9(]+K2Z&`V3O)L)192\5P"K"5M!4FI8$.Y&1,`) M0B%JUT5? M':WK!B:4_NPXI?,7$*P^]J>3S\9C9H78+J#UU05"`=N3&/G%[:2^]DQ;H4#8 MD'UU=&]8F)#ZJV/7`)Q8/>J.<2SH7WIG?T("#>@&!-7;^ZNN-6T9%E)3P0JR M@B5R93M,SZ`T9?5I;:R+2U/,\O'(NN==#WT@(//5$`;&BRBI/>-%C+4_4"J3 MWY8`">Z@W.9]Z( ML"'<8M'LL72'&!@NIJ;V9!S.P5WBY&%C2]C:B8,G@K9ZG>'RI-_[S/U!+`P04````"``N0JA"E`(2Q%TC M``!KAP(`%@`<`&YE;VYD+3(P,3,P,S,Q7V1E9BYX;6Q55`D``U="BE%70HI1 M=7@+``$$)0X```0Y`0``[5U;<^,VLGX_5><_3,T^SW@L)YDDM3E;\BWE/;;E MDCV3LT\JBH0D[E"D`I(>:W_]`4C*(BE<24`-.7I)QC8`=O>'2W>CN_'W?[PL MHW?/"*=A$O_V_O3CI_?O4.PG01C/?WO_Y>GZP\_OW_WC?_[[O_X>A?&WJ9>B M=Z1#G/[V?I%EJU]/3KY___[Q98JCCPF>GPP^?3H[V31\7[;\]24-&ZV_GVW: MGI[\W]WMH[]`2^]#&*>9%_O;7G085K_37W[YY:3X*VF:AK^F1?_;Q/>R@@4I M7>^X+>A/'S;-/M!??3@=?#@[_?B2!J]TD39!]OJ9^@`_GI1_?/^.RLO#/DXB M-$:S=]4_OXQO=ON%<782A,N3JLV)%T7D4Y2(7[/U"OWV/@V7JPAM?K?`:,;E M<4,`)?U'2O3?Z&@G/:@A_T8QG1H?`C3S\B@S2-ONV(8H399>&-LAM!RZ%YW% M$!^6:#E%V"21C7'[4+@@Q&`_GZ(/KXP;I),U>A]JXR0;&ETRU8`%31N"9(/' M*(D#,L3IV:>S_?M7FC--$1D@!]])/E M2<$7O[])RL[+D1^+D1\\C.)L@;+0]Z(N=(I&ZTOU8Y;XW\[)OAQ<),L5F3C% M=O_D32.D2JIPB-[TYD9QCO3$Q^EL1'94/PO\VB(.])'ECF&5PE,3))[:I7%@@L:!71K/ M3-!X9I?&'TS0^(-=&C^;H/&S`9UDN0PSH@]FJ1>3X[DX%X@=JGUD*@S46YYH M3L72PKMIWX0I)_,;X$74^))AI`$15FZ^0T5T^##I]/*V_"WZM>3QXR00*<+80K= MD'^FFZ]$WA1%Q;G%:E;((>X232Q^3;#5>:? MEC]EAI.EBL"J3R8R:A-,-*_?WI,>>4HH25:49KK0WI4VY:\^V7[(W+N*BGYD MD90K__WKWZ.$;*B_O<]PC@!QNHB\-!W-BBU^^!(JS;!VG\G`"GH"7X0`S5>$ M)$BRF."#NF]\ZM1=-GQ:#&!V&T_.K"#"\[,)X&")F8T,FXLW!,GD$#KLS/@MZ[AK>5M:_Q>TU^L`,6RP^\"Q1[17#V M-3$3[BRCDM#S3A@Q>TU^/"R,N$Q4&)TZ`-(P38F^.YRF&?;\3(!+L^'D)T@H M=!2Z7;J=D_Y%CJD371F$5OO)9T@L=N4KPH%!NCL;UH67+D0G/?GSY&=X63-D MR#G+*X+=D7!U&Y".D8_"9ZJ_WZ.LXD@?H5.&`DX2?YO>:#$#]!P;0DC'GT`;7R8H2"&4`ZEDP@)V$-X>VP>:% M[5'CJ=A M$(3EQQ^\,+B)+[Q5F'F1`!5.C\D`.(R@`S@B5APZA(B]EB_SB$8V%S=5-!<. MHP6-''M&-[&?+!$-`+].,`KG<:F5^NLG[,5I5$2K#X-_YVE6N89'LR?O16SJ MFO[:9`#JRN@V-RR)P:$3YQ!3,Y<\5G8L!8YW,H M6V$GS>0AJ^E$HB3Y8W+1,;GHF%QT3"XZ@$R68W*1M;;'0\G^4C.A[-H$9MEA`M>@\()O2D5H8P: M;P#8=*7NZ(GX<L*E0?;%J,>*0N[1)[6WX9TY]/(2:\@^HK&>K!AJS-W`J5'?D^-PXY%BM M7:=JJ"""7L`Y4CIPR;BH8/K)+9@ZZ!X*O8&3J#K")N2F@N^S6_`I*AV<'L"9 M5+U65XV#"IJ?781&3=L0=0-.NNH%4IN-"JE?H*Z-A`6+]^U6H1+:H66(L1?/ M"X&?K[=-'KPU_=7PNX<#I;NEWH.#W$7Y"Q3D$1K-I/2G/`:DUUBFO@%R`V8$ M5HZORZ1@#ORRK62&?$5RP=9HY\2EFDD0V?-DAV>'/-6=>=XR%06R+I ME9&-SX'?`^[`R]DM+/%^G$Q&!>K*#2;HK'+QWI,JHJ/B\ZG\*FVG,>PMIZVU MSYD33.[=V2?^\"CCF13%1CO8*]#]`KC#N$,7<35]J3;-QDD472?X51FBQ=K/ M"17?U.P*E9&`+U;W8T>H"D(V(:R[!;2>!7*E@I**'T#>&=;.Y]*G;L:+AX"P MTM6$+EL]1=`RHQZHY"Q&>4?%EJ!RGT!K>1 M%2'1Q+/)X%\*3U?,5/O`.FB+4A4PSQ!^I5=JRG!ZP%JEBNN*>W/%X\B=A7B= M8R+5'%/CZSI\H?^2.P_XG6!MT%YPB9DR8E\RWMHJ?C6Y2K-P26,$OJ1HED>W MX8P<[M+:_LI]80W#+JJK%FL.V?Y<7G=8>186`](:!R8D5PLBS=.-QZ5DWW3* MIM^\QK?WDS?VB01QX7T9A^DW%9.>WPG"E-^A1F:XLSM`F.EB0?+T!![U3ACC M*?(_SI-G(@>R"+,2Q?+?;?S*WTYNBO]1.GY'R1Q[JT7HC]&#36-5$WF;7H>V M]#OOWPF^R-,L62*<2@[5W<:V5."V!4WS%$YUU0<7FP,22 MX(KW?Y-I(I'KM@EP,JZ^0%NDV[UUW=#T]%TFT9V6P`FTW6=JDP,C)RQ7ON<> MCHN"K_<).?XE(F8U!GYS4%_*7":,U*_A"OHQB==7./33-(GODFD8(9HUG<>A M7VA@Z7`J$;[J`,!/"NH#HL68D9HU7)#N48:3.'R10-%L!OPBH+[`&>0;J27# MG_OEG?Q(?"=?7<9+@VDZC0;\(*#.G7-?+ATRE"^\='%]>7-Q$ZT9/2!U)0<$WD M4#,FN">ISB!`[QN:!;(CVW8M@TMOG8YF8[1*<,$-PF$2/&;AJGS@YB:F3S$* M-2+E$8`>.K0!HA[/T.^6[#ZG`I152J3R3&@@7%5YNK=JH:><3D"AITUJ%$)/ M&1V`0D\%@N1HC%SJG0@]/;YLHH`4&]GC"R?'%TZ.+YP<7SBIR^/XPLG>,3J^ M<&+IA1.^/_BU.$+]R&S24M;Y?4IJM67EGN%^X\*F8.KHAL;8M8OS?4Y9KI-4 M5`>^3[*K%W]!H\""/\)L4=%6_(U_YZ(_%F3.I0%LF%*+XDF3HS"*J7\KOJAR7="R,$E, M"V*J^J-8_5SP24E@DSBF>%RY8\*U*)0Z0YCMW7%1\03.N8_D,?/F\''.7V4$ M*`?=5C6M1Z4<6+,MK(N*NQIX*AN#>G<6CMG;$3M^J3V>1"R.7+*8>CKD+7F> M#-R1_*CAA__)I074&Q+GSIQ^V#AXV)B_(P&-Q&:O"/T[$J<2ZLW?D<`&8FMC MQ&7"H>/G$DVSFS@EMG-1L5^L)>PVMN22LZ\>L%EQ*">Y2:#2@T"\+M9>,%96 M$MC25D&FQ84[NYM9?%S1&`P!M9]Z/R*>I$?=)AM*G[\G3 M(LE3+PZN(AJG*TN2ZS`8\%O3PI7"O/;MRJ/56T!5JAX-HOA89Q`T+=T:B&T6 M+0=F*%)U'TH+!^@/!9P(;PW"%H=.:2>E8LMY#(I&$MS$0?@<`NQ9V46&[I@%D'/) M'2/B#4PJ!YV>%XL0S:[#V(O]T(M&LUGH(RR_:^/W`B[XT66E<[S6$AZMVB_E M=T:S\\3#P6AV22:K3WKS']I1Z09<&J0_-,I,6K9+=B+7E(N%R'I"%P91B\+2 M8<8AOW3%7?42\`B/P_DBV\0P%^82D3=*+[PH0L'YNFJ75@T58@&[C@Q;4T0) M1N'-7B^^W=&S.&&S90ANARCCJB-L?9$^Z,K94?4.R+ MZ\1(>\,6#^F!HRIO#OF"FB1_36A1!>DNS.\$6R[$&'0[+-DM!6(CE0:TY$<' M(%1Y,E()T'C0Y%D;[[7C<^*Q0_ M0V66;7R%52DMH-I&+2IJSLI;A>PRA=X0N69\LLJWR6599TK](?+/%.4MOO22 M6E\/BF7BG>I_,XN9*@I0ZD[$^I,NN/R$-.K$'TF[PZ>SJ:&21<\74QQ MVPNBKMT*VH-V/U&'Q+Y<51>4M.+G=9[E&-V&/I$#ND9(=NVCUATV'TYU)7', M;T7^K%[*;5BXBN=$)T`XC.>7A)LH*0HL*^"D.@!LX:8^2.EP:/>2KL6%Z@V= MN!ML3:9..JHJ6PYY\EO$7N3D!V&A?G8'R()+[R M:#>$+(VD*V,^![*YOY=2.%,:IN37PIL"&+_%-F:*$VMUOMX)JQI^]W"@XM;H M/SAPA1T9_2F/`8UZ//V^`>$],0,K>TLT*I@#=\"4S,A]+8UV+KA5C(+(GB<[ M/+MCDW?G>PQ/MQ,AD5J"L.)-!9Y6`X>*&) MCHK/\YT9_,:P+B9;:Y\S)YCTNN8RM#3]JNG%>Z8G?PB+DCDEOF2ZG\&^U@2RFU9C);[COT MNC/A[[P7-9'7V\%61E(3>9M>A[;TSBZ12J48Y5F:>3'-8APG472=8/I'&ZXU MX0=AZJ/OQ:]D35YO?-()8GU"UN3GSBG4E[_?B]RQ MF[A\7/-WG*16;AKX7P,NS71H\Y$GP3>T/5Z]K$)BF84H [,W1AN4''`I39_=$@:V:6*[.S#U*U:'DQ>ZN7Z;686M*FZ/" M6KVN`YW6AB7K4`YH7U$3VD$Z?XU` MW@:_[EQ?Z$>-0(?,-@0I#Q9Q*LJU@[3=B]%1$_N;B=$!]<^U9K)*C(Y3X9K= M8G1`?4=J(F_3^Q:N_ZZ]$!=UQH9IFB]+,X78XW(]?A\U7 M=C)Z1T]X;W6R7KVLD$],Z$M:BIM8MV,OL^(B5/TV;'SGGB;3'F8R3[;NG',% M+U,YNU,==I\07HH*--O[*&R4+/S$M2;4M[KSCL/TVS5&Z";.$$9IML^=E_7M M`PWP=6[GY]!W,98P%YV-6-88@=^36-:+N?K,5HEN*C;)KG]L?UIMRZ5#$^[ M_](Q M2A'!9D&,M5J96VH]Q:G"[;6\-^R=JKV-AW,MKB80=W:M1Q21,>?45O?P-T1? MYU(%7]85]FIWW\BK2,,AC_#O*$;8BPBYPV!)T*'.F2Q\1JK@*_6'O;S=]PQ0 M%HE##M5NY3CM7'6Z;'#M\._04NX>QNA..45+=Y`=:W-^-I\)(.;=(7W@+4PF M5RP8T%GEH+%1/<`G52X:[1R_WNVXXMDS88=QJV\F%!=1.[Q5ZHKTG1&EWL#W MF=:O'71%X9#:4+&-`K94*NI%.J'2`$`EAW2!X:A]ZBRZ:3' M/%*=;QSS2-]N'NGQ89CCPS#'AV&.#\,<_&1RT_ET?!BFF_/)[8I]1I^#V6'\ M@#:&`RE%?YB%\E0T66ORRQ6[WJQ^K?XVA*<+BN5];%8/7RQ M^K?X'I2]'5]?N+)B]?N>XU.YM*?::MP84;C)[R^2N(CORKV(EOH:R";Z?JEY MFV],B6<[@(2K*?^SI2EZ6A6Q=2-\)AN/"V2/"6*YR-Z1O%-D>^88%F@=I=A8..X)8N%:3!JLV>U5,`PG^=I5J/E MGJ@#FS36BI14@IC&&+"!TAW@TN3-2.0>%ZQ_>G'NX76-FB?=U:4^!&Q<<0>H M]%@S$JC&1>H23;,K:H72#5]Q&0GZP$;5=L!"PHN1N"^M@XA,A3%:X="G%P*= MSR'N*+"1I(:.(2%W1F*;N)"-_"R1$B-;0#J#P$9G=@!,ESDC`3MZ>&FJ#1IC M`,0S%KLF7CJ#`$?C=3JQ-+DS$ARAH>I=1=1*:!&DK>T) M1@$.(3.B\31[H7['>%[ ML4-1RXR0;94Z@P`']G3`39L[,U?:/2$;Q?SBUYW&`8Z6L09, M+=P$3#JZ.*_^S,-L?1,3QO(B2.-5C]O*I,AQ>@W-X]:H`:)D,H"L).W.TN\E M/Y<*+W06P&L>'N>P,?R%R0"RUK3!B6=#+DZ_IOWY&))[#,D]AN0>0W*I+#9U M,"51N/5F?Y'`VS;+[D1O*M?R=:RD?+(WAL](0>C<'K!1JFKB%A)O MUU5!D-[XL"]#C'S24WNV*PT`&X*J/.V5>;$;<_I$_H[^A;SR^QL#4O'&6J4S M;!2J&ARJ?#A4>;#;`REV[D]<4V!W>#ZDTK@'\*B%I3N7CB^D=/=K=>3=':W\ M34PF5RP$T%GEX`LI]?J[TF=2=AN[7C&VX^+G3`HV^^[L%++X&F8[UZNC&H5P MEW.'M(8Q95FBZ;VVL162[9J:UV38H:O,@C#I4JNULA:%K:Q2-64ID/=N2/6! M"MP5M4-?\@[J"G=$=LM\*86@T0XXAKT]G=FBWZ78G6E_Y[VH2;W>#C@`75'J M.Q1;CJ-B/N']A%YHQ3%Y0*M*[T,M<"BX5M;EWBZ&S6@4HG=L=7)!="*W#U#P MN*Y,F5Y^"5=6;U1:?FQ:KB^,1>%9*MV`(K]-@*'`F$.&1M_:D5]12LLW%M7Q MD4_^^9307^WSK4-5$F!CQSO.*1`A.61:V>=[.)]C-"=+\R;.<$B4>/^K%^4V MG_#H3!-L%+WS,U@D-8=N\CH+HERAH]DP",*2^J)=.LRS18+#_XB?IK/W5=C( M?*AIJ2@7EU[[8K^^5RP20R\=\L>"C:+O.TDZ<>O2:UC`KUP.0*I.6`5?QNXA M/?VD7B!^;TH2]YN3`8@7T0TE2"P5UUYBZL)H\1^JV+TN-.EC#X8^,QF`.$J! M)Q9/$!!/'&FEH'$?!C?\AYC;?EF=]9S(X M0`>S/4DX]X)1%^ZNO1`7Y^^0,+ALJH'67H*5?G0R.$#O^9[$8KE2E;FT?N8+ MS,5/]![AE5D+!V!'2B:#`_2O0\K*DS.#M#Q MK,*3Y5I:=8*IVSI.T1A%WJOSFNCEE6 M"]EWL9#1"E$;*Y[?(BI\HK6@++U5*`0B[@A;Y(-)FWK]#GYWB-(<"(I/NA)A*"):&GBKUAZ_/ MH09+)TRW+/[E4'4EQ'X?\.ZG4LA7+_6^83)^0!G"PZDD35_8"[A* MB.KB8>F:4KZL!KIROBZO&"_K"%Q(Q`(B#=;L1H%?>(_$VO`N(@][9669"T(U MPKILP9G,<+I(EQ)4-(="+CL2!_4NK!JMRK)??(0^G'H2TO"U)L!5QKI M@\`N(W8?N[L+4WIT;AYQ2&\CF:BY/6`?L>LE=2%/=I^N>UQY/KI$:3@GGY?) MGM48]BFZ7F+GL6/W\;G*37^-T9\YBOTUQQSE-[95T&`/YJ>$*;LG_'+KLCV^!"=H)NVP`]FB>=G^4[L M6:^/B9&?8QI1?HF>492L*&472@'4XSG&.$JBME.3C6]\%/BS*%$S*;BFHX)U]6$JPI/T=]X MD7KX#W\(T+1L(Z!J<>I0OB6?[GO$VFF5^H$F4%N&<\.>D01&[D'8^OY]DH4^ MDL1N"OJ`)C4;./1DK-G-`"P^>E6%<4I`8+0%S0(V('P>2PXEV54DUDN+B5)Q M6);@9?WAT'VG`HS1,XIS ME%X37*@@,1'"19YFR1)A*KC;A*R"\%DG2:#KD+#I`YI4JR<6=!D8(N6@#VSL M$ZR_#`X\3>&1^@,H/;^C9(Z]U2+TR7XF3D[@]G$K):$KHIR9(F+:G6#V:M>N M$RE_R8;7!SP502AT#DXB9MXL3M!!*G8`LU;;/T7^QWGR?.(G>9SA=0E;]4,; ML>K7DR^/#&BV?X3-'!#.^J;SBX)DHF\7OQ#E%'0?##;/ M0`._?BRZ5%U;E8&G[XDYP%\'@TU1L`EX@T6'RE5O*:<74JE8/^-'8_49#C8K MPKS]TE4&#FT#&YH5S'78[(JNLF8C5^?):OA6]:$'8D+1"\$YYYJ-WQ@VN<*, MU,7,V2:D3MRBD5)7,L#,(HIT^B/]*XCY`FMUR] M^%%.F*)RIY50\LPK(]VN/!R'\?R5>!7WFZE/P+KC>G*A[IXS\2$(=YU)F&7N M.U,R.G!W7D\QG*_9`\B>5;?W5;=!WQ1/JZ#QP\+G46K%"G9?572C8HK+N>-=)#$;<6:+=7D@'=:%V MQV*'"8>\(Q=)_(QP%A+%X8$,BS!&03%WI-!(>L*Z/[N#I<"60RY/&CN4Q*J` MM=K".BO[0,1@Q*$WYFI3Z!)-LRUS.FN*U1/6/VED3?'8LEL`IN4`4\W(%G># M]5O:+-YG4!\4XW:9'ZF!G-(3S%(A%R["<.Y0?NOVVS1;XG M"\9D]W#";\K!2`W1&B/NV,4,(N5A>[P^X+Y*@VW;@:#J1)3T M@_4BJAO&RLS816'SS-GF;='@*7G(L;_P4E2[%N""H=8=U%.G(&(6,AJ<6=UO M:A\K7Q\>(Q_1F/-1W"91^."B\B#6BE5;!$N;/X=\[0\X\1$*B@CIBE@1H"K= M0"LT:T.HS)%+]\21EZ:OCT2.\#B<+[+[G,IE--OZ]2^\*$+!^7HS":N&(EQ[ MC@Q:4KHS]":8-GYAO4DZ#8L7-LJY4?Z[/2O*WT[*ISBHPM7>='BOIZMU!"I/ MW1%3#9[L7E)+*!"5UI5W!:U0W?&45.3*[DLF/9>Z"+7^0X/6M.ZJ^YCAVDC% M2;[57%0T+>O;%R_H\$WG=DO00M8=,6$S8:0@I,M%/2&+6W?6/>0L&:D=Z4X9 M0\CRUIU1XG)BI,:DBO5]DZ8Y]0)4M;3I(V+K+VE18WMSB";/8?T&1&2&JX\& M6LZZOSVNR:BT$B4CKNF$4C`E\X/\\/]02P,$%`````@`+D*H0MU%/6.D7P`` MF+$%`!8`'`!N96]N9"TR,#$S,#,S,5]L86(N>&UL550)``-70HI15T**475X M"P`!!"4.```$.0$``.6];9/D-HX@_/TB[C\P?$_$M".RW>[QL[OCN=VYR'II M;^V6.^NJRO8SX;B84"F963HKI1Q)65TUO_[AB]XI4J1$$4SOA]UI5P(@0`$@ M2(+`O_ZOUT.,7G"61VGR;U]]_.;;KQ!.PG0;)?M_^^JGQT_O__05^E]_^>__ M[5_C*/GM*<@Q(@A)_F]?/1?%\<\?/GSY\N6;UZ!^___[[#^Q7`II' M?\X9_FT:!@43890O)(6@__6^`GM/__3^XQ_??_?QF]=\^Q6=@RR-\3W>(3;\ MGXNW(_ZWK_+H<(PIV^QOSQG>#?,09]D'BO\AP?N@P%M*_T_OR1"<_O\H__P5 MHD`_W=_45!B%4_[AE+_?!\&1$XF#)QQ7I+[Z\!>T`'??4^D__G.;NULZK,AB M?RJ_[]#B2(1'%QS>X2Q*M]?)-%9[V$YY?BB"K)C!=0O?$=^/:1'$DSAN83KB M]3.>-K4CH\936 M&N^+6.NLJU%!%E;,D7^.R%5"?`A3$L\=3[;+TH.Y`I6\I,:3\D';/MK1 M1H[#;_;IRX4P;*M65PKE0U$MB+5D0WY"%YO4_\9M2 M4P58IZHJW2JL1"M$C>T#+JNR:^+;M]2_?XJ#O415 M>S".5+3/6?\SU[\C"@"AD/,X=*5^@U^XK79=@&75[?*4972D*`^#^*\XR,@F M^(IL*R2:)P=WI(0*?OM?NP1%'!918!(-;A$%A]#.A5AWI;9CFM+68"GLLLI< MA<:/A*Q$@;L@CI2VQY=TOT)_A]#,.?RY4K^A;]M6N<[O;M2L/C54.$P)K&/% MZW,J_<(<$-1-VN;9M8(.:L60IG8!W:ALXY$_D;_D(THK0#M66Y%;J1*T5TH& M#*FZ-OEVK;X2#1E2X#ZH2Q7FQJ.OQ!UX$#7NA:I_BF*<79)P9Y]FZG/8'J13Q>YS*=$&!H8J.#@MML*N6Y4= MU`-14[M@3GQQ>CBDR4.1AK\]/`?DLVU.!4U0HGE1:H^L1'3KE]4RR'P;PT(, M;84X(FIA`GII)_(X]MD:>C;@N558T\QC%^1/3(XJS8S9"(Z+.O&L;RSEG_]& MEPU,HZ;-[E.4!$D8D=`IS:.1_`DS=`>&8RA/7]TN@ICF+Q(-P[C(`5,F9LI1 MHZ%TAVI$5&$")TU,4;K*?HQPP:SH,7B*APX198`0EE'Q*->=7QD(O.Y/YA1$ MF3O?7JJV'`I,02_C(,\W.[;ZK%^CH0VJ!@Z$V@YP+ERX41"TV?%X@3@[`@:O MQ=J,IVK&091:IB]2_1807*MZFX&K]!!$B4+'AX`=*O<@KV-:S0'!]-J`YW2, M9Y+OBX/0#KWUSB+<+Z^(R1QEN$MX^5'?'C"FPK^=%*TG?K@AK=T+H+D)6Q`!=B<8M05B+%"@PAGPQR9`E6,X-6<:] M1'TNO#1E?X4P,N6Y8L";LM(6ADUY&`5L#W4;)?B&_%-K\]0"AM@UM7E5;*,I M&&)P\/NE^2R#[)0$K9!ND1I(URJ\SG-+A^?(#4SN$/WM?,'A2,5I87VMK**<`[UU&1XV%57=4I![[H[#CG%<K$?G9YSL3Y$3XR^3/8,9)#EHY"B88I;*W0!=Y' M24(SALK[PH4X;0I@3./SFMTERYAT>NC6,@3AF(W^YGRM"9RY5'S+RQ`)3AJX%>(8-1+$M@Z-%&.K(:W?YC0*HCBD&^G M2ZF&]@LKJ@K'M?G>9?@81-OKUR-.=15]AQ5K8#HU93YJ^3I58 MJ$1C]3$8(NJ%FU"V/4\LS-%R)E?*Y`H[P2B,X4\3BI5*0L>IHKGT#0:FU7<1 M.JB@FTK=S23<)G)\\^C%CE&JXCZ8J`U.P3:V6AM:YU9TA8\TMR[G7'PF/96@]>K90$.9G#GWD&H\IB-]C9;"NP\F4[+?+M[NR(RR0EQ_ M/T5'>D!/`EQE%*E"U$13K6BK2P&`8G>-:MPJMSOP6D\^>T4,L?@7/=OH^`IBJ."IMXE/%'G.8VW)`*@)EF\ M:5SLZI-P:#\&UZR[,/?`L^1Z69]<7-[\WAS_8#6GZ_0P^/F\C__ M?7-[=7W_\`=T_;]_NGG\*Z1MF*IAWWJT\0'M2S]50H4$8T/CJ0\T>LG_=O:/@+`/:W`L_2&L(2$/^\UYOS( M(6$O9*=/]`JQN,Z'>]EA#9?=R/:@`-M5.&X/3R M1L*S>/E1/FTI(9:FAM,?W:5HXD+K3TEC"G:Y1EV&ZR__86T.SV#@[(TM8EY8%E2 M]?1/+37TT?UKEO1PB`IZIT:/1"_3A-8;Q4FH5DPEELNW+TKNA8.[!IH=V7?@ MP=[*S!(A;,.C=Y_3`J,_?0WZ*F17*;9737TP;^0W5[ MM2Z*+'HZ%?3HB434Z"[PY(!^AFB8@8.>T)O?5'ET-]6MS_!S$)]411`'H=T^ MNQC@=N`]0KMPQ@HQP!6ZR?,3W@*^K3#B/>>\OU!`L(<3LV=;LG6?+8!16ID- M,;S*)+,AD$_)8U(?-/!>10"%"*K+*M!C_E($=1P^]_@<"CB;(MW+NDFM@]AI M/$-&]WKA#?!='V)KD,CA%1:-6MO`S#Y9V\ ME&OA1KN&1!04W22H!`:[CY_".WL1_!Y%"0H7XE[O9GXJ[^^CY/U2G!OXRNEZ M$]5ZXY7'M".0/WYSQ!T)J1,2<(#LIM/A%`<%YJ_9B5L_9O@9)SF);&Z2,#W@ MVS3//Z49CO8)OR,*WQZS(,D)$FU&L?V_I[PH7Z)L=H_!J\H#+S&:VXRJ!69K M()>I&J6L>-$9!_&!T#LZU-0='ZZF10P(PNQ_-7EI_H MS%_$!@+UYF>O1RG3([]6E-_-I'JTJBVW/`PD$UH?RO5J>H^+($KP]CK(J$WD M+9FN\"X*(]75F0ZRP[5.2Y:^=51(J,)"[]H&4R(*M[*NUI]),K4%V'(HF#V, MM]P;K'Q+:I57J]&R@OJS0NB[O+[#U\"$3WDP2G4`3G&8E]K@3S[#@!P\CRT? MR&:`<<6^,6W@@;58]\B1ZO$+[PCEOF,\H\6[*@8*MS>.ZE'5@@%5&:Y6X$'Z MKJX`0DXO$Z/K9D#CU(5D&G:=/A5=D!G\*!YL(AMOS[VN+]<5QC^&");>-B## M:(Y/V6>]0?(CV\U(E#)70DB0\"=%2:9=ZFPE`0O61$B(O,E89Z,MN^V^PQGC M4-M4Y`3`3$8ATZCI$%RTR1#'YLD,B.!SD_+#C":)5YI3G5CDCQF-::#:G*38 M/JP\/`G&<-6ID(!7G)IWW=7&I[QJ;1&ZJTRT4,ZC>9KUK&_@P4/I<6O0625+ M#!],>=.D4AK:;U9-*,:EX+$368ONT$S,4K M?6'<$N]88_IC3$HM5!O4,"K@ZR"#0R@E%LR;(8TSFV[^OS=G3Y.$\/'424.7 M%&\8P,^;6KQ,.&S2PH8Q#8-SF*Z)>'G&-$LPGTZ7#/1-83;>G"L)ICQZJ"3% M@%Q!I$<9@ZL'[%F2,?/^G"+-F_>1)Y2@BY[Z]$@&#FZM>N=&:C1(NU7OV(>5 MR(/SHFER>'E29/N3>'5(9%\X?\Z'='S!J!^#/!GB;Q-8$'30:UB\#=__.A97J5=5% M;$"5TN>M_:O8KXC]#&8T.AX<@(QLL M&'.9SI]+0QG0PKZ9M$%<&TFY%4CVUV7S&HVMCP+'H0&I..\K0PV+*F`/-C[3 M!*B:#(%6`![5FKZ*RQ'<;WMR3(L#KI/M%5F8XI1U8"[94NZ%E'A.-TAJ"08: M:V]/88$JO+(:8HT)MVV9)D?6EF.[H!R:^YMEI7"[$=*P#7%WI$)R_OH;QX3F MGC#S8Y#]AELN1V';*B27K\%5O`LG>D%?T_C^[`8WWK/ORUS[?2= M\JB6"^^5Y1C.]V4X(<%`3%A9;P]1$M%`@-;@';?344R7^[=1*80="<=@6M3% M`=OAS9(A6%8&O3W@@A(XW27JV82P/6KM&;[:*@Z?I:9)N M,7K$X7.2QNF>OL!?7Z!WNS0[X"Q^H_]Q^78D;.8X^9KGO:!4V%C"&+*.A+H< M@^Z$M7?`0'?$8/WI3H1AIK;X`M,=*6LT_<8O.+\QRA)LZAXNTD*3#Y] M01Q-EPJO??`C+IY3\LL+YK7[5&;OE`OG=_&N9E=R-$\:KG.#/N4S>.BN[G+MW)E)M'S9\ M$=RUD7[&1>,]%*;9@W-HD'T.A_*(N@&07]4Q=?B/R4\P9C>5.Y>F-:BC?8/J M`KDVHZH";O5Z2N,>78[BT+@4?`]I`HOIZA=\'MRB&_#/>#_R5A+L#02%![U' M'U.:OHI+X:&U_2+(HY#>`$;QJ5`^V1O%!-1]48J^"M4UO6L36"&&Q2_5.1Y, M>K*Y,)5G1W7/1?0>/=72;!>29J)AC\MST6>])YU/EBXQF#&#[Z.YMOM?<+1_ M)@.OR4<,]OCSB7;4W.P8;ZWW._KN8"I!AUYBLLQ]_:P(H9(2XJ1H?O1@@:/% M_8JF)5J;`-%`WZ,OU:0$Y:0D?%+276>95KY1=&G(\RR@;]\3J;GOJ5"^5MKL M>(A->!GH[:,1\QI3 M1/T5B_Z;D7%^_:[HN57UT[I+,]9HJW5"\ICR\Q&=U&];([B\ZK@=#=&_ADUFMVLUPL6_)?(^.9.A!GZ$ M1RI"LIW:6':I`3UQ-;/F;(+G&>Y:R4=DZS5`BUFM@PQGDUC-4%C-4-&:D:"F M`)?UY<5$M-PT4&J8%]/0Z(.O:]5\IVRR=,T8#:!255\"C>5(B>6V3I6"^X&R M07K!J%]7I&9"\D30;C0)=X&Z#.^.RS>-&T&[>6*<3\>LCUI"ZY5%4*.#GM),5^:!/"%32JXMMPF:\\?T'M,IBF+< M27!Z3.W9]C+#.;3^A>9+*//6#$-#YGH@)&8@DI_/SY,`3&.1HJR>QJ1*2"%_ MI?\.Z0R^.]%9B\BL':NY?'KSSS\M:;)]#[;(6,ZC]C*?!;,K-+*18,<%JGA= M@N`R4I?Q+$:V:?C;>P:)VJ#5.P&8DU5#]I\8^V&;?;P0^[K["V\%T"LYX1_[ MWW/V$[RG_1_`!'"ZKU,Z'F%'-PSMVEM>X2-9)R,V./EWC,N3UO6!7AW^8\QW MZJ$[]*2:\O3UJHVV0C4BKZG10H7QKQ:$XG4I6O"5Q;"G3L4S1F\XR!!.MG#Y M@$N(">.074CBTK69>(F^H]/"!7A!FF'B?*\P_]]6"'L9'"/RB?5*]6L3G#`F]J]"_)CO+UL:R).'!KG*6G)?/Y+]HIZ&DO>7+/!&SQ+" M*G=T%[Q17T2W"&&8G<@';V(QLVA&X@O6Z\SG2W7KU*HOPX@Y-%+;K^ M.)DY4U%+>VQ)&Y32^E#3SX+>:P3WVB3AS?ZJ[#H_WHE(`Q?4A$5)-`VU0H3N M9#1%I)KW;)AW6-N2*->X!?41_4VOLI)6Y6DZE9TT*O]SIR1RLA2%,D-A,"D! MK*B3!;GT4R_.(S-L?D:8+TZ&5W6TE,.I)`;O=-2R&CJ?FIA?F5=61._G<$:U MK)[D2$U79DV+55%R;;DDIB\SM-;AWT]1A@FSQ*$4;W?DH]&:K;1**^N5H[!8 M$R(.+=5(-N$0IT2F.9(E.JKP5XA16+$]84T$RBKGB4F8>J8;B71'ET^&Q\3" MBXFE%1I8%VJ%CA1S*=G,#A4=?S*7WM/,C_#S?EAIB\.\U.4!$EH:6.H)`;O0-6R&CK2FMA9 M;`S-1.]O#'>UK'YO##646=-B592<;PRS-,1XRSIUL#SYS9'U^;A^Q5D8Y!&I(,]&Y@.+Q)$<-")1JJ\<`V?',$8J:5,X'28YFZS=%`5T%M=1-V M"Z.(_JYY5M8Z3];106ELW/A7K^`NV^J<%NA\-B ML[M^#5G6^3W90FT2RBVM\TK^AQZ/O`3Q2(=#,S(NVQV8R2?T/F#HM.9,10!1 M"FB3<-_#:@#3?[3(@#4/L")JNB-+>"EJ1D4-R]<(9&VGI@KC99:132J4TRX) M$RQ0:)E@0L-Y*;I!-NYP%M%.?=T,%X6+,2/CLEB=F7R#&]4A/[)"G`8:2,\" MJUDW3U:ZWD>5-!&D0[$@R!97GZ42Z6N93$X+VTTP-Z'2G0D-/_S)FH186?9& MHJF?@UB9KZF)#^Y!1(D,7,>:;HXX-F+H?GD,7=D*^NJ;74TRW?/)5\SZ/$'_ M\ZQX;WKK`O)Y>RB"K%CZ2SWA?930SDT+?B].]CH9O>595.W@W;G$V^GY\3ZR M\RI(I^,Q9A4C@[BJ&'F3[-+LP*LG:Y0QU:7@LDZ2ME1"X9@69E,2%+60/;B4 ML23>-LK#.,U/&4LX":M+&A(XU:1`;V4,=5.HG*.)#M:5'.=W0:2Z;1$@(;J0 MUUS*NX]C^G(L`KLUT6:5M>A&QP%60?IT=[^_M#]W"::OI@E.DRW5ON^^_:[4 M/?8G0K(@:^B![QWN\9$65DGV"A^OA^9`*S7Y%[\[0Z@V[S4*H`]W)XD+G3;1 MJTK!M7`6T_9'_%I<$$*_&:I["P]8W]L2Z*L)Q4(,S2N5GR*,=?ZW:7AB<<)0 M%;L9`EQU`JRH%(?O8U!64?C&-\,53$3'A9LEI!9++ MPM$JWL7@_7`(LC?6KS?:)]$N"FG>>T,#540\V*,8268F@M.RRJ/*)11'EF,X MW]PW6B)RI5H(30FXW-KKRB18SYC)`*Z0\X4K74,ZZAI`-_1&^BCLY_6PG6=M M_/T4%6\:2TX?T&7F19_'P7K)SVF\Q5G^!\3!/5A$1OD>Y=1I]L"@)@CY`5TH M]\VJFB_-6?F<%KB)5+66!7T:3MM8Z4NFTO]*_2DV:H7P7BP0EF2L;!RVOY6A M)HK-KG0)N*^6WBD-T["DL4QHX#JMDSXNB;3>3XGDP4)B18RV+_!BP=%6,['6 M]ABB-Q:CLQ[I(/M@,\JS(I6V>;#R6!'*2V,976K']6K$`P]WE4O74%%VUVM9;5N91]=`;265!8R$;'0BYZ%N+#FFU] M4F0N\BR\@-H`)KL!"5GGJ=CIX1#QIHPTS3!EQZ,XH8>C1OM/0SHN4[,-)13R M21M\G@KW,<734-J3B__##6@*FI=?@E)YMK#,$ZME[#Z9B,EEG@:J\]2.(*-OZ.AC6[;3TS$7 M!8[+A`\%YT(.10E+\VSY6887!F$B`GT"?IOF+1%`\T#&U$9("9$BN'\.^)3C MOY^((5Z_:-X8R%&*R:2 MXP`JO3I!5%`;#WS\+`E\TO;Q\$:*X/Y,*LG3.-JR8)&ES[[IG4"IT)R>-RGY M%\];6N`KG@;]AGXM_]<#&S"4YRZ+DC`ZQK1@%KV6:B'#GAZ-:Y5X5J3`<6T6 M/^5XL[O.B^A`BY$I#*$/Z%#U!1[[RD$`6'V\"L1'?1\5HOX-4I^'U:&OP3TH M"X]6+RE[29$QF]CL:-V"BX!,3XCOH_RW?-Q?3R/C[$FKL7P#_KPAP&[F:=V* MD@9B1'S0]D6D38>D!7H-:U\T5H#DJ10MHT0`7\9.L\/N0UE#&JY7O'LFIV)WBNG4PDT*Q7MH=QN%J:WE^ M^OK?(K]";`!V']CKR-U`K5`]#"+CH&J@&K9:[*$6]H7G:V!*>)_R>E9V0[," M&40L86']$,3J&`"M*(;[?^GO2_5)N&U,H2O70#N'=B?";B-"'^-Y"[*JNRTZ M;E9AI)`#/2OT\)T7'3L<@RBCG&RRJR@_IGD0;W:W:;*_C5[P=IWGN-#87W&D28TQ8K]9\RV&`;V.X.F0R.>(WE?ATM: MJ"*&VM38`M2FYZ$M+S\9'+V9"TX=_1!$Y0S1*W;88[G9MM#W`-,)`MS;-*<) M]`#A,L/;J*#_4E_;R+'?#5&@%>((Y7_X9YYS!*3G>EPZ:F47ISQ* M<)X/'^\YOM094[F!.QTIBOL#+O9>E^R`TWT2F5UW:N`Z/8H:ET0\7^+OR%M( M/MJ-)=%@CWDT]4P\NQE#A#>9WN-W(Y,1<$%-1I1$RV3$:B8^&\^XD#[59-!6 MMW'+Z2,ZKT*Z)=^LB,C2O6=/0_67FE%,E_5(1Z40CN4;C.H]M'^+S"RQ0,N/ MZFF54(-T!,W]LI)C(CGM?W)%[#-.V9GH]2M]5(TU;A`UL)TN+3K2B(L+QV(Q M?@L/E8@^VLTT2>^R='L*Z5N;88EA5QQM3137G'%4Y\G+=0&"=HD"WBB;\'G# M-F/1"Z;W$>-7]9.HN4QXGB2MD$C<*M?1IK,J^\`S=:UIL6LX'\\#+4V&K.91 MJ=>@2=;3E5M(OYY`"JPOD,$UG!0%HE.0QG5:W3+(Q]5NDB"PY^%C.B-M*@0= M$?:?O.GK_"@FX#/+<<41'UOZ:`GF.&/8NF,XN?)[DTP78@E[A^);A%G"1B--&O MC"J\G[`[$XVP)RYLS(2E;<7;2<@8,@G9FNYW378.00NV_!`^X^TI9E54$_+E M<_88ZBXK[^O8`=1-GI_P]C&EU>/2A/U)TZHM47=FW[9F0SC'*^GR6L459?I? M-6W$*"%.'3VFB-,O_^R+V2\^0?2E83-!S`%4$Y2SF8CX!!4I@6,3Q/X,%&SX M.AV`H8M5A])UE79(.[\$JKD>/N9>9QGY])@5Y;QX$VI6K[\$V9:)H+H:LC>& MRPLCBS.C\KBR*R74'@!=O`V5BD=LE-+_PMTFN9BI=-?I)B&?J:>WH;83ZIER M>C-EV^*$^RIK`SC/@V)#DU'6KY&JC$H/SF6.4X]#(?6':1D%0+]2$+BLI;F, M.LU4&OKN0EY2!\B/9`D=4VKX3K9T&_4Y.."K]!!$0N`V>GT]=SCP=(O9\Z52 M8P[D64X%A,3P>19V[$(O$6/F6"`]='GR2/XC/CSA3.4&!H!==\7M\SJ8!52F M/^7H5PX'V^36#LM.S4BJ%8.-:[N0KE7XEX":7#&JO3TXAXK;Y["O`.7OX-HZ MET^7*CKXU?O:V07R+DB3K0^W48)O"GQ0;3IL$/-/:5:?E&C5_3:E M!'/6J2FE\D2S$UY1*J@DX\%-D4613X=#D+W1D\F`B,AO/%+^#.#($O\_H"_E M`D[+0KQ$A5!?#^C@T425%<>+6F1\N-%H^Y(VUS\'\8G[H#P_'?C?IABTE8&` M[S9FS9'N!4=GQ5MU/<4*U4.AUEA^^HR%IJWE4EHS<,KY)>H+H8D[CB9'>^I? M^,_X<(S3-XQYP9UME.&0V!ALKX-%C%'GQF/&*#825^B(0J13OHLJNP`_IFV^ MULFVW#SI)J59'<-=$HO5F1D^V9$_2:O;;S^FO3"%FDPUC`S6<5R.LBX#:UV?J4_!G4?(8:Z]_Q"3J4$W2L9N:4;'&& MDC1Y'](2]7',YB2MYRJF([$,U+*[N!\[(@NV)=\(S2$.YV[*`EP7;S\&_S?- M+D\DZCK@++]XJUO[EJU^I_B:Z<1!',V,N5!YF:H2W<4;8H1139G^J6EQ71'W MTL78G)O&OR2X("$_H\S22/+[W%*7KI!>;.0B/EMI22=@&B M7B"FU2C(&HERZ&H4,S5=;NMFY.`,7/H"4?_5R1@)$!,>E4MEL\I&/_X\!YDN M8SI11AC3U--1N2V.X'O36>OB3>-QAA:V#_VT.M(8MM+RX(6':[F\:*4E:J!V M%ZT6JC<&13D:?0NBA>V#076DF:1XP$\XW$OFA5&)6JAM5"U4B`)G)%+-:EY& M\]&E&([+EPUS/53*BT*V@Q[@=/4)S.-1YEW7(5/HS%#9L2%PYUW<3F2O1L]S MB>E]BE[IO\;?#JF07/9A4_$N]!:K@)D3K<#!]7Z&#+LQ&9QV0!O5(Z'%F1S# MFR#J5N/QA@ZR#R'4K>*%P9$%82%-BM'"=98.HR>)O$9;79!NQX[*.";9TY:X0`DPE5W%+'5VT>682IB>R(+UQ.RG_HV\HY9__1F99M(7VCP[4 MO<-+7P5^2J*"%<$F0:3]J+_`F5QOU7Q]\_`-V.FXFK,'T!-O4;,J[6_]XD[! M'ZX5"DY_=*C@C!H+WF+[35$T-4C!DA=:U'R^OA:17YSW0Z;%*/7SATHU\HGO90M/R]P?M$< M'ITKH?IBN`WB6A'+5VVCJMB#KL(&E19;=*JY,*T3M%2!=JS`MV;[9=1@9S9Q7X#A4:!7G0BML`DNS M5KK*`AZX&HN0:HO@4N%'=:BO]W($&XV&2XJ;1+ZKDD*Z:R,\P*5PA5I]9`($ M%CKHL[L^!/](Y2=+LQG5;`5L,K%I@B$;_LHTM=??5P"S8"7_F3ZE(^;1!G%F M%QV^^M^-_@AL"&K^-A<;VAT>V@9&)Q%0Z47%ZVI[ZW>+B\'CES%M'X!TOABT MN93Z+`+DR6*@8O*/5@6!)T=7A8:,`OV' MWD_`KBT:?'$ZFYK\UO**VB3G^+$FI(H8H6>E=2^QK\S;)MX5,#X3VHZC]% MP245_HU(.5^I@OSYT]7-Y4V2GS*\71\H?ZI%:AC>Y?HDX5APZP1NA3YMHQ"5 MH(C#@BU*FHSSRK1;?$SSJ"`;%T(^V&,41X>HX(5ITR\)^?_T^"(LC]=`%RF5 M"@GKTR"P-T_BFV?["AO0PO;A^7M'&L-'[ZU*&F[?O,R3JGG=O@CG<]_H*WG_ MR??W^*)U:+_";Z&Z-O9KLN`6;[]$6UR6N.^D=-SAC`;,Q,,J+%Z?A$.S-Y!+ ML!*&^I[B5CTA5KV_:4-OL M/N.B'#"GI?#Q]A,1K755*=VRFA%QME,UE$VN3'2/2@A41I,C3@)1&JA]\PRS M*;4G9[_C"^9R4A5'!^8HJM#:_I-?O:-8-[)64J("-)M@BG%VM]M&%"RXDZO@ M+:=-<\K>.&3X*-T^%-'QQ!ICWB27::(^_C*@X,R1F$C5USB*RYM,56VD.#IJ M\,E.'%448#S(;`&),66U@$,U]LP79 MB,W$5+:8R<8+SD+NI(T4L+^-UD-VWK@@S7"T3RY/68:3\.V1V'=.^W:GR0]! ME-RF>7Z!=P3F,7A56)81%9>M#8RD$_H$<&Q4H:,6/J($T#M*XNL5XE00(0/6 M`&&6I!2&+%$9>D?[*N+\:Q)8YJ>8!99L![HKIR*LIJ)H!@`UR0GZ*W10,"!A M(<`LKY?S>QSBZ(56`;TZX?5^G^$]B6:K#;`TWM1%=Q9^:LLC//(K$5&#B:[H M&7"-7!]FP82G\R7+&LFV5++/)YKI1M>UH)81^@C+OI2B;("1KIFY=0-?3=RE MG`(]$.NN(KT:!U)/H(?LS`]HRB(46N-HU<76 MQ5ME*$+A#1@G,%,L?K?3MG[H(&"F0-34G]Y04LOSHR\F;V),78/7PG2V].>; M9.AHRYR$9R%`*=>,,""G-4U\C@4D(G;O?@/)`DJL:A>]8$^NN^U\T_$8`?)H MW-P>IP0*#-_U8=]Z2]2ZB/(HV5^_'G&B/"T?`G9X=#?(JZ!2#1`JH:`.X(SY M#=,<]C1;K@W]$[(!2->J^U-"O$:Z3Z)_X.UC\'J!$[P;OI8=Q7"HQ'*NQ?X% M#20]1T85+)0^3V2](*P_+<7ZL;SY#[+"'OL7>!\E";7(BR"FMYL+L7V=;"TR M/LPOC:_M#>`L^K8X)WW=JTBCDC:JB"-*'1'R MJ*%/=^S-".S]2F<,1`>!B=X=3-'[H)PB7$U11J=H1T-=0BV-HRU+UTQT:4/Z/_S-(D0$5*ZPPBUE3F*HWC(!.>83K:"/^BD'<@IPZ08*J493#3H^=85:Z)YD M&!@(=RW8;YF7VCC`)Q[/H/P9T_PE<[<'F',PIKPC^092=(\B(]7AH]4QSBX^ M&C[JLA\BP1URNIFI^9'2?P3'(,$Y1G_%R>\P4!I1-&NQ$G`AZP4\UC(AD]GY MK=1#ZRT&*O]K0,&9=S61RBP4:D="<#YQCGP3HB%/79N-KUPGE'8=5]'ZRK`. MR=A`N^Y&'QV@_!W1]9R.OGLHTK#;OWY@QR5#<%OV;ICG@7)Q)2`KZ$5!T:\, M&++%'F<)$2J M(P2H^@N:-&H"MU:K/(;/>'N*\6;7'N>.(&&RU&S9@#=Y?L+;QY36'DX3]J?Q M>H]SZ;JK_#A[!H0RB"5%:D)=@ZJIEEK)Z:+'%''*E;)"UX-<;DIHDF+'/(_U ME.1,]HA/"0E/0SXE[,]0E)U#W7)G#!@12O4^>XLHK=JQ,0"@ MBNQ6Q"Y%3$4OWI4ZR'GFIPD,\#14R4!T;4O:7:" MC)^+M\LXR/.QVP0EED/_H>9>=4+$]>SB#3$,Z.N%B7+4YZQ/(W*X-`X-C>J; MA0K%N4%4202TL'KQ1E,'TH3F%*Q?(]6]PPB>2Z,8D4"XTV9@J(%#OU)(.&-8 MB'^G1J"C18(9*)&<%_7O,G&5'H)(V!^T*Y4/P[LLUR_A>$QAT*\<%$SCK3/N MM$*]2D^$E!%"W%B0$&84[G?TT/8C\!-WW\G MLFIF1;D4%C+A:8:3ZF4Y3:'DT,T^6/2R#UX[V0>+/O;A;%SL3*FI)7[[+V?B M8CV7U:Z+G2DL%?4,'.R`>YKF7Q]@W.OG*,&6O&N;E'?.M2/G/-]*29V)PYDG M-?,WWY^+OYDG:T&^<%%]X20"?9`YW7:GN9X6'??'1CREA5YVX"1GFK#.,IK. M0C6#9J_>)-OH)=J>@OCZ-8Q/-"F&)81W@5O["W[.MG>I7F1X2+*&&95 M?>WB[3$JZ*5Y0V;T?!6*):?'7F#S+IY*E5E-%VERXC4;[K*4T&"I3ZQ_)X&G M62B,(N_M5]$$/UD^MVE\JJ8QU9A&MT>`L)Y`/&($XL>U"Q:XH*+=8_YL/W^. MCH\I[X\^>J!O3,FAPS.7LF]@0]Z'/2-J4Z'O)3D=\(L!6Q)W'<470>)B5&*7 M;F2B-O>MWY2,\^2,YPCO/D5)D(11$&]VNRC$V7B:A@K+9<*&DGLA%X)"HQH< ME?!@6[!I4EP%1)'0179*BE1^,N0FHL=I-I^Q^79PQ"](5M(1%FPPQX%6K&V9#&7'2]"BX(EYCV'\.K)?+ M;W].6F4,6*$EUD7N="1_PZ\X"Z.<')1'+ M9+*>E%#@WV="_80:$;YX0B.#2>6$8!05=46A4`]I64,\N M-,L:5%BNC;M;K>7GM(B2_6BXHD)R:-1*WD?J-ZT0AU\J;-"T@8DBY%R$%RY" M-BB"2U,8UZ*^&2@P`%^X-L9Y$>3*]!`5$LR;5Y%WU6O25;O>#$,`?P4[+L`5 MSL,L.E:;W7:IKU[1++#NN*[D`7I"*S$0Q5O:/H:%D[GV$EI&QS=)T2Z^VBL5 M)#VIFT#)VK1.N%-3\;X/+;Y.)PL%6B-(V(K%. MU#BJC?Z3W/ES=UD4XL]8?D4HA7?7%U+*L>1$%E6@B,$B`@S4IU&;\\>T M".+FO/Q((:&Z(TZ?[F,UW9#="M7ZW>L\*`&>MO;F./QFG[Y\B,@2GA=\Y>7_ M[J^Y_*]_NV'_P[*SRZ/S#B<#-JF+Z,`XM640KH9KC/I6;-4S6;?+ZV1)&O87 MMMP1;S-9@,L@?^[QWM0HA[!A,\.HC%D3"^JM&%W'DQ-N/<:X>'LD@X_5X]7$ M!WB%-2:1]*U/B8A:F"OV4HH@0Y?K74:X)[5P$"^6M/11]KQ(C>R/B5&>-!]. MJI"],*Z6+";*5RJ>%P\.G0CEAS'U-4_?DFI,O\Q(HS">#KHWIJ2H-S>J=^#% M\QP+YH])C178T\"UTTKJ6#Z4_40$^'0J3AF^)=%EDN-/&(^]_-%%=]E<2D^> M@2O^"A%13,1148F+*#+PBR`KLE$U13LN6US*MEM4-NW634\4Z^NV2:I]7;Q)I1U6W^AQ358`G?> MZM9ZG\;QIS2C/RI"S:4&=)D/N-2<#7;.?<_(H/90G0CPX@VUX#H<@NRM:C#,T_M2_@#A2"!S]*'.'R8+5?02%6^@ MB7^+VJ20*[C,:&?LR+A3=N/#JK'.TWW5,^7(!\E"5VX+P)"8(&<0#XQU\GV MG*;EF@H?Y5\^'-RK`IO8=NU#@UU;L[U^O48 M9;S*=R7(@LYU<+0S2V&*MCW7T%`@#\;YXGMUHED5G`_^CIW]6#/+7^$H'=,$8JZ?DYO*NJQ; MX>,LZ53TWZ3/G1FAAB217%I!LBH*!_I\?:[$VAOFB@;XJ_9)EC[XR-V,TKD% M9*W/]PNF=<+P=DTT*]CCL<>]SCDXH\!-?U:='6M7?*"2D:7?,+L_^)TTTT_J MF7ZJ9OK)WYF&.7,VG.V125G]5SB/7G3*?I=GU3I+TH(GV,KAO5OIYM<^+3B6YW=*:M^KKOLZE+`5%\'.#GP3`0!W M:+S26&3!N]5F1+1/:;;#$7W1F*^3[<`!(-!NF+=Y8*^W! M:X=S7;<4QYMQ2.+?/U[0?T MWLN0$9\6.]MSO.@.;."ZZUP7LZ7G7<,;2ZZ4O%F__)TBKQ:J1;RD]2V9&1?> M+44RZ3X%4?9S$)_PFFS<#UQ4LO3^B(OG=)O&Z?Y-\4S=Z>@^+3I69G.!?10= M'S$&4(L#MI-J\0#X!A]XAENO\5K3CO;\M(_^C`_'.'W# ML#WP'!JZM>#>8.BS]IMDOX)#HBQ7T4NTQ1_BW#L=R!IRU87=7R#`X.XO:=QB9Y,)'K$ MV4'5G7C)05T[NJ7F#L+#T;%!'9NKR:PECJ,=1N_><)#E0A$GYQYM43,<=&7+ MC'C6H=M]E/_V*C_I;$($ M=@T3OQ\'J#W!]2R\U)"_&_>GMEDGV]?>T,Y=8/B,MZ<8;W;7Y:GL`\Y>HA!+ MA(T9+Q%M6WR/PW2?1/\@LK)[G,LT+_*Q'F8+C>?2S2TT8X)C*\>A-3VJD5`Y M%))YO15JQJ.(S8CE+3EB8T*W5G,^AZET#I_4AIG^$.= M:73I#I>UXKX37&@TUZ[O'N>8S//S.MFV.DC1G7V28VG#-R-LATY)3QKAA+S$ M8KEQ[19O)2)8E[=Y8MUEZ?84%BAKB]=N@283RZ71&NA?WP)U4)UOS7!,:.YI M1EN0_88+\F]=6QI'=;DU&I=#"+XY"D\PK9"\,:$I`@5Q^?+P4(OC@\GHZI@0 MMH_AN3:6'W""LR`F#*VWARB):-XG;4BE:S&:^`[-1E>BOJJ5>$S9NIC>&)`- MT8*N:#X8DY$.]BU*#_D\=[.W&OTZK8]T=OO76T7#3/LW'K?PO4/!IFW&)8=B MVLYO?RK8Y3(;TUN;/4]9%4R!A])+CK8^U<1VUEE15QHAGF2/B0;2/.HE'K@= MZF3!FJ=4[,%4::MA6T;,J0!U;9SWR>3B`#9V-+*I;K='/53784OIDO!VV&.5 M["FB$5T"#H,,;9F$!S<5HC1HJ+P&3$F`Z8)MMQ&%"*H&B*)Q084VDV5J!R@Z M3L]ET&%F5?U80A/;RQW.YS1YP3E]E$_SU_+'M`CB]N\TS/F<%G_%11,`MJ1^;YX6 MF.5[3.^6Z/GE*0D.M-L[W225WDD5MGF_7;)EY),V4;,'/YO'`KHEN99X*J`_ M]CD\%#"82?#:BIY6FUIJ:I%XQ(2^5&65@K*L4MV]Y4AK^Z!0H]^3LRLN@(EK M6A;^URJ(*+UC6WS@LRD/,%HIOXY*+M.$'3F<@I@^'_[CV"KBFIMS*"@P:[;A M^LLTD6F+K?.L0F#U"VA.U&VTZ[;X8(MYN4;1MPG@3AC&-P,&2Y.K2VBTR1"#!ZZ2 M8"Y#VLB0JF5P:;2C6M0W+3F"%P8P^H1?B05M!-)7X`HS`'X(/T6.05/PX"6Z MAD9IF8/QFW#Y80GAFKU&>OR2/CZGISQ(M@_X!2K4D@`@%5)%`C`:JB-3:MMAC/,V]N3UI"R)M44F;,VFC2MHOG`KDGGJ2 MVO8VS68T+!C;^K0_Y45KN,]1@JN,LBIC8L32C&@X,S,SR83<;X;=-3!*H*G5 M5)$`>^UJ44PRYOUQP*C6IP7R(",QD( M\7]!S@71,^L)DFRI)+B6Q(,E7L,8NK:J0EAH>TV(T:6SR[EI!!71S MK9)..UB2;MQU0,864^RPZSJ, M*"SE.0S/&XUHP/H-[=,JJ=OP[;S1CIC,:7AWX&A'-L%E^'3@.,'^-!S&<@>. M5S@'#4:RB:^XTI=M@_UC"@L,A5 MQ75,KU)[(QK?5BBI`%Y8J*73NK/@)`0+\^[:8IJH1$<^.I1MZLW%-.$ZS@/S M[]CW'U[=7V@8X]@5AHJ$!0?R"3]E@R/>XGT0K[P4&K9E$-78SJ@Z65F M!W:2!#,_CUYMBNOE\:M-`3T_@IUHG..99@L?PY8=>S:[=F'#,M1Y3.^(7CP' M.;Y,#X:4 MY+,BU9;\R!K!R*KR!:U/__36@3N6GSY@GQZ_AO&)^<*4UT#RKB3?%"^A4X?/ MB*X%'U@5Z[JCG2CJTB%2OR8#=^:KI/P*3:&J'AL,LE6M!L:93.0;R$F8<\L[ MF1#CA]]/J56Z:X026,C@XOKOIZAXNTE(G,.^5%X?'S()'-TD_?/'Q3 MQA/5^8[S-GT>S0\=P+[\"X>9%B?@\1FCA/U(%Z8D3=Z7O1\Q&^-]-_*,FB%7 MK0"4-YA]EV;HE$3%UU5`ND+%SS'*G;M<60J*)[-Q-NT3FSY>DI,'ZR.<0RM$8586*![= MC`%R&K'\'(T(>!9-]X;-PUIKO1YYUU[CCGROS\$!CY14[H(YM-\>?WT%HS\C M^CMPH>29;+HTA*$OWM?F#@R42HX6.>X#`JBEM`1PZXL#ERZVP"J$>JH+$O>@ M+!RK?$Z3S6X7A3AK-<&FPXQDKHSB.3NR&)>@_^4)!BI1.BWH$5,)V$04P\@DM[>=:),=(.9EC+Q72/?*Z(C@074%A*@4_\D%1+06P M48XJ?^^>0@IN9TVMDL2NH@R'!--X<=4DX'*5U95I:+FMTR$K9!\7WJD"DI$^ MLA485$KMM7B6F'11KG,]MY68GBW/1M8GK--ZV!;\Q"/Y'?\5!WR$*CE+\^6K M'K(S_Z`IBWBE0-`0Q2M-I<[/].2!ZQG*I><(9@GV1@7+N_>%'KQF-3&HKMEK M8=K(8J#DA?/21_Q*6\V-YW/K8;O+%M"49OBF>>`.X5V)^S5\1O8?:@6JI4\P/;]QF;7"B+DVW$5CL.,0!7G(U==-"^P M'?-")0>:B/#0#EYQ(\\6+JEX\C>H4X9;,H&F#HY:03]_4(Y@:_EM0GG:VS5* M5#D`>FAN%UP5_\.ZW=Y_MG`@WP*8"L)X+QJP%<*['=F>T:,G0$,UEN.ZPS5+ M76I]$/*?P+MG/0L96%3E.&>3$53VA_Z9);6QY*8C^59X^YC2/[42GZ0)PNY9 M.(><(O-Y%2I.=2$7RNM=.L_(WKRE[=EX:>8- M5_-6I.S/JRYD,CAO9Y&^--&6K>4WF8[_^W.2Z_T^PWNR`-PD118E>13^',2G M11(MY_/TNW*C\IF?[U=KVJ@FCACUWZ]W-9].?7<;U-,9U=/Y,C2=OR^G.^(; MW'MA&4-GXY;Y,K+9K;?;B*($,7^NLCX5SVD6_0-OEW"\.J.>@VO5FKT%,N'Y MN/30K!F9P^>H&?OL7.NDZ6S-0+LV!PIJ)+1+,Q3E^8D]\PGR5O9)^[Q+>*)U M%KY3WX"M>4>-(9W[/_H=V8/\[=6)..+]'N8(:_>&2N]FCDME[YJ M@J3#IWN<".)4$">SXD'9JG,8GZ.:F-LWKC9EOFS[AHB+?CJRD_ORZ7SS:#Y? M#0=3SARH:WE!/=]4TQ7\F3&ALXG22LY;@:>SS;%BS'.(T#1F;H'X;%,]3NYL MD'\G.U^3N;SI[DY1AN.@W,B605?MCX2UY2S"+UW+M+TUE0]X-DZ-_3^ZGZY= M]<8V!OA#&I%B;.R0`VH)BEJ(4^X<.$BC4F2 M)*XMY!:7+E0T+O"/P6MT.!U*`>G&MRY+A;)H_US0>+3>%P<)?`*<=<]AJ[Q/ MG_S91)O\B)(?#]S(W>I"XYQ#O"F9H;XQ58T)RN/#&R@_Z5K>\@PMDOG)LPBF M5%9@+9H:'.1L',6G(,K83GI-!#ATCPQ9>=(EO(;&H.?@0G3F;H$-+!V6GZFA MUL`KM'`-WZ4=U)39E!8"SJG;XJ6^S])S:9NE-3NW"[[ M+YI-70NSP%9R,B=GL.6 MI^3H':6-7P.R]\8K='PF8Z:'*@6'8S#(5>]OP?&8X3#BUL+VZWD)1P8F-`\L MKZ<(LCWF!+X^RYW[3(>^5`%?738L+(;K0YH5-'^(#U+W`1@JM3F*X6QQ47$M M)*M5L)6?;OIA`%5(G\9]/EPH+8F`Y)OK^S-X_;?$+ MCM,CVPJ7%@CE42S(3QW&P!R400F@R]`WNZZ/T,"S41VS?'4P4()3'H6HD=Q5 MP53S+E2^K)_W#!9]!8HAI@E!+]N':KY"&;!E*2`+5FH81*](I0K#HHF.%\,< M-5@=$L[-5TLNN3%K%K2%M>XY,I;=O33JO`(;OQLA/?`-^I8X["DT\!>K;MD^ M>*3;C:JZYF;7ZD/^F%;\R2^V[%`'KHYI/AO:U3,[ETC\]*(N.TO<5OF2C*.3 MWZHA?"JP.7]VJDFH`G*RLZ]+U!*3[SPMIMF"2TW"G*JB4PW4E/399$0-W@#]@NE%'-ZNB=4&>ZR5:`#&R3GD3DV>Y27?+_;S M"E:HX@B5+/F1:>#1[+?/?U>=F_7Z%.@L$[#F>0';[Q]-V;`0I=[C,-TG49/\ MOMG]E`35;5S_<+Q])KY.MJ,WV9:H.XM2;0T=]BGUN0,7%!U;J38Y`#?V9_)[`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`W7X+EIPE/$:=OQ5>>FO$DV5":0#YO MU[4<+8-NL&QD3`8/`?D0EW&0!3SYZ))\&)S=1H>HH(\YLR+!6?X<'4=LW)R0 MNXQ(,PP%AC,;47$MM'/DL*@&1@0:V'1,^/_C M=__T+1H0XO82VJSL2`%H[XD.07Q MB+YW@=PUX>OR)K1^8S\#JSPPCYH-];28!.]5,Z2+O3YY;0C8-P9E9N9ME."; M`A_T'_N(B&`O"@9D&'E(T.3;4B3$L#QYG[Z0,'`)^C(-4^?E"UB6ZN64K^_7 MR99F?9'12-A%D\#P*TO_DE=\,"?AM`:.MEQ#A4U*9%9BM(..2GS`*@Z+B_BN M)/`U;%D6,\44"[!HXENYTTPR')XRVF/[JFE_=YGF[%H8$.2?_/RFRZ.E4EAY^O`&[/9W\B?I" M@5ZOCII(_ZY5CF#!9*]P'F81JY6\V?7H7S9?7FJ^VOC.3%E?HK[.M##I&[.^ M8:,6-HR1VQ$MW:'/]]?,$+PQ;FN2]4V]+2&@V1N:6=<%Z"(ONX)O$GFWLC$T M']9QSK_14DX3F[U;SB5R#%GT+LT0#L)G5IXLRLBO:4(KE,746$Y)5*QHMPKV M+_\6=8WO)1@[;':SGO%H+^\49UF3?OR23C%IAN:#27/^S4R:X'AGTA(Y9":= MT$IKK'G0N=BRQH<2;+GXDOIIRRVKT;9EBF/9EOM=3];[#+/GB5HFK<`&L6R5 M-$J]&6BL5./"&[JA6*BU*2_EBA+:V(`(%B6T4OKV%!8$*L=$FY_9F57+<#PP M_,G?<:#+45#A>N('1BU.[@[DJ*XO>=89#C:[>QS$USGYKK0`_1%GQ9OB>D>. MXO!B1\&W<-U'0.D&G@(C#HTJ<*BK'%/V2<0>\RNVHC;=F'Y>/X):FJG" MCE0TD^/[8XF?L4&][3Z>%S;')3`U-(+EGW$-BW+;L22)(;WK6M&*]OSQTY1: M&J=O/Q3)PH:N-\#GM(A"S%-LI=LX)8ZSS9N:\S'M1QR^;)8+LT^;*@%?2!(N MP'$9`?0V7C._04<$P#V6AA%T=U8J!`M&R:A>OQ8X(?ON$6,0' M'?/I1QH>A7FZ`5[N56AGRK4_T9Q!'&1R@)L<9IJJV&*8Y2\M=''+ZD]&VT1\]%& MV[+.MU':>OUL;%0E^CJ/@O.R4$%I)UMH0\FUA1INYVXU*C1-)^G06F?(+9[M M33L^N84O^K3$+!B>F"AFP:71S[6#ONE/IN?:`33.B3Z=R-5\RPM3S2/GT/`G MRBL_Q$",SFK\%!6N>I5EV1].AT.0O=%ST@33%X*EX$]O:-],2X;W49I`VO0< MU>[;\R1:%K(+RH'N,-&(I`CVDC<+*F!GF0(27B4K!6K@(!XD3&&99;R4@"OT MF!9!#'1W;SC5;;:)R0+>P:OTN7O3/@AIH^L(#\IODEV:'=@LZY9=U,!TUX]$ M0PK)YA*UD)JZ@^#%%:U+!-@,1%?%>IU!1M%?3W132B_]CFE6T*N\DD?5 M_D^%Y##04_(NE`=@P/PRO`)'%3Q4N#9%`A*398T$N40"EU'8N`[U8RT%A@W_ M7U]E7P=9$B5[F@OZ\!QD>'P!T$!UMP+HR*%*^ZC06"T?A@B_!DR1Z2+(R7:# ME2>)XE;AH@+%:XX1`FX+# MM4)?*N%F23"B%6H4LL3W8.L_7<*+]_NF:4;$$P,M M_8;`I+F)RBG!&ZE"RIEF6E*V;J@%SB:;J8&TU?+^I:3T7C38RE(;TRW2\#?Z MWOH)HRC/3^[K>]N3_W-?3!IX$SF/)WY\6=T0J./P^5^;'L0N+ZU,MU.E;DO. MB3WPSV/.2]-#2\G`O1-9)T7$]H+1"WZ@91&C(L+Y]2NO;DGO;"X;)14W5_KO M1NP,!/*.Q-(?5(TC@KN$CIR:.KT"E$L\(=&S@2"-U91V_0LKH7G M_J4IVPXPQ^___Z? M48?K._*['Z\>9(HL/G_M`[JVNN;QQ@:H+%B631-C&48$\98)%*HU(NB M=#8K_AC+!&D^IX5"!B`34>F6PD0&T?S8^FAOXVXUWL39&P)\*S5I7G2/$8R/ MAF_A']%!3I/N:;!BFN"W?=,MS?*!S.V$5WCR_GFXN$WSYGA9\Y'!&)J[CGEC M_`NWP;A`%*.E=R42>%ZI#5FD[PIFBZ#9^6Z*#-V;=\C>=EK6T&MJI\8YLS!A M?:!/_I>+$2KZYQ,@U#.R4'2P0GR$,PT,]*8G;Z8'=Z*"7AX.KJ8'-!]^$5NR M'`64Q)V?))^>D2K MT!#AE'8(%EJER7AC13AE&("*W7`]JB04%KH2YR+<0ZIY3VO&-+T"]T#9QXMQ MRG%@%5Y>RG)8::"+<2XF`;#BCQ3CE"(`*__X5?@P/)S2R^^8A4#`@X-WY72/ M:`E4*<@N%SJ'YG(4.#U1G=:*JN+!Z?12_`.J^^@QL!3>1OF`+NU^M4%U-G0N)Z#S MF&*671=B1,'UMO$N2T.,MZS0:LF-RLOHH3G]"IS?<)8(<&YCKA3L M(K*R$GH+69D.Y&Y21Z7Z.THECH7%]29YP7E!/5O?Y.ZR*,2;9.@J4!_5V4*J M)4=?71HD<:5$#(]VHH%9,B<)M-[R_J]!C,(@?VXLX,B$6:X2AM[R./M? M*5>:0&88Z9M0=_G3P+,1/<=!GF]VY1";[)[6TJB+'-5)"I=!'./MQ5O%2@F8 MJQR`#=+N(FT;\R`$;)0HS0&J%LQ-AAA\N_Q0DR?#B:.+M\;=5`@YG*=99&:J M"1G?_U+KA0K7EY#\\1FC_(C#:!<1J5L%F1H]*)X#,C-!^(Q"ID"M^`2E&\^E:\,VTH\-F MQYI=;Q^.02AWM0.0SCSG$)="X$%@J+/C4(B!P7@S;6Z)T<6BK_@$8J5>.NS8E@=@\';UA1N\?T'L?$:6WO@JQX^RDGWK,) MJ]*7*!^8_*$S#1-J$,>%1M(JSPTY)7JI4-)"C!ABU-K[H9*>VV?YBPC.`P]> M!1&=F)RM+<52E5J7E`0%6?F)C^P3.Q/=^/@43G8_CE3-G9GT;-6`%'-D M7/Q;0O,OY-_D?YZ(QR8__/]02P,$%`````@`+D*H0MFG+2P<-@``=/4#`!8` M'`!N96]N9"TR,#$S,#,S,5]P&UL550)``-70HI15T**475X"P`!!"4. M```$.0$``.U]67/D-I;N^XVX_\%1\VR7E?*T71WCF4AM'LVHE`I)9=]^8E`D M,H4VDTQS44G]ZR_`)9,+=H)Y2)9>;)5$@/C.=P`"!V?YC_]ZW0;?O:`XP5'X MZX>3'W[\\!T*O;7#U\>K[[_Y<-W__6?__?__$>`PS^?W`1]1QJ$R:\? MGM-T]_>/'[]^_?K#ZU,<_!#%FX^+'W\\_5@]^*%X\N^O"6X\_?6T>O;DX__[ M?//@/:.M^ST.D]0-O4,KV@VKW_B;RW#2'(!W7=]PG MZ+^^KQ[[GO[J^Y/%]Z__N_IVP[]^B'!VUU`AYW_ M[CE&ZU\_A"@*?=+!R>F/IT7S?[N(O&R+0H+1)__%Z1L.UU&\S0?]X3O:\9?[ MZ\;H:2>1CW[PHNU'^O>/PBX^]AS?>10F48!]-T7^DQM0*I)GA-)$<7#\]C9' M=E;T_)#W?.?&1`[/*,6>&YB,4]2;S5$3S4X192Z)UM$.Q3EC)@/F=&1AK$2C M$N1[G'>1P>QB]$R>P2\HB!*-L>MV;%/N#_LWK=;G;O)\%41?3<3.[J?O2*_# M%,5X>T?^$_GW:!?%*5ET%8?':=QW3`_9=NO&;ZOU`]Z$>$VF0I@N/2_*0MK] M'1&(AY&J"!4[ZSWF-/+^?(X"GWS$+A!Y#4Y5!\AHV70UVA1#WTEAC: MT(ZOM;_*C(9]QW*+TANR%I+)_?!,ODJ*`VFWZK\6/"7HKXQ@NWRA(E>>]:UF MEM:D2+R,F*U-JIT>!\.C^Q181E!V:7.-O?PK(WM/O;'RF@^SSNF/C=>%Q37/ M;:U86H.4]V-__=.3(J^YY;50:U#LML>9RQ$2O:>8&0P"I MNK:_.FE*G]M^L)%I2E76C>5=JY[X.(VMR(Y:8GROMC#[^LQR^QATA"#KL&'^R,<:?AAWCSS;&^+/E'9%7W\F4[TBUED;U_@;< MR^FMEPH=6=K-U0S$FNLFM_U@(].C7=J-Y7VG'L.[#MLU`=Q?, M;JTU*M;M3A#'Q1M"M*$&77JW\XG>[9S\+1]V^>L;]PEQY%B_*/K4Z*MH]/$_ MOSO&"`M[[V5H-M16ZZ..^2%UX[3'J&OMCS3NQRAU`Z,1UUH>::QT5IN,=-_N M6#(E!QAD)M-#2XMC3;OCU!;D08)DE=K%**%7M/2+=$.&T1@@6601^4[YU1!I M!SVN?/-;^=Q91Y8(`IB3@Y-A-+@L.G6*X"=\-AH/&,&^B/.OT]3 M]&T,I;A_@A+W_GPA4'_FL\[?IDU`!TS)Q+]#,7&8C5?D-XF$B];3SL_39H,! MI^3C;[!\%&JBSDCM>>>7.7#2`E2R\C/0;K7X<.V=YZB7'Y<841/GTS2YD6$J MZ?D%AIXK'*#XG*RGFR@6'R4:3SHG/TZ9C2Z6DH5/0),DVFZC,+\3RNW%R2I+ MJ:.^G[NJBJ:*H*%S,NE3MQ3:_NS'X>QCVTK4%H4%RQ'?']](:]9N\I1+.TN^ MW[CNKE`=%*1)]9NV#I6_=O;.TZOU%0[).##Y#D0)EMB8=)J;6YDLP,J]BE0` MY`]"V9MTQ=G4?3X6KKV)X"N\0FX*D7#'GP\^*&RN8"2>!VZ2K-;YG%Z^8M8N M0-H&RH3%)T="(@O`M/FL([J(MBX.!41V'X8RA2DQPR:3#6+:+#Z04P)*EG?5 M6'-PG]'V"<6B>.<%< M&/Q[@TDQ7*UD9">+KLF/2E_4_<-0]D#C3VECY+8H!%I^ETE"C@D*6_/F@U!6 M0S$7;-ZZ(Y_%NEK`*@TZR@2VGH>R-/*Y$7'(&/PLJ*1AQJ*]*_DSE-E12@!G MIUH.>1;TE"$MR3WR$'ZA'XE;E):B$$TX03,PPZ4AGU(L\]C)D'W:SL7^Y2MU MA4?+T%^ESRANR$I`N$)K,&.H(>^JD/CN&%.B7Y7H%GY@4Y#N5.X,GN^XH4=> M6O.A/39U%VA'#9M)@>XV"CTIB[PFS@FP94AU4R0$,)<%F6:^2=_N`K>XPODK MPSNZ[R>?'^%*S&_FG``;B%3IE8*8TZ(K76V=$V"SC]Y1)1_N'!;6&^P^X0"G MU$X9^MW89(63IVH7SLE8+$$*5@4M4/-8C&N0UCY`M@H9<0J!\?,]MQJ1#H+8!N4 MW:U4#F<>"Z\P#R;_QH??RED`6ZBL+)#G`MAN98%X"3I;:S>T MS;+N[/.[&V0BCV'&T\X"V-0EH8E[5<0$,HMC4BT*0$9H^U%G`6[5,F"3B6(> MG^2E[^-BW''4PJ"?^!EMW`6X%Y0!LR*P,SCPTL.]-DV"V@P3'Y= M?5ZO.W`=>M$6T:Q85U&,\"8L#@_>VV/LADE04.C_,TO2\JIEM7YT7\76$-MO MG#LJ%M1=:GW&-SW&-SW&-PFGO<8W/<8W/<8W)&P^!Z#^QZ#^QZ#.VV&WV-P M)QN#V]3,(LO0,DN?HQC_ZW`>D=X=M1M.*497CF06ZW`3)CDFKN)<2GY^QW(H M`:G(.*\#Z*A><^9%B.:Q4+,T_3I),NV)7C2"C@ON.\D/*.9Q]\3"*,ZBI]@2 M/&*X+]-M+/.XUFDBO<%_9=0>2(`4?T"AI[Z<,UN#1PR;\\[',X\+G4YJ2*5- MFZ`5>"BQ#M$;#L<%V3:$U>+2Q(>="//P,W!/E7G&?QFD!'G+<:U[7 M,/!S>$^:5[4-FC@3,+C+9@^&VT#XN]FDDDL2K6DX??Z.HU_)%MY/ M>XX4;F$Y+2`N7LNP*9%!L7H$^K)5(#7V5*@/?!86IO,H25?K$I9P,:L]!WV1 MJDU;9_3SL`W]%M-BK7&T%CH#UIZ"OC_5)JXU=ELV'T@WL%7Q50DW99(LE62: MW#;0%Z?:A`J1S,/$V@+U"%O/&^E1(\ ML_B`/J"`]+DA(#^[\9^H)B+A33FO$?3%J@'/8C`S^=*BD,@E(!B7_A:'>5W5 M%+\@.=62EM"7K@9\*R":Q]U,1S8Z7VCH.U4#8ID8YI`?H19,1.14Q(]G!.=J M?\`_0^LH+H..'MU7E'S&813GU9]21`BD^?2:O11.Z9]1^AR1O[R@(A!)I")' M'`7T+:_VMO#(LADLC.#H2DU$4<[6,[(LBP^"G!;@-\6&VL(&,H]KI%N4'I19 M0&GC.?"K7VTBN\.W=1,$.3.KZ,3JBDOA@,]K`G[#JTVI$,D\[H/:$,_]TE:@M_M"LE3XYL%:18'_3\0WCP31$LR#'>#;C/J$+Y:YZ!K%V+J MRF#6(?C=L/:*T`/G]"\6?;H_\3W.#:-73WD0T$\]7.QGP6N>7ZN3AT$O#%2E M)XB+2<--U4@NZM7EJK37FLFJ+,H<4F4%N:.URPEI:1KCIRRE$2./41%SK7+W M8N<-T'>FUO3(HCSF81O635Y#P%/9A+YI!J%A7@A]-VQ1K_05MY_8+*VD*8HA M?=S:!N4`UPSF(7 M:W8R`=Y1FO&ELCY&]A6*(UT'O"FTJ MV5#RF<HGR;1+8[.=6BCRZS`?2^;RB2.;Y/7!G,8@&[0&2T'LY!D9\# M5)Z(EEMZ$/N73$-4FD,[-AY77U0E,H\EA8@P1F1R7*#B_S6AE5FDU2);%#N! M]IT\KBKIR64>'GE=S-U"XUJJU&T.[9"I1ZNJ:K!Q]OU&?2IT(D0;:D`8C4[< M-8J0:^E#LRFT#^IU17+ZBV,.))"&MI&U>&&B$2XJ,6LXW M2`GN+*Z(U.5F90')"[S/1D\T<<_CTW.Y7B./K+N7K]ZS&V[0/5F)5R&5`W71 M(_^C&[07-Y"$4^MTXYR,)<.YUN=&&^(\#"QL@'%/ER&4*:0AVRW"W)!N4$EJ.MP'<7;@C$%9W*U'IS%)`VK M.NCF$:Y?RQE#*]B+[^KJ3SH+Z%3K&EQQ[^4ZB(8[=AXC9"5/]X.WQ1[G'NVH MWURX48]3H1WZ5%5.?SPM%27_EJ#33"S[1'-LCD=X9Z>A/S<'MVT'% MB:A*KJG3RI"FK>`/V7;KQF^K]0/>A'B-/7IK4;A;$*!W48`]:DPY=BA#9P0J M`0G<1B`%H47R%,TEO0Z@@Z_$0N=L"I2137QNU:K*7R`"&*?'GDA%5CJ5E%"- M!V$JJ!^D58SF-DK1!4Z\($JR&"G-&=4^H*=-5]RWD=O3@D\;K M#R)6F#S2MA#SB3LHE8DD;PP]@Y1DSIY4:N"F/9ORA:,;7W=L'=R+=K6NC^,> M!=1_A1;*2/*@MBH89#JJCOBL/F*EN=JO9_")W)M*SBSO+Y9I M+P&TD!8N`L3R;"3Y-AN%$.TK07QGI\?(E=V@[ M^G5X\_U*]]_L)B"?D]98E#XBO#;0$T,D6-YEO0#*U"=&?LT5B:^YWJ^[>AQ\ MJMR.A+!\0&]JQQQ^,^@)9'*U)<,S"R?\+PE:K2^3%),SB]#1OOD@=`9!$SZ[ M"*"]XKE>&T3U/"*%HH!5X:1UY@8N^>4]3OY,Y'/2I!OHA'TZG)KBFT<\U2$7 M3_(8NSY-HM'(K7'X^S((HJ]4(%=1?!%E3^DZ"_89.'+Q"*:\S=>`)_@**8XYU&FD%\V(6G63=#0'.,^H3/WF:A/+["V M0C:`H_WJVS^ZXSLGX\8I_4E\3.6U@L[:9WA*%<&91R!&Z=U#,Z-N0JQGEI"V MA4ZV9[8U50`U8`T\4.[54^A)VX*GT+-#OB!EWJ=IL[_TR?M3G-"4@M3+1WW> M2UJ")\8L4+[TE#8%SP1G<-.I!JHB=`C#WGA<>Q[S M*[EORK&'.U&XUTV5HX/_)4'K+*!W"H7@Y#.H1Y]3\O.Q`G;BKG2=D&28N764 MT';N''KPGI&?!7EL64B82')ODKN*P%Q(UTF2(?\QHF$M49C_2G$V6>D=>E[) M8MPM0YW!K.J*Y+4J($O+1`!TM9%C(6]9OF*1YVWC.6C'6ZO\<2XYVGBG3;.YG`Z" M"'VZ/;UUM^@BVKI8O[9RO]>!>P:W-4+'[MT?^L3UKU9%X#/:/J%8I#V=AZ$= M=XL4;46[ MD_Z=0SOO'F%+8T=(,]'&@[AKB^U]%`174;R7I5*XKEY/T%Z^=I1`>JQ2%<4L M/FJLN5L775T:-&-](?(DR;;%[TQTS<*+H!V-CWFZ[R5>@[F%^&9R!AX^@%=92L;R&8=XFVWO*;E!I:MD M2[8O6WY#"VR9;$-Z]`]]MV`IPZ`U64S\MK&3>!!FCD\]_>!>F\H@FK.WS^X_ MH_@\2])HBV)R]-^/LQRWR;0U[1QZSAHD+[2">=ISLY7;$,BY9MH9#@]ZU!X5 MV?ACCT;"X""C&WW]V:C5(_04U,^.V`/HM.>=FA_I!4I=''Q;CJ2VYR37?5+= M4T;+"[2HC&TEJ;2&" MN<*O]">Y5Q&_$;1_22^NQ;"@;ZX&7MA5?$/DCS3G/P_D-65.H M%2DCT-Z-*OH;Z%8F/YD)A=U@B@83/I(QG(D2Y/VPB5X^XI!,Y[0@M/BY367Q M6^I2:HRF)EQRS5S*+:$,G$H M\Z5)\[@,&Q71^>(4OQ5,E_]H4UW^VOGRP&#S\$HHDI!P> M`4^1K<]&:_#0'S#I''G\*J.C\R1XYFKS.=+$,-J8O#,W#A$-8+F-R(=6P@_K M8?!4T_H4<6%`ES;D1TY&X=MEC+TDB<+/T1,.$(T^RD+L%<6QED\2YE0[`,\6 MK<^F%C3H6H5LOMQ2X:**SGG<60-:6OA1R5@`NQEE0SG67.OA>F3B5'5H["R!#S3#JH(H8 M^MQJ*3R52"E]^P/[J(P3;FR*[E!,%UAW(U(1U2Z97G6G^N0I@D1;B"5>W`60*:Q(31`#_5H#_&7KQY*")!\!^22 M/?4-WN*4=0`4/N\L)E2]38YD'A_XZ^W.Q3'=OZS6-U&XH5[Q?N%J_]\H\*^B MF.QK!%]WI?;.8H+%VM2105O!+04/1C$BB]YY1L8;>F^/1-\3(B""Y#<7AS13 MRAE:1S1/RJM`'S1Z<183JO1FB@_ZFVY'-U;I,XH9U0LI7KY$R.DH_U=0$.O_ M,RN<+LEF:+46J]$P+W06P-9'$XT;4!2CW7&4MS2XU#C@*S';:>YAK5NTKC,JC1V3B<40*<)JV3UY]&QJJ:9R2ID'11T MNW!.@?W'AIJY>W`ES[],>TNX],G[4YP0.94IO07;N>[#SBETV2J#K1@'1DGH MIVD3^B6,D1=M0OPOFG+P]0R%:,VV\DA:.*?`WFTFU(JP["T]HUN9_R"[_^<4 M^4O2L[M!EZ_>,XT2N">;07(T>""2+RKCK-9EGN4BR7[C-$'/$=QUV]8+G-/) MV?ZL0J]4:.+6PM9YLRZ3VFGS1+!F*/;@G$[08JB#K5*(\;G.VM)[T7;0XCN< MTPE9$8=!7^G2^"X.U6:$2%.4>W!.)V3;,\%6L3R$M>YHA=>?HX"@2(J*]4`I MGHN7JR1:;SP(E'6(L)50+2AJQRED'6(T@,XZU!4D^P/*'_VTX\/W2_IYX-+K MY!R;)(J5VV8$F88X)+%)%0*9-J]U1-)(UN[#T&F3A=(9I/$F9UB&):8-?-+M$GOF1&]S%;0:9'UZ>7"L.7#!,EO MYWMTHQ:AQ&DT@D1'6I]7,1)H)S5^?-(^MW,=0%-/KY,DHR5":>!C%!9?)VFD M4K]^H3,GB=ED'2(M`!YKIH/JJO0`AE9'2FZCM#HJ^W_@]+E$E?^-JQ<&?<'F M0+;`*TM=#.4P5A5IRN,@J7M*%C\D0=0**L_3H+1+$<]R)U#H;_'K%/FB>PEI M6[`<4@/IA1[P`5V<06V/0`G1)V2"/"A>4<_]+3]^J!>0Z[2:BC%2`F'B-H_* M]%-(@UXM12&]5>IXM9\%MHVR>6$MSMAC'\.1DFK-T+`!LE^ZRX+S<03=O>]%X*NNR:B M1OE>Z&]37V?MWPM!&Q>9).G?"]DS&<[K7@@ZM9DVO5P8<[`&7:"G]#HDI[R, M+F62;VOW8>AT[T8?53:,B:<-;X*BN1FEWU1>$_!$\&R"5,AL@1A=RO`'%.(H M+LV&F&CI`_)HOK3;*$7)X]?H\3G*$C?T+P,:#R?+ZVK0&7A">"%?S*L[4Y2@ M7]_>&O!@40$>ZI(!-C\-QG\;).S7N3?_MUA:54"_*_!$]X.QW\(XCV0S%^50 MJ2$(A4E)5DSOGZGXZ!7T=>CC%^QG;G#YZ@69C\--?C5UYB;(OW/?\A")9>C? M143H*,5QWK(*W#M[>\0IW3T=NI%N`6&&!%X,P'"G"2@M6TEU@#:T'6!46O>H M"/=(GO'N,;K,LT=*][F:/8$7-0#5&K8BFXAPVG:M\V>,UE MBN4W"?Q6X-453#CDV#$E*,?J!U4,<;4^B]S87ZTOR+3P2.M$LL\2-P.OP]"? M5V68T(ZR]B\>;E3 M6>3;+P7SATNW/>DJOJ>QX)57;GX$Q"E&R;D;!#1=5/E<4CZH,)E->X8NVZ"D M`L*YWPOY#&ZT.*Z6+S/JNL3PK7(=I/:RJ%2/%79:U>P*KB=!WJ39#"IWRV/I\ M+T`NL_0YBFDJ4;4)WVX%7J=`/6&3&,,\K*K-;8@&Q>*&X/4'5%E6@#&/TU-W M^:/)V\FWI0"^"[`H5E.A-7A9`N7@1T4LHSU&E=^@RU<4>SA!=S'VT"WB6]0Y MSX/7&Y`1)A_][(Y(=1N>SO>U:`%>7\#XVUH;/W1QESJG"?)^V$0O'S'9V"5I MP6CQ48^18J/Y^R]@E0 MHM?V*'#B!1$MXJV0>$':%B(70VM0-<^IL[='\G)95@:E]M#Y&90DSUXRE?%- MVX&+#Y."5'1SY3>&3N.@S**N$M0!SED#%,*CY,VA+I$=BF8)GJU3%P"M%])!\G`C`Y>^M$^RV_NK&OD7"TWSO`S5^]Z>7"=-LWF"L M+0-!G[C^T>W(*A\SWZ;#?QC:3#<4J0*'DP[^69P![ZG`))^:_3/05KLC?&8: M6">>Z37'(IW@S7`-X0OX.8QVVHOP9QSB;;:54M1X#MJNUF*`35-GQ+-8 M+#^[KVI\U9^#SKRJQE=[Q-"VZB/MLGE?"95[C?Z=CRB-ZU#?4SM"FHD'MZDL MRJWG*DN3U`UIUJG[*`BNHIC^<0@-%;X0/$^M'9VRK*]RD^5`[]"*C MKG8%PB+HJ&Z7K<)4A/JJW1E\_N.CJZ.9C*!C+<>Q?`+O;J'-\U-;.MDBM!63 M6FQO+T-_^LK\!Z+)J9"_)-/3W2!92.211P">XGG*BB\5K*UPW@F<]KA&3N;9 M8:A)86\4X#FRQSO<8%GV=\=%-G M<'';2K@UZLDD6X`JL8!_9K0&`I[2?7S3Q;Y\R_GQRZSGQVP.)5`9Z\<[(RP* MMIP*GP8YHX.'`YV\QP.]QP.]QP.]QP-I.VA#WP8?TT%[\C%`^O[9P'>C#=G+ M_;,G'R1CYI\-?&/88D#%/]M>,`L444:.V<#796I$M4<\\9B4L7MD0]\D3<(C M>P2Y;("U\/=!2U\BT+_GISUCJ7FK'=#1U@=21&/,`MXTIW/''B2 M2^I)1U*/*-Z*JE<.]U+PX#%PK1],K.^;FXZ,[G'RYU6,T'68(J)OZ3'7?-:[ MIQN$-KI%GRO>F7B0#_&!_#T*2#(R_:A+3,6>%`DJ-3OWNT^+[Y MWT-:%M:TS>VVQ7+V=H]V49PG9I9<=0[]ZO'&'M;<^$^4DI]5-4?6%/I:_MAJHR*/>1@D?T,ABMV`(%WZ M6QQBNOM.\0M2U1RE]M`W^,=6'V6AS,.:9Y8>'?H6_+B;^@[VN?L,32!7.O`5 M=4#KMSH2:OU*;4&OTL<@M"FZNA*8Q;G]5)BR&<+M,0M MVD\K=0"6CE*75,[&61WD++1":;+=1N$+2F@P+MT7)(]1Z@;UO],)=QNE_T#I M82K6\\3U_?CU?3]81DD[.GD\&E-3#;4' M4F>."&UM+::_3>&R/3^T,XD4UM%A=56W^M132;U^TR+LAY#[Z5R?2]'Q3E<3*$<%700ZMCFA679 MVJI&->T]STSK48W]9G!DWY3^TK95CFKDLVFN!:F@KSG'-E_LB]=6/:J13Y#Y M'$NF>H@&5<7LIEQ MW-',M6:N>)8`R'A_!S:^.#LF`PK@;O`:%99J?A1>_[[G6IJVHZ%V)5;I&Y@_ MUS#ZEI]LD%\>=X;2O/9;YEKO=0@=9,JNTL:I7X;V_'B4&RGJSJGX\1@DV;[Y M:.9:YG6P[8*IC*L),\L$S#^]AR>^AR>^AR>^AR<249P';I*LUF5LS"J^IXND M)%21V^8;"%L48I^A*D@C$06MH`,*A5QIT`L?(\@_S*%=FL>S/7Z-'I^C+"%[ MJP?T@L+K/$5#%,OB`DVZ@0X;E)#$/%)I`QP=U[!)JW5&;P((VT+%?!D1*T$`[56M]=8D*WJ-=C#UZ,V'\T>7V`AT*9>F; M*\1GR_78.M\K+XVD.&135Z<3Z(`@`[9UX=GRK#T.V9K[+(T^P"-L;'$M@`?M M*2KX!'N,%4J3;)U.P(-4C+[2FOB@71DU-M:7`3T$MK!H[ZT%O8!'9UC97\L` M0OOF<1F_0D\Q$\L-VKC!TG_!B>J12K\K\`@$`^X-4=IR2+.N`)^)Q)X[8%J' M1=D*K],)N.N\`>G:^,;K3:4&917RZ_\8]0/N`#X8ZTV(XW5K^NQVUZSS*$RR M("4PU)9XC3[`W9N-"->#!^XUI&6`,=G*:?8#[JUKR0HC@SBD]\L48BUNCI,: M$=RS=A*Y$4\L9C"ROQ!EVRW9+:_6=;_T\LOY&-UEY`M+D!'LVRC,?;+DA5-, M>YRNDVR3:^8BUDLHP'D)-3VQ%026^YE?N"G+";8JJHEW]E.'V[#HE,LORCO3_#'<291Z?O M?:*Y69J`1N(L8"LZC6?1Z25!:)<'X.W[(?T"YQMI^0W.`K;FDT6M'4(R`[IQ M@(=2_/P>2O$>2O$>2O$>2D%$4=4AD41/U!_[!@(FVG#GP;$T+&)T@XYHD)4P4@8Q6NM$>9SQB##P"U)@C-L" M.C!!C2OA\$=K>B`:5MT*7>`8>:2E]CQ3Z@`ZZD!YPBFC@3YS054?G?Q_9P6MK*0;:CYH+:CQE1X&O+3LJ M86@1,X0^[?-0O2*&M/9H]V'PX(>A6.7H$%L`LZB;)W.X8CX''@YQ7/Z[V*%/ M`G:XOZ?2DNPT]L^`1T0<89O1!&OK:`"TQN=@I/.Z]A1XW$-3_`**NA$,$^7H M,P[Q-MM*66H\!QZJT.:`S51WS+/X8'YV7]4HJS\''F>@2%EGS//XT(W>HQ@Z MY_HT/(K_!F_FX7M_T3-"!]\C>J4)*N7>PRJMP<,8+''(,O.I"V"T5R4-#QHR MDPZ'1H$W)[<-6)2!+A_,6Q0)KK%RV+HEH'EE<2CR2%-I!N;@;X-)!6C?^!:A MM`O]CA*:I#@O(H4\\N-C1']US-*JJD.`#A$P5$@0,4%?#TY%N9>;38PV9$FX M#M,8APGV?G>#;,AZ1L9C@@Z6&+WZB^0&O?\&G@_%RK!:+WT?%\#SYY)EECY' M,?Z7N(S[<&^%#L"`TFE%R4!GJ+-X:=>M<9]/3F:)>]F=GDY?T,$2?37,"*^M M9'F-<4\L:0V@LZE"]D0&VE3D/5''LU8PYVJ:0^TYG`62`'\>F M3RP7Z,1_P/J:_X?N@??36UH^RM)KG`60X1]8*WFB&&T^0@MQE05.O@W1UAN< M!=`M@15SHU4I0&3=S),&,-VNDO?P3@-\ MMPU'XIQ.\O8&4EKC38BYW$9Q2LV4Q?CWF8Y8_D:2%L[I)*\U5%"!Y[7D\E?' M2N]3P@25F1F*6Q5ROFEX/_!YU>[).9VDR;\/VDH/QE=I9K_>'#0W7XN$&V_5 MIL[I)$WO6O`J:L=75Z:Z8F)$AO-GLZB1B[!*CW;8U0AUW3SU>S=.07V%A]& M@^S)YAOW46&>C/Y`-.4\\I<$E+M!2@=AO4=> MM`GQP6*_6G\)W>H8V#X3U(\"R]"7GI*M].Z<`B?6&&:AM2>;T=:"K'T;J@_& M18;(9Z(T<>[/(F=OY0__'04$2W+YZ@49O24_?\9H?85#-_2P&Y3INT2']R'> MYYP"Y]@81@&'E-9H2U;60),)B,C)R,]!WZ+T8'B/7C`MJ2Q/`V_4F_,3<-:. MP=5)4Q;0?B\VUJ_!%BKV'/MI9OEP+8IE0.>58^3+IC+`:2XN-_2]**1&6$10 MHJ1,FIT6)K]CI\ZN#8QL0,[K`SMH@T*F;*U^(!)CKW:(NK"$FQM$%#"YRE(R MH#*+0J7)1"T5H&KV!)WD6IL9]OG*`/4L,E(HXC[/8DI&?[4I.X).@FU`=R^] MJ<'^EM3F.GS\&M$$G*(<&-I]06?6/K;R-)%#7X4<6X&J'*YV5&C?&W3Z;P`E M:F"'OD4YJAKU5QWH#.3'5I=:RO+>=R%IE+H![)&DN2\LCB3O9Y'!B_0TE(RHG*A#J^W.XN9+5SI&WACY-J-+( M5@)%@+/6`6E&1*7VT`<#12:-U."`<'0%>GYW$_?/F(PAO'*3%&^>48KBY9.D MS(2P%?3N7)D,ED58BFRL*%P3@"C^`:3_0N]Y(C3$,7),]Y)*-;M"+S:3Q_*3(&?/O1UH4"[]7')^8P3>K=\';Z@A+1*;@(93]P6T*5\>E$F1#5: M1[2'G>NA"Y3@#1FYC#C6P]"%<'IQQ@,T6M>NTKYU%:._,G)8?^.N M,3II2@"!U<-2)HI;I$KT.%BA&8FX5;BI(1C=<>\S62J>91^IPS-@M5^DDF5^ MAUH#'^M1;1F&9*F6L%!_"*Q`BQ$-G9%#'["&N*XJ%^T;A3H1XH;@15WZ&4`5 MP(WV<"6X"%"MWZ#>!7@E&`6FF,=I/81C77-OHS!&7A;35(X7Z`4%T8YBHGZC M@E,UMPU8Y18C4MCG;#&XL1))SBQ>C//1K-:M@><'(?R4ISM.,+E)D:Y/4J)66YKX-HEE@D6PX0VF=HY+RUCY*[6]\@-+A/"%HW%(CO0 M]$UP4N(U`:[XS01O@NA$6/O0R<*-- M=IZ/][+TUI8PR'@6N-2"!>9XH.:13[Q$5Z_0*:IWP'H(:3=`56_]R"RA;I-O/@R6WMQQAPPS@(4;A0@V7A/88+5[](+"#"571!?IZA$393C/DC3: MHICJX$U$OALT0Y!N&)M)Q]`!;B**V#.M/]YI1S@]4(L^0S M)8YMX[893T2;*9D<)1$!GCC_Q8RI`^.Z+4K;0$>R"7GB4"O",@9J$^3]L(E> M/GI1%J;Q6\%L^8\VJ>6OG2\/#/8.?X0.4Q/*O$E3<]"6^``M,=K%_EL<9;N$ M)G>C6,E.,?^%*'S-O#/HD#8-ZON!A/;K.+*V/'Z-[&G+OC/H:+@AM:4!$MIE MQ(ZV:&YZ;A0\>$V[A`[$&VHGV$<>\UB2#C.+WNLG8H'(#]4FW4&'#/91`K9: MF4IA%EGY*K0*RQ!TX*$I3^+%I!9].#H[?CG&.Q33ZD;NAN.NP'\8//C0#F<2 M@',URP(E0`:SSO)CIHONKP\24@V4D;:2'7/)4T(TBS6O#?#,3D03);2[31SEE72JEU MP.MK"Z\GZ$NMH?1%A'<>%D6R`[L.R7X,T7V8:&-=?P[Z(JLWW1TT\[B#D,C% M?-L`?1?5FW`%?-92U['LC=V!Q*%PP+>. MQR71EH*Q%7E@$CA?`Y94&;@=5G6LI52V7@.^HAI3F,'QCP,!>=12`:08O(AO*N&G6NLE%=) M2^BSI3G3"L#F85>HU:M68+OU++0W8A]^&5"@LV%9G\T7Z"D]R$5G-K-:0KL' M6IG-/&`SR9#5;]=ZH^"Y;.L5T"Z'$SE`-N0%O=W@I^MKVBA57;C$S<`]'&U2 MQ_)^4(`_B[O+GG)<;FF`R7!+4M$_<'T(!5T89'VI@9^VO]E#]I3DU032RQ?J M00?D<-8>AHJ'+:<)R`5)Z<*#Y)WG"5B'F,/[131C=HG"@F23YW835+L@Y%*IUAS8L*C"#XM7#7!C MI;O\?_3HTEXI[V+L ML:Y.U!J"U?8UU0<-6+9<;5-P6N[FNZ,U`$!EULCK\#[+-6,=BH]P9<#]B"Y483ZY"EZ9CN?A_I\)^(:I)__']0 M2P,$%`````@`+D*H0GNJ@#C)$```=;0``!(`'`!N96]N9"TR,#$S,#,S,2YX M'Q\?$DQHRS`+WVV&!R\&AZ^.CP< M`KD0+S"5%XPOSO`41:$\[GV.4$BF!`<][\4/P`$51PHY:$#NQ0^>1LB`/AZ^ M9'P&4*^&@S\_7$TTKSUO#7P4$OHI@_%TST.#< MA7B0@*7[B41_AM!RC3E%XEYC)0W*&`?]5\.^,L<&S6<1E7R559C`_LL9>Q@D MC66H$>\I#-H*>DMP$N._9I!AKBOQ]D4 M^;*/GY8AHD@ROKJ`_S-*8I1&"SNA0/*!XGX`0'V`PISX&=QZQ!226LP0I4PB M"6O>^W=HN21TRM37:@H=*7;O`,E3'S[>7I:N25JN,^9':GE#-("_1*X4+;[0 MM'L>`=540JQ[#?"44*(Y@D7,ZWL&+?T12'CGFH9WN2'R;I"G8(A&`@=C^EY_ M!EL)Q84"4*M1@I6`V#`V!)O!^RCTH["\@T%&O5OJ^Y11P4(2J&%WCT*U1HHY MQE+$RBYOMFOZ`-0[`:7@1-6`#U8"EKTT)>\D)N5--*W.*CQ10ZR%&P2KLIQC M28`/B_JK@.W&.-S&&-Z/&=I_[ZQQA-&<8%.VQ%QW;;%+"9S=)*^;F60-(CPV M]<9KJMZ/'RF*`@(PG3-,K">_1/,`":+.`88\X)")C:':XMD-]V8;PYVFB7M7 M0+W+!EQK::.D\?04B?E%R!XM$\L.9C?/3UN9!XAZFFIGS7)))3ARBQOXPX); MO&1<0J0:VZ*DS6Z`GY5?180/4RCB&/Y)L+T8W5OC=TJ]DVBQ0'PUGD[(C$*` M[B,J1[X.WD`5-S`N?8*3H=\0UJ[^7_+J3ZBI89ZBYVT(>H9BMPPBF?]ISL(` M6[^VZ/2P,XABS ML[F::RQ5#`$>U60.,7JLSOR7=EV^SNL2T.*`!!`]C=DI54ZB>X$_1R#)^8.: MJ\8%RWUK5^:;HK-E\+P8L6.ZU*XFJW9#6;5_4`@H*QWR;IJ@Z(%GAGQ9JUWAQ5"S MZ*5W4\TYSSRM8WN37<&%$+/HNG=3O\T\DS,L$0E;.3,&Q6Z/8EC:PIM)2'\W M5*G6[_"3C%"XA;T,IMULA0AX"[-Y21<=,U_!W\S.J=)FNR&*T;/5'^WF3"G3 M9796U$'9%5\,EZL4W\VQGCNUR`STDC:[L@LQ;_Y@H\LC7%T-#OQ4*!04%I12 M$+NZ[4&N->CZKO:\3H<-]#XL47R+:-+4RYUL!%#:;-=],;*UY:`[.>Y+59E9@FJA['HO'NQ6Z+V; M(SV7Z<^L-25M=ET7(ES;,4`GA[A=C9F,636(7>&%R+9"X=T]P19+$/<2[Z;#8GD.7'U*W@@HAZV2?!;!H;[WF`?`H'* MVPJ4M9);XH3HOJTX@()#]R2!L=U6DMQTV*\\`_.J'#YMWII#`XC"N/2HM8!& M60V(N/;&%?,UF0H4]5_?X/755_WA0?]P^/))!#%C+?I?2]2R?X/7KG][?8V& M/1L$U>6;!IU5EK0HZ5/W9T4=+CS3JVR#I3^UZKRN1TV0Q"CG/8*D5Z:U:!(<_[<)!PZ4P MU;O?JRBU-N4E3.=\0:<=<95F?)J/"X*@/[69C33V9)FK(8^U@&'LEG'9, M,'J]#1_5I82VWS,U+:M-DL)AFI=-&9T1#>(2.*FA>2*Z'I8KDM&OX5S/X MV,'4U;B.X#M"9Y<2+U3\T_-0`G7/!2C)`S5E48# M*R`5+=( M3:DJ:1M`NR;A31S8K6Y"%"\AGR.R5.WG0&FA-O:/`D\CB(0?D@O^5M%W(N.: M3E15Q2`*,0Q81I.2D>/I#4\NBNG#U4LA(AS<,768Q*C^JEP[>R+HG)ZL;W#` M^5$%7FYQJ,Q^QS34>*F:U./M/Q#G,$8JQM)>R3JG,U-,9!2&"<\C7Y('\UC, MKI'F2*[)6YC_4Y@%(R&P%+8=OQ&X0]O^:20D`R=S3/$'O+C'/+,?%!LSY@G8 M`A'Z;+S_B]VS(M/I;UWBUBCS[M'"M*71)=Y/$*=8K5+7#`@5V;>WNR3!A-'5 M.8120C#Z@=V3$*M]*J(DCH-@<+5*+1,9U;867&!TLOHSQGF]K M/4,K,9ZN`\@XGIQ(LHRTBW1)U<6F0K:@.5+:MH;Q9W0DGGPL@/5+*H`L1)!7 M9$%,?9#$>2@#24L"SC66,-);21*?-$G3E!3[YX+VK0F5[D"^9;.(6^Y@\ M*&)G$1[-9ERG5\T83(O;%",M/:$2SS!_/C-:F5:S[`/Z#^.-Q;1@."5FLHK$ MB\C)ZCI26\9X6BID,WBG1&QF%P'.;WMKQEB[K;7K.;L'6?_`9#:'Y7$$P3ML M%+#0S!&=X5N89Q>,I^NA;DH"ZT)EJ3*S5^O:M[$F]DMMK'GK>HBFUVN!'1G M1D\P);"+:08E`5H3[`-#$-=+")X>V=V<1>KYPGFH]GM+R+P5OE.!:$,))KLI M8/*MRW]-;!G#;;!=DC[F:3P]88@'X^D9X=B7C(NBI'60+DEEJ>M6D4BI!W9H M"TIOHLG)PB65Z9TSWCB2(:DN!V5.=]LB[[C][-6GCSD^?X+8@@A\PXF/KW'& MEJ4@.R<4-D;\=T M!HLB5K/I#*M?#-''SW8YF^.X*&F2*ZA8@^H@'5J`C!-K2XH4VYQ*@%2>4Y=N M#?4(#EE'K]\%CG/A^"U6TP+8-*EC&&OJX#8.PS(*V`_)X"0 M?HJ)W*.NBH0=TQI>2KW"YEWZ2WVMG_%DY[5YR.TP75K`1]$,5K*<&W^^6(9L MA;&YP%(4N16:2_+^$]$('*,4YW<-+-P&RR5IS_`]>(I291MAGI9:LQ+,)7EL M,PTL<8N7X`;#DM-JBE8@NB3S&&+06L8M1FV'Y[S$]6M2*S27Y#W#OF5LU@O< M#L\EB8OK:9P]S/'>9"&N1'1)Y@M\SZV\7^$9!$+!`Q$5.]`VV"Y)_P%Q?UY@ M/K>%VG)RK?"^/8FMES1;H[HE=W&0JM_5C$*5)BL=X*W07)+7YEHT7,U:HSHE MM[F=-XZDRH`&*:_BCMU$,(0A4JP[.MV>B/,IB9$28Z;A3E8;D)LXFSEZ1#S0 M^8,S)'%]E-V.6B:TAF^>\XY<*E&]SLEGK\C9(3)7;;3$KJ54&M@D/FZYI,"N M?A$IUJOW9L"KMTFQ#A27<89Q+P-B^\X=.A.Y5D22+*!XLV.94],FQFJ(XY*D=W..\;\QBGDU&U2Y_]H, MWB4)2W[%JN9TN1[!H?U:IZ(U.;5;CJ>I<9?=F"K`TN)0];0V)/]5EX'*!/N* MYS^;&72'^8+0M0@%JU5`NN-!;+_]K>T7/RG8SYY:(.K8,<;>G(7D(>MO>J6Z M3,35_ZD1^]O`UWE$LU,L66!YB,=8^;N;J9`606R.L MZ@7T[UBH)SR9M3(CY1;(7^YB2X#O]V3A]8#N_4)F`3+*?$M?MNZ<5734SCMJH+[IM*$,R(6N\,MB:X M8_RYYW=3/IO%543-TOP16I+5NF$-B.S#JKT0=&Y7,(8TUCV+,-@TR>ZLE[J3 M5?+A'\F%U"<_C%0FXG1.\/0"G%#J$Q0F@7QN[_@R7;@TVE)"QN_1<*"%O,:I M.Y_L@62NN)9HJ0T!1W509^A]#IIO8'3\C@3ZQ!FP>($`=S;'$G-;H8,:0)<2 M#B6L6D_&ZF%=DNP436!@H=,0<10/IU.L"JWI-^`J`.*2PO(T)TM+^9#6N"Y) M?LUNB$^);TO[95MMXBJT"%`!Y)(L$U5`\@P+,@-6+6+8VUV2 M(,D/7'!=VM]?C9Y(QHVRMW_E-&,@CP*RB&_.7386Y4QKMDH8`]'0(%]G]_G` MJ)Q;9D3Z:Y=&T`B80*'E]FKF>YZM MRRD3,G=05`[V+:1)8)7U.=$1W'B:DT!?DB?W4>ZF?6.49N;\2KF3:QYC%C_`_GT"K.F%-MN>` M%,Y%VF*ZM69?\#F&J0G;598=Z8(<\K$UE&E7% M"SA9_ZI==1V;H@'1(J_TMXE>4Q:T`=$LN<6IBL:V"]W&NI M2Q+'63#U19[1^#9OUNUO`NV2DWP:(E6[ M,V%VS&_50V=SUJO+X!#U\W.G*`Q5A<3U[=H8,%\Q;A_4=K3]/N_ECCA&XZGV M5P*=3,QD6(J-&\,"V^C9V$[--5.3+8EC5$I]]5'H^"9W3E8R6=L0>-Y9.XA_ M(^C]BQ_^!U!+`0(>`Q0````(`"Y"J$)739#\T:D``*;E"0`2`!@```````$` M``"D@0````!N96]N9"TR,#$S,#,S,2YX;6Q55`4``U="BE%U>`L``00E#@`` M!#D!``!02P$"'@,4````"``N0JA"N^@#_PD'``#+7```%@`8```````!```` MI($=J@``;F5O;F0M,C`Q,S`S,S%?8V%L+GAM;%54!0`#5T**475X"P`!!"4. M```$.0$``%!+`0(>`Q0````(`"Y"J$*4`A+$72,``&N'`@`6`!@```````$` M``"D@7:Q``!N96]N9"TR,#$S,#,S,5]D968N>&UL550%``-70HI1=7@+``$$ M)0X```0Y`0``4$L!`AX#%`````@`+D*H0MU%/6.D7P``F+$%`!8`&``````` M`0```*2!(]4``&YE;VYD+3(P,3,P,S,Q7VQA8BYX;6Q55`4``U="BE%U>`L` M`00E#@``!#D!``!02P$"'@,4````"``N0JA"V:`Q0````(`"Y"J$)[JH`XR1```'6T```2`!@` M``````$```"D@8-K`0!N96]N9"TR,#$S,#,S,2YX`L` A`00E#@``!#D!``!02P4&``````8`!@`@`@``F'P!```` ` end XML 36 R1.htm IDEA: XBRL DOCUMENT v2.4.0.6
Document and Entity Information
3 Months Ended
Mar. 31, 2013
May 03, 2013
Document and Entity Information [Abstract]    
Entity Registrant Name Neonode, Inc  
Entity Central Index Key 0000087050  
Amendment Flag false  
Current Fiscal Year End Date --12-31  
Document Type 10-Q  
Document Period End Date Mar. 31, 2013  
Document Fiscal Year Focus 2013  
Document Fiscal Period Focus Q1  
Entity Current Reporting Status Yes  
Entity Filer Category Accelerated Filer  
Entity Common Stock, Shares Outstanding   34,080,153
XML 37 R18.htm IDEA: XBRL DOCUMENT v2.4.0.6
Stockholders' Equity (Tables)
3 Months Ended
Mar. 31, 2013
Stockholders' Equity [Abstract]  
Schedule of conversion of preferred stock issued to common stock
 
   
Shares of Preferred Stock Not Exchanged as of March 31, 2013
   
Conversion Ratio
   
Shares of Common Stock after Conversion of all Outstanding Shares of Preferred Stock Not yet Exchanged at March 31, 2013
 
                   
Series B preferred stock
   
83
     
132.07 
     
10,962
 
XML 38 R4.htm IDEA: XBRL DOCUMENT v2.4.0.6
Condensed Consolidated Statements of Operations (Unaudited) (USD $)
In Thousands, except Share data, unless otherwise specified
3 Months Ended
Mar. 31, 2013
Mar. 31, 2012
Statements Of Operations [Abstract]    
Net revenues $ 548 $ 1,164
Cost of revenues 16 249
Gross margin 532 915
Operating expenses:    
Product research and development 1,634 687
Sales and marketing 805 799
General and administrative 1,652 995
Total operating expenses 4,091 2,481
Loss before provision for income taxes (3,559) (1,566)
Provision for income taxes 11 22
Net loss $ (3,570) $ (1,588)
Loss per common share:    
Basic and diluted loss per share $ (0.11) $ (0.05)
Basic and diluted - weighted average number of common shares outstanding 33,511 32,809
XML 39 R12.htm IDEA: XBRL DOCUMENT v2.4.0.6
Commitments and Contingencies
3 Months Ended
Mar. 31, 2013
Commitments and Contingencies [Abstract]  
Commitments and Contingencies
6.   Commitments and Contingencies
 
Non-Recurring Engineering Development Costs
 
                Neonode and Texas Instruments Inc. (“TI”) entered into an Analog Device Development Agreement (“Agreement”) on January 24, 2010 where TI integrated Neonode’s intellectual property into an Application Specific Integrated Circuit (“ASIC”) developed by TI. The TI ASIC is designated as NN1001 and can be sold by TI exclusively to licensees of Neonode. Under the terms of the Agreement, Neonode is obligated to contribute $500,000 of non-recurring engineering development costs (“NRE”) to TI based on shipments of the NN1001. Neonode will contribute to TI the NRE as follows:
 
For each of the first one million units:  $0.08 per unit
For the next eight million units: $0.05 per unit
 
              In the three months ended March 31, 2013, $217,600 of NRE expense related to this agreement is included in product research and development on the condensed consolidated statement of operations. No amounts were recorded in the three months ended March 31, 2012 as no shipments of NN1001 took place.
  
Operating Leases
 
Neonode Technologies AB has a lease with Vasakronan Fastigheter AB for 2,723 square feet of office space located at Linnegatan 89D, Stockholm, Sweden for approximately $8,000 per month including property tax (excluding VAT). The annual payment for this space equates to approximately $93,000 per year including property tax (excluding VAT). This lease is valid thru December 31, 2014, with a nine month notice period. The contract will be extended for an additional three years if it is not terminated according to the terms in the contract.
 
On April 15, 2012, Neonode Technologies AB entered into a lease with No Picnic for 2,853 square feet of office space located at Storgatan 23C, Stockholm, Sweden for approximately $14,000 per month including property tax (excluding VAT). The annual payment for this space equates to approximately $174,000 per year including property tax (excluding VAT). This lease is valid through April 15, 2013. On April 16, 2013 this lease was extended for one year until April 15, 2014 under the same terms and conditions. Rent remains at approximately $14,000 per month including property tax (excluding VAT).
 
On March 22, 2012, we entered into a three year lease with 2350 Mission Investors LLC for 3,185 square feet of office space located at 2350 Mission College Blvd, Suite 190, Santa Clara, CA 95054 USA. The initial lease payment is $7,007 per month, increasing to $7,657 per month over the term of the lease. This lease is valid through July 31, 2015. The annual payment for this space equates to approximately $86,000 per year.
 
On October 12, 2012, we entered into a two year lease with Space design Inc., Meiko Building 3F, 1-18-2 Shimbashi, Minato-ku, 105-0004 Tokyo for office space located at 608 Bureau Shinagawa, 4-1-6 Konan, Minato-ku, 108-0075 Tokyo, Japan. The lease payment is approximately $3,000 per month. This lease is valid through October 12, 2014. The annual payment for this space equates to approximately $36,000 per year.
 
For the three months ended March  31, 2013 and 2012, the Company recorded approximately $120,000 and $103,000, respectively, for rent expense.
 
A summary of future minimum payments under non-cancellable operating lease commitments as of March 31, 2013 is as follows (in thousands):
 
Year ending December 31,
 
Total
 
2013
 
$
293
 
2014
   
255
 
2015
   
23
 
   
$
571
 
XML 40 R11.htm IDEA: XBRL DOCUMENT v2.4.0.6
Stock-Based Compensation
3 Months Ended
Mar. 31, 2013
Stock-Based Compensation [Abstract]  
Stock-Based Compensation
5.  Stock-Based Compensation
 
We have several approved stock option plans for which stock options and restricted stock awards are available to grant to employees, consultants and directors. All employee and director stock options granted under our stock option plans have an exercise price equal to the market value of the underlying common stock on the grant date. There are no vesting provisions tied to performance conditions for any options, as vesting for all outstanding option grants is based only on continued service as an employee, consultant or director. All of our outstanding stock options and restricted stock awards are classified as equity instruments.
 
Stock Options
 
As of March 31, 2013, we had two equity incentive plans:
 
  The 1998 Non-Officer Stock Option Plan (the 1998 Plan), which expired in June 2008 ;
  The 2006 Equity Incentive Plan (the 2006 Plan).
     
We also had one non-employee director stock option plan as of March 31, 2013:
     
 
The 2001 Non-Employee Director Stock Option Plan (the Director Plan) which expired in March 2011.
  
A summary of the combined activity under all of the stock option plans is set forth below:
 
  
 
Number of Options Outstanding
   
Weighted Average Exercise Price
 
Outstanding at January 1, 2013
   
1,715,200
   
$
5.04
 
Granted
   
15,000
     
5.97
 
Cancelled or expired
   
(200
   
125.00
 
Exercised
   
(38,456
   
4.33
 
Outstanding at March 31, 2013
   
1,691,544
   
$
5.05
 
  
On March 11, 2013, the Board approved the increase of the number of common stock authorized for issuance as incentive stock options under the 2006 Plan by 2 million shares.
 
The aggregate intrinsic value of the 1,691,544 stock options that are outstanding, vested and expected to vest at March 31, 2013 is $2.4 million.
 
               On March 19, 2013, the Company received an aggregate of $167,000 from two employees in connection with the exercise of stock options into 38,456 shares of common stock.  The intrinsic value related to the options exercised was $58,000 on the date of exercise.
 
For the three months ended March 31, 2013 and 2012, the Company recorded $576,000 and $0, respectively, of compensation expense related to the vesting of stock options. The fair value of the stock-based compensation was calculated  using the Black-Scholes option pricing model as of the date of grant of the stock option.
 
We granted an option to purchase 15,000 shares of our common stock to an employee during the three months ended March 31, 2013 with a grant date fair value of $80,000 computed using the Black-Scholes option pricing model. We did not grant any options to purchase shares of our common stock to employees or members of our Board of Directors during the three months ended March 31, 2012.
See below for assumptions used in the valuation of stock options:
 
 
 
For the three months
 
 
 
ended March 31, 2013
 
 
 
 
 
 Annual dividend yield
    -  
 Expected life (years)
    4.3  
 Risk-free interest rate
    0.65%  
 Expected volatility
    154%  
 
The 1998 Plan terminated effective June 15, 2008 and the Director Plan terminated effective March 2011. Although we can no longer issue stock options out of the plans, the outstanding options at the date of termination will remain outstanding and vest in accordance with their terms. Options granted under the Director Plan vested over a one to four-year period, expire five to seven years after the date of grant and have exercise prices reflecting market value of the shares of our common stock on the date of grant. Stock options granted under the 1998 and 2006 Plans are exercisable over a maximum term of ten years from the date of grant, vest in various installments over a one to four-year period and have exercise prices reflecting the market value of the shares of common stock on the date of grant.
 
Warrants
 
During the three months ended March 31, 2013, certain warrant holders exercised their warrants under the cash and net cash provisions, as defined in the agreements. See Note 3 for details of such exercises and number of common stock shares issued.
On December 3, 2010, we issued 120,000 warrants at an exercise price of $1.63 per share to an employee. The fair value of the warrants was $198,000 on the date of grant, using the Black-Scholes option pricing model, which has been amortized to expense over 24 months. During the three months ended March 31, 2012, we recorded $25,000 of stock based compensation expense related to vesting of such warrants.
 
On September 12, 2011, we issued 20,000 three-year stock purchase warrants to an employee at an exercise price of $3.90 per share with a vesting period over 24 months. The warrant granted to an employee had a fair value on the date of grant of $75,000. This amount is expensed over the vesting period and $10,000 and $9,000 of expense related to this warrant is included in product research and development expense for the three months ended March 31, 2013 and 2012, respectively. The fair value of stock-based compensation related to the issuance of warrants is calculated using the Black-Scholes option pricing model as of the grant date of the underlying warrant.
  
The stock-based compensation expense for the three months ended March 31, 2013 and 2012 reflects the fair value of the vested portion of options and warrants granted to directors, employees and non-employees. Stock-based compensation expense in the accompanying consolidated statements of operations is as follows (in thousands):
                            
   
2013
   
2012
 
             
Product research and development
 
$
60
   
$
10
 
Sales and marketing
   
196
     
24
 
General and administrative
   
330
     
--
 
Stock compensation expense
 
$
586
   
$
34
 
 
   
Remaining unamortized
expense at
March 31,
2013
 
Stock-based compensation
 
$
3,060
 
 
The remaining unamortized expense related to stock options and warrants will be recognized on a straight line basis monthly as compensation expense over the remaining vesting period which approximates 3.0 years.
 
The fair value of stock-based awards to employees is calculated using the Black-Scholes option pricing model, even though this model was developed to estimate the fair value of freely tradable, fully transferable options without vesting restrictions, which differ significantly from our stock options. The Black-Scholes model also requires subjective assumptions, including future stock price volatility and expected time to exercise, which greatly affect the calculated values. The expected term and forfeiture rate of options granted is derived from historical data on employee exercises and post-vesting employment termination behavior, as well as expected behavior on outstanding options. The risk-free rate is based on the U.S. Treasury rates in effect during the corresponding period of grant. The expected volatility is based on the historical volatility of our stock price. These factors could change in the future, which would affect fair values of stock options granted in such future periods, and could cause volatility in the total amount of the stock-based compensation expense reported in future periods.
 
A summary of all warrant activity is set forth below:
 
   
March 31, 2013
 
Outstanding and exercisable
 
Warrants
   
Weighted
Average
Exercise Price
   
Weighted
Average
Remaining
Contractual Life
 
January 1, 2013
   
4,704,636
   
$
1.61
     
1.41
 
   Issued
   
--
     
--
     
--
 
   Expired/forfeited
   
(40,000
   
1.00
     
--
 
   Exercised
   
(590,094
)
   
1.17
     
--
 
Outstanding and exercisable, March 31, 2013
   
4,074,542
   
$
1.69
     
1.15
 
  
During the three months ended March 31, 2013, warrant holders (excluding our CFO) exercised warrants to purchase 270,094 shares of common stock using the net exercise provision allowed in the warrant and received 198,512 shares of our common stock.
 
On February 26, 2013, David Brunton, our CFO, exercised warrants to purchase 320,000 shares of common stock using the net exercise provision allowed in the warrant and received 266,228 shares of our common stock.
 
Below is a summary of Outstanding Warrants to Purchase
Common Stock as of March 31, 2013:
 
                   
Description
 
Issue  Date
 
Exercise Price
 
Shares
 
Expiration Date
 
                   
August 2009 Employee Warrants
 
8/25/2009
 
$
0.50
 
80,000
   
8/25/2016
 
2007 Debt Extension Warrants
 
9/22/2010
 
$
1.00
 
16,000
   
9/22/2015
 
September 2010 Repricing Warrant
 
9/28/2010
 
$
1.38
 
4,000
   
9/28/2013
 
October 2010 Repricing Warrants
 
10/18/2010
 
$
1.38
 
2,078,433
   
10/18/2013
 
October 2010 Employee Warrants
 
10/15/2010
 
$
1.38
 
920,000
   
10/15/2013
 
December 2010 Employee Warrants
 
12/3/2010
 
$
1.63
 
200,000
   
12/3/2015
 
January 2011 Employee Warrant
 
1/21/2011
 
$
2.00
 
20,000
   
1/21/2014
 
February 2011 Legal Advisor Warrant
 
2/22/2011
 
$
2.50
 
80,000
   
2/22/2016
 
March  2011 Investor Warrants
 
3/9/2011
 
$
3.13
 
602,009
   
3/9/2016
 
March  2011 Investor Warrants
 
4/7/2011
 
$
3.13
 
34,100
   
4/7/2016
 
May 2011 Consultant Warrant
 
5/17/2011
 
$
4.05
 
20,000
   
5/17/2014
 
September 2011 Employee Warrant
 
9/12/2011
 
$
3.90
 
20,000
   
9/12/2014
 
Total Warrants Outstanding
           
4,074,542
       
XML 41 R23.htm IDEA: XBRL DOCUMENT v2.4.0.6
Summary of Significant Accounting Policies (Details)
3 Months Ended
Mar. 31, 2013
Computer equipment [Member]
 
Estimated useful lives of property and equipment  
Estimated useful lives 3 years
Furniture and fixtures [Member]
 
Estimated useful lives of property and equipment  
Estimated useful lives 5 years
XML 42 R19.htm IDEA: XBRL DOCUMENT v2.4.0.6
Stock-Based Compensation (Tables)
3 Months Ended
Mar. 31, 2013
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Summary of all stock option plans / warrant activity
   
March 31, 2013
 
Outstanding and exercisable
 
Warrants
   
Weighted
Average
Exercise Price
   
Weighted
Average
Remaining
Contractual Life
 
January 1, 2013
   
4,704,636
   
$
1.61
     
1.41
 
   Issued
   
--
     
--
     
--
 
   Expired/forfeited
   
(40,000
   
1.00
     
--
 
   Exercised
   
(590,094
)
   
1.17
     
--
 
Outstanding and exercisable, March 31, 2013
   
4,074,542
   
$
1.69
     
1.15
 
Summary of assumptions used to value stock options granted to employees and directors
   
For the three months
 
   
ended
March 31,
2013
 
       
 Annual dividend yield
   
-
 
 Expected life (years)
   
4.3
 
 Risk-free interest rate
   
0.65
%
 Expected volatility
   
154
%
Summary of stock-based compensation expense
 
   
2013
   
2012
 
             
Product research and development
 
$
60
   
$
10
 
Sales and marketing
   
196
     
24
 
General and administrative
   
330
     
--
 
Stock compensation expense
 
$
586
   
$
34
 
 
   
Remaining unamortized
expense at
March 31,
2013
 
Stock-based compensation
 
$
3,060
 
 
Summary of all warrant activity
                 
Description
 
Issue  Date
 
Exercise Price
 
Shares
 
Expiration Date
 
                   
August 2009 Employee Warrants
 
8/25/2009
 
$
0.50
 
80,000
   
8/25/2016
 
2007 Debt Extension Warrants
 
9/22/2010
 
$
1.00
 
16,000
   
9/22/2015
 
September 2010 Repricing Warrant
 
9/28/2010
 
$
1.38
 
4,000
   
9/28/2013
 
October 2010 Repricing Warrants
 
10/18/2010
 
$
1.38
 
2,078,433
   
10/18/2013
 
October 2010 Employee Warrants
 
10/15/2010
 
$
1.38
 
920,000
   
10/15/2013
 
December 2010 Employee Warrants
 
12/3/2010
 
$
1.63
 
200,000
   
12/3/2015
 
January 2011 Employee Warrant
 
1/21/2011
 
$
2.00
 
20,000
   
1/21/2014
 
February 2011 Legal Advisor Warrant
 
2/22/2011
 
$
2.50
 
80,000
   
2/22/2016
 
March  2011 Investor Warrants
 
3/9/2011
 
$
3.13
 
602,009
   
3/9/2016
 
March  2011 Investor Warrants
 
4/7/2011
 
$
3.13
 
34,100
   
4/7/2016
 
May 2011 Consultant Warrant
 
5/17/2011
 
$
4.05
 
20,000
   
5/17/2014
 
September 2011 Employee Warrant
 
9/12/2011
 
$
3.90
 
20,000
   
9/12/2014
 
Total Warrants Outstanding
           
4,074,542
       
Stock Options [Member]
 
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Summary of all stock option plans / warrant activity
 
  
 
Number of Options Outstanding
   
Weighted Average Exercise Price
 
Outstanding at January 1, 2013
   
1,715,200
   
$
5.04
 
Granted
   
15,000
     
5.97
 
Cancelled or expired
   
(200
   
125.00
 
Exercised
   
(38,456
   
4.33
 
Outstanding at March 31, 2013
   
1,691,544
   
$
5.05
 
 
XML 43 R15.htm IDEA: XBRL DOCUMENT v2.4.0.6
Subsequent Events
3 Months Ended
Mar. 31, 2013
Subsequent Events [Abstract]  
Subsequent Events
9.  Subsequent Events
 
On April 1, 2013, warrant holders exercised warrants to purchase 55,000 shares of common stock using the net exercise provision allowed in the warrant and received 25,720 shares of our common stock.
 
On April 3, 2013, the Company issued a warrant to an investor to purchase 40,000 shares of common stock at an exercise price of $1.00 per share. On April 4, 2013 the warrant holder paid $40,000 and exercised the warrant.
 
On April 5, 2013, a warrant holder paid $120,244 in connection with a cash exercise of a warrant to purchase 80,000 shares of common stock with an exercise price of $1.38 per share and a warrant to purchase 3,145 shares of common stock with an exercise price of $3.13 per share.
 
On April 16, 2013, Neonode Technologies AB renewed a lease with No Picnic for 2,853 square feet of office space located at Storgatan 23C, Stockholm, Sweden for approximately $14,000 per month including property tax (excluding VAT). The annual payment for this space equates to approximately $174,000 per year including property tax (excluding VAT). This lease is valid through April 15, 2014.
 
On April 18, 2013, a warrant holder exercised a warrant to purchase 40,000 shares of common stock using the net exercise provision allowed in the warrant and received 30,663 shares of our common stock.
 
On May 3, 2013, a warrant holder paid $34,500 in connection with a cash exercise of a warrant to purchase 25,000 shares of common stock with an exercise price of $1.38 per share.
XML 44 R13.htm IDEA: XBRL DOCUMENT v2.4.0.6
Segment Information
3 Months Ended
Mar. 31, 2013
Segment Information [Abstract]  
Segment Information
7Segment Information
 
The Company has one reportable segment, which is comprised of the touchscreen technology licensing business. All of our sales for the three months ended March 31, 2013 and 2012 were to customers located in the U.S., Europe and Asia.
 
The following table presents net revenues by geographic region for the three months ended March 31, 2013 and 2012 (dollars in thousands):
 
   
2013
 
   
Amount
   
Percentage
 
Net revenues from customers in the U.S.
 
$
292
     
53
%
Net revenues from customers in Europe
   
18
     
43
Net revenues from customers in Asia
   
238
     
44
%
                 
 Total
 
$
548
     
100
%
       
   
2012
 
   
Amount
   
Percentage
 
Net revenues from customers in the U.S.
 
$
974
     
84
%
Net revenues from customers in Europe
   
--
       
 --
Net revenues from customers in Asia
   
190
     
16
%
                 
 Total
 
$
1,164
     
100
%
 
XML 45 R14.htm IDEA: XBRL DOCUMENT v2.4.0.6
Net Loss Per Share
3 Months Ended
Mar. 31, 2013
Net Loss Per Share [Abstract]  
Net Loss Per Share
8.  Net Loss Per Share
 
Basic net loss per common share for the three months ended March 31, 2013 and 2012 was computed by dividing the net loss for the relevant period by the weighted average number of shares of common stock outstanding. Diluted loss per common share is computed by dividing net loss by the weighted average number of shares of common stock and common stock equivalents outstanding.
 
Potential common stock equivalents of approximately 309,000 and 11,500 outstanding stock options, 2.8 million and 3.2 million outstanding stock warrants under the treasury stock method and 11,000 and 52,000 shares issuable upon conversion of preferred stock are excluded from the diluted earnings per share calculation for the periods ended March 31, 2013 and 2012, respectively, due to their anti-dilutive effect.
(in thousands, except per share amounts)
 
Three Months ended
March 31,
 
   
2013
   
2012
 
BASIC AND DILUTED
           
Weighted average number of common shares outstanding
    33,511       32,809  
Number of shares for computation of net loss per share
    33,511       32,809  
                 
Net loss
  $ (3,570 )   $ (1,588 )
                 
Net loss per share - basic and diluted
  $ (0.11 )   $ (0.05 )
XML 46 R16.htm IDEA: XBRL DOCUMENT v2.4.0.6
Summary of Significant Accounting Policies (Policies)
3 Months Ended
Mar. 31, 2013
Summary Of Significant Accounting Policies [Abstract]  
Principles of Consolidation
Principles of Consolidation
 
The condensed consolidated balance sheet at December 31, 2012 and the condensed consolidated statements of operations, other comprehensive loss, and cash flows for the three months ended March 31, 2012 includes our accounts and the accounts of our wholly owned Swedish subsidiary Neonode Technologies AB (“NTAB”).  All significant intercompany accounts and transactions have been eliminated.
The condensed consolidated balance sheet at March 31, 2013 and the condensed consolidated statements of operations, other comprehensive loss, and cash flows for the three months ended March 31, 2013  include our accounts and the accounts of our wholly owned subsidiaries, NTAB, Neonode Americas Inc. (“NAI”), Neonode Japan Inc. (“NJKK”), NEON Technologies Inc. (“NTI”) and Neonode UI AB (“NUIAB”).  All significant intercompany accounts and transactions have been eliminated.
 
Neonode management has made several strategic decisions to establish their presence in international markets that provide access to tier one customers and demonstrate Neonode’s long term commitment to these markets. NJKK was created in January 2013 to reach out to customers with global reach in electronics, automotive and home appliance markets.  NUIAB was created to address particular opportunities that exist in this significant user interface arena as some aspects of our technology lends itself to ease of interacting with electronic devices. NTI and NAI were established to create a more focused organization with specific marketing, research and development goals. Furthermore, by creating separate entities, their performances can be directed and observed more clearly.
Estimates
Estimates
 
The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires making estimates and assumptions that affect, at the date of the financial statements, the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities and the reported amounts of revenue and expenses. Actual results could differ from these estimates. Significant estimates include, but are not limited to, collectibility of accounts receivable, recoverability of long-lived assets, the valuation allowance related to our deferred tax assets and the fair value of options and warrants issued for stock-based compensation.
Concentration of Cash Balance Risks
Concentration of Cash Balance Risks
 
Cash balances are maintained at various banks in the U.S., Japan and Sweden. At times, deposits held with financial institutions in the United States of America may exceed the amount of insurance provided by the Federal Deposit Insurance Corporation (“FDIC”), which provides basic deposit coverage with limits up to $250,000 per owner. The Swedish government provides insurance coverage up to 100,000 euro per customer and covers deposits in all types of accounts. As of March 31, 2013, the Company has approximately $7.2 million in excess of insurance limits.
Accounts Receivable and Allowance for Doubtful Accounts
Accounts Receivable and Allowance for Doubtful Accounts  
 
Our accounts receivable are stated at net realizable value. Our policy is to maintain allowances for estimated losses resulting from the inability of our customers to make required payments. Credit limits are established through a process of reviewing the financial history and stability of each customer. Where appropriate, we obtain credit rating reports and financial statements of the customer when determining or modifying its credit limits. We regularly evaluate the collectibility of our trade receivable balances based on a combination of factors. When a customer’s account balance becomes past due, we initiate dialogue with the customer to determine the cause. If it is determined that the customer will be unable to meet its financial obligation, such as in the case of a bankruptcy filing, deterioration in the customer’s operating results or financial position or other material events impacting its business, we record a specific allowance to reduce the related receivable to the amount we expect to recover. Should all efforts fail to recover the related receivable, we will write-off the account. We also record an allowance based on certain other factors including the length of time the receivables are past due and historical collection experience with customers.  We determined that an allowance for doubtful accounts was not necessary at March 31, 2013 and December 31, 2012.
Property and Equipment
Property and Equipment
 
Property and equipment are stated at cost, net of accumulated depreciation and amortization. Depreciation and amortization are computed using the straight-line method based upon estimated useful lives of the assets as follows:
 
 
Estimated useful lives
Computer equipment
3 years
Furniture and fixtures
5 years
 
Equipment purchased under capital leases is amortized on a straight-line basis over the estimated useful life of the asset or the term of the lease, whichever is shorter.
 
Upon retirement or sale of property and equipment, cost and accumulated depreciation and amortization are removed from the accounts and any gains or losses are reflected in the consolidated statement of operations. Maintenance and repairs are charged to expense as incurred.
Long-lived Assets
Long-lived Assets
 
We assess any impairment by estimating the future cash flow from the associated asset in accordance with relevant accounting guidance. If the estimated undiscounted future cash flow related to these assets decreases or the useful life is shorter than originally estimated, we may incur charges for impairment of these assets.  At March 31, 2013, we believe there is no impairment of our long-lived assets.
Foreign Currency Translation and Transaction Gains and Losses
Foreign Currency Translation and Transaction Gains and Losses
 
The functional currency of our foreign subsidiaries is the applicable local currency, the Swedish Krona and Japanese Yen. The translation from Swedish Krona and Japanese Yen to U.S. Dollars is performed for balance sheet accounts using current exchange rates in effect at the balance sheet date and for income statement accounts using a weighted-average exchange rate during the period. Foreign currency translation gains were $13,000 and $44,000 during the three months ended March 31, 2013 and 2012, respectively. Gains or losses resulting from translation are included as a separate component of accumulated other comprehensive loss. Gains or losses resulting from foreign currency transactions are included in general and administrative expense in the accompanying condensed consolidated statements of operations and were $37,000 and $62,000 during the three months ended March 31, 2013 and 2012, respectively.
Concentration of Credit and Business Risks
Concentration of Credit and Business Risks
 
Our accounts receivable as of March 31, 2013 was due from twelve customers, five of which accounted for 72% of our accounts receivable as of March 31, 2013. Our net revenues for the three months ended March 31, 2013 was earned from nine customers. Our customers are located in the U.S., Europe and Asia. Customers which accounted for 10% or more of our net revenues during the three months ended March 31, 2013 are as follows:
 
        
Kobo - 44%
●        
Sony Corporation -20%
●        
Netronix – 21%
●        
Barnes & Noble – 10%
 
Our accounts receivable as of December 31, 2012 was due from fifteen customers, none of which accounted for more than10% of our accounts receivable as of December 31, 2012. Our net revenues for the three months ended March 31, 2012 was earned from ten customers. Our customers are located in the U.S., Europe and Asia. Customers which accounted for 10% or more of our net revenues during the three months ended March 31, 2012 are as follows:
 
●        
Amazon - 55%
●        
Sony Corporation -16%
Revenue Recognition
Revenue Recognition
 
Licensing Revenues:
 
We derive revenue from the licensing of internally developed intellectual property (“IP”). We enter into IP licensing agreements that generally provide licensees the right to incorporate our IP components in their products with terms and conditions that vary by licensee. The IP licensing agreements generally include a nonexclusive license for the underlying IP. Fees under these agreements may include license fees relating to our IP and royalties payable following the distribution by our licensees of products incorporating the licensed technology. The license for our IP has standalone value and can be used by the licensee without maintenance and support. Neonode meets all the accounting requirements for revenue recognition as per unit royalty products are distributed or licensed by the Company’s customers.  For technology license arrangements that do not require significant modification or customization of the underlying technology, we recognize technology license revenue when: (1) we enter into a legally binding arrangement with a customer for the license of technology; (2) the customer distributes or licenses the products; (3) the customer payment is deemed fixed or determinable and free of contingencies or significant uncertainties; and (4) collection is reasonably assured. Our customers report to us the quantities of products distributed or licensed by them after the end of the reporting period stipulated in the contract, generally 30 to 45 days after the end of the month or quarter.
Explicit return rights are not offered to customers. There have been no returns through March 31, 2013.
 
Engineering Services:
 
We may sell engineering consulting services to our customers on a flat rate or hourly rate basis. We recognize revenue from these services when all of the following conditions are met: (1) evidence existed of an arrangement with the customer, typically consisting of a purchase order or contract; (2) our services were performed and risk of loss passed to the customer; (3) we completed all of the necessary terms of the contract; (4) the amount of revenue to which we were entitled was fixed or determinable; and (5) we believed it was probable that we would be able to collect the amount due from the customer. To the extent that one or more of these conditions has not been satisfied, we defer recognition of revenue.  Generally, we recognize revenue as the engineering services stipulated under the contract are completed and accepted by our customers.
Deferred Revenue
Deferred Revenue
 
From time-to-time the Company receives pre-payments from its customers related to future services or future license fee revenues. We defer the license fees until we have met all accounting requirements for revenue recognition as per unit royalty products are distributed or licensed by the Company’s customers and the engineering development fee revenue until such time as the engineering work has been completed and accepted by our customers.
Advertising
Advertising
 
Advertising costs are expensed as incurred. Advertising costs for the quarters ended March 31, 2013 and 2012 amounted to approximately $124,000 and $197,000, respectively.
Product Research and Development
Product Research and Development
 
Research and development (“R&D”) costs are expensed as incurred. R&D costs consist mainly of personnel related costs in addition to some external consultancy costs such as testing, certifying and measurements.
Stock-Based Compensation Expense
Stock-Based Compensation Expense
 
We measure the cost of employee services received in exchange for an award of equity instruments, including stock options, based on the fair value of the award on the grant date, and recognize the value as compensation expense over the period the employee is required to provide services in exchange for the award, usually the vesting period, net of estimated forfeitures.
 
 We account for equity instruments issued to non-employees at their fair value. The measurement date for the fair value for the equity instruments issued is determined at the earlier of (i) the date at which a commitment for performance by the consultant or vendor is reached, or (ii) the date at which the consultant or vendor’s performance is complete. In the case of equity instruments issued to consultants, the fair value of the equity instruments is primarily recognized over the term of the consulting agreement. The fair value of the stock-based compensation is periodically re-measured and expense is recognized during the vesting term.
 
When determining stock-based compensation expense involving options and warrants, we determine the estimated fair value of options and warrants using the Black-Scholes option pricing model.
Income Taxes
Income Taxes
 
We recognize deferred tax liabilities and assets for the expected future tax consequences of items that have been included in the consolidated financial statements or tax returns. We estimate income taxes based on rates in effect in each of the jurisdictions in which we operate. Deferred income tax assets and liabilities are determined based upon differences between the financial statement and income tax bases of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse. The realization of deferred tax assets is based on historical tax positions and expectations about future taxable income. Valuation allowances are recorded against net deferred tax assets when, in our opinion, realization is uncertain based on the “more likely than not” criteria of the accounting guidance.
 
Based on the uncertainty of future pre-tax income, we fully reserved our net deferred tax assets as of March 31, 2013 and December 31, 2012. In the event we were to determine that we would be able to realize our deferred tax assets in the future, an adjustment to the deferred tax asset would increase income in the period such determination was made. The provision for income taxes represents the net change in deferred tax amounts, plus income taxes paid or payable for the current period.
 
We follow the relevant accounting guidance related to uncertain tax positions, which provisions include a two-step approach to recognizing, de-recognizing and measuring uncertain tax positions.  As a result, we did not recognize a liability for unrecognized tax benefits.  As of March 31, 2013 and December 31, 2012, we had no unrecognized tax benefits.
Net Loss Per Share
Net Loss Per Share
 
Net loss per share amounts have been computed based on the weighted-average number of shares of common stock outstanding during the period. Net loss per share, assuming dilution amounts from common stock equivalents, is computed based on the weighted-average number of shares of common stock and potential common stock equivalents outstanding during the period. The weighted-average number of shares of common stock and potential common stock equivalents used in computing the net loss per share for periods ended March 31, 2013 and 2012 exclude the potential common stock equivalents, as the effect would be anti-dilutive (See Note 8).
Comprehensive Income (Loss)
Comprehensive Income (Loss)
 
Our comprehensive loss includes foreign currency translation gains and losses.  The cumulative amount of translation gains and losses are reflected as a separate component of stockholder’ equity in the condensed consolidated balance sheets as accumulated other comprehensive income.
Cash Flow Information
Cash Flow Information
 
Cash flows in foreign currencies have been converted to U.S. dollars at an approximate weighted-average exchange rate for the respective reporting periods. The weighted-average exchange rate for the consolidated statements of operations and comprehensive loss was 6.43 and 6.75 Swedish Krona to one U.S. Dollar for the three months ended March 31, 2013 and 2012, respectively. The exchange rate for the consolidated balance sheets was 6.52 and 6.52  Swedish Krona to one U.S. Dollar as of March 31, 2013 and December 31, 2012, respectively.  The weighted-average exchange rate for the consolidated statement of operations and comprehensive loss was 92.19 Japanese Yen to one U.S. Dollar for the three months ended March 31, 2013. The exchange rate for the consolidated balance sheet was 94.16 Japanese Yen to one U.S. Dollar as of March 31, 2013.
XML 47 R34.htm IDEA: XBRL DOCUMENT v2.4.0.6
Commitments and Contingencies (Details) (USD $)
In Thousands, unless otherwise specified
Mar. 31, 2013
Summary of future minimum payments under non-cancellable operating lease commitments  
2013 $ 293
2014 255
2015 23
Total $ 571
XML 48 R21.htm IDEA: XBRL DOCUMENT v2.4.0.6
Segment Information (Tables)
3 Months Ended
Mar. 31, 2013
Segment Information [Abstract]  
Summary of net revenues by geographic region
   
2013
 
   
Amount
   
Percentage
 
Net revenues from customers in the U.S.
 
$
292
     
53
%
Net revenues from customers in Europe
   
18
     
43
Net revenues from customers in Asia
   
238
     
44
%
                 
 Total
 
$
548
     
100
%
       
   
2012
 
   
Amount
   
Percentage
 
Net revenues from customers in the U.S.
 
$
974
     
84
%
Net revenues from customers in Europe
   
--
       
 --
Net revenues from customers in Asia
   
190
     
16
%
                 
 Total
 
$
1,164
     
100
%
XML 49 R26.htm IDEA: XBRL DOCUMENT v2.4.0.6
Stockholders' Equity (Details Textual) (USD $)
In Thousands, except Share data, unless otherwise specified
3 Months Ended 0 Months Ended 3 Months Ended 0 Months Ended 3 Months Ended 0 Months Ended
Mar. 31, 2013
Dec. 31, 2012
Dec. 31, 2011
Dec. 31, 2010
Feb. 26, 2013
David Brunton [Member]
Mar. 16, 2012
John Reardon [Member]
Mar. 21, 2013
Series A Preferred Stock [Member]
Mar. 31, 2013
Series A Preferred Stock [Member]
Dec. 31, 2012
Series A Preferred Stock [Member]
Mar. 21, 2013
Series B Preferred Stock [Member]
Feb. 27, 2013
Series B Preferred Stock [Member]
Mar. 31, 2013
Series B Preferred Stock [Member]
Dec. 31, 2012
Series B Preferred Stock [Member]
Mar. 21, 2013
Common Stock
Series A Preferred Stock [Member]
Mar. 21, 2013
Common Stock
Series B Preferred Stock [Member]
Feb. 27, 2013
Common Stock
Series B Preferred Stock [Member]
Stockholders Equity (Textual)                                
Common stock issuable upon exercise of warrants 270,094       320,000 200,000                    
Conversion of Stock, Shares Issued             83     8 4     39,790 929 528
Preferred stock, liquidation preference               $ 0.001 $ 0.001     $ 0.001 $ 0.001      
Preferred stock, voting rights               One vote for each share       One vote for each share        
Preferred stock conversion ratio per share of common stock               480.63       132.07        
Common Stock, Value $ 34 $ 33                            
Conversion of warrant into common stock, shares converted 198,512       266,228 174,798                    
Common stock, shares authorized 70,000,000 70,000,000 70,000,000 848,000,000                        
Preferred stock, shares authorized     1,000,000 2,000,000       444,541 444,541     54,425 54,425      
Stockholders' equity, reverse stock split 1-for-25                              
Common stock, shares issued 33,875,625 33,331,182                            
XML 50 R5.htm IDEA: XBRL DOCUMENT v2.4.0.6
Condensed Consolidated Statements of Comprehensive Loss (Unaudited) (USD $)
In Thousands, unless otherwise specified
3 Months Ended
Mar. 31, 2013
Mar. 31, 2012
Statements Of Comprehensive Loss [Abstract]    
Net loss $ (3,570) $ (1,588)
Other comprehensive gain (loss):    
Foreign currency translation adjustments 13 44
Total comprehensive loss $ (3,557) $ (1,544)
XML 51 R10.htm IDEA: XBRL DOCUMENT v2.4.0.6
Deferred Revenue
3 Months Ended
Mar. 31, 2013
Deferred Revenue [Abstract]  
Deferred Revenue
4.  Deferred Revenue
 
As of March 31, 2013 and December 31, 2012, we have $2.0 million and $2.1 million, respectively, of deferred license fee revenue related to prepayments for future license fees from three customers and a total of $0.9 million and $0.6 million, respectively, of deferred engineering development fees from thirteen customers. We defer the license fees until we have met all accounting requirements for revenue recognition as per unit royalty products are distributed or licensed by the Company’s customers and the engineering development fee revenue until such time as the engineering work has been completed and accepted by our customers.
XML 52 R27.htm IDEA: XBRL DOCUMENT v2.4.0.6
Deferred Revenue (Details) (USD $)
In Thousands, unless otherwise specified
3 Months Ended
Mar. 31, 2013
Customer
Dec. 31, 2012
Deferred Revenue (Textual)    
Deferred fees $ 2,920 $ 2,725
Prepayments from future license fees [Member]
   
Deferred Revenue (Textual)    
Deferred fees 2,000 2,100
Number of customer 3  
Deferred engineering development fees [Member]
   
Deferred Revenue (Textual)    
Deferred fees $ 900 $ 600
Number of customer 13  
XML 53 FilingSummary.xml IDEA: XBRL DOCUMENT 2.4.0.6 Html 143 206 1 false 53 0 false 9 false false R1.htm 001 - Document - Document and Entity Information Sheet http://www.neonode.com/role/Documentandentityinformation Document and Entity Information true false R2.htm 002 - Statement - Condensed Consolidated Balance Sheets Sheet http://www.neonode.com/role/Consolidatedbalancesheets Condensed Consolidated Balance Sheets false false R3.htm 003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) Sheet http://www.neonode.com/role/ConsolidatedBalanceSheetsParentheticals Condensed Consolidated Balance Sheets (Parenthetical) false false R4.htm 004 - Statement - Condensed Consolidated Statements of Operations (Unaudited) Sheet http://www.neonode.com/role/Consolidatedstatementsofoperations Condensed Consolidated Statements of Operations (Unaudited) false false R5.htm 005 - Statement - Condensed Consolidated Statements of Comprehensive Loss (Unaudited) Sheet http://www.neonode.com/role/Condensedconsolidatedstatementsofcomprehensiveloss Condensed Consolidated Statements of Comprehensive Loss (Unaudited) false false R6.htm 006 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) Sheet http://www.neonode.com/role/ConsolidatedStatementsOfCashFlows Condensed Consolidated Statements of Cash Flows (Unaudited) false false R7.htm 007 - Disclosure - Interim Period Reporting Sheet http://www.neonode.com/role/InterimPeriodReporting Interim Period Reporting false false R8.htm 008 - Disclosure - Summary of Significant Accounting Policies Sheet http://www.neonode.com/role/SummaryOfSignificantAccountingPolicies Summary of Significant Accounting Policies false false R9.htm 009 - Disclosure - Stockholders' Equity Sheet http://www.neonode.com/role/StockholdersDeficit Stockholders' Equity false false R10.htm 010 - Disclosure - Deferred Revenue Sheet http://www.neonode.com/role/DeferredRevenue Deferred Revenue false false R11.htm 011 - Disclosure - Stock-Based Compensation Sheet http://www.neonode.com/role/StockBasedCompensation Stock-Based Compensation false false R12.htm 012 - Disclosure - Commitments and Contingencies Sheet http://www.neonode.com/role/CommitmentsAndContingencies Commitments and Contingencies false false R13.htm 013 - Disclosure - Segment Information Sheet http://www.neonode.com/role/SegmentInformation Segment Information false false R14.htm 014 - Disclosure - Net Loss Per Share Sheet http://www.neonode.com/role/NetLossPerShare Net Loss Per Share false false R15.htm 015 - Disclosure - Subsequent Events Sheet http://www.neonode.com/role/SubsequentEvents Subsequent Events false false R16.htm 016 - Disclosure - Summary of Significant Accounting Policies (Policies) Sheet http://www.neonode.com/role/SummaryofSignificantAccountingPoliciesPolicies Summary of Significant Accounting Policies (Policies) false false R17.htm 017 - Disclosure - Summary of Significant Accounting Policies (Tables) Sheet http://www.neonode.com/role/SummaryofSignificantAccountingPoliciesTables Summary of Significant Accounting Policies (Tables) false false R18.htm 018 - Disclosure - Stockholders' Equity (Tables) Sheet http://www.neonode.com/role/StockholdersEquityTables Stockholders' Equity (Tables) false false R19.htm 019 - Disclosure - Stock-Based Compensation (Tables) Sheet http://www.neonode.com/role/StockBasedCompensationTables Stock-Based Compensation (Tables) false false R20.htm 020 - Disclosure - Commitments and Contingencies (Tables) Sheet http://www.neonode.com/role/CommitmentsandContingenciesTables Commitments and Contingencies (Tables) false false R21.htm 021 - Disclosure - Segment Information (Tables) Sheet http://www.neonode.com/role/SegmentInformationTables Segment Information (Tables) false false R22.htm 022 - Disclosure - Net Loss Per Share (Tables) Sheet http://www.neonode.com/role/NetLossPerShareTables Net Loss Per Share (Tables) false false R23.htm 023 - Disclosure - Summary of Significant Accounting Policies (Details) Sheet http://www.neonode.com/role/SummaryofSignificantAccountingPoliciesDetails Summary of Significant Accounting Policies (Details) false false R24.htm 024 - Disclosure - Summary of Significant Accounting Policies (Details Textual) Sheet http://www.neonode.com/role/SummaryofSignificantAccountingPoliciesDetailsTextual Summary of Significant Accounting Policies (Details Textual) false false R25.htm 025 - Disclosure - Stockholders' Equity (Details) Sheet http://www.neonode.com/role/StockholdersEquityDetails Stockholders' Equity (Details) false false R26.htm 026 - Disclosure - Stockholders' Equity (Details Textual) Sheet http://www.neonode.com/role/StockholdersEquityDetailsTextual Stockholders' Equity (Details Textual) false false R27.htm 027 - Disclosure - Deferred Revenue (Details) Sheet http://www.neonode.com/role/DeferredRevenueDetails Deferred Revenue (Details) false false R28.htm 028 - Disclosure - Stock-Based Compensation (Details) Sheet http://www.neonode.com/role/Stockbasedcompensationdetails Stock-Based Compensation (Details) false false R29.htm 029 - Disclosure - Stock-Based Compensation (Details 1) Sheet http://www.neonode.com/role/Stockbasedcompensationdetails1 Stock-Based Compensation (Details 1) false false R30.htm 030 - Disclosure - Stock-Based Compensation (Details 2) Sheet http://www.neonode.com/role/Stockbasedcompensationdetails2 Stock-Based Compensation (Details 2) false false R31.htm 031 - Disclosure - Stock-Based Compensation (Details 3) Sheet http://www.neonode.com/role/Stockbasedcompensationdetails3 Stock-Based Compensation (Details 3) false false R32.htm 032 - Disclosure - Stock-Based Compensation (Details 4) Sheet http://www.neonode.com/role/Stockbasedcompensationdetails4 Stock-Based Compensation (Details 4) false false R33.htm 033 - Disclosure - Stock-Based Compensation (Details Textual) Sheet http://www.neonode.com/role/Stockbasedcompensationdetails7 Stock-Based Compensation (Details Textual) false false R34.htm 034 - Disclosure - Commitments and Contingencies (Details) Sheet http://www.neonode.com/role/Commitmentsandcontingenciesdetailstextual Commitments and Contingencies (Details) false false R35.htm 035 - Disclosure - Commitments and Contingencies (Details Textual) Sheet http://www.neonode.com/role/CommitmentsandContingenciesDetails Commitments and Contingencies (Details Textual) false false R36.htm 036 - Disclosure - Segment Information (Details) Sheet http://www.neonode.com/role/Segmentinformationdetails Segment Information (Details) false false R37.htm 037 - Disclosure - Segment Information (Details Textual) Sheet http://www.neonode.com/role/Segmentinformationdetailstextual Segment Information (Details Textual) false false R38.htm 038 - Disclosure - Net Loss Per Share (Details) Sheet http://www.neonode.com/role/NetLossPerShareDetails Net Loss Per Share (Details) false false R39.htm 039 - Disclosure - Net Loss Per Share (Details Textual) Sheet http://www.neonode.com/role/NetLossPerShareDetailsTextual Net Loss Per Share (Details Textual) false false R40.htm 040 - Disclosure - Subsequent Events (Details) Sheet http://www.neonode.com/role/SubsequentEventsDetails Subsequent Events (Details) false false All Reports Book All Reports Element neond_CompensationExpenseRelatedToVestingOfStockOptions had a mix of decimals attribute values: -3 0. Element us-gaap_DeferredRevenueCurrent had a mix of decimals attribute values: -5 -3. 'Monetary' elements on report '033 - Disclosure - Stock-Based Compensation (Details Textual)' had a mix of different decimal attribute values. Process Flow-Through: 002 - Statement - Condensed Consolidated Balance Sheets Process Flow-Through: 003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) Process Flow-Through: Removing column 'Dec. 31, 2011' Process Flow-Through: Removing column 'Dec. 31, 2010' Process Flow-Through: 004 - Statement - Condensed Consolidated Statements of Operations (Unaudited) Process Flow-Through: 005 - Statement - Condensed Consolidated Statements of Comprehensive Loss (Unaudited) Process Flow-Through: 006 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) neond-20130331.xml neond-20130331.xsd neond-20130331_cal.xml neond-20130331_def.xml neond-20130331_lab.xml neond-20130331_pre.xml true true XML 54 R38.htm IDEA: XBRL DOCUMENT v2.4.0.6
Net Loss Per Share (Details) (USD $)
In Thousands, except Share data, unless otherwise specified
3 Months Ended
Mar. 31, 2013
Mar. 31, 2012
BASIC AND DILUTED    
Weighted average number of common shares outstanding 33,511 32,809
Number of shares for computation of net loss per share 33,511 32,809
Net loss $ (3,570) $ (1,588)
Net loss per share - basic and diluted $ (0.11) $ (0.05)
XML 55 R20.htm IDEA: XBRL DOCUMENT v2.4.0.6
Commitments and Contingencies (Tables)
3 Months Ended
Mar. 31, 2013
Commitments and Contingencies [Abstract]  
Summary of future minimum payments under non-cancellable operating lease commitments
 
Year ending December 31,
 
Total
 
2013
 
$
293
 
2014
   
255
 
2015
   
23
 
   
$
571